Common Infections — MCQs

Q: A 25-year-old woman presents with a 2-week history of sore throat, fever, and fatigue. She has cervical lymphadenopathy and splenomegaly. Her throat swab is negative for Group A Streptococcus. What is the most likely diagnosis?

Infectious mononucleosis. ***Infectious mononucleosis***- The constellation of a 2-week history of **sore throat**, **fever**, profound **fatigue**, widespread **cervical lymphadenopathy**, and **splenomegaly** in a young adult is the classic presentation of infectious mononucleosis, primarily caused by **Epstein-Barr Virus (EBV)**.- The **negative throat swab for Group A Streptococcus** further supports a non-bacterial cause, and the prolonged symptoms with significant systemic involvement are key indicators.*Viral pharyngitis*- Typical **viral pharyngitis** is generally milder, resolves more quickly (within 3-5 days), and does not typically cause the significant systemic features such as profound **fatigue** and **splenomegaly** described.- While lymphadenopathy can occur, it is usually less generalized and prominent compared to the widespread involvement seen here.*Bacterial pharyngitis*- The patient's **negative throat swab for Group A Streptococcus** effectively rules out the most common bacterial cause of pharyngitis (strep throat).- Bacterial pharyngitis usually has a more acute onset, a shorter course, and rarely involves systemic findings like significant **fatigue** or **splenomegaly**.*Diphtheria*- **Diphtheria** is primarily characterized by the formation of a thick, adherent, **grayish-white pseudomembrane** over the tonsils and pharynx, which is not mentioned in the patient's presentation.- Although it can cause pharyngitis and fever, the combination of **splenomegaly** and diffuse, persistent lymphadenopathy is not typical for diphtheria.*Candidiasis*- **Oral candidiasis** (thrush) typically presents with creamy **white plaques** on the oral mucosa that can be scraped off, usually in immunocompromised individuals.- This is a localized fungal infection and would not cause the systemic findings of high fever, widespread lymphadenopathy, and **splenomegaly**.

Q: A 25-year-old woman presents with a 2-week history of sore throat, fever, and fatigue. She has cervical lymphadenopathy and splenomegaly. Her throat swab is negative for Group A Streptococcus. What is the most likely diagnosis?

Infectious mononucleosis. ***Infectious mononucleosis***- The constellation of prolonged **fever**, **pharyngitis**, diffuse **lymphadenopathy**, and **splenomegaly** in a young adult is the classic presentation of primary infection with **Epstein-Barr Virus (EBV)**.- The relatively long duration of symptoms (2 weeks), the presence of **splenomegaly**, and the **negative Group A Strep swab** strongly suggest infectious mononucleosis.*Viral pharyngitis*- Common viral causes (e.g., rhinovirus, adenovirus) usually result in an acute illness, lasting less than 10 days, and do not typically cause sustained systemic symptoms or significant **splenomegaly**.- While presenting with sore throat and fever, non-EBV viral pharyngitis lacks the profound, persistent **fatigue** and notable **lymphadenopathy** seen in infectious mononucleosis.*Bacterial pharyngitis*- This is typically caused by *Streptococcus pyogenes* (Group A Strep), which was **ruled out by the negative throat swab**.- **Bacterial pharyngitis** rarely causes the sustained constitutional symptoms and concurrent **splenomegaly** seen in this case.*Diphtheria*- The hallmark of **diphtheria** is the presence of a thick, adherent, gray-white **pseudomembrane** on the tonsils and pharynx, which is not described in this patient.- It is rare in vaccinated populations and often leads to severe systemic toxicity (e.g., **myocarditis**) rather than the classic infectious mononucleosis triad.*Candidiasis*- Pharyngeal **candidiasis (thrush)** presents as white, easily removable plaques, often favored by antibiotic use or **immunosuppression**.- It is primarily a localized mucosal infection and usually does not cause the fever, systemic illness, or **splenomegaly** seen here.

Q: A 31-year-old man presents with fever, sore throat, and a widespread maculopapular rash after taking amoxicillin prescribed by his GP. What is the most likely underlying diagnosis?

Infectious mononucleosis. ***Infectious mononucleosis*** - The combination of **fever**, **sore throat**, and a widespread **maculopapular rash** after taking amoxicillin is a classic presentation for **Epstein-Barr virus (EBV)** infection (infectious mononucleosis). - Approximately 80-90% of patients with infectious mononucleosis develop a non-allergic, diffuse rash when treated with **amoxicillin** or **ampicillin**. *Penicillin allergy* - A true **penicillin allergy** (Type I hypersensitivity) typically manifests as rapid onset **urticaria**, angioedema, or anaphylaxis, or a delayed itchy morbilliform rash, usually without the characteristic mononucleosis triad of symptoms. - The rash in mononucleosis patients taking amoxicillin is a **pharmacological interaction** with the underlying viral process, not a typical immunological allergic reaction. *Scarlet fever* - Characterized by a **sandpaper-like erythrodermic rash** and **circumoral pallor**, caused by *Streptococcus pyogenes* erythrogenic toxins. - The current presentation with a maculopapular rash specifically after amoxicillin is not typical of a streptococcal rash and strongly points towards a viral etiology. *Kawasaki disease* - This is a **medium-vessel vasculitis** primarily affecting **children** (typically under 5 years old), making it a highly unlikely diagnosis in a 31-year-old man. - Diagnosis requires persistent fever plus specific criteria like conjunctivitis, oral changes, peripheral extremity changes, lymphadenopathy, and a polymorphous rash. *Stevens-Johnson syndrome* - SJS is a severe, life-threatening **mucocutaneous reaction** characterized by **atypical target lesions** and prominent involvement of **mucous membranes** (oral, ocular, genital). - This condition involves significant **epidermal detachment** (less than 10% of total body surface area) and is distinct from a simple widespread maculopapular rash.

Q: A 58-year-old man with diabetes presents with severe foot pain and a deep ulcer exposing bone. X-ray shows osteolytic changes. What is the most likely complication?

Osteomyelitis. ***Osteomyelitis***- The patient's presentation of a **deep ulcer exposing bone** in the setting of **diabetes**, coupled with **severe foot pain** and **osteolytic changes** on X-ray, are classic indicators of osteomyelitis (bone infection).- **Diabetic foot ulcers** provide a direct pathway for bacterial invasion into the underlying bone, leading to destructive changes visible on imaging like X-rays.*Cellulitis*- Cellulitis is a bacterial infection of the **superficial skin and subcutaneous tissue**, characterized by **erythema**, warmth, and localized swelling.- It typically does not involve the underlying bone and therefore would not present with **bone exposure** or **osteolytic changes** on X-ray.*Charcot arthropathy*- **Charcot arthropathy** is a neuropathic joint degeneration, commonly seen in advanced diabetes, causing progressive joint destruction and deformity, often a **"rocker-bottom" foot**.- While it can lead to foot deformity and subsequent ulceration, it is typically **painless** due to significant neuropathy, contrasting with the patient's **severe pain**, and direct osteolytic changes of infection are not its primary X-ray feature.*Peripheral arterial disease*- **Peripheral arterial disease (PAD)** causes reduced blood flow to the extremities, leading to symptoms like **claudication**, **ischemic ulcers** (often on toes/heels), and rest pain.- While a significant comorbidity in diabetics and a risk factor for ulcers, PAD primarily involves vascular insufficiency and does not directly cause the **osteolytic changes** indicative of bone infection.*Deep vein thrombosis*- **Deep vein thrombosis (DVT)** is a blood clot in a deep vein, typically presenting as **unilateral leg swelling**, pain, and warmth.- It is a vascular issue not primarily associated with ulcers exposing bone, nor does it cause the **osteolytic changes** on a foot X-ray.

Q: A 72-year-old man with chronic obstructive pulmonary disease is admitted with an exacerbation and started on prednisolone 30mg daily. On day 3 of admission, he develops a painful, erythematous rash on his right shin. The affected area is warm and tender with a well-demarcated, raised border and has a characteristic orange-peel (peau d'orange) appearance. His temperature is 38.4°C. Blood tests show WCC 16.2 × 10⁹/L, CRP 128 mg/L. Which organism is most likely responsible for this infection?

Streptococcus pyogenes (Group A Streptococcus). ***Streptococcus pyogenes (Group A Streptococcus)***- This patient presents with **erysipelas**, a superficial skin infection most commonly caused by **Group A Streptococcus**.- Characteristic features include a **well-demarcated**, raised border and a **peau d'orange** appearance due to involvement of the superficial lymphatics.*Staphylococcus aureus*- More commonly associated with **cellulitis**, which involves deeper dermis and subcutaneous fat with less defined borders.- Often linked to **purulent infections** and abscess formation, rather than the clear-cut edges seen here.*Pseudomonas aeruginosa*- Typically associated with **hot tub folliculitis** or infections following exposure to **contaminated water/moist environments**.- Usually presents in **immunocompromised patients** as ecthyma gangrenosum, which features necrotic ulcers rather than orange-peel skin.*Haemophilus influenzae*- A rare cause of skin infections in adults, occasionally causing facial cellulitis in **unvaccinated children**.- Clinical presentation usually lacks the specific **well-demarcated raised border** seen in this patient’s shin lesion.*Pasteurella multocida*- Primarily associated with cellulitis following **animal bites or scratches**, particularly from **cats or dogs**.- Onset is typically very rapid (within 24 hours of a bite), which does not correlate with this hospital-acquired presentation.

Q: A 61-year-old man presents with a 4-day history of a painful red swelling on his upper back. On examination, there is a 5cm area of indurated, erythematous skin with multiple pustular openings discharging purulent material from several adjacent hair follicles. His temperature is 37.8°C. He has well-controlled type 2 diabetes. What is this lesion called?

Carbuncle. ***Carbuncle***- A **carbuncle** is a deep, painful infection involving a cluster of interconnected **furuncles** that coalesce to form a single inflammatory mass with **multiple pustular openings** discharging purulent material from several adjacent hair follicles.- It commonly occurs in areas like the **upper back** and neck, often associated with systemic symptoms like fever and risk factors such as **type 2 diabetes mellitus**.*Furuncle*- A **furuncle**, or boil, is a deep infection of a **single hair follicle** and surrounding tissue, presenting as a solitary, tender nodule.- Unlike a carbuncle, it does not involve the **coalescence of multiple adjacent follicles** or widespread induration with multiple drainage points.*Hidradenitis suppurativa*- This is a chronic inflammatory condition primarily affecting **apocrine gland-bearing areas** such as the axillae, groin, and inframammary folds, not typically the upper back.- It is characterized by recurrent abscesses, **sinus tracts**, and significant **scarring**, features not described in this acute presentation.*Folliculitis*- **Folliculitis** is a superficial inflammation limited to the **hair follicle** itself, presenting as small, individual follicular pustules.- It lacks the deep induration, extensive size (5cm), and **multiple purulent openings** characteristic of a carbuncle.*Erysipelas*- **Erysipelas** is a superficial skin infection of the **upper dermis** and lymphatics, typically caused by *Streptococcus pyogenes*.- It presents as a bright red, edematous plaque with **sharply demarcated borders**, without the deep suppuration and **multiple follicular drainage points** seen in a carbuncle.

A 34-year-old woman with Crohn's disease on adalimumab presents with a 10-day history of multiple painful nodules on both shins. The lesions are 2-4cm in diameter, raised, tender, and erythematous without ulceration or pustulation. She reports associated joint pains in her knees and ankles but no fever. Recent colonoscopy showed active inflammation. Blood tests reveal WCC 11.2 × 10⁹/L, CRP 78 mg/L, ESR 65 mm/hr. What is the most likely diagnosis?

A 72-year-old man with chronic obstructive pulmonary disease is admitted with an exacerbation and started on prednisolone 30mg daily. On day 3 of admission, he develops a painful, erythematous rash on his right shin. The affected area is warm and tender with a well-demarcated, raised border and has a characteristic orange-peel (peau d'orange) appearance. His temperature is 38.4°C. Blood tests show WCC 16.2 × 10⁹/L, CRP 128 mg/L. Which organism is most likely responsible for this infection?

A 61-year-old man presents with a 4-day history of a painful red swelling on his upper back. On examination, there is a 5cm area of indurated, erythematous skin with multiple pustular openings discharging purulent material from several adjacent hair follicles. His temperature is 37.8°C. He has well-controlled type 2 diabetes. What is this lesion called?

A hospital trust implements a new antimicrobial stewardship intervention where all prescriptions for restricted antibiotics (carbapenems, colistin, linezolid, daptomycin, tigecycline) require approval from the on-call microbiology consultant before administration. After 6 months, audit data shows a 35% reduction in use of restricted antibiotics, but there have been 8 incidents where patients experienced delayed antibiotic administration due to difficulty contacting the on-call microbiologist. What modification to this intervention would best maintain stewardship benefits while improving patient safety?

Q10

A 43-year-old woman with ulcerative colitis on infliximab presents with a 3-day history of painful vesicular lesions on her right buttock and posterior thigh following a dermatomal distribution. The lesions are at various stages with some showing crusting. She is immunosuppressed but otherwise systemically well with no fever. What is the most appropriate management?

Common Infections UK Medical PG Practice Questions and MCQs

Question 1: A 16-year-old boy presents with a 1-week history of sore throat and fever. He has developed a widespread maculopapular rash after taking amoxicillin prescribed by his GP. What is the most likely underlying diagnosis?

A. Penicillin allergy
B. Infectious mononucleosis (Correct Answer)
C. Scarlet fever
D. Kawasaki disease
E. Stevens-Johnson syndrome

Explanation: ***Infectious mononucleosis***- The classic triad of **fever**, **pharyngitis** (sore throat), and **lymphadenopathy** in a young patient is highly suggestive of infectious mononucleosis, commonly caused by **Epstein-Barr virus (EBV)**.- A **widespread maculopapular rash** following amoxicillin administration is a very common and characteristic reaction in patients with infectious mononucleosis, often misinterpreted as a penicillin allergy.*Penicillin allergy*- While a rash after amoxicillin can indicate a penicillin allergy, the preceding symptoms of **sore throat and fever** for a week make an underlying infection, specifically mononucleosis, a more likely cause for the rash.- True penicillin allergies often present with **urticaria**, angioedema, or anaphylaxis, rather than a widespread maculopapular rash exacerbated by a viral illness.*Scarlet fever*- Scarlet fever is caused by **Streptococcus pyogenes** and presents with a characteristic **sandpaper-like rash** (finely papular, erythematous) and **strawberry tongue**, which are not described here.- While it causes sore throat and fever, the rash associated with scarlet fever is distinct from a generalized maculopapular rash triggered by amoxicillin in the context of mononucleosis.*Kawasaki disease*- Kawasaki disease primarily affects **young children** (typically under 5 years old) and is characterized by prolonged fever, **conjunctival injection**, **mucosal changes** (strawberry tongue, red lips), **polymorphous rash**, **cervical lymphadenopathy**, and **extremity changes**.- The patient's age (16 years old) and the specific rash reaction to amoxicillin make Kawasaki disease highly unlikely.*Stevens-Johnson syndrome*- **Stevens-Johnson syndrome (SJS)** is a severe mucocutaneous reaction, often drug-induced, characterized by widespread **bullae**, **erosions**, and **mucosal involvement** (oral, ocular, genital) with significant skin detachment (less than 10% total body surface area).- The description of a **widespread maculopapular rash** in this case is not consistent with the severe blistering and erosions typical of SJS.

Question 2: A 25-year-old woman presents with a 2-week history of sore throat, fever, and fatigue. She has cervical lymphadenopathy and splenomegaly. Her throat swab is negative for Group A Streptococcus. What is the most likely diagnosis?

A. Viral pharyngitis
B. Infectious mononucleosis (Correct Answer)
C. Bacterial pharyngitis
D. Diphtheria
E. Candidiasis

Explanation: ***Infectious mononucleosis***- The constellation of a 2-week history of **sore throat**, **fever**, profound **fatigue**, widespread **cervical lymphadenopathy**, and **splenomegaly** in a young adult is the classic presentation of infectious mononucleosis, primarily caused by **Epstein-Barr Virus (EBV)**.- The **negative throat swab for Group A Streptococcus** further supports a non-bacterial cause, and the prolonged symptoms with significant systemic involvement are key indicators.*Viral pharyngitis*- Typical **viral pharyngitis** is generally milder, resolves more quickly (within 3-5 days), and does not typically cause the significant systemic features such as profound **fatigue** and **splenomegaly** described.- While lymphadenopathy can occur, it is usually less generalized and prominent compared to the widespread involvement seen here.*Bacterial pharyngitis*- The patient's **negative throat swab for Group A Streptococcus** effectively rules out the most common bacterial cause of pharyngitis (strep throat).- Bacterial pharyngitis usually has a more acute onset, a shorter course, and rarely involves systemic findings like significant **fatigue** or **splenomegaly**.*Diphtheria*- **Diphtheria** is primarily characterized by the formation of a thick, adherent, **grayish-white pseudomembrane** over the tonsils and pharynx, which is not mentioned in the patient's presentation.- Although it can cause pharyngitis and fever, the combination of **splenomegaly** and diffuse, persistent lymphadenopathy is not typical for diphtheria.*Candidiasis*- **Oral candidiasis** (thrush) typically presents with creamy **white plaques** on the oral mucosa that can be scraped off, usually in immunocompromised individuals.- This is a localized fungal infection and would not cause the systemic findings of high fever, widespread lymphadenopathy, and **splenomegaly**.

Question 3: A 25-year-old woman presents with a 2-week history of sore throat, fever, and fatigue. She has cervical lymphadenopathy and splenomegaly. Her throat swab is negative for Group A Streptococcus. What is the most likely diagnosis?

A. Viral pharyngitis
B. Infectious mononucleosis (Correct Answer)
C. Bacterial pharyngitis
D. Diphtheria
E. Candidiasis

Explanation: ***Infectious mononucleosis***- The constellation of prolonged **fever**, **pharyngitis**, diffuse **lymphadenopathy**, and **splenomegaly** in a young adult is the classic presentation of primary infection with **Epstein-Barr Virus (EBV)**.- The relatively long duration of symptoms (2 weeks), the presence of **splenomegaly**, and the **negative Group A Strep swab** strongly suggest infectious mononucleosis.*Viral pharyngitis*- Common viral causes (e.g., rhinovirus, adenovirus) usually result in an acute illness, lasting less than 10 days, and do not typically cause sustained systemic symptoms or significant **splenomegaly**.- While presenting with sore throat and fever, non-EBV viral pharyngitis lacks the profound, persistent **fatigue** and notable **lymphadenopathy** seen in infectious mononucleosis.*Bacterial pharyngitis*- This is typically caused by *Streptococcus pyogenes* (Group A Strep), which was **ruled out by the negative throat swab**.- **Bacterial pharyngitis** rarely causes the sustained constitutional symptoms and concurrent **splenomegaly** seen in this case.*Diphtheria*- The hallmark of **diphtheria** is the presence of a thick, adherent, gray-white **pseudomembrane** on the tonsils and pharynx, which is not described in this patient.- It is rare in vaccinated populations and often leads to severe systemic toxicity (e.g., **myocarditis**) rather than the classic infectious mononucleosis triad.*Candidiasis*- Pharyngeal **candidiasis (thrush)** presents as white, easily removable plaques, often favored by antibiotic use or **immunosuppression**.- It is primarily a localized mucosal infection and usually does not cause the fever, systemic illness, or **splenomegaly** seen here.

Question 4: A 31-year-old man presents with fever, sore throat, and a widespread maculopapular rash after taking amoxicillin prescribed by his GP. What is the most likely underlying diagnosis?

A. Penicillin allergy
B. Infectious mononucleosis (Correct Answer)
C. Scarlet fever
D. Kawasaki disease
E. Stevens-Johnson syndrome

Explanation: ***Infectious mononucleosis*** - The combination of **fever**, **sore throat**, and a widespread **maculopapular rash** after taking amoxicillin is a classic presentation for **Epstein-Barr virus (EBV)** infection (infectious mononucleosis). - Approximately 80-90% of patients with infectious mononucleosis develop a non-allergic, diffuse rash when treated with **amoxicillin** or **ampicillin**. *Penicillin allergy* - A true **penicillin allergy** (Type I hypersensitivity) typically manifests as rapid onset **urticaria**, angioedema, or anaphylaxis, or a delayed itchy morbilliform rash, usually without the characteristic mononucleosis triad of symptoms. - The rash in mononucleosis patients taking amoxicillin is a **pharmacological interaction** with the underlying viral process, not a typical immunological allergic reaction. *Scarlet fever* - Characterized by a **sandpaper-like erythrodermic rash** and **circumoral pallor**, caused by *Streptococcus pyogenes* erythrogenic toxins. - The current presentation with a maculopapular rash specifically after amoxicillin is not typical of a streptococcal rash and strongly points towards a viral etiology. *Kawasaki disease* - This is a **medium-vessel vasculitis** primarily affecting **children** (typically under 5 years old), making it a highly unlikely diagnosis in a 31-year-old man. - Diagnosis requires persistent fever plus specific criteria like conjunctivitis, oral changes, peripheral extremity changes, lymphadenopathy, and a polymorphous rash. *Stevens-Johnson syndrome* - SJS is a severe, life-threatening **mucocutaneous reaction** characterized by **atypical target lesions** and prominent involvement of **mucous membranes** (oral, ocular, genital). - This condition involves significant **epidermal detachment** (less than 10% of total body surface area) and is distinct from a simple widespread maculopapular rash.

Question 5: A 58-year-old man with diabetes presents with severe foot pain and a deep ulcer exposing bone. X-ray shows osteolytic changes. What is the most likely complication?

A. Cellulitis
B. Osteomyelitis (Correct Answer)
C. Charcot arthropathy
D. Peripheral arterial disease
E. Deep vein thrombosis

Explanation: ***Osteomyelitis***- The patient's presentation of a **deep ulcer exposing bone** in the setting of **diabetes**, coupled with **severe foot pain** and **osteolytic changes** on X-ray, are classic indicators of osteomyelitis (bone infection).- **Diabetic foot ulcers** provide a direct pathway for bacterial invasion into the underlying bone, leading to destructive changes visible on imaging like X-rays.*Cellulitis*- Cellulitis is a bacterial infection of the **superficial skin and subcutaneous tissue**, characterized by **erythema**, warmth, and localized swelling.- It typically does not involve the underlying bone and therefore would not present with **bone exposure** or **osteolytic changes** on X-ray.*Charcot arthropathy*- **Charcot arthropathy** is a neuropathic joint degeneration, commonly seen in advanced diabetes, causing progressive joint destruction and deformity, often a **"rocker-bottom" foot**.- While it can lead to foot deformity and subsequent ulceration, it is typically **painless** due to significant neuropathy, contrasting with the patient's **severe pain**, and direct osteolytic changes of infection are not its primary X-ray feature.*Peripheral arterial disease*- **Peripheral arterial disease (PAD)** causes reduced blood flow to the extremities, leading to symptoms like **claudication**, **ischemic ulcers** (often on toes/heels), and rest pain.- While a significant comorbidity in diabetics and a risk factor for ulcers, PAD primarily involves vascular insufficiency and does not directly cause the **osteolytic changes** indicative of bone infection.*Deep vein thrombosis*- **Deep vein thrombosis (DVT)** is a blood clot in a deep vein, typically presenting as **unilateral leg swelling**, pain, and warmth.- It is a vascular issue not primarily associated with ulcers exposing bone, nor does it cause the **osteolytic changes** on a foot X-ray.

Question 6: A 34-year-old woman with Crohn's disease on adalimumab presents with a 10-day history of multiple painful nodules on both shins. The lesions are 2-4cm in diameter, raised, tender, and erythematous without ulceration or pustulation. She reports associated joint pains in her knees and ankles but no fever. Recent colonoscopy showed active inflammation. Blood tests reveal WCC 11.2 × 10⁹/L, CRP 78 mg/L, ESR 65 mm/hr. What is the most likely diagnosis?

A. Cellulitis secondary to immunosuppression
B. Pyoderma gangrenosum
C. Erythema nodosum (Correct Answer)
D. Sweet's syndrome (acute febrile neutrophilic dermatosis)
E. Subcutaneous nodular panniculitis from adalimumab injection sites

Explanation: ***Erythema nodosum*** - This patient presents with classic **tender, erythematous nodules** on the **shins** and associated **arthralgia** in the knees and ankles, which is a common extraintestinal manifestation of **Crohn's disease**. - The active intestinal inflammation noted on colonoscopy and elevated **CRP** and **ESR** correlate well with the onset of erythema nodosum, which often reflects underlying disease activity. *Cellulitis secondary to immunosuppression* - Typically presents as a **unilateral**, diffuse area of skin erythema and warmth, often with a spreading border, rather than discrete, **bilateral nodules**. - Usually accompanied by systemic features such as **fever** and significant pain upon touch, which are not explicitly reported here as the primary presenting features. *Pyoderma gangrenosum* - Characterized by rapidly enlarging, **painful ulcers** with **undermined violaceous borders** and purulent bases, whereas this patient has non-ulcerated nodules. - While also associated with **Inflammatory Bowel Disease (IBD)**, its distinctive ulcerative morphology is a key differentiator from the patient's presentation. *Sweet's syndrome (acute febrile neutrophilic dermatosis)* - Typically presents with the sudden onset of painful, edematous, **erythematous plaques** or nodules frequently associated with a **high fever** and marked **peripheral neutrophilia**. - The absence of fever and the nodular presentation without prominent plaques make this diagnosis less likely compared to erythema nodosum. *Subcutaneous nodular panniculitis from adalimumab injection sites* - These reactions would be localized strictly to the **site of injection**, commonly the **abdomen or thighs**, and would not typically manifest as widespread bilateral shin nodules. - Such reactions are usually local inflammatory responses and not typically indicative of a systemic flare-up of Crohn's disease with corresponding elevated inflammatory markers like **CRP** and **ESR**.

Question 7: A 72-year-old man with chronic obstructive pulmonary disease is admitted with an exacerbation and started on prednisolone 30mg daily. On day 3 of admission, he develops a painful, erythematous rash on his right shin. The affected area is warm and tender with a well-demarcated, raised border and has a characteristic orange-peel (peau d'orange) appearance. His temperature is 38.4°C. Blood tests show WCC 16.2 × 10⁹/L, CRP 128 mg/L. Which organism is most likely responsible for this infection?

A. Staphylococcus aureus
B. Streptococcus pyogenes (Group A Streptococcus) (Correct Answer)
C. Pseudomonas aeruginosa
D. Haemophilus influenzae
E. Pasteurella multocida

Explanation: ***Streptococcus pyogenes (Group A Streptococcus)***- This patient presents with **erysipelas**, a superficial skin infection most commonly caused by **Group A Streptococcus**.- Characteristic features include a **well-demarcated**, raised border and a **peau d'orange** appearance due to involvement of the superficial lymphatics.*Staphylococcus aureus*- More commonly associated with **cellulitis**, which involves deeper dermis and subcutaneous fat with less defined borders.- Often linked to **purulent infections** and abscess formation, rather than the clear-cut edges seen here.*Pseudomonas aeruginosa*- Typically associated with **hot tub folliculitis** or infections following exposure to **contaminated water/moist environments**.- Usually presents in **immunocompromised patients** as ecthyma gangrenosum, which features necrotic ulcers rather than orange-peel skin.*Haemophilus influenzae*- A rare cause of skin infections in adults, occasionally causing facial cellulitis in **unvaccinated children**.- Clinical presentation usually lacks the specific **well-demarcated raised border** seen in this patient’s shin lesion.*Pasteurella multocida*- Primarily associated with cellulitis following **animal bites or scratches**, particularly from **cats or dogs**.- Onset is typically very rapid (within 24 hours of a bite), which does not correlate with this hospital-acquired presentation.

Question 8: A 61-year-old man presents with a 4-day history of a painful red swelling on his upper back. On examination, there is a 5cm area of indurated, erythematous skin with multiple pustular openings discharging purulent material from several adjacent hair follicles. His temperature is 37.8°C. He has well-controlled type 2 diabetes. What is this lesion called?

A. Furuncle
B. Carbuncle (Correct Answer)
C. Hidradenitis suppurativa
D. Folliculitis
E. Erysipelas

Explanation: ***Carbuncle***- A **carbuncle** is a deep, painful infection involving a cluster of interconnected **furuncles** that coalesce to form a single inflammatory mass with **multiple pustular openings** discharging purulent material from several adjacent hair follicles.- It commonly occurs in areas like the **upper back** and neck, often associated with systemic symptoms like fever and risk factors such as **type 2 diabetes mellitus**.*Furuncle*- A **furuncle**, or boil, is a deep infection of a **single hair follicle** and surrounding tissue, presenting as a solitary, tender nodule.- Unlike a carbuncle, it does not involve the **coalescence of multiple adjacent follicles** or widespread induration with multiple drainage points.*Hidradenitis suppurativa*- This is a chronic inflammatory condition primarily affecting **apocrine gland-bearing areas** such as the axillae, groin, and inframammary folds, not typically the upper back.- It is characterized by recurrent abscesses, **sinus tracts**, and significant **scarring**, features not described in this acute presentation.*Folliculitis*- **Folliculitis** is a superficial inflammation limited to the **hair follicle** itself, presenting as small, individual follicular pustules.- It lacks the deep induration, extensive size (5cm), and **multiple purulent openings** characteristic of a carbuncle.*Erysipelas*- **Erysipelas** is a superficial skin infection of the **upper dermis** and lymphatics, typically caused by *Streptococcus pyogenes*.- It presents as a bright red, edematous plaque with **sharply demarcated borders**, without the deep suppuration and **multiple follicular drainage points** seen in a carbuncle.

Question 9: A hospital trust implements a new antimicrobial stewardship intervention where all prescriptions for restricted antibiotics (carbapenems, colistin, linezolid, daptomycin, tigecycline) require approval from the on-call microbiology consultant before administration. After 6 months, audit data shows a 35% reduction in use of restricted antibiotics, but there have been 8 incidents where patients experienced delayed antibiotic administration due to difficulty contacting the on-call microbiologist. What modification to this intervention would best maintain stewardship benefits while improving patient safety?

A. Allow approval by infectious diseases specialty trainees (ST4 and above) as well as consultants
B. Implement a policy allowing administration of the first dose pending approval, with mandatory review within 24 hours (Correct Answer)
C. Restrict the approval requirement to working hours only (9am-5pm, Monday-Friday)
D. Provide a 24-hour dedicated antimicrobial stewardship telephone hotline with guaranteed response within 30 minutes
E. Allow junior doctors to prescribe restricted antibiotics with consultant countersignature within 12 hours

Explanation: ***Implement a policy allowing administration of the first dose pending approval, with mandatory review within 24 hours*** - This modification aligns with the **'Start Smart - Then Focus'** framework, ensuring timely administration of urgent therapy while maintaining strict **prospective audit and feedback**. - It eliminates **delays in treatment** for critically ill patients, directly addressing the safety incidents while preserving the 35% reduction in long-term inappropriate use. *Allow approval by infectious diseases specialty trainees (ST4 and above) as well as consultants* - While this increases the number of available staff, it does not solve the **fundamental barrier** of clinical urgency where even a short delay in contacting someone can be harmful. - **Safety incidents** may still occur if the trainee is busy in clinic or theater, failing to guarantee immediate access for the first dose. *Restrict the approval requirement to working hours only (9am-5pm, Monday-Friday)* - This significantly weakens the **antimicrobial stewardship** intervention, as a large volume of antibiotic prescribing occurs during out-of-hours and weekend shifts. - It creates a **"weekend effect"** where restricted drug use could spike, undermining the goal of reducing overall institutional resistance patterns. *Provide a 24-hour dedicated antimicrobial stewardship telephone hotline with guaranteed response within 30 minutes* - Even a **30-minute delay** can be clinically significant in cases of **sepsis** or septic shock, where every hour delay in antibiotics increases mortality. - This solution is **resource-intensive** and may not be sustainable or scalable for many hospital trusts compared to a policy-based change. *Allow junior doctors to prescribe restricted antibiotics with consultant countersignature within 12 hours* - This shift in responsibility to **non-specialist consultants** may lead to "prescriber creep" where stewardship goals are bypassed by clinicians less familiar with resistance profiles. - It lacks the **expert oversight** of a microbiologist or ID specialist during the critical initial decision-making phase, potentially increasing inappropriate use.

Question 10: A 43-year-old woman with ulcerative colitis on infliximab presents with a 3-day history of painful vesicular lesions on her right buttock and posterior thigh following a dermatomal distribution. The lesions are at various stages with some showing crusting. She is immunosuppressed but otherwise systemically well with no fever. What is the most appropriate management?

A. Oral aciclovir 800mg five times daily for 7 days
B. Intravenous aciclovir 10mg/kg three times daily for 7-10 days (Correct Answer)
C. Oral valaciclovir 1g three times daily for 7 days
D. Topical aciclovir 5% cream five times daily for 5 days
E. Oral famciclovir 500mg three times daily for 7 days

Explanation: ***Intravenous aciclovir 10mg/kg three times daily for 7-10 days*** - Patients on **biologic therapy** such as **infliximab** are considered severely **immunocompromised**, necessitating intravenous treatment to prevent **disseminated** or visceral disease. - **IV aciclovir** ensures higher systemic levels compared to oral routes, which is vital in preventing complications like **meningoencephalitis** or **organ involvement** in suppressed hosts. *Oral aciclovir 800mg five times daily for 7 days* - While this is a standard dose for **immunocompetent** patients, it has **poor bioavailability** and is insufficient for those on potent immunosuppressants. - Oral therapy carries a higher risk of **treatment failure** and progression to **disseminated zoster** in this clinical context. *Oral valaciclovir 1g three times daily for 7 days* - Although **valaciclovir** has better oral bioavailability than aciclovir, it is still not the preferred gold standard for **severely immunosuppressed** patients. - It is generally reserved for patients with more **moderate immunosuppression** or those who are transitionally stable from IV therapy. *Topical aciclovir 5% cream five times daily for 5 days* - **Topical antivirals** have no clinical role in the management of **herpes zoster** (shingles) as they do not address the viral replication in the **dorsal root ganglion**. - Relying on topical treatment would significantly increase the risk of **post-herpetic neuralgia** and systemic spread. *Oral famciclovir 500mg three times daily for 7 days* - **Famciclovir** is a prodrug of penciclovir used for uncomplicated shingles in **immunocompetent individuals** and is not recommended as monotherapy here. - The severity of the patient's **immunosuppression** from TNF-alpha inhibitors overrides the convenience of oral administration in favor of **parenteral therapy**.

Question 11: A 55-year-old man with poorly controlled type 2 diabetes (HbA1c 102 mmol/mol) presents with a 5-day history of severe perineal pain and swelling. On examination, there is extensive erythema, oedema, and crepitus in the perineum extending to the anterior abdominal wall. Several areas show skin necrosis and purulent discharge. His temperature is 38.9°C, heart rate 125 bpm, blood pressure 92/58 mmHg, respiratory rate 24/min. Blood glucose is 22.4 mmol/L. What is the most critical immediate management step?

A. Commence broad-spectrum intravenous antibiotics covering Gram-positives, Gram-negatives, and anaerobes
B. Arrange emergency surgical debridement of necrotic tissue (Correct Answer)
C. Commence intravenous fluid resuscitation and insulin infusion for diabetic ketoacidosis
D. Obtain blood cultures, wound swabs, and tissue samples for microbiological analysis
E. Transfer to the intensive care unit for organ support and monitoring

Explanation: ***Arrange emergency surgical debridement of necrotic tissue*** - The patient's presentation with severe perineal pain, swelling, **crepitus**, **skin necrosis**, and signs of septic shock (fever, tachycardia, hypotension) in a diabetic patient is characteristic of **Fournier's gangrene**, a fulminant necrotizing fasciitis. - **Emergency surgical debridement** of all necrotic tissue is the most critical and immediate intervention to achieve source control, prevent rapid disease progression, and significantly reduce mortality. *Commence broad-spectrum intravenous antibiotics covering Gram-positives, Gram-negatives, and anaerobes* - While empirical **broad-spectrum antibiotics** are essential, they are an adjunct to and cannot replace surgical debridement in necrotizing infections where antibiotics struggle to penetrate **devitalized tissue**. - Delaying surgical intervention to prioritize antibiotics in the presence of **tissue necrosis** and crepitus will worsen the patient's prognosis due to unchecked bacterial proliferation. *Commence intravenous fluid resuscitation and insulin infusion for diabetic ketoacidosis* - **Fluid resuscitation** for shock and aggressive management of hyperglycemia are crucial supportive measures, given the patient's hypotension and high blood glucose. - However, there is no evidence of **ketosis or acidosis** to confirm diabetic ketoacidosis, and addressing the **septic source** surgically is paramount before definitive metabolic correction can be fully effective. *Obtain blood cultures, wound swabs, and tissue samples for microbiological analysis* - Microbiological sampling is important for guiding specific antibiotic therapy, but it should never delay the most time-sensitive intervention: **emergency surgical debridement**. - **Intraoperative tissue samples** provide the most accurate cultures for necrotizing infections and can be collected during the debridement procedure itself. *Transfer to the intensive care unit for organ support and monitoring* - Transfer to the **intensive care unit (ICU)** is often required for ongoing hemodynamic support, organ monitoring, and advanced critical care for patients in septic shock. - However, ICU admission is a setting for supportive care, not the definitive treatment for the rapidly progressing necrotizing infection; the most critical immediate step is the **surgical removal of infected tissue**.

Question 12: A hospital antimicrobial stewardship committee reviews audit data showing that 40% of patients receiving intravenous antibiotics for community-acquired pneumonia remain on IV therapy beyond 48 hours despite clinical stability and ability to take oral medications. Average length of hospital stay for pneumonia patients is 7.2 days. Which intervention is most likely to reduce this inappropriate continued use of intravenous antibiotics?

A. Implement automatic stop orders for all intravenous antibiotics after 72 hours
B. Introduce a mandatory daily checklist requiring documentation of IV-to-oral switch criteria assessment (Correct Answer)
C. Restrict authority to prescribe intravenous antibiotics to consultant grade doctors only
D. Send weekly emails to clinical teams highlighting patients eligible for oral switch
E. Require microbiology approval for continuation of IV antibiotics beyond 48 hours

Explanation: ***Introduce a mandatory daily checklist requiring documentation of IV-to-oral switch criteria assessment*** - This intervention directly targets the **clinical decision-making** process by forcing clinicians to actively evaluate **clinical stability** and the patient's **ability to take oral medications** daily. - It provides a **systematic** and **sustainable** method to reduce **unnecessary IV duration** and length of hospital stay by embedding accountability and prompting appropriate action into the routine workflow. *Implement automatic stop orders for all intravenous antibiotics after 72 hours* - This is a potentially **high-risk intervention** that may lead to the unintended cessation of therapy in patients who still require intravenous treatment for severe or complicated infections. - It relies on a rigid administrative cutoff that does not account for individual patient variations and may compromise **patient safety** without fostering improved **clinical judgment**. *Restrict authority to prescribe intravenous antibiotics to consultant grade doctors only* - This creates significant **barriers to timely initiation of appropriate care** and increases the administrative burden on senior staff, potentially delaying critical treatment. - It fails to address the specific problem of **delayed transitioning** from IV to oral therapy once a patient is stable, as it focuses on initial prescribing rather than ongoing management. *Send weekly emails to clinical teams highlighting patients eligible for oral switch* - Periodic emails lack the **immediacy** and interactivity required for daily clinical decisions; by the time the email is read, the patient may have already missed several opportunities for switching. - This strategy is prone to **information overload** and is often ignored, making it a less effective behavioral intervention compared to point-of-care tools like checklists. *Require microbiology approval for continuation of IV antibiotics beyond 48 hours* - This approach is extremely **resource-intensive** for microbiology departments and creates a bottleneck that may delay necessary antibiotic continuation in complex or prolonged cases. - While it offers oversight, it is less effective at empowering and changing the day-to-day **prescribing habits** of the treating bedside clinicians globally compared to a checklist that guides their assessment.

Question 13: A 29-year-old woman presents to her GP with a 4-day history of a painful red lump in her left axilla. She reports it started as a small tender area but has progressively enlarged. On examination, there is a 3cm fluctuant, erythematous swelling with central pointing in the left axilla. There is no surrounding cellulitis or lymphangitis. She is systemically well with no fever. What is the most appropriate initial management?

A. Prescribe oral flucloxacillin 500mg four times daily for 7 days
B. Arrange urgent incision and drainage with wound packing, with antibiotics only if spreading cellulitis develops (Correct Answer)
C. Prescribe oral co-amoxiclav 500/125mg three times daily for 7 days
D. Arrange ultrasound-guided aspiration of the abscess with antibiotic cover
E. Advise warm compresses and analgesia, with review in 48 hours

Explanation: ***Arrange urgent incision and drainage with wound packing, with antibiotics only if spreading cellulitis develops*** - The presence of a **fluctuant, erythematous swelling with central pointing** indicates a mature abscess that requires **incision and drainage** for definitive treatment. - For a systemically well patient without **spreading cellulitis** or **lymphangitis**, antibiotics are generally not required after successful drainage, promoting antimicrobial stewardship. *Prescribe oral flucloxacillin 500mg four times daily for 7 days* - **Antibiotics alone** are often ineffective for treating a mature abscess because they have poor penetration into the avascular, purulent material. - This approach risks **treatment failure** and delayed resolution, as the pus needs to be physically drained. *Prescribe oral co-amoxiclav 500/125mg three times daily for 7 days* - Similar to other antibiotics, **co-amoxiclav** will not resolve a fluctuant abscess on its own without physical drainage. - It is also a **broader-spectrum antibiotic**, which is generally not warranted for a localized skin abscess in an otherwise healthy individual without specific risk factors. *Arrange ultrasound-guided aspiration of the abscess with antibiotic cover* - While **needle aspiration** can be used for some abscesses, **incision and drainage** is the preferred method for superficial cutaneous abscesses to ensure complete evacuation and reduce recurrence. - Routine **antibiotic cover** is not indicated for a simple, localized abscess after a procedure unless there are signs of systemic infection or immunocompromise. *Advise warm compresses and analgesia, with review in 48 hours* - **Warm compresses** may be beneficial for early inflammation, but they are insufficient for a **fluctuant, pointing abscess** that has already formed a significant collection of pus. - Delaying definitive management (incision and drainage) for 48 hours will prolong pain and risks progression to **spreading cellulitis** or systemic symptoms.

Question 14: A 38-year-old man who works as a sewage worker presents to the Emergency Department with a 36-hour history of a rapidly painful, swollen left forearm following a puncture injury at work. On examination, there is marked swelling with tense, shiny skin, severe pain out of proportion to examination findings, and pain on passive extension of the fingers. His temperature is 38.7°C. X-ray of the forearm shows subcutaneous gas. Blood tests reveal WCC 18.4 × 10⁹/L, CRP 245 mg/L, creatine kinase 3,800 U/L. What is the most likely causative organism?

A. Clostridium perfringens
B. Vibrio vulnificus
C. Aeromonas hydrophila (Correct Answer)
D. Eikenella corrodens
E. Streptococcus pyogenes

Explanation: ***Aeromonas hydrophila*** - This patient exhibits **necrotising soft tissue infection (NSTI)** with hallmarks such as pain out of proportion to findings, **subcutaneous gas**, and markedly elevated **creatine kinase** indicating myonecrosis. - **Aeromonas hydrophila** is specifically associated with **sewage worker** occupations and injuries contaminated by fresh or brackish water, leading to rapidly progressive, life-threatening infections. *Clostridium perfringens* - While it is a classic cause of **gas gangrene** (clostridial myonecrosis), it is typically associated with deep wounds contaminated with **soil** or following gastrointestinal surgery. - The specific exposure to **sewage** in this occupational context makes the Gram-negative Aeromonas a more likely culprit than this Gram-positive anaerobe. *Vibrio vulnificus* - This organism also causes rapid necrotising infections but is classically linked to **seawater** exposure or handling contaminated **seafood**. - It is less likely in this scenario involving **sewage**, which typically facilitates the growth of Aeromonas species. *Eikenella corrodens* - This is a slow-growing Gram-negative bacterium that is part of the normal human **oral flora**. - It is commonly associated with **human bite** injuries or "clenched fist" injuries, rather than environmental exposure in sewage. *Streptococcus pyogenes* - This is the leading cause of Type II **necrotising fasciitis** (monomicrobial) but usually follows minor skin trauma or surgical procedures. - It does not specifically correlate with the **sewage exposure** mentioned in the patient's occupational history.

Question 15: According to the UK 'Start Smart - Then Focus' antimicrobial stewardship framework, what is the recommended timeframe for reviewing all antimicrobial prescriptions and documenting a clinical decision?

A. Only if there is clinical deterioration or lack of improvement
B. Within 24 hours of initiating antimicrobial therapy
C. Within 48-72 hours of initiating antimicrobial therapy (Correct Answer)
D. Within 5 days of initiating antimicrobial therapy
E. At completion of the antimicrobial course

Explanation: ***Within 48-72 hours of initiating antimicrobial therapy***- According to the **UK 'Start Smart - Then Focus'** framework, this timeframe is crucial for the initial **antimicrobial review**.- This window allows for evaluation of **microbiological results** (e.g., culture and sensitivity) and the patient's **clinical response**, enabling a timely decision to **stop, switch, change, continue**, or move to **OPAT**.*Only if there is clinical deterioration or lack of improvement*- This approach is reactive and not in line with the **proactive principles** of antimicrobial stewardship, which advocates for a systematic review for **all patients**.- Waiting for deterioration misses opportunities to **de-escalate** or discontinue unnecessary broad-spectrum therapy in improving patients, contributing to **antimicrobial resistance**.*Within 24 hours of initiating antimicrobial therapy*- While early reassessment is valuable, **24 hours** is often too soon for definitive **microbiological culture and sensitivity results** to be available.- The framework balances the need for timely intervention with having sufficient **diagnostic information** to make evidence-based adjustments to therapy.*Within 5 days of initiating antimicrobial therapy*- Delaying the formal review until **5 days** can result in **prolonged unnecessary broad-spectrum antibiotic exposure**, increasing the risk of **adverse effects** and **C. difficile infection**.- This timeframe misses the optimal window for **early de-escalation** and tailoring therapy to the causative pathogen, which is a cornerstone of effective stewardship.*At completion of the antimicrobial course*- Reviewing treatment only at **completion** is a retrospective audit and not an active part of **antimicrobial stewardship**, which focuses on optimizing therapy *during* treatment.- Such a delay eliminates the possibility of **early intervention** to improve patient outcomes, reduce drug toxicity, and minimize the development of **antimicrobial resistance**.

Question 16: A 67-year-old woman with chronic lymphocytic leukaemia receiving ibrutinib presents with a 48-hour history of severe pain and rapidly progressive erythema and swelling of her left hand following a minor scratch from her cat. On examination, there is dusky erythema extending from her hand to the forearm with several haemorrhagic bullae and crepitus on palpation. Her temperature is 39.1°C, heart rate 118 bpm, blood pressure 98/62 mmHg. Lactate is 3.8 mmol/L. What is the most appropriate initial antimicrobial regimen?

A. Intravenous flucloxacillin 2g four times daily and oral metronidazole 400mg three times daily
B. Intravenous co-amoxiclav 1.2g three times daily and clindamycin 600mg four times daily
C. Intravenous piperacillin-tazobactam 4.5g three times daily, clindamycin 600mg four times daily, and linezolid 600mg twice daily (Correct Answer)
D. Intravenous meropenem 1g three times daily and vancomycin 1g twice daily
E. Intravenous benzylpenicillin 2.4g four times daily and clindamycin 900mg three times daily

Explanation: ***Intravenous piperacillin-tazobactam 4.5g three times daily, clindamycin 600mg four times daily, and linezolid 600mg twice daily*** - This patient presents with features highly suggestive of **necrotising fasciitis** (crepitus, haemorrhagic bullae, rapidly progressive erythema, severe pain) and **septic shock** (hypotension, tachycardia, elevated lactate). - The regimen provides broad-spectrum coverage for **polymicrobial infections** including Gram-negatives (piperacillin-tazobactam), anaerobes (piperacillin-tazobactam and clindamycin), and severe staphylococcal/streptococcal infections, with **clindamycin** to inhibit toxin production and **linezolid** for MRSA and additional antitoxin effects, crucial in an **immunosuppressed** patient. *Intravenous flucloxacillin 2g four times daily and oral metronidazole 400mg three times daily* - This regimen is **insufficient** for the broad-spectrum needs of suspected **necrotising fasciitis**, particularly lacking cover for many Gram-negatives and atypical organisms associated with cat scratches. - **Oral metronidazole** is inappropriate for a critically ill patient in **septic shock** as it would have unreliable absorption; intravenous administration is essential. *Intravenous co-amoxiclav 1.2g three times daily and clindamycin 600mg four times daily* - While better than flucloxacillin alone, this combination may still lack sufficient empirical coverage for **resistant Gram-negative organisms** and **MRSA**, which are important considerations in an **immunosuppressed** patient with CLL. - It does not offer the comprehensive empirical protection or the specific additional **antitoxin effects** of linezolid, which is beneficial in severe soft tissue infections. *Intravenous meropenem 1g three times daily and vancomycin 1g twice daily* - Meropenem and vancomycin provide excellent broad-spectrum antibacterial coverage, but this regimen critically **lacks clindamycin** or **linezolid**, which are vital for inhibiting **bacterial toxin production** in necrotising infections. - The absence of a strong antitoxin agent like clindamycin can lead to poorer outcomes, as toxin suppression is a key aspect of managing the severe inflammatory response in **necrotising fasciitis**. *Intravenous benzylpenicillin 2.4g four times daily and clindamycin 900mg three times daily* - This dual therapy is primarily indicated for **Type II (monomicrobial) necrotising fasciitis**, typically caused by **Group A Streptococcus** (GAS). - It is inadequate for this patient who is at high risk for **Type I (polymicrobial) necrotising fasciitis** involving Gram-negative bacteria and anaerobes, especially given her **immunosuppression** and the cat scratch.

Question 17: A 52-year-old man who recently started training mixed martial arts presents with multiple small pustules and furuncles on his neck, shoulders, and upper back. Several training partners have had similar skin lesions. He is otherwise well with no fever. Skin swab culture grows Staphylococcus aureus resistant to penicillin but sensitive to flucloxacillin. After treating the acute infection, what is the most appropriate next step in management?

A. Advise regular application of topical mupirocin to anterior nares for 5 days monthly as long-term prophylaxis
B. Prescribe long-term oral flucloxacillin 250mg twice daily as secondary prophylaxis
C. Perform MRSA screening of household contacts and treat if positive
D. Implement a decolonisation regimen with nasal mupirocin and chlorhexidine body washes for 5 days, and advise gym hygiene measures (Correct Answer)
E. Arrange for punch biopsy of a lesion to exclude hidradenitis suppurativa

Explanation: ***Implement a decolonisation regimen with nasal mupirocin and chlorhexidine body washes for 5 days, and advise gym hygiene measures*** - Decolonization is the gold standard for managing recurrent **Staphylococcus aureus** skin infections, especially in high-contact environments like mixed martial arts where transmission is common. - This comprehensive approach targets both **nasal carriage** (with mupirocin) and **skin colonization** (with chlorhexidine), coupled with **gym hygiene** to address environmental factors and prevent reinfection. *Advise regular application of topical mupirocin to anterior nares for 5 days monthly as long-term prophylaxis* - Long-term, intermittent use of **mupirocin** can contribute to the development of **antibiotic resistance** and is not recommended as a sustained prophylactic strategy. - This approach only addresses nasal carriage and fails to target **skin colonization** or the **environmental transmission** prevalent in the training facility. *Prescribe long-term oral flucloxacillin 250mg twice daily as secondary prophylaxis* - Continuous long-term **systemic antibiotics** like flucloxacillin carry risks of adverse effects and can significantly promote **antibiotic resistance**. - For recurrent localized staphylococcal skin infections, decolonization strategies and **hygiene measures** are preferred over daily oral antimicrobial suppression. *Perform MRSA screening of household contacts and treat if positive* - The culture results explicitly indicated **Staphylococcus aureus** sensitive to flucloxacillin, meaning it is **MSSA** (Methicillin-Sensitive S. aureus), not MRSA. - The epidemiological link clearly points to the **martial arts training** environment as the source, making household contact screening less relevant. *Arrange for punch biopsy of a lesion to exclude hidradenitis suppurativa* - The clinical presentation involves multiple acute **pustules and furuncles** in a contact-sport setting with similar cases among partners, strongly suggesting an infectious etiology. - **Hidradenitis suppurativa** typically presents with chronic, painful **nodules, abscesses, and sinus tracts** primarily in **intertriginous areas** (e.g., axillae, groin), which is inconsistent with this scenario.

Question 18: A hospital antimicrobial stewardship team is developing a new policy to reduce inappropriate prescribing of broad-spectrum antibiotics. They plan to implement prospective audit and feedback for all prescriptions of carbapenems, piperacillin-tazobactam, and glycopeptides. Which additional component would be most effective in improving the success of this antimicrobial stewardship intervention?

A. Monthly email bulletins to all prescribers summarising antibiotic consumption data
B. Mandatory antimicrobial prescribing education for all new junior doctors during induction
C. Real-time decision support integrated into the electronic prescribing system with indication prompts (Correct Answer)
D. Quarterly antimicrobial resistance surveillance reports distributed to clinical departments
E. Restriction of antibiotic prescribing authority to consultant-level clinicians only

Explanation: ***Real-time decision support integrated into the electronic prescribing system with indication prompts*** - **Real-time decision support** provides immediate, context-specific guidance at the point of prescribing, which is more effective than retrospective reviews for changing clinician behavior. - Integrating **indication prompts** and dosage optimization within the **electronic prescribing system** ensures that stewardship principles are applied before the drug is even administered, directly influencing the choice and appropriateness. *Monthly email bulletins to all prescribers summarising antibiotic consumption data* - While **passive education** through bulletins increases awareness, it lacks the **immediacy** required to influence individual clinical decisions at the bedside. - Data summaries are often perceived as **post-hoc** and may be ignored by busy clinicians who do not see the direct relevance to their current patients. *Mandatory antimicrobial prescribing education for all new junior doctors during induction* - **One-time educational interventions** have been shown to have limited long-term impact on prescribing habits without continuous clinical reinforcement. - Education alone does not address the **complex behavioral factors** and systemic pressures that lead to inappropriate broad-spectrum antibiotic use. *Quarterly antimicrobial resistance surveillance reports distributed to clinical departments* - **Surveillance reports** provide important epidemiological context but are too infrequent to guide the daily management of **acute infections**. - There is often a significant **time lag** between data collection and report distribution, making the information less actionable for real-time stewardship. *Restriction of antibiotic prescribing authority to consultant-level clinicians only* - Although **pre-authorization** can control costs, it often leads to significant **delays in treatment** for critically ill patients requiring urgent antibiotics. - Universal restriction can create a **bottleneck in clinical workflow** and fails to provide the educational feedback necessary for junior staff to improve their skills.

Question 19: A 45-year-old woman with type 2 diabetes presents to the Emergency Department with a 3-day history of increasing pain, swelling, and redness of her right lower leg. On examination, there is a well-demarcated area of erythema extending from her ankle to mid-calf with associated warmth and tenderness. Her temperature is 38.2°C, heart rate 95 bpm, blood pressure 135/82 mmHg. Blood tests show WCC 14.2 × 10⁹/L, CRP 85 mg/L. What is the most appropriate first-line oral antibiotic treatment according to current UK guidelines?

A. Flucloxacillin 500mg four times daily for 7 days (Correct Answer)
B. Co-amoxiclav 500/125mg three times daily for 7 days
C. Clarithromycin 500mg twice daily for 7 days
D. Doxycycline 200mg loading dose then 100mg once daily for 7 days
E. Clindamycin 300mg four times daily for 7 days

Explanation: ***Flucloxacillin 500mg four times daily for 7 days***- **Flucloxacillin** is the first-line oral antibiotic recommended by **NICE/PHE guidelines** for uncomplicated cellulitis in non-penicillin-allergic patients due to its excellent efficacy.- It provides targeted coverage against **Staphylococcus aureus** and **Streptococcus pyogenes**, the most common bacterial causes of skin and soft tissue infections like cellulitis.*Co-amoxiclav 500/125mg three times daily for 7 days*- This broad-spectrum antibiotic is typically reserved for cellulitis caused by **animal or human bites**, or when there is concern for polymicrobial infection or involvement of **anaerobes**.- It is not preferred for standard cellulitis as it covers a wider range of bacteria, including **Gram-negative organisms**, potentially contributing to antimicrobial resistance without added benefit in this scenario.*Clarithromycin 500mg twice daily for 7 days*- **Clarithromycin**, a macrolide, is an appropriate alternative for patients with a **true penicillin allergy** or when **flucloxacillin** is contraindicated.- However, for non-allergic patients, **flucloxacillin** is generally more effective and less likely to induce resistance or adverse effects, especially gastrointestinal ones.*Doxycycline 200mg loading dose then 100mg once daily for 7 days*- **Doxycycline** is primarily used for cellulitis when there is a suspected or confirmed **MRSA** (Methicillin-resistant Staphylococcus aureus) infection, or in cases of **penicillin allergy**.- It is not the first-line choice for typical community-acquired cellulitis in the UK where **Staphylococcus aureus** is usually methicillin-sensitive.*Clindamycin 300mg four times daily for 7 days*- **Clindamycin** is another alternative for patients with **penicillin allergy** or when **MRSA** is strongly suspected, particularly in severe infections or those requiring anaerobic coverage.- Its use is associated with a higher risk of **Clostridioides difficile infection** compared to flucloxacillin, making it a less favourable first-line option for routine cellulitis.

Question 20: A hospital trust introduces a comprehensive antimicrobial stewardship program including: automatic 72-hour prescription review, mandatory indication documentation, antimicrobial ward rounds, and formulary restrictions for reserve antibiotics. After 18 months, evaluation shows: 40% reduction in carbapenem use, 30% reduction in overall antibiotic consumption, 50% improvement in documentation of indication, maintained or improved clinical outcomes, but a 15% increase in antimicrobial stewardship team workload-related burnout scores. From a healthcare systems perspective, which evaluation framework component requires urgent attention?

A. The program has achieved its primary aim of reducing consumption and should continue unchanged with focus on sustaining gains
B. Staff burnout represents a critical sustainability threat requiring intervention redesign and resource allocation to prevent program failure (Correct Answer)
C. Clinical outcomes are maintained therefore the workload concerns are secondary and team members should adapt to new expectations
D. The documentation improvements demonstrate success and the burnout issue will resolve once the program becomes routine practice
E. Carbapenem reduction is the key metric and other concerns are acceptable trade-offs for this patient safety achievement

Explanation: ***Staff burnout represents a critical sustainability threat requiring intervention redesign and resource allocation to prevent program failure***- Effective **healthcare systems evaluation** must consider the **Quadruple Aim**, which includes the **well-being of healthcare providers** alongside clinical and cost outcomes.- A 15% increase in **burnout scores** is a significant predictor of future program collapse, as it leads to **staff turnover**, reduced engagement, and a high risk of long-term failure despite initial successes.*The program has achieved its primary aim of reducing consumption and should continue unchanged with focus on sustaining gains*- Continuing unchanged ignores the **sustainability risk** posed by the workforce's deteriorating mental health and high workload.- Sustainable **improvement science** dictates that technical gains cannot be maintained if the **human system** powering the program is failing.*Clinical outcomes are maintained therefore the workload concerns are secondary and team members should adapt to new expectations*- Dismissing **staff burnout** as secondary is a poor leadership approach that frequently leads to **medical errors** and low morale.- Successful **antimicrobial stewardship** requires active, high-quality clinical input that cannot be sustained by an overextended, disengaged team.*The documentation improvements demonstrate success and the burnout issue will resolve once the program becomes routine practice*- After 18 months, the program is already becoming routine; an increase in burnout at this stage suggests the **workload intensity** is fundamentally mismatched with available resources.- Transitioning to **routine practice** usually stabilizes workload; if burnout is still rising, the **program design** itself is likely the issue.*Carbapenem reduction is the key metric and other concerns are acceptable trade-offs for this patient safety achievement*- While **carbapenem reduction** is an important safety metric, workforce exhaustion creates new, cross-cutting **patient safety risks** across the hospital.- In **systems thinking**, no single clinical metric justifies a trade-off that compromises the overall **integrity and stability** of the clinical team.

Question 21: A 72-year-old man with type 2 diabetes, peripheral vascular disease, and chronic kidney disease stage 3b (eGFR 38 mL/min/1.73m²) presents with a diabetic foot ulcer over the first metatarsal head. The ulcer probes to bone. There is surrounding erythema extending 3cm from the ulcer margin, purulent discharge, and a foul odour. Plain radiograph shows erosion of the first metatarsal head consistent with osteomyelitis. His temperature is 38.4°C. What is the most appropriate empirical antibiotic regimen while awaiting deep tissue culture results?

A. Intravenous flucloxacillin 2g four times daily and oral metronidazole 400mg three times daily with dose adjustments for renal impairment
B. Intravenous co-amoxiclav 1.2g three times daily dose-adjusted for renal function
C. Intravenous piperacillin-tazobactam 4.5g three times daily with renal dose adjustment (Correct Answer)
D. Intravenous teicoplanin loading dose followed by maintenance dosing plus intravenous ciprofloxacin and oral metronidazole
E. Oral co-amoxiclav 625mg three times daily and oral ciprofloxacin 500mg twice daily

Explanation: ***Intravenous piperacillin-tazobactam 4.5g three times daily with renal dose adjustment*** - This patient has a **severe diabetic foot infection** with **osteomyelitis** (probe-to-bone positive) and systemic symptoms (fever), necessitating broad-spectrum coverage for **polymicrobial** organisms including **Pseudomonas aeruginosa**, anaerobes, and gram-positive bacteria. - **Piperacillin-tazobactam** provides the necessary coverage for chronic, limb-threatening infections and requires **renal dose adjustment** given the patient's **CKD stage 3b** (eGFR 38 mL/min/1.73m²). *Intravenous flucloxacillin 2g four times daily and oral metronidazole 400mg three times daily with dose adjustments for renal impairment* - While **flucloxacillin** covers *Staphylococcus aureus*, this regimen lacks sufficient coverage for **aerobic gram-negative bacilli**, which are common in deep, chronic diabetic foot ulcers. - This combination is more suitable for mild-to-moderate cellulitis rather than a **severe infection** with suspected multi-organism involvement and **osteomyelitis**. *Intravenous co-amoxiclav 1.2g three times daily dose-adjusted for renal function* - **Co-amoxiclav** provides good aerobic and anaerobic coverage but lacks activity against **Pseudomonas aeruginosa**, which is a significant pathogen in chronic or severe diabetic foot infections with **peripheral vascular disease**. - It is generally reserved for moderate infections rather than severe, limb-threatening cases presenting with **systemic inflammatory response** features like fever. *Intravenous teicoplanin loading dose followed by maintenance dosing plus intravenous ciprofloxacin and oral metronidazole* - This regimen is unnecessarily broad for initial empirical therapy unless there is a high suspicion of **MRSA** or a history of previous MRSA colonization, which is not mentioned. - Although it covers many pathogens, the risk-to-benefit ratio and stewardship guidelines favor **Piperacillin-tazobactam** as a more streamlined first-line IV choice for severe infections. *Oral co-amoxiclav 625mg three times daily and oral ciprofloxacin 500mg twice daily* - **Oral therapy** is inappropriate for a patient presenting with **systemic symptoms** (fever) and **osteomyelitis**, where high-dose **intravenous antibiotics** are required to ensure adequate tissue and bone penetration. - The severity of the infection and the presence of **peripheral vascular disease** mean oral absorption and delivery to the site of infection are likely to be compromised.

Question 22: According to the UK 'Start Smart - Then Focus' antimicrobial stewardship framework, which of the following represents a core element of the 'Start Smart' component when initiating empirical antibiotic therapy?

A. Only start antibiotics after obtaining blood cultures, urine cultures, and radiological investigations in all cases
B. Take appropriate cultures before starting antibiotics, give antibiotics within one hour for severe sepsis, and document clinical indication and planned review date on the prescription (Correct Answer)
C. Prescribe the broadest spectrum antibiotic available until culture results guide de-escalation
D. Obtain microbiology consultation approval before initiating any empirical antimicrobial therapy
E. Calculate a severity score using a validated tool and only start antibiotics if the score exceeds local thresholds

Explanation: ***Take appropriate cultures before starting antibiotics, give antibiotics within one hour for severe sepsis, and document clinical indication and planned review date on the prescription*** - The **'Start Smart'** component emphasizes rapid initiation (within **one hour**) for severe sepsis while ensuring **appropriate cultures** are taken to guide later therapy. - Documentation of the **clinical indication** and a **review/stop date** on the prescription is a mandatory stewardship requirement to prevent indefinite antibiotic use.*Only start antibiotics after obtaining blood cultures, urine cultures, and radiological investigations in all cases* - While cultures are ideal, necessary treatment for **life-threatening infections** should never be delayed by waiting for time-consuming **radiological investigations**. - The framework focuses on taking **representative cultures** efficiently rather than awaiting all possible tests before the first dose.*Prescribe the broadest spectrum antibiotic available until culture results guide de-escalation* - Stewardship guidelines advise using the **narrowest spectrum** antibiotic appropriate for the suspected infection based on **local guidelines**. - Overuse of **broad-spectrum agents** increases the risk of antimicrobial resistance and healthcare-associated infections like **C. diff**.*Obtain microbiology consultation approval before initiating any empirical antimicrobial therapy* - Requiring **prior approval** for all empirical therapy would cause dangerous delays in treating **acutely unwell patients**. - Clinicians are encouraged to follow **local empirical protocols** created by microbiology, only seeking consultation for complex or resistant cases.*Calculate a severity score using a validated tool and only start antibiotics if the score exceeds local thresholds* - While **severity scores** (like CURB-65) assist in decision-making, they do not replace **clinical judgment** or serve as rigid exclusion criteria for antibiotics. - The framework focuses on the **quality and timing** of prescribing rather than setting numerical thresholds for initiating therapy.

Question 23: A 59-year-old woman with rheumatoid arthritis on methotrexate 15mg weekly and prednisolone 10mg daily presents with a 2-day history of rapidly progressive erythema and swelling of her right hand and forearm following a rose thorn injury to her thumb 5 days previously. She is systemically well with temperature 37.6°C. Examination shows lymphangitic streaking up the forearm and tender axillary lymphadenopathy. The thumb puncture site has a small pustule. Blood tests show WCC 11.2 × 10⁹/L and CRP 68 mg/L. What is the most appropriate management approach for this patient?

A. Oral flucloxacillin 500mg four times daily for 7 days as outpatient with 48-hour review
B. Hospital admission for intravenous antibiotics due to immunosuppression risk factors (Correct Answer)
C. Oral co-amoxiclav 625mg three times daily with advice to temporarily withhold methotrexate
D. Incision and drainage of the pustule followed by oral clindamycin pending culture results
E. Oral clarithromycin 500mg twice daily to cover atypical organisms from plant material

Explanation: ***Hospital admission for intravenous antibiotics due to immunosuppression risk factors***- This patient presents with **rapidly progressive erythema and swelling** of the hand and forearm, **lymphangitic streaking**, and **tender axillary lymphadenopathy**, indicating a severe, spreading infection. Her concurrent use of **methotrexate** and **prednisolone** renders her immunocompromised, significantly increasing the risk of rapid clinical deterioration and sepsis, thus mandating immediate **hospital admission**.- For a patient with such a rapidly spreading infection and compromised immune status, **intravenous antibiotics** are crucial to ensure adequate drug concentrations at the site of infection and throughout the body, providing a more aggressive and effective treatment than oral regimens.*Oral flucloxacillin 500mg four times daily for 7 days as outpatient with 48-hour review*- While **flucloxacillin** is a common choice for Gram-positive skin infections, **oral therapy** is inadequate for an immunosuppressed patient with signs of systemic spread like **lymphangitis** and **lymphadenopathy**.- Outpatient management, even with close follow-up, carries a high risk of worsening infection and complications in this vulnerable patient population, who require constant monitoring and aggressive initial treatment.*Oral co-amoxiclav 625mg three times daily with advice to temporarily withhold methotrexate*- Although **withholding methotrexate** during an acute infection is appropriate, **oral co-amoxiclav**, despite its broad spectrum, is insufficient for a severe, rapidly progressing infection in an immunocompromised individual.- The presence of **lymphangitic streaking** and the patient's immune status necessitate the more potent and rapidly effective systemic levels achieved with **intravenous antibiotic administration** rather than oral treatment.*Incision and drainage of the pustule followed by oral clindamycin pending culture results*- **Incision and drainage** is appropriate for a localized abscess, but it would not adequately address the extensive **lymphangitic streaking** and **lymphadenopathy** indicating a widespread cellulitis.- **Oral clindamycin** is typically used for specific indications, such as penicillin allergy or MRSA, and the **oral route** is inappropriate for a severe, spreading infection in an immunosuppressed patient.*Oral clarithromycin 500mg twice daily to cover atypical organisms from plant material*- The rapid onset and progression of **erythema**, swelling, **lymphangitis**, and **lymphadenopathy** are highly suggestive of an acute bacterial infection (e.g., *Staphylococcus aureus* or *Streptococcus pyogenes*), not an atypical organism.- While thorn injuries can introduce atypical pathogens like ***Sporothrix schenckii***, these infections typically present as subacute or chronic nodular lymphocutaneous lesions, which contrasts with this patient's acute presentation.

Question 24: A 34-year-old man who recently joined a Brazilian Jiu-Jitsu club presents with multiple painful pustules and furuncles affecting his neck, forearms, and thighs. The lesions started appearing 2 weeks after beginning training. Several of his training partners have had similar skin problems. He is otherwise well with no fever. Swabs from the lesions grow Staphylococcus aureus that is methicillin-resistant (MRSA) but sensitive to doxycycline, clindamycin, and trimethoprim. What is the most comprehensive management approach for this patient?

A. Oral flucloxacillin 500mg four times daily for 7 days and advise temporary cessation of training
B. Oral doxycycline 200mg loading dose then 100mg twice daily for 7 days, MRSA decolonisation therapy, and notification to the gym (Correct Answer)
C. Incision and drainage of all lesions without antibiotics, as this is adequate for abscess management
D. Oral trimethoprim 200mg twice daily for 5 days and advice on personal hygiene measures only
E. Intravenous vancomycin for 7 days followed by oral suppressive therapy and exclusion from training

Explanation: ***Oral doxycycline 200mg loading dose then 100mg twice daily for 7 days, MRSA decolonisation therapy, and notification to the gym*** - This patient has **Community-Acquired MRSA (CA-MRSA)**; oral **doxycycline** is an appropriate first-line treatment as the isolate is sensitive and the patient is systemically well. - Comprehensive management must include **MRSA decolonisation** (nasal mupirocin/chlorhexidine) to prevent recurrence and **gym notification** to manage a clear **outbreak** among training partners. *Oral flucloxacillin 500mg four times daily for 7 days and advise temporary cessation of training* - **Flucloxacillin** is ineffective against **MRSA** because the organism possess the **mecA gene**, which alters penicillin-binding proteins. - While training cessation is necessary, this approach fails to address the **colonisation** or the **public health** requirement of notifying the facility. *Incision and drainage of all lesions without antibiotics, as this is adequate for abscess management* - **Incision and drainage** is the gold standard for singular large abscesses, but **antibiotics** are indicated here due to the **multiple** nature of the lesions and the MRSA status. - Relying solely on drainage does not address the **MRSA carriage** or the risk of further spread within the high-contact sports environment. *Oral trimethoprim 200mg twice daily for 5 days and advice on personal hygiene measures only* - While the isolate is sensitive to **trimethoprim**, the dose and duration are suboptimal for managing an emerging MRSA **outbreak** in a sports setting. - This plan lacks **decolonisation therapy**, which is critical for patients with recurrent or multiple CA-MRSA furuncles. *Intravenous vancomycin for 7 days followed by oral suppressive therapy and exclusion from training* - **Intravenous vancomycin** is unnecessary and excessive for a patient who is **systemically well** with no signs of sepsis or deep-seated infection. - Professional guidelines recommend **oral therapy** (like doxycycline or clindamycin) for uncomplicated skin and soft tissue infections regardless of MRSA status.

Question 25: A hospital antimicrobial stewardship committee reviews prescribing data for surgical prophylaxis and finds that 68% of patients undergoing elective colorectal surgery receive prophylactic antibiotics that continue beyond 24 hours post-operatively, despite local and national guidelines recommending single-dose or maximum 24-hour prophylaxis. The surgical team argues that their infection rates are low and changing practice might increase surgical site infections. Which evidence-based principle best supports the antimicrobial stewardship team's recommendation to reduce prophylaxis duration?

A. Prolonged prophylaxis beyond 24 hours has no additional benefit in reducing surgical site infections but significantly increases Clostridioides difficile risk (Correct Answer)
B. Shorter courses of prophylaxis are more cost-effective and patient satisfaction scores are higher with reduced antibiotic exposure
C. Extended prophylaxis leads to antibiotic resistance in the patient's microbiome which increases their risk of future MRSA colonisation
D. Single-dose prophylaxis is easier for nursing staff to administer and reduces medication errors on surgical wards
E. The current low infection rate is likely due to other factors such as surgical technique and continuing antibiotics will eventually lead to resistance

Explanation: ***Prolonged prophylaxis beyond 24 hours has no additional benefit in reducing surgical site infections but significantly increases Clostridioides difficile risk***- Numerous studies confirm that extending **surgical prophylaxis** beyond 24 hours provides no additional protection against **surgical site infections (SSIs)**.- However, this prolonged exposure significantly elevates the risk of **Clostridioides difficile infection** and other antibiotic-associated toxicities like acute kidney injury.*Shorter courses of prophylaxis are more cost-effective and patient satisfaction scores are higher with reduced antibiotic exposure*- While **cost-effectiveness** and potentially higher **patient satisfaction** are positive outcomes of reduced antibiotic use, they are secondary benefits.- These factors are important for healthcare economics and patient experience, but not the primary **evidence-based clinical principle** dictating prophylaxis duration regarding patient harm.*Extended prophylaxis leads to antibiotic resistance in the patient's microbiome which increases their risk of future MRSA colonisation*- Prolonged antibiotic use does disrupt the **patient's microbiome** and contributes to **antibiotic resistance** development over time.- However, the immediate and direct evidence-based concern in the postoperative period is the increased risk of **Clostridioides difficile infection**, which is a more acute and well-documented adverse outcome than future MRSA colonization.*Single-dose prophylaxis is easier for nursing staff to administer and reduces medication errors on surgical wards*- Easing administrative burden for **nursing staff** and reducing **medication errors** are valid operational benefits.- These are logistical advantages rather than the fundamental **evidence-based clinical rationale** for changing antibiotic duration to improve patient outcomes and safety.*The current low infection rate is likely due to other factors such as surgical technique and continuing antibiotics will eventually lead to resistance*- Attributing a low infection rate solely to **surgical technique** is speculative and does not address the lack of proven benefit for extended antibiotics.- While **antibiotic resistance** is a critical long-term concern, the most direct and immediate evidence-based principle for reducing duration focuses on the lack of additional benefit in preventing **SSIs** and the increased risk of **Clostridioides difficile**.

Question 26: A 68-year-old woman with end-stage renal failure on haemodialysis (Monday-Wednesday-Friday schedule) presents on a Saturday morning with fever, rigors, and a painful, fluctuant swelling at her arteriovenous fistula site in the left forearm. Examination reveals a 3cm tender, erythematous, fluctuant mass with surrounding cellulitis extending 5cm along the forearm. Her temperature is 38.9°C, blood pressure 142/88 mmHg, and heart rate 102 bpm. Blood cultures are taken. What is the most appropriate antibiotic regimen while awaiting culture results?

A. Intravenous flucloxacillin 2g four times daily with dose adjustment for renal function
B. Intravenous vancomycin 1g loading dose then dosing according to levels post-dialysis
C. Intravenous teicoplanin loading dose 800mg followed by levels-guided maintenance (Correct Answer)
D. Oral co-amoxiclav 625mg three times daily with incision and drainage only
E. Intravenous daptomycin 500mg once daily with no dose adjustment required

Explanation: ***Intravenous teicoplanin loading dose 800mg followed by levels-guided maintenance***- **Teicoplanin** is the preferred glycopeptide in hemodialysis patients because it is **not significantly removed by hemodialysis**, allowing for more stable levels and convenient dosing (e.g., once daily or every other day) without complex post-dialysis adjustments.- It provides essential **Gram-positive coverage**, including **MRSA**, which is a high-risk pathogen in vascular access infections for dialysis patients, necessitating empirical coverage.*Intravenous flucloxacillin 2g four times daily with dose adjustment for renal function*- Flucloxacillin does not provide coverage for **MRSA**, which must be empirically covered in a hemodialysis patient with a fistula site infection.- High-dose flucloxacillin in end-stage renal failure increases the risk of **neurotoxicity** and requires frequent dosing, making it less ideal than glycopeptides.*Intravenous vancomycin 1g loading dose then dosing according to levels post-dialysis*- Vancomycin is **partially cleared by modern high-flux hemodialysis** membranes, necessitating complex timing around dialysis sessions and frequent level monitoring.- While it covers MRSA, the risk of sub-therapeutic dosing between dialysis sessions (especially over a long weekend) makes **teicoplanin** a superior choice for maintaining stable drug levels.*Oral co-amoxiclav 625mg three times daily with incision and drainage only*- Oral therapy is insufficient for a patient presenting with **systemic inflammatory response syndrome (SIRS)** symptoms like fever (38.9°C) and rigors, indicating a severe infection.- Arteriovenous fistula infections are high-risk for **bacteremia** and endocarditis, requiring immediate, high-bioavailability **intravenous antibiotics**.*Intravenous daptomycin 500mg once daily with no dose adjustment required*- Daptomycin actually **requires significant dose adjustment** (usually given every 48 hours) in patients with a creatinine clearance of less than 30 mL/min or those on dialysis.- While effective against MRSA, it is generally reserved for cases where glycopeptides are contraindicated or in specific **VRE** infections, and the claim of no dose adjustment is incorrect.

Question 27: A 51-year-old man is admitted with community-acquired pneumonia and commenced on intravenous co-amoxiclav 1.2g three times daily. On day 3, he is clinically improved with temperature 37.2°C, respiratory rate 16/min, oxygen saturations 96% on room air, and he is eating and drinking normally. Blood tests show WCC 9.2 × 10⁹/L (down from 16.8 on admission) and CRP 42 mg/L (down from 168 on admission). According to the 'Start Smart - Then Focus' antimicrobial stewardship framework, what is the most appropriate management at this stage?

A. Continue intravenous co-amoxiclav for a total of 7 days as per standard pneumonia protocol
B. Switch to oral co-amoxiclav 625mg three times daily and review response in 24 hours (Correct Answer)
C. Stop antibiotics as the patient has completed 72 hours of therapy and is clinically well
D. Continue intravenous antibiotics but reduce frequency to twice daily dosing
E. Switch to oral clarithromycin monotherapy for atypical organism coverage

Explanation: ***Switch to oral co-amoxiclav 625mg three times daily and review response in 24 hours*** - The patient meets criteria for **IV-to-oral switch (IVOS)**: he is clinically stable, **apyrexial**, improving inflammatory markers (**CRP and WCC**), and able to tolerate oral intake. - Early IVOS is a cornerstone of the **'Start Smart – Then Focus'** framework, reducing **cannula-related infections** and facilitating earlier hospital discharge. *Continue intravenous co-amoxiclav for a total of 7 days as per standard pneumonia protocol* - Continuing **intravenous therapy** unnecessarily increases the risk of **thrombophlebitis** and bacteremia when clinical oral absorption is sufficient. - Standard protocol mandates a review at **48-72 hours** to de-escalate treatment based on clinical response, rather than sticking to a fixed IV duration. *Stop antibiotics as the patient has completed 72 hours of therapy and is clinically well* - While the patient is improving, a **3-day course** is generally insufficient for community-acquired pneumonia requiring hospitalization; a total of **5-7 days** is typically recommended. - **Premature cessation** of antibiotics before the full clinical course is completed increases the risk of **relapse** or treatment failure. *Continue intravenous antibiotics but reduce frequency to twice daily dosing* - Reducing the frequency of **IV co-amoxiclav** is not a standard pharmacokinetic approach and results in **sub-therapeutic levels** of the drug. - The priority in antimicrobial stewardship is to change the **route of administration** rather than adjusting frequency of a currently indicated IV drug. *Switch to oral clarithromycin monotherapy for atypical organism coverage* - There is no clinical or microbiological indication to switch to **monotherapy** with a different class when the patient is already responding well to **co-amoxiclav**. - Antimicrobial stewardship encourages sticking to effective therapy; switching to **clarithromycin** without cause may provide inadequate coverage for the primary pathogen.

Question 28: A 47-year-old woman with a BMI of 41 kg/m² presents with a 36-hour history of severe pain, swelling, and discolouration of her right thigh. She reports initial symptoms started as a small red area following a minor scratch 3 days ago. On examination, the affected area is dusky red with purple discolouration, there are bullae present, and she has severe pain disproportionate to the clinical findings. There is crepitus palpable in the tissue. Her temperature is 39.1°C, heart rate 118 bpm, blood pressure 98/62 mmHg, and she appears confused. Blood tests show WCC 22.4 × 10⁹/L, CRP 285 mg/L, creatinine 178 μmol/L, and lactate 4.2 mmol/L. What is the most critical immediate management priority?

A. Urgent CT scan of the affected limb to determine extent of tissue involvement
B. Immediate empirical broad-spectrum antibiotics including clindamycin and urgent surgical consultation (Correct Answer)
C. Blood cultures followed by intravenous flucloxacillin and close observation
D. Fascial biopsy and tissue culture to guide targeted antibiotic therapy
E. Aggressive fluid resuscitation and transfer to high-dependency unit for monitoring

Explanation: ***Immediate empirical broad-spectrum antibiotics including clindamycin and urgent surgical consultation*** - This patient presents with classic signs of **necrotising fasciitis (NF)**, including **pain disproportionate to findings**, **crepitus**, and **hemodynamic instability**, which requires urgent **surgical debridement**. - **Clindamycin** is essential as it acts as a **protein synthesis inhibitor**, effectively neutralizing the **exotoxins** produced by pathogens like Group A Streptococcus and Staphylococcus aureus. *Urgent CT scan of the affected limb to determine extent of tissue involvement* - While CT imaging can show **subcutaneous gas** or fascial thickening, it must **never delay** the time-to-surgery in a clinically evident case like this. - The diagnosis of NF is primarily **clinical**; waiting for imaging in the presence of **septic shock** and **crepitus** increases mortality risks. *Blood cultures followed by intravenous flucloxacillin and close observation* - **Flucloxacillin** alone is inadequate as it lacks coverage for **anaerobes** and the **polymicrobial nature** (Type I NF) often seen in patients with high BMI or comorbidities. - "Close observation" is inappropriate for an **acute surgical emergency** that carries a mortality rate of 20-40% if not managed aggressively. *Fascial biopsy and tissue culture to guide targeted antibiotic therapy* - Targeted therapy is a later goal; **empirical broad-spectrum coverage** is mandatory at presentation to combat life-threatening sepsis. - Waiting for **culture results** would result in fatal delays, as NF can spread at a rate of several centimeters per hour. *Aggressive fluid resuscitation and transfer to high-dependency unit for monitoring* - While **fluid resuscitation** is a critical component of the **Sepsis Six** bundle, it is supportive and does not address the underlying source of infection. - Definite management requires **source control** (surgery), which cannot be replaced by monitoring in an HDU or ICU setting.

Question 29: A hospital trust implements a new antimicrobial stewardship intervention whereby all patients prescribed carbapenems must have the prescription reviewed and authorised by a consultant microbiologist or infectious diseases physician within 24 hours. After 12 months, audit data shows a 35% reduction in carbapenem consumption, but there has been a corresponding 28% increase in piperacillin-tazobactam use and no change in overall antimicrobial consumption. What does this pattern most likely represent?

A. Successful antimicrobial stewardship demonstrating appropriate antibiotic selection
B. Antibiotic substitution effect without genuine stewardship benefit (Correct Answer)
C. Appropriate response to changing local resistance patterns
D. Evidence of improved microbiological sampling leading to targeted therapy
E. Carbapenem-sparing strategy consistent with best practice guidelines

Explanation: ***Antibiotic substitution effect without genuine stewardship benefit*** - This phenomenon, often termed the **'squeeze the balloon' effect**, occurs when restricting one class of antibiotics leads to a compensatory increase in the use of another class. - Because **total antimicrobial consumption** remains unchanged, the intervention has failed to promote true **de-escalation** or eliminate unnecessary use, merely shifting the selective pressure to **piperacillin-tazobactam**. *Successful antimicrobial stewardship demonstrating appropriate antibiotic selection* - Success in stewardship is measured by the **optimization of therapy** and a reduction in inappropriate use, not just shifting between broad-spectrum agents. - The lack of change in **overall consumption** suggests that clinical decision-making regarding the necessity of broad-spectrum coverage has not improved. *Appropriate response to changing local resistance patterns* - There is no data provided suggesting a shift in **antibiograms** or an increase in infections necessitating **piperacillin-tazobactam** over carbapenems. - The direct temporal link between the **new policy** and the shift in prescribing strongly points to a behavioral response rather than an epidemiological shift. *Evidence of improved microbiological sampling leading to targeted therapy* - Improved sampling and **targeted therapy** should ideally lead to a decrease in overall broad-spectrum use as patients are switched to narrow-spectrum agents. - Replacing one **broad-spectrum empiric agent** (carbapenem) with another (piperacillin-tazobactam) indicates that therapy remains non-targeted. *Carbapenem-sparing strategy consistent with best practice guidelines* - While **carbapenem-sparing** is a goal for managing **ESBL-producing organisms**, it should be part of a broader strategy that reduces the total ecological burden of antibiotics. - Merely substituting agents without addressing **total volume of use** does not align with best practices for limiting the development of **multidrug-resistant organisms**.

Question 30: A 62-year-old man with chronic venous insufficiency and lymphoedema of both lower limbs presents with his fifth episode of right leg cellulitis in 18 months. Each episode has required hospital admission for intravenous antibiotics. He is currently well with no active infection. His BMI is 32 kg/m², and he has well-controlled type 2 diabetes (HbA1c 52 mmol/mol). Skin swabs from previous episodes have grown beta-haemolytic streptococci (not group A). What is the most appropriate long-term prophylactic antibiotic strategy for this patient?

A. Oral penicillin V 250-500mg once daily (Correct Answer)
B. Oral flucloxacillin 250mg twice daily
C. Oral co-amoxiclav 625mg once daily
D. Oral erythromycin 250mg twice daily
E. Rotating courses of different antibiotics every 2 months

Explanation: ***Oral penicillin V 250-500mg once daily*** - Long-term **antibiotic prophylaxis** is indicated for patients who have experienced **two or more episodes** of cellulitis within a 12-month period, especially with risk factors like **lymphoedema** and **chronic venous insufficiency**. - **Penicillin V** (phenoxymethylpenicillin) is the first-line choice because it specifically targets **beta-haemolytic streptococci**, which were identified in previous skin swabs and are the most common cause of recurrent cellulitis in this setting. *Oral flucloxacillin 250mg twice daily* - While effective for acute **Staphylococcus aureus** infections, **flucloxacillin** is less effective than penicillin V for long-term prophylaxis against **beta-haemolytic streptococci**. - Guidelines specifically recommend **phenoxymethylpenicillin** (Penicillin V) over flucloxacillin for the prevention of recurrent streptococcal skin infections. *Oral co-amoxiclav 625mg once daily* - This provides an unnecessarily **broad spectrum** of coverage, including gram-negative and anaerobic organisms, which is not required for standard prophylaxis against **streptococci**. - Its use increases the risk of **antimicrobial resistance** and healthcare-associated infections like ***Clostridioides difficile***, making it inappropriate for routine prophylaxis. *Oral erythromycin 250mg twice daily* - This is a secondary option reserved specifically for patients with a documented **penicillin allergy**. - In non-allergic patients, **penicillin V** is preferred due to superior efficacy, narrower spectrum, and a more favorable side-effect profile regarding gastrointestinal tolerance. *Rotating courses of different antibiotics every 2 months* - There is no clinical evidence to support **rotating antibiotics** as a standard strategy for preventing recurrent soft tissue infections. - This approach is more likely to drive **multidrug resistance** and complicates the management of breakthrough infections, without providing additional benefit.

Question 31: A 43-year-old man who works as a plumber presents with a 4-day history of a progressively enlarging, tender abscess on his left forearm. He reports having sustained a minor puncture wound from a rusty nail while working 10 days ago. On examination, there is a 4cm fluctuant, erythematous swelling with surrounding cellulitis extending 2cm beyond the abscess margin. His temperature is 37.8°C. Incision and drainage is performed, yielding 15ml of purulent material. What is the most appropriate antibiotic management following the drainage procedure?

A. No antibiotics required as adequate drainage has been achieved
B. Oral flucloxacillin 500mg four times daily for 7 days (Correct Answer)
C. Intravenous co-amoxiclav 1.2g three times daily for 5 days
D. Oral metronidazole 400mg three times daily for 7 days
E. Intramuscular benzylpenicillin 1.2g immediately followed by oral phenoxymethylpenicillin

Explanation: ***Oral flucloxacillin 500mg four times daily for 7 days***- Antibiotics are indicated following incision and drainage (I&D) when there is **associated cellulitis** extending beyond the abscess margin or systemic upset.- **Oral flucloxacillin** is the first-line choice to target the most common skin pathogens, **Staphylococcus aureus** and **Streptococcus pyogenes**.*No antibiotics required as adequate drainage has been achieved*- While simple abscesses without systemic symptoms or cellulitis can be managed with I&D alone, this patient has **surrounding cellulitis** and a fever.- The guidelines recommend antimicrobial therapy when the **erythema** extends significantly beyond the abscess wall.*Intravenous co-amoxiclav 1.2g three times daily for 5 days*- **Intravenous antibiotics** are generally reserved for patients with severe sepsis, rapidly progressing infection, or those unable to tolerate oral medication.- Co-amoxiclav is unnecessarily **broad-spectrum** for a localized skin abscess in a patient who is hemodynamically stable.*Oral metronidazole 400mg three times daily for 7 days*- Metronidazole treats **anaerobic infections** but lacks the necessary activity against the **gram-positive cocci** (staphylococci and streptococci) typical of skin abscesses.- It is not indicated for standard cutaneous abscesses unless there is evidence of specific anaerobic involvement, such as a **foul odor** or origin in the perineal region.*Intramuscular benzylpenicillin 1.2g immediately followed by oral phenoxymethylpenicillin*- **Benzylpenicillin** and phenoxymethylpenicillin have a narrow spectrum and are ineffective against **beta-lactamase-producing** S. aureus (common in abscesses).- These agents are primarily used for confirmed **Group A Streptococcal** infections like erysipelas, rather than staphylococcal-dominant abscesses.

Question 32: A hospital antimicrobial stewardship team reviews quarterly audit data and identifies that the average duration of intravenous antibiotic therapy for uncomplicated community-acquired pneumonia on the medical wards is 7 days, despite most patients showing clinical improvement by day 3. Microbiological cultures are positive in only 15% of cases. Which antimicrobial stewardship intervention would be most appropriate to address this finding?

A. Implement automatic stop orders for all antibiotics after 5 days
B. Introduce a mandatory 48-72 hour review policy with emphasis on IV-to-oral switch criteria (Correct Answer)
C. Require infectious diseases consultation for all pneumonia cases before antibiotic initiation
D. Replace all intravenous antibiotics with oral formulations at admission
E. Mandate blood cultures and sputum cultures before any antibiotic prescription

Explanation: ***Introduce a mandatory 48-72 hour review policy with emphasis on IV-to-oral switch criteria*** - This intervention directly addresses the audit finding of prolonged **intravenous (IV) antibiotic duration** despite **early clinical improvement**, facilitating a timely transition to oral therapy. - It aligns with **antimicrobial stewardship principles** by requiring reassessment of IV therapy necessity and promoting the **IV-to-oral switch**, which reduces hospital stay and **catheter-related complications**. *Implement automatic stop orders for all antibiotics after 5 days* - This approach is overly rigid and could lead to **premature cessation** of antibiotics, potentially jeopardizing patient outcomes, especially for those with a slower clinical response. - **Individualized patient assessment** for treatment duration is crucial, as an arbitrary stop order does not account for clinical variability. *Require infectious diseases consultation for all pneumonia cases before antibiotic initiation* - This strategy is **resource-intensive and impractical** for all cases of uncomplicated community-acquired pneumonia (CAP) in a general hospital setting. - While beneficial for complex cases, it is not an efficient or scalable intervention to address the specific issue of **prolonged IV duration** in clinically stable patients. *Replace all intravenous antibiotics with oral formulations at admission* - This approach disregards the initial **clinical severity** and the need for **high bioavailability** and rapid systemic levels often required for hospitalized patients with pneumonia. - Many patients admitted for pneumonia require initial **IV therapy** to achieve adequate drug concentrations, especially if they are acutely ill or have impaired gastrointestinal absorption. *Mandate blood cultures and sputum cultures before any antibiotic prescription* - Although important for diagnosis and guiding therapy, the problem highlighted is the **duration of IV therapy** in clinically improving patients, not primarily the initial diagnostic workup. - The scenario states that microbiological cultures are positive in only 15% of cases, indicating that even if mandated, cultures would often not provide the specific guidance needed to significantly shorten **IV treatment duration** in most uncomplicated CAP patients.

Question 33: A 55-year-old woman with type 2 diabetes presents to the Emergency Department with a 3-day history of a painful, red, swollen right lower leg. On examination, there is a well-demarcated area of erythema extending from the ankle to mid-calf with associated warmth and tenderness. Her temperature is 38.2°C, heart rate 95 bpm, and blood pressure 135/82 mmHg. Blood tests show WCC 13.2 × 10⁹/L and CRP 78 mg/L. What is the recommended first-line antibiotic treatment for this patient according to current UK guidance?

A. Oral flucloxacillin 500mg four times daily
B. Intravenous flucloxacillin 1-2g four times daily (Correct Answer)
C. Oral co-amoxiclav 625mg three times daily
D. Intravenous vancomycin 1g twice daily
E. Oral doxycycline 200mg loading dose then 100mg twice daily

Explanation: ***Intravenous flucloxacillin 1-2g four times daily*** - This patient exhibits **systemic features** (fever, tachycardia, raised WCC/CRP), classifying this as **Eron Class III cellulitis**, which requires **intravenous antibiotics**. - **Flucloxacillin** is the first-line empirical choice as it effectively targets the most common pathogens, **Staphylococcus aureus** and **Streptococcus pyogenes**. *Oral flucloxacillin 500mg four times daily* - This is the treatment of choice for **Class I or II cellulitis** where the patient is systemically well and has no significant comorbidities. - Given the **fever (38.2°C)** and significantly **raised inflammatory markers**, oral therapy is considered insufficient for initial management in this case. *Oral co-amoxiclav 625mg three times daily* - **Co-amoxiclav** is not first-line for uncomplicated cellulitis and is typically reserved for cases involving **human or animal bites** or facial involvement. - Using a **broad-spectrum antibiotic** like this unnecessarily increases the risk of resistance and **Clostridioides difficile** infection. *Intravenous vancomycin 1g twice daily* - **Vancomycin** is indicated only if there is a known **penicillin allergy** or a high suspicion of **MRSA infection**. - There are no risk factors mentioned for MRSA, and the patient has no documented allergy to **beta-lactams**. *Oral doxycycline 200mg loading dose then 100mg twice daily* - **Doxycycline** serves as an alternative for patients with **penicillin allergy**, but intravenous therapy is still preferred for systemic illness. - The route is inappropriate for a patient with **systemic inflammatory response** signs, and it does not provide the same level of bactericidal activity as **flucloxacillin** for this presentation.

Question 34: A 39-year-old man who works as a marine biologist presents with a 5-day history of multiple painless papular lesions on both hands and forearms that have progressed to form violaceous nodules. He reports regular handling of sea urchins and coral samples. The lesions have a verrucous appearance and do not respond to a 3-day course of flucloxacillin. He is otherwise well with no systemic symptoms. What is the most likely causative organism?

A. Mycobacterium marinum (Correct Answer)
B. Erysipelothrix rhusiopathiae
C. Vibrio vulnificus
D. Sporothrix schenckii
E. Nocardia species

Explanation: ***Mycobacterium marinum*** - This infection, known as **Fish Tank Granuloma**, occurs after trauma in marine environments; it characteristically presents as **violaceous nodules** or verrucous plaques on distal extremities. - The organism grows optimally at **30-32°C**, explaining why it affects cooler areas like the hands and why it fails to respond to standard **beta-lactam antibiotics** like flucloxacillin. *Erysipelothrix rhusiopathiae* - Causes **erysipeloid**, which typically presents as a painful, sharply demarcated, diamond-shaped **erythematous plaque** rather than verrucous nodules. - It is usually very sensitive to **penicillin**, unlike the slow-growing mycobacteria seen in this case. *Vibrio vulnificus* - Presents as a **rapidly progressive** and life-threatening cellulitis with **hemorrhagic bullae** and severe systemic toxicity. - It is frequently associated with **undercooked seafood** or wound exposure to warm seawater in patients with underlying liver disease. *Sporothrix schenckii* - Causes **sporotrichosis** (Rose Gardener's Disease), which can share the lymphangitic spread pattern but is linked to **soil, hay, or moss**, not marine life. - The lesions are usually small, painless papules that eventually **ulcerate**, which differs from the verrucous nodular appearance described. *Nocardia species* - Cutaneous **nocardiosis** usually presents with abscesses or cellulitis and is predominantly seen in **immunocompromised** individuals. - This organism is associated with **soil and organic matter** inoculation, and it does not specifically correlate with the professional marine exposure mentioned.

Question 35: A hospital trust antimicrobial stewardship team analyses prescribing data and identifies that empirical antibiotic regimens for severe community-acquired pneumonia vary significantly between different medical teams, with some using co-amoxiclav and clarithromycin, others using co-amoxiclav and doxycycline, and some using dual beta-lactam combinations. Understanding the principles of antimicrobial stewardship, what is the primary reason why this variation in practice should be addressed?

A. Variation increases the risk of prescribing errors and reduces reliability of care delivery (Correct Answer)
B. Some regimens are more expensive than others, impacting healthcare costs unnecessarily
C. Dual beta-lactam combinations provide no additional microbiological coverage
D. This variation makes audit and monitoring of antimicrobial prescribing more difficult
E. Different regimens have different adverse effect profiles affecting patient safety

Explanation: ***Variation increases the risk of prescribing errors and reduces reliability of care delivery***- Standardizing care pathways according to **antimicrobial stewardship** principles minimizes **cognitive load** for clinicians, which reduces the likelihood of dosing or drug-selection errors.- Consistent application of **evidence-based guidelines** ensures a predictable, high-quality standard of care for all patients, regardless of which medical team is managing them.*Some regimens are more expensive than others, impacting healthcare costs unnecessarily*- While **cost-effectiveness** is a pillar of healthcare management, antimicrobial stewardship prioritizes **clinical outcomes** and the prevention of **resistance** over simple budgetary savings.- Economic considerations are a secondary benefit of standardization rather than the primary driver for clinical safety initiatives.*Dual beta-lactam combinations provide no additional microbiological coverage*- Using two **beta-lactams** simultaneously is clinically irrational due to overlapping mechanisms, but this is a specific clinical error rather than the systemic reason for addressing overall **practice variation**.- Addressing this specific regimen only fixes one localized issue instead of improving the **reliability of the prescribing system** as a whole.*This variation makes audit and monitoring of antimicrobial prescribing more difficult*- While non-standardized practice complicates **clinical audits** and data collection, this is an administrative hurdle rather than a direct threat to **patient safety**.- The goal of stewardship is to improve patient care; easier data monitoring is a functional outcome of standardization, not its primary objective.*Different regimens have different adverse effect profiles affecting patient safety*- All antibiotics carry risks of **side effects** (e.g., C. difficile, toxicity), but the primary stewardship concern with variation is the **lack of a systematic approach** to managing these risks.- The variability itself creates a higher risk of **unforeseen drug interactions** and monitoring failures compared to a single, well-known trust guideline.

Question 36: A 61-year-old man with decompensated alcoholic liver cirrhosis (Child-Pugh C, MELD 28) presents with a 48-hour history of erythema, warmth, and swelling of his right lower leg without a defined entry point. He is haemodynamically stable. Blood tests show platelet count 45 × 10⁹/L, INR 2.1, and albumin 23 g/L. Which organism should empirical antibiotic therapy specifically cover in addition to the usual causes of cellulitis?

A. Vibrio vulnificus (Correct Answer)
B. Aeromonas hydrophila
C. Listeria monocytogenes
D. Cryptococcus neoformans
E. Capnocytophaga canimorsus

Explanation: ***Vibrio vulnificus*** - Patients with **decompensated cirrhosis**, particularly with underlying **iron overload**, are at extremely high risk for rapidly progressive and fatal infections from **Vibrio vulnificus**. - This organism commonly causes **fulminant cellulitis** (often with **hemorrhagic bullae**), primary **sepsis**, and can occur spontaneously or after seafood/saltwater exposure. *Aeromonas hydrophila* - While **Aeromonas** can cause serious skin and soft tissue infections, especially in immunocompromised individuals or those with **freshwater exposure**, it is not the primary organism of concern for spontaneous, rapidly progressive cellulitis in a cirrhotic patient without clear aquatic exposure, as compared to **Vibrio**. - It can cause similar symptoms but is less specifically associated with the high mortality and rapid progression seen in cirrhotic patients with **Vibrio vulnificus** infections. *Listeria monocytogenes* - **Listeria** is primarily known for causing **meningitis** and **sepsis** in vulnerable populations like the elderly, neonates, pregnant women, and other immunocompromised individuals (e.g., solid organ transplant recipients). - It is not a typical pathogen for **cellulitis** or spontaneous soft tissue infections in the context of alcoholic liver cirrhosis. *Cryptococcus neoformans* - **Cryptococcus** is an **opportunistic fungus** that primarily affects individuals with severe T-cell mediated immunodeficiency, most notably those with advanced **HIV/AIDS** or recipients of solid organ transplants on immunosuppressants. - It typically causes **meningitis** or pulmonary infections; cutaneous manifestations are usually papules or nodules and not an acute, rapidly spreading **cellulitis**. *Capnocytophaga canimorsus* - **Capnocytophaga canimorsus** is typically associated with severe infections, including sepsis and cellulitis, following **dog or cat bites/scratches**, especially in individuals with **asplenia** or chronic liver disease. - The patient's presentation of spontaneous cellulitis without a history of animal contact makes this organism a less likely primary target for empirical therapy in this specific scenario.

Question 37: A 48-year-old woman with hidradenitis suppurativa presents with recurrent painful nodules and draining sinuses in her axillae and groin. She has failed multiple courses of antibiotics. Wound cultures have grown mixed flora including Staphylococcus aureus, Streptococcus milleri group, and anaerobes. According to current guidance, what is the most appropriate long-term antimicrobial management strategy?

A. Long-term oral clindamycin 300mg twice daily for 12 weeks combined with rifampicin 300mg twice daily for 12 weeks (Correct Answer)
B. Long-term oral doxycycline 100mg twice daily as suppressive therapy
C. Rotating courses of different antibiotics every 2-4 weeks to prevent resistance
D. Intravenous ertapenem 1g daily for 6 weeks
E. No antimicrobial therapy; focus on surgical management and biologics

Explanation: ***Long-term oral clindamycin 300mg twice daily for 12 weeks combined with rifampicin 300mg twice daily for 12 weeks*** - This **combination therapy** with **clindamycin and rifampicin** is a first-line systemic treatment for moderate to severe **Hidradenitis Suppurativa (HS)**, especially when initial antibiotic courses have failed. - **Clindamycin** targets gram-positive bacteria like *Staphylococcus aureus* and **anaerobes**, while **rifampicin** reduces **biofilm formation** and synergizes with clindamycin, effectively managing the deep-seated infections characteristic of this condition. *Long-term oral doxycycline 100mg twice daily as suppressive therapy* - **Tetracyclines** like doxycycline are primarily used for **mild Hidradenitis Suppurativa (Hurley stage I)** due to their anti-inflammatory properties. - The patient's presentation with **recurrent painful nodules** and **draining sinuses** indicates more advanced disease that requires a more potent and comprehensive antimicrobial approach. *Rotating courses of different antibiotics every 2-4 weeks to prevent resistance* - This strategy is **not evidence-based** for hidradenitis suppurativa and does not align with current treatment guidelines. - **Frequent antibiotic rotation** can actually contribute to the development of **antimicrobial resistance** and does not provide the sustained therapeutic levels needed for deep-seated infections in HS. *Intravenous ertapenem 1g daily for 6 weeks* - **Intravenous ertapenem** is a broad-spectrum antibiotic generally reserved for **severe, refractory cases** of HS or acute flares, often as a short-term "rescue" therapy. - It is not considered a standard **long-term management strategy** due to its intravenous administration, which poses significant logistical challenges and risks for prolonged outpatient use. *No antimicrobial therapy; focus on surgical management and biologics* - While **surgical management** and **biologic therapies** (e.g., adalimumab) are crucial for moderate to severe HS, they are often used *in conjunction with* antimicrobials. - Given the **mixed flora** and active inflammatory components, entirely omitting antimicrobial therapy would neglect the infectious burden and could hinder overall disease control.

Question 38: A hospital antimicrobial stewardship committee reviews prescribing data showing that the average duration of antibiotic therapy for uncomplicated community-acquired pneumonia is 9.2 days, despite most patients being apyrexial and clinically stable by day 5. Which of the following quality improvement interventions would most effectively address this issue while maintaining patient safety?

A. Implement automatic stop orders for all pneumonia prescriptions at 5 days unless renewed
B. Develop and implement a clinical decision support tool with evidence-based stop/review dates at time of prescribing (Correct Answer)
C. Conduct educational sessions for junior doctors on guideline-recommended durations
D. Require consultant approval for all antibiotic prescriptions beyond 5 days
E. Send weekly emails to all prescribers highlighting the audit findings and guidelines

Explanation: ***Develop and implement a clinical decision support tool with evidence-based stop/review dates at time of prescribing*** - This approach integrates **evidence-based guidelines** directly into the prescribing workflow, making the correct behavior the **default easy option** and promoting adherence. - It allows for **proactive planning** of antibiotic duration based on clinical context while still permitting overrides for individual patient needs, thus maintaining safety. *Implement automatic stop orders for all pneumonia prescriptions at 5 days unless renewed* - **Hard stops** without integrated clinical decision support can potentially compromise **patient safety** if a patient genuinely requires a longer course and the order is inadvertently terminated. - This method shifts the responsibility to reactively re-prescribe rather than encouraging **proactive, evidence-based duration planning** at the initial prescribing stage. *Conduct educational sessions for junior doctors on guideline-recommended durations* - While beneficial for knowledge, **educational interventions** alone are generally considered "low-reliability" strategies for sustained behavioral change and often have limited impact on prescribing habits. - They do not address **systemic barriers** or provide immediate, in-workflow guidance at the point of prescribing, where decisions are made. *Require consultant approval for all antibiotic prescriptions beyond 5 days* - This creates a **significant bureaucratic burden** on consultants and may lead to delays in necessary therapy or contribute to **physician burnout** due to increased workload. - It is a highly **resource-intensive** measure that focuses on oversight and restriction rather than empowering prescribers with tools for better decision-making. *Send weekly emails to all prescribers highlighting the audit findings and guidelines* - **Passive interventions** like mass emails are often subject to "information overload" and have been shown to have very **low effectiveness** in consistently changing established clinical habits. - **Audit and feedback** are more impactful when delivered in a personalized manner and integrated directly into the **clinical workflow** rather than through generic, non-interactive communication.

Question 39: A 73-year-old woman with breast cancer on chemotherapy develops neutropenic sepsis and is treated with piperacillin-tazobactam. On day 4, she develops a new painful erythematous rash on her thigh. The area is warm, swollen, and tender with a sharply demarcated raised border. Her neutrophil count has now recovered to 2.1 × 10⁹/L. Blood cultures from admission grew Escherichia coli sensitive to piperacillin-tazobactam. What is the most likely explanation for the new rash?

A. Immune reconstitution inflammatory syndrome as neutrophils recover (Correct Answer)
B. Breakthrough infection with a resistant organism
C. Allergic reaction to piperacillin-tazobactam
D. Cellulitis caused by a separate bacterial infection
E. Cutaneous manifestation of underlying malignancy

Explanation: ***Immune reconstitution inflammatory syndrome as neutrophils recover*** - The inflammatory response was initially absent during the **neutropenic** phase; as the **neutrophil count** recovers to 2.1 × 10⁹/L, the body mounts a sudden response against bacteria (like the *E. coli* found in blood) that had seeded into tissues. - This leads to the appearance of a **new, painful, erythematous rash** with a raised border, mimicking a worsening infection despite effective antibiotic treatment. *Breakthrough infection with a resistant organism* - The admission blood cultures grew *E. coli* which was **sensitive** to the current regimen of **piperacillin-tazobactam**, making resistance unlikely. - A breakthrough infection typically results in clinical deterioration rather than localized inflammation coinciding exactly with **neutrophil recovery**. *Allergic reaction to piperacillin-tazobactam* - Drug allergies usually present as a **diffuse maculopapular rash** or urticaria rather than a localized, sharply demarcated, warm, and swollen area on one thigh. - An allergic reaction would not typically correspond with the specific timing of **bone marrow recovery**. *Cellulitis caused by a separate bacterial infection* - While localized inflammation resembles **cellulitis**, the rapid onset coinciding with recovery of the **neutrophil count** suggests an inflammatory rebound rather than a de novo infection. - Standard cellulitis would be unlikely to develop while the patient is already receiving broad-spectrum **antipseudomonal** coverage (piperacillin-tazobactam). *Cutaneous manifestation of underlying malignancy* - Paraneoplastic syndromes usually present with chronic, progressive, or recurring morphological patterns rather than an **acute inflammatory** rash during sepsis treatment. - The timing and clinical history of **neutropenic sepsis** point towards an infectious or immune-mediated etiology rather than a direct effect of **breast cancer**.

Question 40: According to UK antimicrobial stewardship guidance, which of the following interventions has the strongest evidence base for reducing healthcare-associated Clostridioides difficile infection rates in hospital settings?

A. Implementing antimicrobial formulary restrictions for fluoroquinolones and cephalosporins (Correct Answer)
B. Mandatory hand hygiene audits with alcohol-based hand rub on all clinical areas
C. Universal screening of all hospital admissions for Clostridioides difficile carriage
D. Routine prophylactic administration of probiotics to patients receiving antibiotics
E. Weekly environmental cleaning audits with ATP bioluminescence monitoring

Explanation: ***Implementing antimicrobial formulary restrictions for fluoroquinolones and cephalosporins*** - Restricting high-risk antibiotics, particularly **fluoroquinolones**, **cephalosporins**, and clindamycin, is the most robust evidence-based strategy for reducing **healthcare-associated CDI** rates. - Clinical evidence and UK national stewardship initiatives have demonstrated that such **formulary interventions** directly correlate with a significant decline in *C. difficile* incidence. *Mandatory hand hygiene audits with alcohol-based hand rub on all clinical areas* - **Alcohol-based hand rubs** are ineffective against **Clostridioides difficile spores**, which are resistant to alcohol-mediated denaturation. - Effective hand hygiene for *C. difficile* requires physical removal of spores using **soap and water** washing rather than just alcohol-based sanitization. *Universal screening of all hospital admissions for Clostridioides difficile carriage* - Universal screening is not currently recommended as it is not **cost-effective** and many patients carry the bacteria without progressing to **active disease**. - Primary management focuses on **symptomatic patients** and reducing the selective pressure of antibiotics rather than identifying asymptomatic carriers. *Routine prophylactic administration of probiotics to patients receiving antibiotics* - Evidence for **probiotic prophylaxis** is inconsistent and lacks the strong clinical weighting required for universal UK antimicrobial stewardship recommendations. - There are significant safety concerns regarding the use of probiotics in **immunocompromised patients**, where they may lead to **fungemia** or bacteremia. *Weekly environmental cleaning audits with ATP bioluminescence monitoring* - While **environmental decontamination** with sporicidal agents is essential, cleaning audits alone have a weaker direct evidence base for reducing infection rates than **antimicrobial stewardship**. - ATP bioluminescence measures general **organic material** but does not specifically confirm the elimination of hardy **C. difficile spores**.

Question 41: A 56-year-old man with poorly controlled type 2 diabetes (HbA1c 104 mmol/mol) presents with a 2-day history of severe perineal pain and swelling. On examination, he has scrotal oedema, crepitus on palpation, and foul-smelling discharge. His temperature is 38.9°C, heart rate 118 bpm, blood pressure 95/60 mmHg, and blood glucose 24.3 mmol/L. What is the most critical immediate intervention?

A. Commence broad-spectrum intravenous antibiotics including anaerobic cover
B. Obtain urgent surgical review for debridement (Correct Answer)
C. Commence insulin infusion to control hyperglycaemia
D. Fluid resuscitation with crystalloid and vasopressor support
E. Obtain urgent CT scan of pelvis and perineum to delineate extent of infection

Explanation: ***Obtain urgent surgical review for debridement***- This patient has **Fournier's gangrene**, a necrotizing fasciitis of the perineum; **urgent surgical debridement** is the definitive treatment to stop disease progression and reduce high mortality rates.- Clinical signs like **crepitus**, foul-smelling discharge, and rapid systemic decline make this a clinical diagnosis where **source control** takes absolute precedence over all other interventions.*Commence broad-spectrum intravenous antibiotics including anaerobic cover*- While **early antibiotics** are essential to manage polymicrobial infection, they cannot penetrate the **necrotic tissue** and are insufficient without surgical removal of the infected focus.- Antibiotic therapy is an **adjunctive measure** and should be started immediately, but it does not replace the need for an emergent surgical consultation.*Commence insulin infusion to control hyperglycaemia*- Managing **hyperglycemia** and metabolic derangements (HbA1c 104 mmol/mol) is important for wound healing and immune function, but it is a **supportive intervention** rather than a life-saving one in this acute setting.- Metabolic stabilization should occur **concurrently** with surgical preparation but should never delay the trip to the operating room.*Fluid resuscitation with crystalloid and vasopressor support*- Aggressive **fluid resuscitation** is vital for managing **septic shock** (hypotension and tachycardia), but it is supportive and will fail without addressing the underlying source of sepsis.- Hemodynamic stabilization should be initiated in the **pre-operative phase** while the surgical team is being mobilized.*Obtain urgent CT scan of pelvis and perineum to delineate extent of infection*- Imaging such as a **CT scan** can help determine the extent of gas and tissue involvement, but it should **never delay surgery** when the diagnosis is clear clinically.- In a patient with **crepitus and systemic shock**, a macroscopic diagnosis is sufficient, and the priority is avoid time-to-debridement delays.

Question 42: A 41-year-old man who recently underwent allogeneic stem cell transplantation for acute myeloid leukaemia presents with a painful ulcerated lesion on his left leg with surrounding cellulitis. He is currently on immunosuppression with ciclosporin and prednisolone. The lesion has a necrotic centre with violaceous borders. Skin biopsy shows vasculitis and tissue culture grows Pseudomonas aeruginosa. What is the most likely diagnosis?

A. Ecthyma gangrenosum (Correct Answer)
B. Pyoderma gangrenosum
C. Necrotising fasciitis
D. Cutaneous mucormycosis
E. Sweet's syndrome

Explanation: ***Ecthyma gangrenosum***- This is a classic cutaneous sign of **Pseudomonas aeruginosa** bacteremia, typically occurring in **immunocompromised** patients such as stem cell transplant recipients.- The characteristic lesion features a **necrotic center** (black eschar) with a **violaceous border**, caused by bacterial invasion of blood vessels leading to **perivascular vasculitis**.*Pyoderma gangrenosum*- Although it presents as a painful ulcer with violaceous edges, it is a **sterile neutrophilic dermatosis** and would not grow Pseudomonas on culture.- It is frequently associated with **inflammatory bowel disease** or hematologic malignancies but does not involve infectious vasculitis.*Necrotising fasciitis*- This typically presents as a rapidly spreading infection of the **deep fascia** with severe systemic toxicity and **dishwater discharge**.- While it can be caused by various bacteria, it lacks the specific **ecthyma-like eschar** and localized vascular invasion characteristic of Pseudomonas.*Cutaneous mucormycosis*- This fungal infection also causes necrotic lesions in immunocompromised hosts, but tissue culture would reveal **broad, non-septate hyphae**.- It does not grow **Pseudomonas aeruginosa**, which is the specific causative agent identified in this clinical scenario.*Sweet's syndrome*- Also known as **acute febrile neutrophilic dermatosis**, it presents with tender, erythematous plaques or nodules rather than necrotic ulcers.- Histology shows a dense **neutrophilic infiltrate** in the dermis without the presence of bacteria or true vasculitis.

Question 43: A hospital implements a new antimicrobial stewardship intervention requiring all patients started on restricted antimicrobials to have documented microbiology review within 48 hours. After 6 months, audit data shows 85% compliance with this target. However, overall antimicrobial consumption measured in defined daily doses (DDDs) has not changed significantly. Which aspect of the intervention most likely explains this observation?

A. The intervention focused on process measures rather than outcome measures that directly impact prescribing behaviour (Correct Answer)
B. Microbiology review at 48 hours is too early to influence antimicrobial de-escalation decisions
C. The defined daily dose methodology is inappropriate for measuring antimicrobial consumption in hospital settings
D. Restricted antimicrobials represent too small a proportion of total antimicrobial use to affect overall consumption
E. Compliance of 85% is insufficient to achieve measurable changes in antimicrobial consumption patterns

Explanation: ***The intervention focused on process measures rather than outcome measures that directly impact prescribing behaviour*** - High compliance with a **process measure** (documenting a review) does not guarantee a change in clinical practice or **prescribing behaviour**. - For an intervention to reduce **Defined Daily Doses (DDDs)**, it must actively lead to **de-escalation**, discontinuation, or optimization of therapy, not just documentation. *Microbiology review at 48 hours is too early to influence antimicrobial de-escalation decisions* - A **48-hour review** is standard practice because it typically coincides with the availability of **preliminary culture results** and sensitivity data. - This timeframe is considered the "antibiotic time-out," where clinicians have enough information to switch from **empiric to directed therapy**. *The defined daily dose methodology is inappropriate for measuring antimicrobial consumption in hospital settings* - **DDDs** are the **WHO-standardized** unit for monitoring antimicrobial consumption and comparing usage data across different settings. - While it has limitations in children or patients with renal failure, it is a robust and widely accepted **outcome measure** for hospital-wide stewardship. *Restricted antimicrobials represent too small a proportion of total antimicrobial use to affect overall consumption* - **Restricted antimicrobials** are often broad-spectrum agents that contribute significantly to the total **DDD count** and selection pressure for resistance. - Managing these high-priority drugs is a core component of **antimicrobial stewardship** and should theoretically impact consumption metrics if done effectively. *Compliance of 85% is insufficient to achieve measurable changes in antimicrobial consumption patterns* - An **85% compliance rate** is generally considered high in quality improvement audits and should be sufficient to demonstrate a trend if the intervention was effective. - The lack of impact on **DDDs** despite high compliance suggests the weakness lies in the **intervention design** (the nature of the review), not the level of adherence.

Question 44: A 67-year-old woman with chronic lymphocytic leukaemia on ibrutinib presents with a 4-day history of facial cellulitis. She has a documented penicillin allergy (anaphylaxis). Blood cultures grow Gram-positive cocci in clusters. She has been receiving intravenous vancomycin but after 72 hours shows minimal clinical improvement. Her renal function is normal. What is the most appropriate next step in her antimicrobial management?

A. Request vancomycin trough levels and adjust dosing accordingly (Correct Answer)
B. Switch to intravenous linezolid 600mg twice daily
C. Add intravenous rifampicin to the vancomycin regimen
D. Switch to intravenous daptomycin 6mg/kg once daily
E. Switch to intravenous teicoplanin with loading doses

Explanation: ***Request vancomycin trough levels and adjust dosing accordingly*** - Success with **vancomycin** therapy is highly dependent on achieving therapeutic **trough levels** (typically 15-20 mg/L for serious Gram-positive infections like bacteremia or cellulitis with systemic signs); subtherapeutic levels are a primary cause of apparent treatment failure. - Before escalating to alternative antibiotics or concluding vancomycin failure, **therapeutic drug monitoring (TDM)** is crucial to ensure optimal dosing, especially since the patient has **normal renal function**, allowing for safe dose adjustments. *Switch to intravenous linezolid 600mg twice daily* - **Linezolid** is typically reserved for confirmed **vancomycin-resistant** Gram-positive infections (e.g., VRE, VRSA) or in cases of severe vancomycin intolerance, not merely for slow clinical response without documented subtherapeutic levels. - As a **bacteriostatic** agent against staphylococci, it might be less effective than an optimized vancomycin regimen in severe infections if the initial vancomycin dose was inadequate. *Add intravenous rifampicin to the vancomycin regimen* - Adding **rifampicin** is primarily considered for **staphylococcal infections** involving **prosthetic material** (e.g., joint prostheses, heart valves, vascular grafts) due to its activity against **biofilms**. Simple cellulitis without foreign bodies does not typically warrant its addition. - Rifampicin is a potent **CYP450 inducer**, leading to numerous **drug interactions**, and can cause **hepatotoxicity**, making its use in simple cellulitis without a clear indication generally avoided. *Switch to intravenous daptomycin 6mg/kg once daily* - **Daptomycin** is a potent bactericidal agent against Gram-positive bacteria, including **MRSA**, and is an appropriate alternative for complicated skin and soft tissue infections. However, like linezolid, it should be considered after confirming **vancomycin failure** or contraindication. - Switching before optimizing vancomycin risks premature use of a valuable agent, potentially contributing to **resistance development** and incurring higher costs, especially when vancomycin efficacy hasn't been fully explored. *Switch to intravenous teicoplanin with loading doses* - **Teicoplanin** is another glycopeptide antibiotic with a similar mechanism of action and spectrum to vancomycin. Simply switching to teicoplanin without addressing the potential issue of **inadequate vancomycin levels** is unlikely to resolve the treatment failure. - While an alternative for penicillin-allergic patients or those intolerant to vancomycin, its primary role here would be if vancomycin itself was deemed ineffective despite appropriate levels, or if there was a vancomycin-specific adverse effect.

Question 45: A 34-year-old man presents with a 3-day history of progressive pain and swelling of his right index finger following a minor cut while gardening. Examination reveals a tender, erythematous, swollen finger with purulent discharge from the nail fold and flexor tenosynovitis. What is the most important immediate management step?

A. Commence oral flucloxacillin and review in 48 hours
B. Obtain urgent hand surgery referral for incision and drainage with irrigation (Correct Answer)
C. Perform bedside incision and drainage in the Emergency Department
D. Commence intravenous co-amoxiclav and admit for observation
E. Obtain wound swab for culture and commence oral doxycycline

Explanation: ***Obtain urgent hand surgery referral for incision and drainage with irrigation*** - The clinical presentation of progressive pain, swelling, purulent discharge, and **flexor tenosynovitis** following a minor cut strongly indicates an **infectious flexor tenosynovitis**, which is a surgical emergency. - **Urgent surgical decompression and irrigation** are paramount to prevent irreversible damage to the tendon, such as necrosis, and to preserve hand function. *Commence oral flucloxacillin and review in 48 hours* - Delaying definitive treatment for 48 hours is unacceptable for **infectious flexor tenosynovitis**, as rapid progression of infection can lead to permanent **tendon damage** or loss of function. - **Oral antibiotics** alone are insufficient to manage a closed-space infection requiring mechanical debridement and drainage. *Perform bedside incision and drainage in the Emergency Department* - **Flexor tenosynovitis** requires a formal surgical approach in an operating room to ensure complete **irrigation of the entire tendon sheath** and to avoid damaging vital neurovascular structures. - A bedside incision may be inadequate for thorough drainage and carries a high risk of complications, including incomplete infection resolution and injury to adjacent structures. *Commence intravenous co-amoxiclav and admit for observation* - While **intravenous antibiotics** are an important adjunct, they cannot replace the need for **surgical drainage** of the pus in a closed-space infection. - Observation without surgical intervention in cases of **flexor tenosynovitis** will lead to continued pressure and inflammation, resulting in tendon necrosis and permanent functional impairment. *Obtain wound swab for culture and commence oral doxycycline* - **Doxycycline** is not the appropriate empiric antibiotic for typical acute hand infections, which are commonly caused by **Staphylococcus aureus** or **Streptococcus species**. - Waiting for **culture results** before initiating definitive **surgical management** is not advisable for a rapidly progressing infection like **flexor tenosynovitis** due to the risk of irreversible tissue damage.

Question 46: A hospital antimicrobial stewardship team is evaluating the implementation of an intravenous to oral switch policy. Which of the following clinical scenarios represents the most appropriate criterion for IV to oral antimicrobial switch in a patient with severe cellulitis who has been receiving IV flucloxacillin for 3 days?

A. Temperature normalised for 24 hours, clinical improvement evident, tolerating oral intake, and C-reactive protein decreased by 25% from admission (Correct Answer)
B. Temperature reduced from 39.2°C to 37.8°C, white cell count decreased from 16 to 12 × 10⁹/L, but patient still reporting significant pain
C. Complete resolution of erythema and swelling, patient ambulatory, but temperature still 37.9°C on day 3
D. Patient requesting oral therapy, temperature normalised, but C-reactive protein increased from 120 to 145 mg/L
E. Clinical improvement noted by nursing staff, temperature 37.2°C, but patient has one episode of vomiting in the past 24 hours

Explanation: ***Temperature normalised for 24 hours, clinical improvement evident, tolerating oral intake, and C-reactive protein decreased by 25% from admission*** - This scenario meets the core **clinical stability** criteria, including being **afebrile** for at least 24 hours and showing clear signs of **infection resolution**. - Successful switch requires a functional **gastrointestinal tract** to ensure adequate **bioavailability** and absorption of the oral antibiotic, alongside improving inflammatory markers like **CRP**. *Temperature reduced from 39.2°C to 37.8°C, white cell count decreased from 16 to 12 × 10⁹/L, but patient still reporting significant pain* - The patient is not yet **afebrile**, as a temperature of 37.8°C indicates a low-grade fever, failing the **temperature normalization** criterion. - Persistent **significant pain** suggests the local infection is not sufficiently controlled or resolving adequately to transition away from **parenteral therapy**. *Complete resolution of erythema and swelling, patient ambulatory, but temperature still 37.9°C on day 3* - A persistent fever of 37.9°C remains an **exclusion criterion** for IV to oral switch according to most **antimicrobial stewardship** guidelines, indicating ongoing systemic infection. - While local physical signs have improved, the systemic **inflammatory response** has not fully subsided, which is crucial for a safe switch. *Patient requesting oral therapy, temperature normalised, but C-reactive protein increased from 120 to 145 mg/L* - An **increasing C-reactive protein (CRP)** level suggests a failure of the current regimen or an escalating **inflammatory process**, which contradicts clinical improvement and warrants further investigation. - Decisions for switch should be based on **objective clinical data** and biochemical trends rather than solely on **patient preference**, even if the temperature is normal. *Clinical improvement noted by nursing staff, temperature 37.2°C, but patient has one episode of vomiting in the past 24 hours* - Any active **vomiting** or significant gastrointestinal upset is a contraindication as it jeopardizes the **gastric absorption** and **bioavailability** of oral medications. - Reliable **oral intake** for at least 24 hours without gastrointestinal distress is generally required to ensure **therapeutic efficacy** after the switch.

Question 47: A 52-year-old woman with recurrent MRSA skin infections has completed decolonisation therapy. According to current UK guidance, what is the recommended decolonisation regimen for MRSA carriage?

A. Mupirocin nasal ointment three times daily for 5 days and chlorhexidine body wash daily for 5 days (Correct Answer)
B. Fusidic acid nasal ointment twice daily for 7 days and povidone-iodine body wash daily for 7 days
C. Mupirocin nasal ointment twice daily for 10 days and triclosan body wash daily for 10 days
D. Bacitracin nasal ointment three times daily for 5 days and benzalkonium chloride body wash daily for 5 days
E. Polymyxin B nasal spray twice daily for 7 days and chlorhexidine body wash daily for 7 days

Explanation: ***Mupirocin nasal ointment three times daily for 5 days and chlorhexidine body wash daily for 5 days*** - This regimen reflects the standard **UK NICE and PHE guidelines** for MRSA decolonisation, targeting **MRSA reservoirs** in the nose and on the skin. - The protocol specifically uses 2% **mupirocin** applied to the inner vestibule of both nostrils **three times daily** for **5 days**, combined with **chlorhexidine** body wash. *Fusidic acid nasal ointment twice daily for 7 days and povidone-iodine body wash daily for 7 days* - **Fusidic acid** is generally not recommended as a first-line nasal decolonisation agent due to concerns about rapid development of bacterial **resistance**. - The recommended duration for standard decolonisation is typically **5 days**, not 7, and **povidone-iodine** is not the routinely specified antiseptic wash in UK guidelines. *Mupirocin nasal ointment twice daily for 10 days and triclosan body wash daily for 10 days* - While **mupirocin** is correct, the frequency of **twice daily** is insufficient for optimal efficacy; the standard is **three times daily**. - A **10-day duration** is unnecessarily prolonged for initial decolonisation and **triclosan** is not the standard body wash compared to chlorhexidine in current UK protocols. *Bacitracin nasal ointment three times daily for 5 days and benzalkonium chloride body wash daily for 5 days* - **Bacitracin** is not a standard component of UK MRSA decolonisation regimens due to its inferior efficacy compared to **mupirocin**. - **Benzalkonium chloride** is not the primary recommended antiseptic for **skin decolonisation** in MRSA carriers according to current UK guidance. *Polymyxin B nasal spray twice daily for 7 days and chlorhexidine body wash daily for 7 days* - **Polymyxin B** is primarily active against **Gram-negative bacteria** and is therefore ineffective against **Gram-positive MRSA**. - Nasal sprays are typically not as effective as ointments for decolonisation because they do not consistently coat the **nasal vestibule**, which is the main carriage site.

Question 48: A hospital antimicrobial stewardship committee reviews prescribing data showing that the median duration of antibiotic therapy for community-acquired pneumonia has decreased from 9 days to 6 days following implementation of new guidelines. However, 30-day readmission rates for pneumonia have increased from 8% to 14%. Which of the following represents the most appropriate interpretation and response to this data?

A. The shorter duration is causing treatment failure and guidelines should be revised to recommend 9-day courses
B. Further investigation is required to determine if readmissions are causally related to shorter antibiotic duration or reflect other factors (Correct Answer)
C. The increase in readmissions is an acceptable trade-off for reduced antimicrobial consumption
D. All patients should have extended antibiotic courses until the readmission rate returns to baseline
E. The data confirms that antimicrobial stewardship interventions compromise patient safety

Explanation: ***Further investigation is required to determine if readmissions are causally related to shorter antibiotic duration or reflect other factors***- A **temporal association** between shorter antibiotic courses and increased readmission suggests a safety signal, but **correlation does not equal causation**.- Investigating underlying factors like **illness severity**, **patient demographics**, or **microbiology of relapse** is essential before concluding the stewardship intervention is at fault.*The shorter duration is causing treatment failure and guidelines should be revised to recommend 9-day courses*- Reverting to longer courses prematurely ignores the potential for **confounding variables** that could be driving the increase in readmission rates.- Current guidelines for **community-acquired pneumonia (CAP)** generally support shorter courses (5-7 days), so an immediate shift back to 9 days without proof of failure is not **evidence-based practice**.*The increase in readmissions is an acceptable trade-off for reduced antimicrobial consumption*- Antimicrobial stewardship aims to balance **efficacy and safety**; patient safety should never be compromised for the sake of reduced consumption.- Ignoring an increase in **30-day readmission rates** would be a failure of the monitoring phase of any clinical intervention.*All patients should have extended antibiotic courses until the readmission rate returns to baseline*- Implementing **blanket extended courses** lacks clinical precision and exposes many patients to unnecessary **antibiotic side effects** and risk of **C. difficile**.- Effective stewardship requires a **targeted approach**, identifying which specific subgroups might be failing rather than altering therapy for all patients.*The data confirms that antimicrobial stewardship interventions compromise patient safety*- Stewardship is designed to optimize outcomes; while this data indicates a **safety signal**, it does not prove that stewardship inherently compromises care.- Proper stewardship involves the **continuous monitoring** of patient safety data to refine protocols and ensure that optimal care is maintained while reducing resistance.

Question 49: A 49-year-old man with poorly controlled type 2 diabetes (HbA1c 98 mmol/mol) presents with a 4-day history of increasing pain, swelling and discharge from his right ear. Examination reveals granulation tissue in the external auditory canal with purulent otorrhoea. He has severe otalgia and right-sided facial nerve weakness (House-Brackmann grade III). Temperature is 38.4°C. CT temporal bone shows soft tissue in the external canal with bone erosion of the mastoid. Which antibiotic regimen provides the most appropriate empirical coverage?

A. Intravenous ciprofloxacin (Correct Answer)
B. Oral ciprofloxacin and topical gentamicin drops
C. Intravenous piperacillin-tazobactam and ciprofloxacin
D. Intravenous flucloxacillin and metronidazole
E. Intravenous ceftazidime

Explanation: ***Intravenous ciprofloxacin*** - The clinical presentation of severe otalgia, **granulation tissue**, bone erosion on CT, and **facial nerve palsy** in a diabetic patient confirms **malignant otitis externa** (necrotising otitis externa). - **Ciprofloxacin** is the first-line treatment as it provides specific and potent activity against **Pseudomonas aeruginosa**, which causes over 90% of cases, and has excellent **bone penetration**. *Oral ciprofloxacin and topical gentamicin drops* - While oral quinolones have high bioavailability, **intravenous administration** is the preferred initial choice for severe cases involving **cranial nerve palsy** and systemic symptoms like fever. - **Topical therapy** alone or as an adjunct is insufficient to treat the deep-seated **skull base osteomyelitis** associated with this condition. *Intravenous piperacillin-tazobactam and ciprofloxacin* - **Dual antipseudomonal therapy** is generally not required for empirical treatment of malignant otitis externa and increases the risk of **adverse effects** and drug resistance. - Piperacillin-tazobactam lacks the specific **pharmacokinetic benefits** of fluoroquinolones for treating chronic bone infections unless multidrug resistance is confirmed. *Intravenous flucloxacillin and metronidazole* - This regimen targets **Staphylococcus aureus** and **anaerobes**, which are not the primary pathogens in necrotising otitis externa. - It provides inadequate coverage against **Pseudomonas aeruginosa**, leading to a high risk of treatment failure and disease progression. *Intravenous ceftazidime* - Although ceftazidime has strong **antipseudomonal activity**, it is usually reserved for cases resistant to ciprofloxacin or when quinolones are contraindicated. - It is less practical for the long-term treatment (typically 6–8 weeks) required for this condition because it lacks an **oral step-down formulation** with equivalent efficacy.

Question 50: What is the primary mechanism by which antimicrobial stewardship programs reduce healthcare-associated Clostridioides difficile infection rates?

A. Reducing overall antimicrobial consumption, particularly broad-spectrum agents (Correct Answer)
B. Increasing use of probiotics alongside antibiotic therapy
C. Improving hand hygiene compliance among healthcare workers
D. Implementing universal contact precautions for all patients receiving antibiotics
E. Routine screening of all admitted patients for asymptomatic C. difficile carriage

Explanation: ***Reducing overall antimicrobial consumption, particularly broad-spectrum agents***- Antimicrobial stewardship primarily works by preserving the **normal gut flora**, which provides **colonization resistance** against *C. difficile* spores.- Reducing the use of high-risk agents known as the **'4 Cs'** (**clindamycin, cephalosporins, co-amoxiclav, and carbapenems/fluoroquinolones**) significantly lowers the risk of *C. difficile* overgrowth and toxin production.*Increasing use of probiotics alongside antibiotic therapy*- While some studies suggest potential benefits, clinical guidelines provide **insufficient evidence** to recommend probiotics as a standard primary prevention mechanism within stewardship programs.- Stewardship focuses on **rationalizing drug use** and minimizing harm from antibiotics, rather than primarily relying on adjunctive therapies.*Improving hand hygiene compliance among healthcare workers*- This is a critical **infection control** measure aimed at preventing the physical transmission of spores, but it is distinct from the primary focus of **antimicrobial stewardship** on antibiotic prescribing.- Specifically, *C. difficile* spores are resistant to **alcohol-based hand rubs**, requiring **soap and water** for physical removal.*Implementing universal contact precautions for all patients receiving antibiotics*- Universal contact precautions are **impractical** and not cost-effective; guidelines usually recommend precautions only for patients with **active diarrhea** due to *C. difficile*.- This strategy focuses on containing transmission rather than addressing the underlying **antibiotic pressure** that predisposes patients to infection.*Routine screening of all admitted patients for asymptomatic C. difficile carriage*- Identifying **asymptomatic carriers** is not routinely recommended because treatment of carriers does not prevent disease and can worsen **dysbiosis**.- Screening does not address the core stewardship goal of reducing the **selective advantage** antibiotics provide to *C. difficile* within the host microbiome.

Question 51: A 71-year-old man with type 2 diabetes presents with a 3-day history of painful swelling of his right lower leg. On examination, there is erythema and oedema extending from mid-calf to ankle, with a clear demarcated edge. Temperature is 37.8°C. His right leg has chronic venous changes with haemosiderin deposition and lipodermatosclerosis. An area of shallow ulceration (2 cm × 1.5 cm) is present on the medial malleolus with fibrinous base and no purulent discharge. Which clinical feature best indicates that systemic antibiotic therapy is required?

A. The presence of chronic venous changes including lipodermatosclerosis
B. The presence of a venous leg ulcer in the affected area
C. The acute spreading erythema with systemic temperature elevation (Correct Answer)
D. The patient's history of type 2 diabetes mellitus
E. The haemosiderin deposition indicating chronic venous insufficiency

Explanation: ***The acute spreading erythema with systemic temperature elevation***- The presence of **acute spreading erythema** combined with **systemic symptoms** such as fever (37.8°C) is diagnostic of **cellulitis**, which requires systemic antibiotic therapy.- It is essential to distinguish between **bacterial colonization** of a chronic wound and a true **spreading infection** where antibiotics are indicated.*The presence of chronic venous changes including lipodermatosclerosis*- These findings indicate **chronic venous insufficiency** and are not markers of an acute infectious process requiring antibiotics.- While **lipodermatosclerosis** can cause redness (stasis dermatitis), it is generally bilateral and lacks the **acute onset** and fever associated with infection.*The presence of a venous leg ulcer in the affected area*- A **venous leg ulcer** is a risk factor and portal of entry for infection, but its presence alone only indicates **bacterial colonization**.- Routine use of systemic antibiotics for **non-infected ulcers** is discouraged as it does not improve healing and promotes **antimicrobial resistance**.*The patient's history of type 2 diabetes mellitus*- **Diabetes mellitus** is a significant risk factor for complications and severe infections, but it is not a direct indication for starting antibiotics.- Antibiotic therapy must be based on **clinical signs of infection** rather than comorbidities alone.*The haemosiderin deposition indicating chronic venous insufficiency*- **Haemosiderin deposition** is a permanent skin discoloration caused by red blood cell breakdown in the setting of **venous hypertension**.- This is a feature of **long-term venous disease** and does not represent an acute inflammatory or infectious state.

Question 52: A 28-year-old woman presents with a 2-day history of a tender, red lump on her left buttock. On examination, there is a 3 cm × 3 cm fluctuant, erythematous swelling with central purulent pointing. She is systemically well with temperature 37.3°C. The abscess is incised and drained in the Emergency Department with 8 mL of pus evacuated. The wound is packed. What is the most appropriate antibiotic management?

A. Prescribe oral flucloxacillin for 7 days
B. No antibiotics required - incision and drainage is sufficient treatment (Correct Answer)
C. Prescribe oral co-amoxiclav for 5 days
D. Send pus for culture and await results before deciding on antibiotics
E. Prescribe oral doxycycline for 5 days

Explanation: ***No antibiotics required - incision and drainage is sufficient treatment*** - For a simple **cutaneous abscess** in an immunocompetent patient without systemic symptoms, **incision and drainage (I&D)** is the gold standard and definitive treatment. - Clinical guidelines (e.g., NICE, IDSA) confirm that antibiotics do not improve cure rates or speed up recovery once **source control** (drainage) is achieved in otherwise healthy individuals. *Prescribe oral flucloxacillin for 7 days* - **Flucloxacillin** targets Gram-positive bacteria like *Staphylococcus aureus*, common in skin infections, but it offers no additional benefit for a simple abscess that has already been successfully drained. - Unnecessary antibiotic use promotes **antimicrobial resistance** and can lead to adverse effects, making it inappropriate for this clinical scenario. *Prescribe oral co-amoxiclav for 5 days* - **Co-amoxiclav** is a broad-spectrum antibiotic, generally reserved for more complex infections or those involving a wider range of pathogens, not a simple localized abscess in a **systemically well** patient. - Antibiotics are typically only considered if there is significant **surrounding cellulitis**, systemic signs of sepsis, or if the patient is **immunocompromised**. *Send pus for culture and await results before deciding on antibiotics* - While **microbiology cultures** of pus are often collected for surveillance or in cases of treatment failure, they are not usually needed to guide initial management for a simple, successfully drained abscess. - Given that **incision and drainage** is curative for this presentation, delaying treatment decisions pending culture results is unnecessary and would not alter the primary management strategy. *Prescribe oral doxycycline for 5 days* - **Doxycycline** is effective against community-acquired **MRSA** and could be considered in areas with high MRSA prevalence or in penicillin-allergic patients, but neither factor is specified here. - Regardless of the specific antibiotic, the definitive treatment for a simple abscess without systemic involvement remains **incision and drainage** alone.

Question 53: A hospital trust introduces a new antimicrobial stewardship intervention using an electronic prescribing system that automatically prompts prescribers to document indication, planned duration, and review date for all antibiotic prescriptions. Six months post-implementation, audit data shows 92% compliance with documentation but no significant change in overall antibiotic consumption or rates of Clostridioides difficile infection. What does this finding best demonstrate?

A. Electronic prescribing systems are ineffective for antimicrobial stewardship
B. Documentation compliance alone does not necessarily translate into improved antimicrobial prescribing behaviour (Correct Answer)
C. The intervention should be abandoned as it has failed to meet its objectives
D. Clostridioides difficile rates are unrelated to antimicrobial stewardship interventions
E. Six months is insufficient time to detect meaningful changes in antimicrobial consumption

Explanation: ***Documentation compliance alone does not necessarily translate into improved antimicrobial prescribing behaviour***- This finding highlights the gap between **process measures** (like documentation) and **outcome measures** (like antibiotic consumption or infection rates).- While the electronic system achieved high compliance in data entry, it did not significantly impact **clinical decision-making** or actual prescribing practices, indicating a passive intervention's limitation.*Electronic prescribing systems are ineffective for antimicrobial stewardship*- Electronic prescribing systems are powerful tools for **antimicrobial stewardship** when integrated with robust clinical decision support, alerts, or mandatory review processes.- The ineffectiveness in this scenario lies with the **design of the intervention** (merely prompting documentation), not the inherent capability of the electronic system itself.*The intervention should be abandoned as it has failed to meet its objectives*- Abandoning the intervention is premature, as the high documentation compliance shows a successful **infrastructure implementation**.- The intervention should instead be **refined** by adding more active components, such as automatic alerts for inappropriate prescriptions or requiring specialist approval.*Clostridioides difficile rates are unrelated to antimicrobial stewardship interventions*- This statement is medically incorrect; there is a well-established and direct link between **antibiotic use**, especially **broad-spectrum** agents, and the incidence of **Clostridioides difficile infection**.- The lack of change in C. difficile rates in this case is due to the intervention's failure to reduce **overall antibiotic consumption**, rather than a lack of relationship.*Six months is insufficient time to detect meaningful changes in antimicrobial consumption*- Significant changes in **antimicrobial consumption** can often be detected within a few months, particularly with impactful and effective interventions.- The 92% compliance rate suggests that the intervention was fully adopted and operational; therefore, the lack of change points to a flaw in the **intervention's strategy** rather than merely insufficient time.

Question 54: A 36-year-old previously healthy man presents with a 16-hour history of severe pain in his left hand following a minor puncture wound sustained while cleaning his aquarium. On examination, the dorsum of his left hand is markedly swollen, erythematous, and exquisitely tender. There are multiple haemorrhagic bullae. Temperature is 38.9°C, heart rate 118 bpm, blood pressure 108/65 mmHg. Blood tests show: WCC 18.4 × 10⁹/L, CRP 168 mg/L, lactate 3.2 mmol/L. What is the most likely causative organism?

A. Streptococcus pyogenes
B. Vibrio vulnificus
C. Mycobacterium marinum
D. Aeromonas hydrophila (Correct Answer)
E. Erysipelothrix rhusiopathiae

Explanation: ***Aeromonas hydrophila*** - **Aeromonas hydrophila** is a Gram-negative rod found in **freshwater environments** (like aquariums) that causes rapidly progressive soft tissue infections, including **necrotizing fasciitis**. - The presence of **haemorrhagic bullae**, rapid onset within hours, and systemic toxicity (fever, tachycardia, hypotension, elevated WCC, CRP, lactate) in the context of freshwater exposure is classic for this organism. *Vibrio vulnificus* - While it causes similar severe infections with **haemorrhagic bullae** and rapid progression, it is specifically associated with **seawater or saltwater** and raw seafood exposure. - This patient was cleaning a **freshwater aquarium**, making Aeromonas a more statistically likely pathogen than Vibrio. *Mycobacterium marinum* - Known as "**fish tank granuloma**," this infection typically presents as a **chronic**, slow-growing granulomatous lesion or sporotrichoid spread. - It develops over **weeks or months**, not as an acute, fulminant necrotizing infection with systemic sepsis. *Erysipelothrix rhusiopathiae* - This organism causes **erysipeloid**, a localized skin infection typically seen in fishermen or butchers after handling **raw meat or fish**. - It usually presents as a well-defined **purple-red lesion** on the hand that lacks systemic toxicity and typically does not form bullae. *Streptococcus pyogenes* - While **Group A Streptococcus** (GAS) is a leading cause of necrotizing fasciitis and sepsis, it is not specifically associated with **aquarium-related puncture wounds**. - Although clinically similar, the specific **environmental exposure** provided in the history strongly points toward a water-associated Gram-negative rod.

Question 55: A 53-year-old woman undergoes emergency laparotomy for perforated diverticulitis. She received intravenous co-amoxiclav 1.2g and metronidazole 500mg at induction of anaesthesia at 14:00. The operation was completed at 17:30. Post-operatively she remains on the surgical ward, is haemodynamically stable, and is receiving intravenous fluids. According to current UK antimicrobial stewardship guidance on surgical prophylaxis, what is the most appropriate antibiotic management?

A. Continue co-amoxiclav and metronidazole intravenously for 5 days (Correct Answer)
B. Give one further dose of co-amoxiclav and metronidazole then stop
C. Stop all antibiotics immediately as prophylaxis is complete
D. Continue co-amoxiclav and metronidazole for 24 hours post-operatively then stop
E. Switch to oral co-amoxiclav and metronidazole for 5 days

Explanation: ***Continue co-amoxiclav and metronidazole intravenously for 5 days***- This patient has **perforated diverticulitis**, which represents an **established intra-abdominal infection** (peritonitis) rather than a simple case requiring only surgical prophylaxis.- Current **antimicrobial stewardship** guidelines specify that when established infection or perforation is encountered, a **therapeutic course** (typically 5 days) is required instead of single-dose prophylaxis.*Give one further dose of co-amoxiclav and metronidazole then stop*- Extending prophylaxis by a single dose is generally not recommended in modern guidelines; prophylaxis should ideally be a **single preoperative dose**.- This approach is insufficient here because the surgery confirmed a **perforation**, which necessitates a full treatment course to manage bacterial contamination.*Stop all antibiotics immediately as prophylaxis is complete*- While **surgical prophylaxis** for clean-contaminated cases should ideally be a single dose, this rule does not apply to **therapeutic treatment** of active infections.- Stopping immediately after surgery for a perforation would carry a high risk of **treatment failure** and postoperative abscess formation.*Continue co-amoxiclav and metronidazole for 24 hours post-operatively then stop*- A **24-hour limit** is often the maximum duration for prophylaxis in prolonged or complex surgeries, but it is not intended for cases with **gross fecal contamination**.- Perforated diverticulitis requires a longer duration of antibiotics to ensure the **inflammatory process** and bacterial load are adequately controlled.*Switch to oral co-amoxiclav and metronidazole for 5 days*- While an **IV-to-oral switch** is a key stewardship principle, it is usually only appropriate once the patient is **clinically improving**, afebrile, and tolerating oral intake.- Immediately post-laparotomy for perforation, the patient is likely to have an **ileus** or restricted oral intake, making intravenous administration the more reliable route initially.

Question 56: A 67-year-old man with chronic venous insufficiency and recurrent cellulitis presents with his fourth episode in 14 months affecting the right lower leg. Each episode has required hospital admission and intravenous antibiotics. He has been treated for venous eczema and uses compression stockings irregularly. BMI is 32 kg/m². He has type 2 diabetes with HbA1c of 64 mmol/mol. Interdigital tinea pedis is noted on examination. Which intervention is most likely to reduce future episodes of cellulitis?

A. Prophylactic oral phenoxymethylpenicillin 500mg once daily
B. Ensuring optimal diabetes control and treating tinea pedis with topical antifungal therapy (Correct Answer)
C. Prescribing prophylactic flucloxacillin 500mg twice daily
D. Arranging elective saphenofemoral junction ligation surgery
E. Prescribing long-term oral doxycycline 100mg daily

Explanation: ***Ensuring optimal diabetes control and treating tinea pedis with topical antifungal therapy***- Addressing **modifiable risk factors** and portal of entry (like **tinea pedis**) is the primary step in preventing recurrent cellulitis.- Managing **blood glucose levels** and skin integrity significantly reduces the risk of bacterial invasion before considering long-term antibiotic prophylaxis.*Prophylactic oral phenoxymethylpenicillin 500mg once daily*- Guidelines recommend **antibiotic prophylaxis** only after all other predisposing factors have been optimized.- While it can be used for recurrent episodes, it is not the first-line intervention when active **tinea pedis** and poorly controlled **diabetes** are present.*Prescribing prophylactic flucloxacillin 500mg twice daily*- **Flucloxacillin** is typically used for acute treatment of staph infections but is not the preferred agent for long-term **streptococcal prophylaxis**.- It has a higher side-effect profile regarding **gastrointestinal tolerance** compared to phenoxymethylpenicillin.*Arranging elective saphenofemoral junction ligation surgery*- While venous insufficiency is a risk factor, **surgical ligation** is not an established primary prevention strategy for recurrent cellulitis.- Conservative management of venous disease with **compression stockings** and weight loss is prioritized over surgical intervention in this context.*Prescribing long-term oral doxycycline 100mg daily*- **Tetracyclines** are not the first-choice antibiotics for the prophylaxis of **Group A Streptococcus**, the most common cause of cellulitis.- This approach does not address the **underlying skin breaches** or metabolic factors contributing to the patient's recurrent infections.

Question 57: According to the UK 'Start Smart - Then Focus' antimicrobial stewardship toolkit, which of the following scenarios constitutes an appropriate indication for NOT performing the 'Senior Review' at 48-72 hours?

A. A patient on oral antibiotics for uncomplicated lower urinary tract infection being managed in the community (Correct Answer)
B. A patient receiving intravenous meropenem for hospital-acquired pneumonia on a general medical ward
C. A patient on oral co-amoxiclav for cellulitis admitted under the acute medical unit
D. A patient receiving intravenous vancomycin for suspected endocarditis under the cardiology team
E. A neutropenic patient receiving empirical piperacillin-tazobactam on the haematology ward

Explanation: ***A patient on oral antibiotics for uncomplicated lower urinary tract infection being managed in the community*** - The **'Start Smart - Then Focus'** toolkit is specifically designed for **secondary care (hospital)** settings to ensure antimicrobial stewardship during inpatient stays. - **Community-managed cases** follow primary care guidelines and do not mandate the formal 48-72 hour **clinical review** required for all hospital antibiotic prescriptions. *A patient receiving intravenous meropenem for hospital-acquired pneumonia on a general medical ward* - All **hospital inpatients** initiated on antibiotics must have a **Senior Review** at 48-72 hours to decide on stopping, switching, or narrowing therapy. - Broad-spectrum agents like **meropenem** specifically require documented stewardship decisions to prevent the development of **antimicrobial resistance**. *A patient on oral co-amoxiclav for cellulitis admitted under the acute medical unit* - The requirement for a **48-72 hour review** applies to **all antibiotics** in a hospital setting, regardless of whether the route is **intravenous or oral**. - This review ensures that the initial **empirical diagnosis** is still valid and determines if a definite **stop date** can be established. *A patient receiving intravenous vancomycin for suspected endocarditis under the cardiology team* - **Complex infections** such as endocarditis require rigorous oversight to review **microbiology results** and clinical response at the 72-hour mark. - The toolkit mandates that a **clear clinical plan** (Stop, Switch, Change, or Continue) is documented for every inpatient by a senior clinician. *A neutropenic patient receiving empirical piperacillin-tazobactam on the haematology ward* - High-risk patients on **broad-spectrum empiric therapy** must be reviewed to check for **de-escalation** opportunities based on culture results. - Failure to perform a **Senior Review** in this scenario would be a breach of the **antimicrobial stewardship** standards defined by the UK Health Security Agency.

Question 58: A 42-year-old man who works as a sous chef presents with a 5-day history of a progressively enlarging, painful swelling on his right index finger. The paronychia was initially treated with oral flucloxacillin by his GP 3 days ago with no improvement. On examination, there is marked erythema, swelling of the entire finger extending to the proximal interphalangeal joint, with a small area of purulent discharge at the nail fold. He is systemically well. Which organism is most likely responsible for the treatment failure?

A. Methicillin-resistant Staphylococcus aureus
B. Streptococcus pyogenes
C. Candida albicans (Correct Answer)
D. Eikenella corrodens
E. Pasteurella multocida

Explanation: ***Candida albicans*** - The patient's occupation as a **sous chef** involves frequent **wet work**, a well-established risk factor for **chronic paronychia** caused by **Candida albicans**. - Failure of symptoms to improve after 3 days of **oral flucloxacillin** (an antibacterial) strongly suggests a non-bacterial etiology, making a fungal infection the most probable cause. *Methicillin-resistant Staphylococcus aureus* - While **MRSA** would not respond to flucloxacillin, the patient's occupational exposure to moisture makes **fungal infection** a more likely primary diagnosis for this paronychia. - **MRSA** often presents with more severe or acute local infections, and less typically as a progressively chronic paronychia in this specific occupational setting. *Streptococcus pyogenes* - **Streptococcus pyogenes** is generally highly susceptible to **flucloxacillin**; therefore, treatment failure makes this organism an unlikely cause. - An infection by this bacterium would typically show signs of improvement rather than progression after appropriate antibiotic therapy. *Eikenella corrodens* - **Eikenella corrodens** is typically associated with infections resulting from **human bites** or **clenched-fist injuries**. - There is no history in the patient's presentation to suggest such an exposure, making this pathogen improbable. *Pasteurella multocida* - This organism is a common cause of infection following **animal bites**, particularly from **cats or dogs**. - The clinical context lacks any history of animal contact or bites, ruling out **Pasteurella multocida** as the likely pathogen.

Question 59: A hospital antimicrobial stewardship committee reviews consumption data showing that use of carbapenems has increased by 35% over 12 months, while microbiological culture rates have remained static. An audit of 50 carbapenem prescriptions reveals that 26 were started empirically in the Emergency Department, 12 were continued from ICU step-down without review, and 12 were prescribed following positive culture results. Which intervention is most likely to reduce inappropriate carbapenem use?

A. Implementing an automatic 72-hour stop order for all carbapenem prescriptions
B. Requiring microbiology approval for all carbapenem prescriptions before dispensing
C. Introducing a mandatory antimicrobial ward round review at 48-72 hours (Correct Answer)
D. Removing carbapenems from the hospital formulary
E. Implementing educational sessions on carbapenem indications for Emergency Department staff

Explanation: ***Introducing a mandatory antimicrobial ward round review at 48-72 hours*** - This intervention directly addresses the 76% of inappropriate carbapenem use identified, covering both **empirical starts** and **unreviewed continuations** from ICU step-down. - A mandatory review allows for timely **de-escalation** or discontinuation of broad-spectrum therapy based on **microbiological culture results** and clinical status, aligning with best **antimicrobial stewardship** practices. *Implementing an automatic 72-hour stop order for all carbapenem prescriptions* - An **automatic stop order** without clinical review can be dangerous, risking **premature cessation** of critical treatment for patients who still require carbapenems for severe or **multi-drug resistant infections**. - This approach fails to provide a mechanism for **therapy optimization** or **alternative antibiotic selection**, potentially compromising patient safety and promoting treatment failure. *Requiring microbiology approval for all carbapenem prescriptions before dispensing* - **Pre-authorization** by microbiology can lead to **critical delays** in initiating life-saving broad-spectrum antibiotics, especially for patients presenting with **sepsis** or severe infections in the Emergency Department. - While it controls initial prescribing, it does not adequately address the issue of **prolonged or unreviewed therapy** once the prescription has been approved and started. *Removing carbapenems from the hospital formulary* - **Removing carbapenems** from the formulary is an **extreme measure** that eliminates essential treatment options for severe infections caused by **Extended-Spectrum Beta-Lactamase (ESBL)**-producing organisms or other **multi-drug resistant (MDR)** pathogens. - This approach would leave clinicians without vital tools for managing complex infections, potentially increasing **morbidity and mortality** rather than promoting judicious use. *Implementing educational sessions on carbapenem indications for Emergency Department staff* - While **education** is a foundational element of antimicrobial stewardship, it is often **insufficient alone** to significantly alter entrenched prescribing behaviors or achieve rapid, substantial reductions in inappropriate use. - This intervention only targets the **Emergency Department**, neglecting the significant portion of inappropriate carbapenem use (24%) identified from **unreviewed continuations** during ICU step-down.

Question 60: A 58-year-old woman presents to the Emergency Department with a 30-hour history of a painful, swollen, erythematous right calf. She has type 2 diabetes treated with metformin. Temperature is 38.2°C, heart rate 98 bpm, blood pressure 135/82 mmHg. The affected area measures 18 cm × 12 cm with a clearly demarcated edge and is tender to touch. There is no crepitus, no blistering, and no systemic signs of sepsis. Blood tests show WCC 13.2 × 10⁹/L, CRP 78 mg/L, creatinine 82 μmol/L. What is the most appropriate antibiotic choice?

A. Oral flucloxacillin (Correct Answer)
B. Intravenous flucloxacillin and clindamycin
C. Oral co-amoxiclav
D. Intravenous piperacillin-tazobactam, clindamycin and gentamicin
E. Oral doxycycline

Explanation: ***Oral flucloxacillin***- This patient presents with uncomplicated **cellulitis/erysipelas** categorized as **Eron Class II** (stable with single comorbidity but stable vitals), for which oral therapy is first-line.- **Flucloxacillin** provides excellent narrow-spectrum coverage for the most common causative organisms, **Staphylococci** and **Streptococci**, and the patient has no signs of severe sepsis or impaired absorption.*Intravenous flucloxacillin and clindamycin*- **Intravenous** administration is reserved for **Eron Class III or IV** patients who exhibit significant systemic upset, instability, or rapidly progressing infection.- The addition of **clindamycin** is typically used in suspected **toxic shock syndrome** or necrotizing infections to inhibit toxin production, which is not indicated here.*Oral co-amoxiclav*- **Co-amoxiclav** is a broad-spectrum antibiotic that is usually reserved for **bite wounds**, facial cellulitis, or infections where **Gram-negative** or anaerobic coverage is specifically required.- It is not recommended as first-line for simple limb cellulitis to avoid unnecessary broad-spectrum use and the risk of **Clostridioides difficile**.*Intravenous piperacillin-tazobactam, clindamycin and gentamicin*- This intensive combination therapy is designated for **life-threatening infections** such as **necrotizing fasciitis** or severe hospital-acquired sepsis.- Clinical features like the **clearly demarcated edge** and absence of **crepitus** or disproportionate pain rule out the need for such aggressive, multi-drug IV coverage.*Oral doxycycline*- **Doxycycline** is primarily used as an alternative for cellulitis in patients with a confirmed **penicillin allergy**.- It is not the preferred first-line agent because **flucloxacillin** is generally more effective against the **beta-hemolytic streptococci** frequently responsible for these presentations.

Question 61: A 45-year-old man with community-acquired pneumonia has been on intravenous co-amoxiclav for 72 hours. He is apyrexial, oxygen saturations are 96% on room air, his white cell count has normalised, and C-reactive protein has dropped from 185 mg/L to 42 mg/L. He is eating and drinking normally. According to antimicrobial stewardship principles, what is the most appropriate next step in management?

A. Switch to oral co-amoxiclav and plan discharge (Correct Answer)
B. Continue intravenous co-amoxiclav for a total of 7 days
C. Stop antibiotics as clinical parameters have normalised
D. Switch to intravenous ceftriaxone monotherapy
E. Continue intravenous co-amoxiclav until CRP normalises completely

Explanation: ***Switch to oral co-amoxiclav and plan discharge*** - This patient meets the criteria for an **IV-to-oral switch** as he is clinically improving, **apyrexial**, has a falling **CRP**, and is capable of **oral intake**. - This practice follows **antimicrobial stewardship** principles, reducing the risk of **cannula-related infections** and facilitating early hospital discharge. *Continue intravenous co-amoxiclav for a total of 7 days* - Continuing **intravenous (IV)** therapy when the oral route is viable is unnecessary and increases the risk of **thrombophlebitis**. - Modern guidelines advocate for the **earliest possible switch** to oral therapy once clinical stability is achieved, rather than fixed IV durations. *Stop antibiotics as clinical parameters have normalised* - While the patient is improving, **community-acquired pneumonia (CAP)** typically requires a full course (usually 5–7 days) to ensure complete **pathogen eradication**. - Stopping therapy after only 72 hours of IV treatment without a following oral course may lead to **clinical relapse** or treatment failure. *Switch to intravenous ceftriaxone monotherapy* - There is no clinical indication to escalate or change to a **broad-spectrum cephalosporin**, which could increase the risk of **Clostridioides difficile** infection. - Ceftriaxone is an **IV/IM** medication; the goal in stewardship for a stable patient is to transition to the **oral route**. *Continue intravenous co-amoxiclav until CRP normalises completely* - **C-reactive protein (CRP)** has a relatively long half-life and may take several days to reach the normal range despite effective treatment. - Stewardship guidelines emphasize **clinical stability** and a **significant trend downwards** in CRP, rather than waiting for it to reach baseline.

Question 62: A hospital trust implements a new antimicrobial stewardship initiative using intravenous-to-oral switch protocols for patients on IV antibiotics who meet specific criteria: afebrile for 24 hours, improving clinically, able to swallow, and functioning gastrointestinal tract. After 6 months, audit data shows that the median duration of IV therapy has decreased from 5.5 days to 3.2 days, with no increase in treatment failures or readmissions. What is the primary benefit of this intervention in terms of antimicrobial stewardship principles?

A. Reduction in antimicrobial resistance rates
B. Decreased risk of catheter-related bloodstream infections and reduced length of hospital stay (Correct Answer)
C. Improved bioavailability of antibiotics
D. Lower overall antibiotic consumption
E. Enhanced penetration of antibiotics into infected tissues

Explanation: ***Decreased risk of catheter-related bloodstream infections and reduced length of hospital stay***- Switching from **intravenous (IV)** to **oral (PO)** therapy eliminates the need for vascular access, thereby reducing the incidence of **catheter-related bloodstream infections (CRBSI)** and thrombophlebitis.- It facilitates earlier **hospital discharge**, as patients no longer require inpatient nursing care for IV administration, leading to lower healthcare costs and improved patient mobility.*Reduction in antimicrobial resistance rates*- While stewardship aims to reduce resistance, switching from IV to PO using the same agent does not change the **selection pressure** exerted on bacterial populations.- Resistance rates are more closely linked to the **spectrum of activity** and the total **duration of therapy**, rather than solely the route of administration.*Improved bioavailability of antibiotics*- Bioavailability refers to the fraction of a drug that reaches systemic circulation; **intravenous** administration inherently provides **100% bioavailability**.- Oral therapy may have equal (e.g., **linezolid**, **metronidazole**) but never higher bioavailability than the equivalent IV dose of the same drug.*Lower overall antibiotic consumption*- This intervention focuses on the **route of delivery** rather than the total amount of antibiotic used; the total **course duration** usually remains unchanged.- Stewardship strategies that reduce consumption typically involve **shortening therapy duration** or employing **watchful waiting** protocols.*Enhanced penetration of antibiotics into infected tissues*- Tissue penetration is a pharmacokinetic property determined by the drug's lipid solubility and molecular size, not the **route of entry** into the bloodstream.- While IV administration achieves higher **peak plasma concentrations (Cmax)** initially, the oral route is not inherently superior for tissue penetration when an equivalent dose is given.

Question 63: A 33-year-old woman who keeps pet reptiles presents with a 5-day history of multiple painful nodules on her shins that have not ulcerated. She also reports fever, malaise, and joint pains. The nodules are tender, erythematous, raised, and located on the anterior shins bilaterally without ulceration. What is the most likely diagnosis and appropriate initial investigation?

A. Sporotrichosis – skin biopsy for fungal culture
B. Erythema nodosum – chest X-ray and tuberculosis screening (Correct Answer)
C. Cutaneous tuberculosis – skin biopsy for mycobacterial culture
D. Nocardiosis – skin biopsy and modified acid-fast stain
E. Cellulitis – blood cultures and soft tissue ultrasound

Explanation: ***Erythema nodosum – chest X-ray and tuberculosis screening*** - The patient presents with classic **erythema nodosum (EN)**, characterized by tender, erythematous, **non-ulcerating nodules** on the anterior shins accompanied by systemic symptoms like fever and **arthralgia**. - Initial management involves screening for common underlying triggers such as **sarcoidosis** or **tuberculosis** via a **chest X-ray** and IGRA/Mantoux test.*Sporotrichosis – skin biopsy for fungal culture* - **Sporotrichosis** typically presents with a **lymphocutaneous spread**, manifesting as a chain of nodules along lymphatic drainage lines that frequently **ulcerate**. - While exposure to plants or soil is common, the bilateral, non-ulcerating shin distribution described here is more representative of systemic **panniculitis**.*Cutaneous tuberculosis – skin biopsy for mycobacterial culture* - Primary **cutaneous tuberculosis** (like lupus vulgaris) usually presents as indolent, **asymmetric plaques or ulcers** rather than multiple acute, tender nodules on the shins. - While TB can trigger **reactive EN**, the primary cutaneous infection itself lacks the classic rapid-onset bilateral shin distribution seen in this case.*Nocardiosis – skin biopsy and modified acid-fast stain* - **Nocardiosis** typically affects **immunocompromised** individuals and presents as localized abscesses or **cellulitic lesions** that may drain fluid. - It does not characteristically present as sterile, symmetrical, tender nodules isolated to the anterior shins.*Cellulitis – blood cultures and soft tissue ultrasound* - **Cellulitis** is usually **unilateral**, poorly demarcated, and involves spreading skin warmth and edema rather than discrete, multiple **raised nodules**. - The bilateral involvement of the shins and the specific nodular appearance are almost always indicative of a **reactive panniculitis** like EN rather than a primary bacterial skin infection.

Question 64: A 58-year-old man with poorly controlled type 2 diabetes (HbA1c 96 mmol/mol) presents with a 6-day history of increasing otalgia, otorrhoea, and headache. Examination reveals granulation tissue in the external auditory canal, severe tenderness over the mastoid, and left facial nerve palsy. Temperature is 38.1°C. CT temporal bone shows bony erosion of the skull base. What is the most appropriate antimicrobial management?

A. Oral ciprofloxacin 750mg twice daily for 6 weeks
B. Intravenous flucloxacillin 2g four times daily for 6 weeks
C. Intravenous ciprofloxacin 400mg three times daily (or intravenous antipseudomonal beta-lactam) for at least 6 weeks with surgical debridement (Correct Answer)
D. Topical ciprofloxacin ear drops for 4 weeks
E. Intravenous meropenem 1g three times daily for 2 weeks

Explanation: ***Intravenous ciprofloxacin 400mg three times daily (or intravenous antipseudomonal beta-lactam) for at least 6 weeks with surgical debridement*** - This patient presents with **malignant (necrotising) otitis externa**, indicated by **granulation tissue** in the external auditory canal, **left facial nerve palsy**, and **bony erosion** of the skull base, all in a diabetic patient. - The treatment requires prolonged (minimum of 6 weeks) **intravenous antipseudomonal therapy** (such as ciprofloxacin or an antipseudomonal beta-lactam) and often includes **surgical debridement** due to the associated skull base osteomyelitis. *Oral ciprofloxacin 750mg twice daily for 6 weeks* - While ciprofloxacin is effective against *Pseudomonas aeruginosa*, **intravenous therapy** is crucial initially for severe **malignant otitis externa** with **cranial nerve involvement** and **bony erosion** to ensure adequate tissue penetration and rapid infection control. - Oral ciprofloxacin may be used for step-down therapy after initial clinical improvement, but it is not the preferred initial treatment for this advanced stage of disease. *Intravenous flucloxacillin 2g four times daily for 6 weeks* - **Flucloxacillin** primarily targets Gram-positive organisms like *Staphylococcus aureus* and lacks significant activity against **Pseudomonas aeruginosa**, which is the most common causative pathogen in malignant otitis externa. - Administering an antibiotic without **antipseudomonal coverage** would be ineffective and would lead to treatment failure and progression of the infection. *Topical ciprofloxacin ear drops for 4 weeks* - Topical treatments are only indicated for **superficial otitis externa** and are entirely insufficient for invasive infections like **malignant otitis externa** that involve the **skull base** and manifest with **cranial nerve palsies**. - Systemic antibiotics are essential to reach the deep-seated infection and achieve therapeutic concentrations at the site of bone involvement. *Intravenous meropenem 1g three times daily for 2 weeks* - Although **meropenem** is a highly effective **intravenous antipseudomonal antibiotic**, a treatment duration of only **2 weeks is far too short** for **skull base osteomyelitis** associated with malignant otitis externa. - **Malignant otitis externa** requires prolonged antibiotic therapy, typically for a minimum of 6 weeks and often longer, to achieve complete eradication of the infection from the bone and prevent recurrence.

Question 65: A hospital antimicrobial stewardship committee is reviewing strategies to reduce healthcare-associated Clostridioides difficile infections (CDI), which have increased by 30% over the past year. Analysis shows that most cases follow treatment with broad-spectrum antibiotics, particularly co-amoxiclav, cephalosporins, and fluoroquinolones. Which of the following interventions would most effectively reduce CDI incidence based on current evidence?

A. Universal prescribing of probiotics alongside all broad-spectrum antibiotics
B. Implementing an automatic stop order for all antibiotics after 7 days
C. Restricting use of high-risk antibiotics (particularly cephalosporins, co-amoxiclav, and fluoroquinolones) and promoting narrow-spectrum alternatives (Correct Answer)
D. Routine screening of all admitted patients for C. difficile colonisation
E. Mandatory use of fidaxomicin instead of vancomycin for all CDI treatment

Explanation: ***Restricting use of high-risk antibiotics (particularly cephalosporins, co-amoxiclav, and fluoroquinolones) and promoting narrow-spectrum alternatives***- Reducing exposure to **high-risk antibiotics** (the "Four Cs": Cephalosporins, Co-amoxiclav, Clindamycin, and Quinolones) is the most effective evidence-based strategy for preventing **C. difficile infection (CDI)**.- **Antimicrobial stewardship** interventions that promote **narrow-spectrum alternatives** preserve the protective intestinal microbiota and significantly decrease hospital CDI rates.*Universal prescribing of probiotics alongside all broad-spectrum antibiotics*- Current clinical guidelines do not provide sufficient evidence to support the **routine use of probiotics** for the primary prevention of CDI in a hospital setting.- There are concerns regarding the **quality of evidence** and the risk of rare complications like **fungemia or bacteremia** in immunocompromised patients.*Implementing an automatic stop order for all antibiotics after 7 days*- This approach is often too arbitrary and may lead to **inappropriate treatment durations** for infections that require longer courses, such as endocarditis or osteomyelitis.- While reducing duration is helpful, it does not specifically address the **risk profile of the drug classes** being used, which is a stronger driver of CDI.*Routine screening of all admitted patients for C. difficile colonisation*- Screening for **asymptomatic colonization** is not routinely recommended as it does not distinguish between colonization and active disease and can lead to **unnecessary treatment**.- This intervention focuses on identification rather than **preventing the primary disruption** of gut flora that leads to infection.*Mandatory use of fidaxomicin instead of vancomycin for all CDI treatment*- While **fidaxomicin** is associated with lower rates of **recurrence** compared to vancomycin, it is a treatment strategy rather than a primary prevention strategy.- Changing the treatment of existing cases does not reduce the **initial incidence** of CDI caused by broad-spectrum antibiotic use in the general patient population.

Question 66: A 69-year-old man with compensated liver cirrhosis (Child-Pugh B) due to alcohol-related liver disease presents with a 2-day history of a painful, rapidly spreading erythematous rash on his right leg after paddling in seawater at the beach. Examination reveals a haemorrhagic bullous cellulitis extending from ankle to knee. Temperature is 38.9°C, BP 108/68 mmHg, and heart rate 102 bpm. Which pathogen is most likely responsible and what is the appropriate antibiotic therapy?

A. Aeromonas hydrophila – intravenous ciprofloxacin and doxycycline
B. Vibrio vulnificus – intravenous ceftriaxone and doxycycline (Correct Answer)
C. Streptococcus pyogenes – intravenous benzylpenicillin and clindamycin
D. Pseudomonas aeruginosa – intravenous piperacillin-tazobactam
E. Staphylococcus aureus – intravenous flucloxacillin

Explanation: ***Vibrio vulnificus – intravenous ceftriaxone and doxycycline*** - **Vibrio vulnificus** is a halophilic bacterium found in **warm seawater**; patients with **liver cirrhosis** are at high risk for fulminant sepsis and **haemorrhagic bullous cellulitis**. - The recommended definitive treatment is a combination of a **third-generation cephalosporin** (like ceftriaxone) and **doxycycline** to cover this aggressive gram-negative pathogen. *Aeromonas hydrophila – intravenous ciprofloxacin and doxycycline* - While it presents similarly with necrotizing skin infections, **Aeromonas** is classically associated with **freshwater** exposure rather than seawater. - Although the antibiotic coverage is similar, the **environmental context** of the beach specifically points toward Vibrio species. *Streptococcus pyogenes – intravenous benzylpenicillin and clindamycin* - **Streptococcus pyogenes** is the leading cause of non-bullous cellulitis and necrotizing fasciitis, but it lacks a specific association with **seawater exposure**. - While clindamycin is used for its anti-toxin effects in necrotizing infections, this regimen lacks the necessary coverage for **marine gram-negative bacilli**. *Pseudomonas aeruginosa – intravenous piperacillin-tazobactam* - **Pseudomonas** is typically associated with hot tubs, puncture wounds through sneakers, or burns, rather than general seawater exposure in a cirrhotic patient. - While piperacillin-tazobactam has broad activity, it is not the **first-line specific recommendation** for the characteristic bullous lesions of Vibrio. *Staphylococcus aureus – intravenous flucloxacillin* - **Staphylococcus aureus** causes common skin infections and abscesses but does not typically present as **rapidly spreading haemorrhagic bullae** triggered by seawater. - **Flucloxacillin** is ineffective against the gram-negative marine organisms that are the primary concern in this specific clinical scenario.

Question 67: A 47-year-old woman with rheumatoid arthritis on methotrexate 20mg weekly and adalimumab (anti-TNF therapy) presents with a 3-day history of pain and swelling of her right index finger. Examination reveals a tender, fluctuant swelling over the flexor tendon sheath of the finger with the finger held in slight flexion. Passive extension causes severe pain. There is no lymphangitis or systemic features. What is the most important immediate management step?

A. Commence intravenous flucloxacillin and observe for 48 hours
B. Urgent hand surgery referral for incision and drainage within 24 hours (Correct Answer)
C. Aspiration of the swelling and commence oral co-amoxiclav
D. Arrange urgent MRI scan to assess extent of infection
E. Increase prednisolone dose and add oral antibiotics

Explanation: ***Urgent hand surgery referral for incision and drainage within 24 hours*** - The patient's presentation with flexion posture, fusiform swelling, tenderness along the flexor sheath, and severe pain on passive extension are the classic **Kanavel's signs**, highly indicative of **pyogenic flexor tenosynovitis**. - This condition is a **surgical emergency** requiring prompt incision and drainage to prevent rapid progression to **tendon necrosis**, adhesion formation, and permanent functional impairment, especially in an **immunosuppressed** patient on **anti-TNF therapy**. *Commence intravenous flucloxacillin and observe for 48 hours* - While intravenous antibiotics are necessary, they are insufficient as **monotherapy** for pyogenic flexor tenosynovitis because they cannot adequately penetrate the infected, **pressure-closed tendon sheath**. - **Observing for 48 hours** is dangerous and can lead to irreversible **tendon damage** or rupture due to sustained infection and pressure within the sheath. *Aspiration of the swelling and commence oral co-amoxiclav* - **Aspiration** is not an effective or definitive treatment for pyogenic flexor tenosynovitis, as it rarely achieves complete drainage of the complex tendon sheath and risks disseminating the infection. - **Oral co-amoxiclav** is inadequate for a severe, deep-seated infection in an immunocompromised patient; **intravenous antibiotics** are required. *Arrange urgent MRI scan to assess extent of infection* - The diagnosis of pyogenic flexor tenosynovitis is primarily **clinical**, based on the presence of **Kanavel's signs**, making an MRI scan unnecessary for diagnosis. - Waiting for an **MRI scan** would cause a critical delay in definitive surgical management, increasing the risk of severe complications such as **tendon necrosis**. *Increase prednisolone dose and add oral antibiotics* - Increasing the **prednisolone** dose would further suppress the patient's already compromised immune system due to **methotrexate** and **adalimumab**, exacerbating the bacterial infection. - This approach wrongly treats the acute infection as an **inflammatory flare** of rheumatoid arthritis, which can have devastating consequences in the context of a surgical emergency.

Question 68: A hospital trust conducts a point prevalence survey and finds that 35% of all inpatients are receiving at least one antimicrobial agent. Further analysis reveals that documentation of the indication, review date, and route of administration is missing in 42% of prescriptions. Which of the following interventions aligns best with the 'Start Smart - Then Focus' antimicrobial stewardship framework to address this documentation issue?

A. Implementing a hospital-wide ban on verbal antibiotic orders
B. Requiring completion of an antimicrobial prescription form documenting indication, route, dose, duration/review date, and signature at the time of prescribing (Correct Answer)
C. Reducing the hospital formulary to include only narrow-spectrum antibiotics
D. Mandating infectious disease consultation for all antimicrobial prescriptions
E. Introducing financial penalties for prescribers with poor documentation rates

Explanation: ***Requiring completion of an antimicrobial prescription form documenting indication, route, dose, duration/review date, and signature at the time of prescribing*** - The **'Start Smart'** component of the framework mandates that every antimicrobial prescription must include clinical **indication**, dose, **route**, and a clear **duration or review date**. - Implementing a structured form directly addresses the 42% documentation gap by making these fields a mandatory requirement for the initiation of therapy. *Implementing a hospital-wide ban on verbal antibiotic orders* - While banning verbal orders improves **patient safety** and reduces errors, it does not ensure that the necessary **clinical indication** or **review date** is actually recorded. - This intervention focuses on **communication protocol** rather than the systematic documentation requirements of the 'Start Smart' toolkit. *Reducing the hospital formulary to include only narrow-spectrum antibiotics* - Formulary restriction is a **stewardship strategy** to limit the use of broad-spectrum agents, but it does not fix issues related to **missing documentation**. - It addresses **antibiotic selection** rather than the clinical governance and **auditability** of the prescribing process. *Mandating infectious disease consultation for all antimicrobial prescriptions* - This approach is highly **resource-intensive** and impractical for the high volume of prescriptions seen in a hospital prevalence survey. - The framework emphasizes providing **prescribers** with the tools to document correctly themselves rather than transferring all **decision-making** to specialists. *Introducing financial penalties for prescribers with poor documentation rates* - Financial penalties are **punitive measures** that do not provide the systems-based support needed to improve **clinical workflow** or documentation habits. - Effective stewardship relies on **behavioral change** and structural supports, such as standardized forms, rather than negative reinforcement.

Question 69: A 41-year-old man who works as a butcher presents with a 4-day history of a painless, black eschar on his right forearm surrounded by significant non-pitting oedema extending to his upper arm. He recalls a minor cut at work 1 week ago. He is systemically well with normal observations. What is the most likely diagnosis and appropriate first-line antibiotic therapy?

A. Anthrax – intravenous ciprofloxacin and clindamycin (Correct Answer)
B. Necrotising fasciitis – intravenous piperacillin-tazobactam and clindamycin
C. Ecthyma gangrenosum – intravenous meropenem
D. Tularaemia – oral doxycycline
E. Cutaneous leishmaniasis – liposomal amphotericin B

Explanation: ***Anthrax – intravenous ciprofloxacin and clindamycin*** - The hallmark of **cutaneous anthrax** is a **painless black eschar** surrounded by extensive **non-pitting oedema**, often following occupational exposure to infected animal products (e.g., a **butcher**). - Treatment requires **ciprofloxacin** for bactericidal action and **clindamycin** to inhibit the production of potent **anthrax toxins**. *Necrotising fasciitis – intravenous piperacillin-tazobactam and clindamycin* - This is a surgical emergency characterized by **exquisite pain out of proportion** to clinical findings and rapid **systemic toxicity**, unlike the painless lesion and normal observations in this scenario. - It involves deep tissue destruction and often presents with crepitus, rather than a localized, stable, painless eschar with massive oedema. *Ecthyma gangrenosum – intravenous meropenem* - Typically occurs in **severely neutropenic** or immunocompromised patients as a result of **Pseudomonas aeruginosa** septicaemia. - The lesions are usually multiple, painful or tender, and develop into necrotic ulcers rather than being associated with occupational hide/meat exposure. *Tularaemia – oral doxycycline* - Caused by *Francisella tularensis*, this usually presents as a **painful ulcer** at the site of inoculation accompanied by significant regional **lymphadenopathy**. - While it can be zoonotic, it lacks the classic wide-spreading **gelatinous oedema** seen in cutaneous anthrax. *Cutaneous leishmaniasis – liposomal amphotericin B* - This parasitic infection typically presents as a **slow-growing chronic ulcer** or nodule that develops over weeks to months in travelers to endemic regions. - It does not present with the acute, massive oedema or the specific **black eschar** morphology within a 1-week timeframe.

Question 70: A 54-year-old woman with end-stage renal failure on continuous ambulatory peritoneal dialysis (CAPD) presents with a 2-day history of cloudy peritoneal dialysate fluid and diffuse abdominal pain. She is afebrile with stable observations. Dialysate white cell count is 480 cells/μL (>100 cells/μL abnormal) with 78% neutrophils. Gram stain shows gram-positive cocci in clusters. According to ISPD guidelines, what is the most appropriate initial empirical antibiotic regimen pending culture results?

A. Intraperitoneal vancomycin and intraperitoneal ceftazidime (Correct Answer)
B. Intravenous flucloxacillin and intravenous gentamicin
C. Intraperitoneal vancomycin alone
D. Intravenous vancomycin and intravenous meropenem
E. Intraperitoneal cefazolin and intraperitoneal gentamicin

Explanation: ***Intraperitoneal vancomycin and intraperitoneal ceftazidime***- Per the **ISPD guidelines**, empirical therapy for **CAPD-associated peritonitis** must cover both **Gram-positive** and **Gram-negative** organisms regardless of the initial Gram stain.- The **intraperitoneal (IP) route** is preferred over intravenous administration as it achieves significantly higher concentrations at the site of infection.*Intravenous flucloxacillin and intravenous gentamicin*- The **intravenous route** is less effective than the intraperitoneal route for treating the local peritoneal infection and is generally reserved for patients with **systemic sepsis**.- **Flucloxacillin** does not provide adequate coverage for **methicillin-resistant Staphylococcus aureus (MRSA)**, which is a common pathogen in dialysis patients.*Intraperitoneal vancomycin alone*- While the Gram stain suggests **Gram-positive cocci**, empirical treatment must remain broad-spectrum to include Gram-negative coverage until **culture results** are finalized.- Monotherapy risks treatment failure if a **polymicrobial infection** or a Gram-negative organism is present but not captured on the initial stain.*Intravenous vancomycin and intravenous meropenem*- **Meropenem** is unnecessarily broad for initial empirical therapy and should be reserved for **multidrug-resistant** organisms or severe clinical deterioration.- As with other intravenous options, this delivery method is inferior to **intraperitoneal administration** for achieving therapeutic levels in the dialysate.*Intraperitoneal cefazolin and intraperitoneal gentamicin*- **Cefazolin** is an acceptable alternative for Gram-positive coverage only in centers with very low rates of **MRSA**; vancomycin is preferred if resistance is a concern.- While **gentamicin** provides Gram-negative coverage, the combination of **vancomycin and ceftazidime** is often favored due to the potential **ototoxicity** and nephrotoxicity associated with aminoglycosides.

Question 71: What is the typical causative organism of erysipelas?

A. Staphylococcus aureus
B. Streptococcus pyogenes (Group A Streptococcus) (Correct Answer)
C. Pseudomonas aeruginosa
D. Escherichia coli
E. Pasteurella multocida

Explanation: ***Streptococcus pyogenes (Group A Streptococcus)***- **Erysipelas** is a superficial skin infection characteristically caused by **Group A beta-hemolytic Streptococcus**, involving the upper dermis and superficial lymphatics.- It presents as a bright red, edematous plaque with **sharply demarcated borders**, distinguishing it from deeper infections like cellulitis.*Staphylococcus aureus*- **Staphylococcus aureus** is the primary cause of many skin infections like **folliculitis**, **furuncles**, and **abscesses**, but is a rare cause of classic erysipelas.- While it can cause **cellulitis**, it typically lacks the raised, clear-cut margin seen in streptococcal erysipelas.*Pseudomonas aeruginosa*- This organism is an opportunistic pathogen typically associated with **burn wound infections**, **puncture wounds** through sneakers, or **hot tub folliculitis**.- It is not a common cause of primary **erysipelas** in a healthy individual.*Escherichia coli*- **E. coli** is a common cause of **urinary tract infections** and neonatal meningitis but is an infrequent cause of primary skin and soft tissue infections.- Skin involvement with E. coli is usually seen in **immunocompromised** patients or as part of a **polymicrobial** surgical site infection.*Pasteurella multocida*- This organism is classically associated with infections following **animal bites**, particularly from **cats or dogs**.- It produces a rapid-onset cellulitis rather than the **sharply circumscribed erythema** typical of erysipelas.

Question 72: A hospital antimicrobial stewardship team reviews prescribing patterns for community-acquired pneumonia and finds that 68% of patients admitted with low-severity pneumonia (CURB-65 score 0-1) are receiving dual therapy with co-amoxiclav and clarithromycin rather than the recommended single-agent oral amoxicillin. Which behavioural intervention strategy would be most effective in improving guideline adherence?

A. Sending monthly email reminders to all prescribers about the guidelines
B. Implementing restrictive antimicrobial approval requiring consultant approval for dual therapy in low-severity pneumonia
C. Embedding clinical decision support into the electronic prescribing system that prompts guideline-concordant choices based on CURB-65 score (Correct Answer)
D. Conducting annual mandatory e-learning modules on antimicrobial prescribing
E. Publishing audit results in the hospital newsletter with names of high prescribers

Explanation: ***Embedding clinical decision support into the electronic prescribing system that prompts guideline-concordant choices based on CURB-65 score*** - **Clinical Decision Support Systems (CDSS)** are highly effective because they provide **real-time, point-of-care guidance** at the exact moment a prescribing decision is made. - This intervention utilizes **nudge theory**, making the guideline-concordant choice the **default or easiest option**, thereby reducing cognitive load and errors in judgment. *Sending monthly email reminders to all prescribers about the guidelines* - This is a **passive intervention** that is often ignored due to **information overload** and lack of relevance to the immediate clinical context. - Reminders lack the **immediacy** required to change behavior during the actual workflow of admitting a patient. *Implementing restrictive antimicrobial approval requiring consultant approval for dual therapy in low-severity pneumonia* - While **restrictive stewardship** can be effective, it often creates **workflow barriers** and may unnecessarily delay treatment in a busy clinical environment. - This approach can lead to **clinician frustration** and "workarounds" rather than fostering a genuine understanding of guideline adherence. *Conducting annual mandatory e-learning modules on antimicrobial prescribing* - **E-learning modules** improve knowledge but are generally ineffective at producing **sustained behavioral change** when used as a standalone strategy. - The long gap between the training and the clinical application means the **retention of specific guidelines** like CURB-65 thresholds is often poor. *Publishing audit results in the hospital newsletter with names of high prescribers* - Using **public shaming** or peer pressure, while sometimes effective for specific issues, can create a **negative working environment** and foster resentment rather than genuine engagement with stewardship goals. - This strategy focuses on **retrospective judgment** rather than proactive, real-time support to prevent inappropriate prescribing.

Question 73: A 76-year-old man with ischaemic heart disease, chronic kidney disease stage 3b (eGFR 38 mL/min/1.73m²), and atrial fibrillation on apixaban presents with a 5-day history of a painful swollen right leg. Examination reveals extensive erythema from mid-calf to groin with areas of skin blistering and purple discolouration. Temperature is 39.4°C, BP 98/62 mmHg, heart rate 118 bpm. Blood tests show WCC 19.8 × 10⁹/L, CRP 285 mg/L, creatinine 198 μmol/L (baseline 142), lactate 3.8 mmol/L, and creatine kinase 1,820 U/L. What is the most appropriate empirical antibiotic regimen?

A. Intravenous flucloxacillin 2g four times daily
B. Intravenous co-amoxiclav 1.2g three times daily and clarithromycin 500mg twice daily
C. Intravenous meropenem 1g three times daily and clindamycin 600mg four times daily
D. Intravenous piperacillin-tazobactam 4.5g three times daily, clindamycin 600mg four times daily, and linezolid 600mg twice daily (Correct Answer)
E. Intravenous vancomycin 1g twice daily and metronidazole 500mg three times daily

Explanation: ***Intravenous piperacillin-tazobactam 4.5g three times daily, clindamycin 600mg four times daily, and linezolid 600mg twice daily***- The patient presents with classic signs of **necrotising fasciitis**, including severe systemic toxicity (septic shock), rapidly progressing skin changes with **blistering and purple discolouration** (tissue necrosis), elevated **lactate**, and a significantly raised **creatine kinase**, necessitating broad-spectrum coverage for aerobes and anaerobes.- This regimen provides extensive coverage: **piperacillin-tazobactam** targets Gram-positives, Gram-negatives (including Pseudomonas), and anaerobes; **linezolid** adds crucial coverage for **MRSA**; and **clindamycin** is vital for inhibiting bacterial **toxin production** and protein synthesis, which is key in mitigating the systemic inflammatory response in necrotising fasciitis.*Intravenous flucloxacillin 2g four times daily*- This regimen offers narrow-spectrum coverage primarily for penicillin-sensitive **Staphylococcus aureus** and **Group A Streptococcus**, which is insufficient for a suspected polymicrobial **necrotising fasciitis**.- It completely lacks activity against crucial pathogens such as **Gram-negative bacilli** (e.g., Pseudomonas), **anaerobes**, and **MRSA**, and does not provide the toxin-inhibiting properties of clindamycin.*Intravenous co-amoxiclav 1.2g three times daily and clarithromycin 500mg twice daily*- While co-amoxiclav provides some broad-spectrum coverage, this combination is typically used for severe **cellulitis** or community-acquired pneumonia, not for a life-threatening necrotising soft tissue infection.- It fails to provide adequate empirical coverage for potential **MRSA**, highly resistant **Gram-negative organisms**, or the strong **anti-toxin effect** required for necrotising fasciitis.*Intravenous meropenem 1g three times daily and clindamycin 600mg four times daily*- Meropenem provides excellent broad-spectrum coverage for Gram-positives, Gram-negatives (including Pseudomonas), and anaerobes, making it a strong base for severe infections, and clindamycin is crucial for toxin suppression.- However, this specific regimen **lacks empiric coverage for MRSA**, which is a significant pathogen in severe necrotising infections, and a crucial component of initial broad-spectrum therapy in critically ill patients.*Intravenous vancomycin 1g twice daily and metronidazole 500mg three times daily*- Vancomycin covers Gram-positives, including **MRSA**, and metronidazole covers anaerobes, but this combination is incomplete for a suspected necrotising fasciitis.- This regimen lacks adequate broad-spectrum coverage for common **Gram-negative pathogens** (including Pseudomonas) and omits the critical addition of **clindamycin** for its specific role in modulating the severe toxin-mediated inflammatory response.

Question 74: According to UK antimicrobial stewardship guidance, which statement best describes the concept of 'antibiotic heterogeneity' as a strategy to reduce antimicrobial resistance at the population level?

A. Using narrow-spectrum antibiotics preferentially over broad-spectrum agents
B. Rotating or diversifying antimicrobial use across a healthcare system to reduce selection pressure on specific resistance mechanisms (Correct Answer)
C. Prescribing combination therapy to cover multiple potential pathogens
D. Implementing therapeutic drug monitoring for all antimicrobial agents
E. Using different antibiotic classes for empirical versus culture-directed therapy

Explanation: ***Rotating or diversifying antimicrobial use across a healthcare system to reduce selection pressure on specific resistance mechanisms*** - **Antibiotic heterogeneity** (also known as **antibiotic mixing**) is a population-level strategy designed to distribute **selection pressure** across different antibiotic classes. - By avoiding the dominance of a single drug type, the healthcare system reduces the likelihood that specific **resistance genes** will gain a competitive advantage and spread rapidly. *Using narrow-spectrum antibiotics preferentially over broad-spectrum agents* - This describes **de-escalation** or **targeted therapy**, which is a core stewardship principle but not the definition of heterogeneity. - While it reduces general pressure, it does not specifically address the **diversification** of drugs across a population. *Prescribing combination therapy to cover multiple potential pathogens* - **Combination therapy** aims to broaden empirical coverage or achieve **synergy**, rather than managing population-wide resistance patterns through diversification. - This approach is patient-specific and can sometimes lead to increased overall **antimicrobial consumption**. *Implementing therapeutic drug monitoring for all antimicrobial agents* - **Therapeutic drug monitoring (TDM)** is used to ensure individual patient safety and efficacy for drugs with **narrow therapeutic indices** like Gentamicin. - TDM relates to **pharmacokinetics** and toxicity management rather than a population-level strategy for antimicrobial diversification. *Using different antibiotic classes for empirical versus culture-directed therapy* - This describes the process of **clinical review** and narrowing therapy based on **microbiology results**. - While essential for stewardship, it focuses on individual treatment optimization rather than intentional **population-wide rotation** or mixing of agents.

Question 75: A 63-year-old woman with type 2 diabetes presents with a painful red swelling on her left thigh that has been present for 3 days. On examination, there is a 6cm area of erythema, warmth, and tenderness with central fluctuance. Her temperature is 38.2°C, heart rate 96 bpm, and blood pressure 132/78 mmHg. Blood tests show WCC 13.2 × 10⁹/L and CRP 82 mg/L. What is the most appropriate initial management?

A. Oral flucloxacillin and warm compresses
B. Intravenous flucloxacillin
C. Incision and drainage with oral antibiotics (Correct Answer)
D. Aspiration with needle and oral antibiotics
E. Incision and drainage alone without antibiotics

Explanation: ***Incision and drainage with oral antibiotics*** - The presence of **central fluctuance** confirms a cutaneous **abscess**, for which the definitive gold-standard management is surgical **incision and drainage (I&D)**. - This patient requires **adjunctive antibiotics** in addition to drainage because of her **comorbid diabetes**, systemic symptoms (**fever**), and elevated inflammatory markers (CRP 82 mg/L). *Oral flucloxacillin and warm compresses* - Antibiotics alone are insufficient because they cannot adequately penetrate the **walled-off purulent collection** of an abscess. - Warm compresses may help a small lesion spontaneously drain, but they do not replace the need for **surgical source control** in a patient with systemic features. *Intravenous flucloxacillin* - While the patient is febrile, she is **hemodynamically stable** and tolerating oral intake, making **intravenous (IV)** therapy unnecessary unless she fails to respond to oral treatment. - Similar to oral therapy, IV antibiotics without **I&D** will fail to resolve a fluctuant abscess as the source of infection remains undrained. *Aspiration with needle and oral antibiotics* - Needle aspiration is associated with higher **recurrence rates** compared to incision and drainage because it often fails to completely evacuate the loculated pus. - **Incision and drainage** allows for thorough exploration and breakdown of any internal septations within the abscess cavity. *Incision and drainage alone without antibiotics* - While I&D alone is appropriate for small, simple abscesses, this patient has **high-risk factors** including **type 2 diabetes** and signs of systemic inflammatory response. - Guidelines suggest that **concomitant antibiotics** are necessary when significant **surrounding cellulitis** or constitutional symptoms (fever) are present.

Question 76: A hospital antimicrobial stewardship committee reviews prescribing data showing that empirical carbapenem use has increased by 35% over 12 months, primarily for intra-abdominal sepsis and complicated urinary tract infections. Which stewardship intervention would be most effective in reducing inappropriate carbapenem use while maintaining patient safety?

A. Complete removal of carbapenems from the hospital formulary
B. Requiring infectious diseases consultant approval for all carbapenem prescriptions with 24-hour turn-around time
C. Implementing a clinical decision support tool with audit and feedback that prompts consideration of narrower-spectrum alternatives with clear criteria for carbapenem use (Correct Answer)
D. Restricting carbapenem use to critical care areas only
E. Mandatory stop orders after 48 hours requiring represcribing justification

Explanation: ***Implementing a clinical decision support tool with audit and feedback that prompts consideration of narrower-spectrum alternatives with clear criteria for carbapenem use***- This approach is highly effective as it combines **prospective audit and feedback** with real-time education, helping clinicians choose narrower agents like **piperacillin-tazobactam** when appropriate.- It balances **antibiotic stewardship** with patient safety by allowing immediate use for confirmed **ESBL infections** while mandating review based on evidence-based criteria.*Complete removal of carbapenems from the hospital formulary*- This is an extreme measure that compromises safety for patients with **multi-drug resistant (MDR)** infections that clinically require carbapenems.- Eliminating access entirely prevents the treatment of **ESBL-producing Enterobacteriaceae**, which can lead to increased mortality.*Requiring infectious diseases consultant approval for all carbapenem prescriptions with 24-hour turn-around time*- A mandatory 24-hour delay can lead to **suboptimal clinical outcomes** or death in patients presenting with **septic shock**.- While restrictive, this method creates a **barrier to timely care** and often results in high administrative burden without the educational benefit of real-time feedback.*Restricting carbapenem use to critical care areas only*- This ignores appropriate clinical indications for carbapenems on medical or surgical wards, such as stable patients with **resistant urosepsis**.- It creates a **geographic restriction** that does not account for the patient's specific microbiology or clinical complexity.*Mandatory stop orders after 48 hours requiring represcribing justification*- Mandatory stops can cause **treatment interruptions** if clinicians are unable to re-prescribe in time, potentially leading to treatment failure.- This intervention focuses on **administrative burden** rather than clinical decision-making and does not necessarily guide the prescriber toward better empirical choices at the start of therapy.

Question 77: A 48-year-old woman presents with a 4-day history of right upper eyelid swelling and erythema. Yesterday she developed fever (38.4°C) and diplopia. On examination, there is marked periorbital oedema and erythema, proptosis, ophthalmoplegia (particularly on lateral gaze), and reduced visual acuity in the right eye. CT orbits shows inflammatory changes in the right orbit with involvement of the orbital fat and extraocular muscles. What is the most appropriate immediate antimicrobial management?

A. Oral co-amoxiclav 625mg three times daily and urgent ophthalmology review
B. Intravenous cefuroxime 1.5g three times daily and ophthalmology review within 24 hours
C. Intravenous ceftriaxone 2g once daily, intravenous metronidazole 500mg three times daily, and urgent ENT/ophthalmology review (Correct Answer)
D. Intravenous flucloxacillin 2g four times daily and routine ophthalmology follow-up
E. Intravenous benzylpenicillin 2.4g four times daily and intravenous gentamicin

Explanation: ***Intravenous ceftriaxone 2g once daily, intravenous metronidazole 500mg three times daily, and urgent ENT/ophthalmology review*** - This patient presents with **orbital cellulitis**, evidenced by **proptosis**, **ophthalmoplegia**, and **reduced visual acuity**, which are hallmarks of post-septal involvement and require aggressive treatment. - Treatment requires broad-spectrum IV antibiotics like **ceftriaxone** (covering *S. pneumoniae* and *H. influenzae*) and **metronidazole** (covering anaerobes), plus urgent consultation to evaluate for surgical drainage. *Oral co-amoxiclav 625mg three times daily and urgent ophthalmology review* - **Oral antibiotics** are insufficient for managing orbital cellulitis due to poor penetration and the significant risk of rapid progression to permanent vision loss or **intracranial spread**. - While co-amoxiclav covers many respiratory pathogens, it is inadequate for a patient presenting with systemic symptoms and **sight-threatening complications** requiring intravenous therapy. *Intravenous cefuroxime 1.5g three times daily and ophthalmology review within 24 hours* - Waiting **24 hours** for a specialist review is dangerously slow in orbital cellulitis; immediate assessment is required to prevent **optic nerve compression** and irreversible damage. - Although cefuroxime provides gram-positive and some gram-negative coverage, it often lacks the specific **anaerobic coverage** typically required for infections originating from the paranasal sinuses. *Intravenous flucloxacillin 2g four times daily and routine ophthalmology follow-up* - **Flucloxacillin** is excellent for *S. aureus* skin infections but has a spectrum that is too narrow for the likely **polymicrobial** causes of orbital cellulitis, especially from sinus origin. - A **routine follow-up** is entirely inappropriate for a surgical emergency characterized by systemic fever, compromised cranial nerve function, and potential vision loss. *Intravenous benzylpenicillin 2.4g four times daily and intravenous gentamicin* - This combination lacks adequate **anaerobic coverage** and is not the standard empirical choice for **sinus-derived** orbital infections given the likely polymicrobial nature. - While **gentamicin** covers many gram-negative organisms, the potential for **nephrotoxicity** and the availability of more effective, safer cephalosporins make this an inferior empirical regimen.

Question 78: A 35-year-old man who works as a landscaper presents with a 10-day history of multiple painless, violaceous nodular lesions tracking up his right forearm following a penetrating injury from a rose thorn. He is systemically well with normal observations. Histopathology from a skin biopsy shows granulomatous inflammation. Which organism is most likely responsible and what is the appropriate antimicrobial treatment?

A. Mycobacterium marinum; clarithromycin and rifampicin for 3-4 months
B. Sporothrix schenckii; oral itraconazole for 3-6 months (Correct Answer)
C. Nocardia brasiliensis; co-trimoxazole for 6-12 months
D. Mycobacterium chelonae; clarithromycin and ciprofloxacin for 4-6 months
E. Chromoblastomycosis; oral terbinafine for 6-12 months

Explanation: ***Sporothrix schenckii; oral itraconazole for 3-6 months*** - The classic presentation of **lymphocutaneous spread** (multiple painless, violaceous nodular lesions tracking up the forearm) following a **rose thorn** injury in a landscaper is highly characteristic of **Sporothrix schenckii**, also known as **Rose Gardener's disease**. - **Oral itraconazole** is the first-line treatment for lymphocutaneous sporotrichosis, typically continued for 3-6 months or longer until resolution and for 2-4 weeks beyond apparent cure to prevent relapse. *Mycobacterium marinum; clarithromycin and rifampicin for 3-4 months* - While *Mycobacterium marinum* can cause a **sporotrichoid pattern** with granulomatous inflammation, it is primarily associated with exposure to **contaminated freshwater** (e.g., aquariums, swimming pools), not typically rose thorn injuries. - Treatment involves combination therapy, often including macrolides and rifampicin, but the epidemiologic context differs. *Nocardia brasiliensis; co-trimoxazole for 6-12 months* - *Nocardia brasiliensis* can cause cutaneous infections and lymphocutaneous spread, often after soil contamination, but it is less commonly linked to rose thorn injuries with this specific clinical picture. - Diagnosis usually requires demonstrating **Gram-positive, weakly acid-fast filamentous bacteria**, and treatment with **co-trimoxazole** is typically for a prolonged duration. *Mycobacterium chelonae; clarithromycin and ciprofloxacin for 4-6 months* - *Mycobacterium chelonae* is a rapid-growing atypical mycobacterium commonly associated with **surgical site infections**, cosmetic procedures, or trauma, presenting as abscesses or nodules, but typically not a classic lymphangitic spread from a thorn. - Its treatment often involves a combination of macrolides and fluoroquinolones, but the specific injury mechanism and clinical progression are less characteristic. *Chromoblastomycosis; oral terbinafine for 6-12 months* - **Chromoblastomycosis** usually presents as chronic, slow-growing, **verrucous (wart-like) plaques** or cauliflower-like lesions, not the acute, linear tracking nodules seen here. - Histopathology characteristically reveals specific fungal structures called **Medlar bodies** (sclerotic cells), which would be a key differentiating feature.

Question 79: A hospital trust implements a comprehensive antimicrobial stewardship program including prospective audit and feedback, formulary restrictions on carbapenems, and mandatory infectious diseases consultation for certain infections. After 18 months, antimicrobial consumption has decreased by 15%, but an increase in 30-day readmission rates for infections is noted (from 8.2% to 11.7%). How should the antimicrobial stewardship team interpret and respond to these findings?

A. The program has been successful in reducing consumption and the increased readmissions are unrelated; continue current approach
B. The increased readmissions indicate the program is causing harm; immediately cease all restrictive interventions
C. Conduct detailed analysis of readmissions to identify if they represent treatment failures, and adjust stewardship interventions accordingly (Correct Answer)
D. The readmission increase is expected and acceptable given the reduction in antimicrobial use; no changes needed
E. Increase antibiotic treatment durations across all infection types to reduce readmission rates

Explanation: ***Conduct detailed analysis of readmissions to identify if they represent treatment failures, and adjust stewardship interventions accordingly*** - A core goal of **antimicrobial stewardship (ASP)** is to optimize patient outcomes while reducing consumption; an increase in **30-day readmissions** serves as a potential safety signal that requires investigation. - The team must differentiate between true **treatment failures** (e.g., inadequate dosing or premature de-escalation) and unrelated confounding factors before modifying established protocols. *The program has been successful in reducing consumption and the increased readmissions are unrelated; continue current approach* - This approach is incorrect because it ignores a significant change in **clinical outcome metrics**, which could be directly linked to overly restrictive stewardship. - **Balancing metrics** are essential in ASP to ensure that the primary goal of **patient safety** is not compromised by the secondary goal of cost or usage reduction. *The increased readmissions indicate the program is causing harm; immediately cease all restrictive interventions* - Ceasing all interventions is a premature reaction that lacks **causality analysis**, potentially losing the benefits of reduced **multidrug-resistant organisms (MDROs)**. - Stewardship success should be managed through **data-driven refinements** rather than complete abandonment of evidence-based practices. *The readmission increase is expected and acceptable given the reduction in antimicrobial use; no changes needed* - An increase in infection-related readmissions is never "acceptable," as it impacts **morbidity**, healthcare costs, and overall patient quality of care. - Stewardship programs are ethically obligated to maintain **non-inferiority in clinical outcomes** compared to standard care while improving prescribing habits. *Increase antibiotic treatment durations across all infection types to reduce readmission rates* - Implementing a blanket increase in **treatment duration** contradicts the principles of stewardship and may lead to increased **toxicity** and resistance. - Evidence-based stewardship promotes the **shortest effective duration** of therapy, making arbitrary increases inappropriate without specific evidence of failure.

Question 80: A 66-year-old man with end-stage renal failure on haemodialysis presents with fever and a painful, erythematous tunnelled dialysis catheter site with purulent discharge. Blood cultures grow methicillin-resistant Staphylococcus aureus (MRSA). The catheter is removed and a new temporary catheter is inserted at a different site. He weighs 78kg. What is the most appropriate vancomycin dosing regimen for this patient?

A. Vancomycin 1g intravenously twice daily with trough level monitoring before the third dose
B. Vancomycin 15-20mg/kg loading dose (approximately 1.5g) then 500mg after each dialysis session (Correct Answer)
C. Vancomycin 1g intravenously once daily with trough level monitoring after 48 hours
D. Vancomycin 500mg intravenously four times daily with dose adjustments based on renal function
E. Vancomycin continuous infusion of 30mg/kg over 24 hours after loading dose

Explanation: ***Vancomycin 15-20mg/kg loading dose (approximately 1.5g) then 500mg after each dialysis session***- In **end-stage renal failure** patients on **haemodialysis**, a weight-based loading dose is essential to rapidly achieve therapeutic concentrations for serious infections like **MRSA**.- Maintenance doses should be administered **post-dialysis** because high-flux membranes significantly remove vancomycin during the procedure, necessitating replenishment to maintain trough levels.*Vancomycin 1g intravenously twice daily with trough level monitoring before the third dose*- This is a standard regimen for patients with **normal renal function**; however, it would cause severe drug accumulation and **ototoxicity** or nephrotoxicity in anuric patients.- Vancomycin's **half-life** is prolonged from ~6 hours to over 100 hours in renal failure, making twice-daily dosing inappropriate.*Vancomycin 1g intravenously once daily with trough level monitoring after 48 hours*- Once-daily dosing is still too frequent for a patient on dialysis and does not align with the intermittent nature of **dialytic clearance**.- Dosing should be linked to the **haemodialysis schedule** rather than a fixed 24-hour interval to ensure stable serum concentrations.*Vancomycin 500mg intravenously four times daily with dose adjustments based on renal function*- Four times daily dosing is never indicated for vancomycin in adults, regardless of renal function, due to the drug's **pharmacokinetic profile**.- In the setting of **anuria**, such frequent dosing would lead to rapid, dangerous toxicity because the drug cannot be cleared via the **renal route**.*Vancomycin continuous infusion of 30mg/kg over 24 hours after loading dose*- Continuous infusion is not standard practice for patients on intermittent **haemodialysis**, as the dialysis sessions would cause massive fluctuations in steady-state levels.- Intermittent **post-dialysis bolus dosing** is the gold standard as it is simpler to manage and allows for reliable **trough level monitoring** before dialysis sessions.

Question 81: A 54-year-old woman who is a commercial shellfish processor presents with a 36-hour history of rapidly progressive pain, swelling, and discoloration of her right hand following a minor cut while shucking oysters. On examination, her hand is markedly swollen with haemorrhagic bullae and areas of dusky discoloration. Her temperature is 38.9°C, blood pressure 88/54 mmHg, and heart rate 128 bpm. She has a history of chronic liver disease secondary to alcohol excess. What is the most likely causative organism and appropriate antimicrobial therapy?

A. Staphylococcus aureus; intravenous flucloxacillin and surgical debridement
B. Streptococcus pyogenes; intravenous benzylpenicillin and clindamycin
C. Vibrio vulnificus; intravenous doxycycline and intravenous ceftazidime (Correct Answer)
D. Erysipelothrix rhusiopathiae; oral amoxicillin and observation
E. Aeromonas hydrophila; intravenous ciprofloxacin and metronidazole

Explanation: ***Vibrio vulnificus; intravenous doxycycline and intravenous ceftazidime***- This patient demonstrates a classic triad for **Vibrio vulnificus**: exposure to **shellfish/seawater**, underlying **chronic liver disease** (cirrhosis), and rapidly progressive **hemorrhagic bullae** with septic shock.- Standard treatment requires a combination of a **tetracycline (doxycycline)** and a **third-generation cephalosporin (ceftazidime)** along with urgent surgical debridement.*Staphylococcus aureus; intravenous flucloxacillin and surgical debridement*- While a common cause of **cellulitis** and soft tissue infection, it is less specifically associated with **seawater/shellfish** exposure compared to Vibrio.- Flucloxacillin would be inadequate for the gram-negative coverage potentially required in this high-risk marine exposure scenario and does not cover *Vibrio vulnificus*.*Streptococcus pyogenes; intravenous benzylpenicillin and clindamycin*- Known for causing **necrotizing fasciitis** (Type II), it usually presents with severe pain out of proportion to exam findings rather than a specific link to **shellfish processing**.- While clindamycin helps inhibit **toxin production**, the epidemiological link to **saltwater/shellfish** and **liver disease** strongly favors *Vibrio*.*Erysipelothrix rhusiopathiae; oral amoxicillin and observation*- Commonly causes **erysipeloid** in fish handlers, which is typically a localized, self-limiting skin infection without systemic toxicity.- It does not present with **septic shock** or large **hemorrhagic bullae** in its typical presentation, and the suggested treatment is inadequate for severe infection.*Aeromonas hydrophila; intravenous ciprofloxacin and metronidazole*- *Aeromonas hydrophila* is typically associated with **freshwater** exposure or contaminated soil, not the marine (saltwater) environment associated with **oysters**.- While it can cause necrotizing infections, the specific clinical context of **saltwater/shellfish** and **liver disease** points to *Vibrio vulnificus*.

Question 82: A hospital antimicrobial stewardship team conducts an audit of antibiotic prescribing on medical wards. They find that 62% of antibiotic prescriptions have documented indication, microbiology results are reviewed in 45% of cases at 48-72 hours, and IV-to-oral switch occurs at a median of 5 days. The team plans an intervention to improve these metrics. Which intervention is most likely to achieve the greatest improvement in antimicrobial stewardship compliance?

A. Weekly educational lectures for junior doctors on antimicrobial prescribing
B. Implementing mandatory electronic prescribing prompts requiring indication documentation and 48-hour review (Correct Answer)
C. Distributing pocket cards with local antibiotic guidelines to all prescribers
D. Monthly feedback emails to consultants showing their team's prescribing data
E. Introducing a weekly antimicrobial stewardship ward round led by infectious diseases consultants

Explanation: ***Implementing mandatory electronic prescribing prompts requiring indication documentation and 48-hour review***- This intervention represents a **systems-based approach** that integrates directly into the clinical workflow, forcing compliance at the **point of prescribing**.- Evidence confirms that **mandatory electronic prompts** and **decision support tools** are superior to passive education for ensuring documentation and timely clinical reviews.*Weekly educational lectures for junior doctors on antimicrobial prescribing*- While education is necessary, it is a **low-reliability intervention** that depends on individual attendance and memory, often failing to change long-term habits.- Lectures do not address **environmental barriers** or the time pressures that prevent clinicians from following guidelines during busy shifts.*Distributing pocket cards with local antibiotic guidelines to all prescribers*- Pocket cards and printed guidelines are **passive forms of dissemination** that are frequently lost, ignored, or become outdated quickly.- They provide information but do not create the **active accountability** needed to improve clinical audit metrics like review rates.*Monthly feedback emails to consultants showing their team's prescribing data*- Although **audit and feedback** is useful for identifying outliers, a monthly interval is too infrequent to influence rapid daily decisions like an **IV-to-oral switch**.- Prescribers often view retrospective data as disconnected from current patient care, leading to limited **sustained behavioral change**.*Introducing a weekly antimicrobial stewardship ward round led by infectious diseases consultants*- Specialized ward rounds provide high-quality reviews but are **resource-intensive** and only occur once a week, missing daily opportunities for antibiotic de-escalation.- A **weekly** round cannot address the 48-72 hour review requirement for all patients as effectively as a daily **integrated electronic system**.

Question 83: A 47-year-old man with poorly controlled type 2 diabetes (HbA1c 96 mmol/mol) presents with a 3-day history of severe otalgia and purulent otorrhoea. On examination, he has marked periauricular erythema and swelling, with granulation tissue visible in the external auditory canal. His temperature is 37.9°C. CT temporal bone shows soft tissue swelling and bone erosion of the temporal bone. Blood tests show WCC 14.5 × 10⁹/L, CRP 156 mg/L, and glucose 18.2 mmol/L. What is the most appropriate initial antimicrobial management?

A. Topical ciprofloxacin ear drops and oral ciprofloxacin 500mg twice daily
B. Intravenous flucloxacillin 2g four times daily and intravenous gentamicin
C. Intravenous ciprofloxacin 400mg twice daily or intravenous piperacillin-tazobactam 4.5g three times daily (Correct Answer)
D. Intravenous vancomycin 1g twice daily and oral ciprofloxacin 750mg twice daily
E. Intravenous meropenem 1g three times daily and intravenous vancomycin 1g twice daily

Explanation: ***Intravenous ciprofloxacin 400mg twice daily or intravenous piperacillin-tazobactam 4.5g three times daily***- This patient presents with **malignant (necrotizing) otitis externa**, suggested by persistent ear pain, **granulation tissue**, and CT evidence of **temporal bone erosion** in a diabetic patient.- The primary pathogen is **Pseudomonas aeruginosa**, requiring high-dose **intravenous antipseudomonal antibiotics** to penetrate bone and prevent further skull base spread.*Topical ciprofloxacin ear drops and oral ciprofloxacin 500mg twice daily*- Topical treatments are insufficient as a primary therapy when there is **bone erosion (osteomyelitis)**, which requires systemic penetration.- While oral ciprofloxacin is often used for step-down, the initial severity and **elevated inflammatory markers** necessitate high-dose intravenous therapy.*Intravenous flucloxacillin 2g four times daily and intravenous gentamicin*- Flucloxacillin is effective against **Staphylococcus aureus** but provides no coverage for **Pseudomonas**, the hallmark pathogen in this condition.- Although gentamicin covers Pseudomonas, it carries a high risk of **ototoxicity and nephrotoxicity**, making more modern antipseudomonals safer choices.*Intravenous vancomycin 1g twice daily and oral ciprofloxacin 750mg twice daily*- Vancomycin targets **MRSA**, which is not the primary concern in typical malignant otitis externa unless specifically cultured.- Initial management should prioritize **intravenous antipseudomonal** dosing rather than relying on oral regimens in the presence of bone destruction.*Intravenous meropenem 1g three times daily and intravenous vancomycin 1g twice daily*- This combination is overly broad and represents **escalated therapy** usually reserved for multi-drug resistant organisms.- **Meropenem** is generally kept as a reserve antibiotic and is not first-line unless standard antipseudomonal therapies fail or are contraindicated.

Question 84: A 52-year-old woman undergoes total abdominal hysterectomy. She received cefuroxime 1.5g intravenously at induction of anaesthesia. The operation lasted 3.5 hours with an estimated blood loss of 800mL. She is clinically stable postoperatively with normal observations. According to antimicrobial stewardship principles and current surgical prophylaxis guidelines, what is the most appropriate antibiotic management?

A. No further antibiotics required
B. Give one further dose of cefuroxime 1.5g intravenously within 6 hours postoperatively then stop (Correct Answer)
C. Continue cefuroxime 1.5g three times daily intravenously until oral intake is established
D. Continue cefuroxime 1.5g three times daily intravenously for 24 hours then switch to oral co-amoxiclav for 5 days
E. Give intraoperative redose of cefuroxime 1.5g then continue three times daily for 48 hours

Explanation: ***Give one further dose of cefuroxime 1.5g intravenously within 6 hours postoperatively then stop*** - Surgical prophylaxis guidelines recommend **redosing** if the procedure duration exceeds **two half-lives** of the antibiotic (cefuroxime half-life is ~1.5 hours, so >3 hours) or if there is significant **blood loss** (>1500mL or 20mL/kg). Given the 3.5-hour duration and 800mL blood loss, an additional dose is warranted. - Since an intraoperative redose was not administered, a single postoperative dose within **6 hours** is appropriate to maintain adequate **therapeutic tissue levels** during the critical period for preventing surgical site infection (SSI). *No further antibiotics required* - While initial single-dose prophylaxis is standard, the **3.5-hour operation duration** and **800mL blood loss** mean the initial dose's effectiveness would have significantly decreased. - Omitting further antibiotics in this scenario increases the risk of **surgical site infection (SSI)** due to sub-therapeutic antibiotic concentrations during the critical postoperative period. *Continue cefuroxime 1.5g three times daily intravenously until oral intake is established* - Continuing antibiotic prophylaxis beyond the immediate perioperative period (typically up to **24 hours**) is not recommended by **antimicrobial stewardship** principles as it does not further reduce SSI risk for this procedure. - Prolonged intravenous antibiotic administration increases the risk of **adverse effects**, such as **Clostridioides difficile infection** and catheter-related complications, without added benefit. *Continue cefuroxime 1.5g three times daily intravenously for 24 hours then switch to oral co-amoxiclav for 5 days* - This regimen describes **treatment for an active infection**, not prophylaxis. Prophylactic antibiotics should not be extended into multi-day courses or switched to oral regimens unless there is confirmed **evidence of infection**. - Such an extended course of antibiotics significantly contributes to **antimicrobial resistance** and increases the patient's susceptibility to **adverse drug reactions** and superinfections. *Give intraoperative redose of cefuroxime 1.5g then continue three times daily for 48 hours* - An **intraoperative redose** was indeed indicated physiologically. However, the question states it was not given, and the clinical scenario is *postoperative* management. - Continuing prophylaxis for **48 hours** post-surgery is excessive for total abdominal hysterectomy and violates current guidelines, which advocate for **short-duration prophylaxis** to minimize resistance and drug-related harm.

Question 85: A 61-year-old man with type 2 diabetes presents with a 5-day history of progressive right lower leg cellulitis. He was started on oral flucloxacillin 1g four times daily by his GP 48 hours ago but has deteriorated. On examination, there is extensive erythema from mid-calf to ankle with blistering and areas of skin necrosis. His temperature is 38.8°C, heart rate 115 bpm, blood pressure 95/60 mmHg, and respiratory rate 24/min. Blood results show: WCC 18.2 × 10⁹/L, CRP 285 mg/L, creatinine 145 μmol/L (baseline 78 μmol/L), lactate 3.8 mmol/L. What is the most appropriate antimicrobial management?

A. Switch to intravenous flucloxacillin 2g four times daily and add intravenous benzylpenicillin 2.4g four times daily (Correct Answer)
B. Switch to intravenous co-amoxiclav 1.2g three times daily and add intravenous gentamicin
C. Switch to intravenous vancomycin 1g twice daily and add intravenous metronidazole 500mg three times daily
D. Switch to intravenous meropenem 1g three times daily
E. Continue oral flucloxacillin but increase dose to 2g four times daily

Explanation: ***Switch to intravenous flucloxacillin 2g four times daily and add intravenous benzylpenicillin 2.4g four times daily*** - The patient presents with signs of **severe necrotizing soft tissue infection**, indicated by **skin necrosis**, **blistering**, **rapid deterioration**, and **septic shock** (hypotension, elevated lactate, AKI). - This combination provides robust empirical coverage for common causative agents like **Staphylococcus aureus** and **Group A Streptococcus**, essential for this life-threatening condition. *Switch to intravenous co-amoxiclav 1.2g three times daily and add intravenous gentamicin* - While co-amoxiclav offers broad-spectrum coverage, **high-dose benzylpenicillin** is preferred over amoxicillin for suspected **Group A Streptococcus** in necrotizing infections. - **Gentamicin** is an **aminoglycoside** that can exacerbate the patient's existing **acute kidney injury**, making it a less suitable choice here. *Switch to intravenous vancomycin 1g twice daily and add intravenous metronidazole 500mg three times daily* - **Vancomycin** is primarily used for suspected **MRSA** or in patients with severe **beta-lactam allergy**, neither of which is indicated as first-line here. - **Metronidazole** specifically targets **anaerobes**, which are not the primary pathogens in typical monomicrobial necrotizing cellulitis unless there's a specific context like deep abscess or gut origin. *Switch to intravenous meropenem 1g three times daily* - **Meropenem** is a very broad-spectrum **carbapenem** used for highly resistant bacteria or complex polymicrobial infections, and its use here would be **overkill** and contribute to **antimicrobial resistance**. - While it covers many relevant bacteria, it lacks the specific high-dose penicillin activity considered vital for **toxin-producing streptococci** in necrotizing infections. *Continue oral flucloxacillin but increase dose to 2g four times daily* - Continuing oral antibiotics is inappropriate given the patient's **rapid clinical deterioration**, signs of **septic shock**, and evidence of **severe local infection** (necrosis). - **Oral absorption** may be compromised in a critically ill patient, and immediate **intravenous therapy** is mandatory for systemic infection and potential necrotizing process.

Question 86: A 43-year-old woman with rheumatoid arthritis on methotrexate 20mg weekly and prednisolone 10mg daily presents with a 3-day history of pain and swelling in her right elbow. On examination, the elbow is erythematous, warm, swollen with a palpable effusion, and severely tender. Her temperature is 38.5°C. Aspiration yields 15mL of turbid fluid. Synovial fluid analysis shows: WCC 45,000/μL (90% neutrophils), no crystals seen on microscopy. What is the most appropriate initial antibiotic regimen while awaiting culture results?

A. Oral flucloxacillin 1g four times daily
B. Intravenous flucloxacillin 2g four times daily (Correct Answer)
C. Intravenous vancomycin 1g twice daily
D. Intravenous ceftriaxone 2g once daily and intravenous flucloxacillin 2g four times daily
E. Intravenous piperacillin-tazobactam 4.5g three times daily

Explanation: ***Intravenous flucloxacillin 2g four times daily*** - High-dose **intravenous flucloxacillin** is the recommended first-line empirical therapy for native joint **septic arthritis**, as it provides excellent coverage against **Staphylococcus aureus** and **Streptococcus species**.- The clinical presentation of a warm, swollen joint, fever, and a synovial white cell count of **45,000/μL** (predominantly neutrophils) strongly indicates a bacterial infection requiring urgent IV antibiotics.*Oral flucloxacillin 1g four times daily* - Oral administration is inadequate for the initial management of **septic arthritis**, which is a medical emergency requiring high peak **serum and synovial concentrations** achieved through IV dosing.- Transition to oral therapy is only considered after clinical improvement and once **culture and sensitivity** results are available to guide targeted treatment.*Intravenous vancomycin 1g twice daily* - **Vancomycin** is indicated for empirical therapy only when there is a high suspicion of **MRSA**, a history of MRSA colonization, or if the patient has a severe **penicillin allergy**.- It is not the standard first-line choice for community-acquired native joint sepsis in patients without specific risk factors for resistant organisms.*Intravenous ceftriaxone 2g once daily and intravenous flucloxacillin 2g four times daily* - This combination is typically reserved for patients where **Gram-negative** organisms are strongly suspected, such as the frail elderly, those with recent abdominal surgery, or those with suspected **disseminated gonococcal infection**.- Although the patient is taking methotrexate, high-dose flucloxacillin monotherapy remains the standard empirical choice unless there are clear risk factors for **atypical pathogens** or Gram-negative sepsis.*Intravenous piperacillin-tazobactam 4.5g three times daily* - This agent is unnecessarily **broad-spectrum** and is generally reserved for healthcare-associated infections or patients with significant **neutropenia**.- Escalating to this level of coverage is inappropriate before culture results demonstrate a resistant **Gram-negative** or anaerobic organism not covered by standard penicillin-based regimens.

Question 87: A hospital implements a new antimicrobial stewardship intervention requiring pharmacist review of all antimicrobial prescriptions within 72 hours of initiation. During the 'Review' phase of the 'Start Smart - Then Focus' framework, which of the following actions would be LEAST appropriate for the reviewing pharmacist to recommend?

A. Switching from intravenous to oral antibiotics when the patient is clinically improving and able to take oral medications
B. Discontinuing antibiotics when clinical and laboratory evidence suggests a non-infective diagnosis
C. Extending the duration of therapy from 5 to 10 days for cellulitis that is responding well to treatment (Correct Answer)
D. De-escalating from broad-spectrum to narrow-spectrum antibiotics based on microbiology culture results
E. Adjusting antibiotic doses based on renal function and therapeutic drug monitoring results

Explanation: ***Extending the duration of therapy from 5 to 10 days for cellulitis that is responding well to treatment*** - This action is **least appropriate** because antimicrobial stewardship principles advocate for the **shortest effective duration** of therapy to minimize resistance and side effects. - Current guidelines suggest that uncomplicated **cellulitis** typically responds well to 5–7 days of treatment; extending this unnecessarily increases antibiotic exposure without additional clinical benefit. *Switching from intravenous to oral antibiotics when the patient is clinically improving and able to take oral medications* - This is a core component of the **IV-to-oral switch (IVOS)** strategy, which reduces the risk of line-related infections and decreases hospital stay length. - It is one of the key **"Focus"** decisions in the stewardship framework used when patients meet clinical stability criteria. *Discontinuing antibiotics when clinical and laboratory evidence suggests a non-infective diagnosis* - A primary goal of the **"Review"** phase is to **stop** antibiotics promptly if further investigation suggests a non-infectious etiology, such as stasis dermatitis or gout. - This prevents unnecessary **selective pressure** on the patient's microbiome and reduces the risk of adverse drug reactions. *De-escalating from broad-spectrum to narrow-spectrum antibiotics based on microbiology culture results* - Known as **narrowing**, this action utilizes **culture and sensitivity** data to target the specific pathogen, which is a hallmark of good stewardship. - It helps preserve the efficacy of **broad-spectrum** agents for more severe, undiagnosed infections and limits the risk of *C. difficile*. *Adjusting antibiotic doses based on renal function and therapeutic drug monitoring results* - **Dose optimization** ensures that the patient receives a therapeutic amount of the drug while minimizing **dose-dependent toxicity**, such as nephrotoxicity from aminoglycosides. - This is an essential pharmacist intervention during the review phase to ensure both **patient safety** and maximal antibiotic efficacy.

Question 88: A 56-year-old man with a history of injection drug use presents to the Emergency Department with a 4-day history of a painful, swollen right forearm. On examination, there is a 6cm area of erythema, warmth, and induration with purulent discharge from a central puncture site. His temperature is 38.2°C, heart rate 102 bpm, and blood pressure 128/78 mmHg. What is the most appropriate initial management for this patient?

A. Start oral flucloxacillin and arrange outpatient follow-up
B. Obtain wound swab, start oral co-amoxiclav, and arrange review in 48 hours
C. Admit for intravenous flucloxacillin and surgical assessment (Correct Answer)
D. Perform incision and drainage in the Emergency Department and prescribe oral antibiotics
E. Obtain blood cultures, start oral linezolid, and arrange outpatient parenteral antimicrobial therapy

Explanation: ***Admit for intravenous flucloxacillin and surgical assessment*** - The patient presents with **systemic inflammatory response syndrome (SIRS)** criteria (fever and tachycardia) and a local infection with **purulent discharge** and **induration**, which strongly suggests an abscess or severe cellulitis, necessitating **inpatient admission** for intravenous antibiotics. - **Injection drug use (IDU)** carries a high risk for deep-seated infections or **abscess formation**; therefore, a **surgical assessment** is critical to determine if operative debridement or wash-out is required to adequately manage the infection. *Start oral flucloxacillin and arrange outpatient follow-up* - Oral therapy is insufficient for patients showing **systemic features** of infection like tachycardia and fever, as it may not reach adequate tissue concentrations quickly enough to combat a severe infection. - Outpatient management is inappropriate due to the **high-risk nature of IDU** and the potential for rapid progression to **sepsis** or necrotizing fasciitis, requiring close inpatient monitoring. *Obtain wound swab, start oral co-amoxiclav, and arrange review in 48 hours* - Waiting 48 hours for review is unsafe given the **systemic signs** (fever, tachycardia) and the risk of underlying **deep tissue involvement** in a drug user, which could rapidly deteriorate. - While **wound swabs** can guide therapy, **oral co-amoxiclav** may not cover common pathogens like MRSA in IDU, and **blood cultures** are more critical for systemic infections. *Perform incision and drainage in the Emergency Department and prescribe oral antibiotics* - While drainage is necessary for purulence, simple **incision and drainage (I&D)** in the ED may be inadequate if there is extensive **induration**, deep abscesses, or fascial involvement requiring formal surgical exploration. - Prescribing **oral antibiotics** alone ignores the need for high-dose **intravenous therapy** recommended for cellulitis with systemic involvement and potential deep-seated infection. *Obtain blood cultures, start oral linezolid, and arrange outpatient parenteral antimicrobial therapy* - While **blood cultures** are appropriate, **oral linezolid** as initial therapy is less standard than intravenous agents in an acute, systemically unwell patient, and its primary use is for MRSA. - **Outpatient parenteral antimicrobial therapy (OPAT)** is typically reserved for stable patients after initial inpatient stabilization, not for acute presentations with **fever and tachycardia** requiring immediate inpatient monitoring.

Question 89: A hospital antimicrobial stewardship committee is reviewing prescribing patterns for surgical prophylaxis. They identify that in colorectal surgery, antibiotic prophylaxis is being continued for an average of 3 days postoperatively. According to UK antimicrobial stewardship principles and current surgical prophylaxis guidelines, what is the recommended maximum duration for surgical antibiotic prophylaxis in clean-contaminated procedures?

A. Single preoperative dose only
B. Continued for 24 hours postoperatively (Correct Answer)
C. Continued for 48 hours postoperatively
D. Continued for 72 hours postoperatively
E. Continued until drains are removed

Explanation: ***Continued for 24 hours postoperatively***- Current **antimicrobial stewardship** and **NICE guidelines** state that surgical prophylaxis should rarely exceed a **24-hour duration** to prevent the development of **antimicrobial resistance**.- While a single dose is often preferred, extending prophylaxis up to 24 hours is the maximum recommended limit for **clean-contaminated** procedures like colorectal surgery if repeated doses are deemed necessary.*Single preoperative dose only*- Although a **single preoperative dose** is the gold standard for many procedures, guidelines allow for a duration of up to 24 hours in specific **clean-contaminated** contexts.- This option is technically a goal, but the question asks for the **maximum recommended duration** allowed under stewardship principles before it is considered inappropriate.*Continued for 48 hours postoperatively*- Extending prophylaxis to **48 hours** provides no additional benefit in reducing **surgical site infections (SSI)** and increases the risk of **Clostridioides difficile** infection.- Stewardship principles specifically target the reduction of prophylaxis to under 24 hours to minimize **drug toxicity** and hospital costs.*Continued for 72 hours postoperatively*- A **72-hour** duration is considered therapeutic treatment rather than prophylaxis and is inappropriate for standard postoperative care without evidence of **active infection**.- Prolonged exposure significantly increases the selection pressure for **multidrug-resistant organisms** within the hospital environment.*Continued until drains are removed*- There is no clinical evidence supporting the continuation of antibiotics until **surgical drains** are removed; this practice is discouraged by modern **surgical guidelines**.- Keeping patients on antibiotics based on the presence of drains contributes to unnecessary antimicrobial use and does not prevent **retrograde contamination**.

Question 90: A 38-year-old woman presents to her GP with a 2-day history of a tender, warm, erythematous area on her left shin measuring approximately 8cm in diameter. She has no systemic symptoms and observations are normal. She has no known allergies and no significant past medical history. According to current UK antimicrobial guidance, what is the recommended first-line oral antibiotic for this patient?

A. Amoxicillin 500mg three times daily
B. Flucloxacillin 500mg four times daily (Correct Answer)
C. Clarithromycin 500mg twice daily
D. Co-amoxiclav 625mg three times daily
E. Doxycycline 200mg loading dose then 100mg once daily

Explanation: ***Flucloxacillin 500mg four times daily***- **Flucloxacillin** is the first-line treatment for uncomplicated **cellulitis** in patients with no penicillin allergy, offering target coverage against **Staphylococcus aureus** and **Streptococcus pyogenes**.- Per **NICE guidelines**, the standard oral dose for adults is **500mg to 1g** four times daily for a duration of 5 to 7 days.*Amoxicillin 500mg three times daily*- This agent is highly effective against **group A streptococcus** but lacks activity against **Staphylococcus aureus**, which produces beta-lactamases.- It is generally reserved for **erysipelas** where streptococci are the primary pathogen, rather than standard cellulitis.*Clarithromycin 500mg twice daily*- This is a **macrolide** antibiotic used as an alternative first-line option for patients with a **penicillin allergy**.- In this case, the patient has no known allergies, so it is not the initial treatment of choice.*Co-amoxiclav 625mg three times daily*- This is a broad-spectrum antibiotic reserved for **complex cellulitis**, such as infections following **animal/human bites** or facial involvement.- Using it for simple cellulitis unnecessarily increases the risk of **antibiotic resistance** and side effects like C. diff.*Doxycycline 200mg loading dose then 100mg once daily*- **Doxycycline** is recommended as a second-line alternative for patients who are **penicillin-allergic** and cannot tolerate macrolides.- It is not indicated as a first-line therapy for an otherwise healthy patient with no drug allergies.

Question 91: According to the UK 'Start Smart - Then Focus' antimicrobial stewardship toolkit, what is the PRIMARY purpose of the 'Start Smart' component?

A. To ensure antibiotics are only prescribed when there is clear evidence of bacterial infection
B. To promote the use of narrow-spectrum antibiotics as first-line therapy
C. To ensure appropriate microbiological sampling before starting antibiotics
D. To initiate prompt, effective antibiotic therapy within one hour for patients with severe sepsis (Correct Answer)
E. To document clear indication, choice, dose, route and duration for all antibiotic prescriptions

Explanation: ***To initiate prompt, effective antibiotic therapy within one hour for patients with severe sepsis*** - The **Start Smart** component emphasizes the timely initiation of effective treatment, specifically highlighting the **one-hour** window for critically ill patients with severe sepsis. - It prioritizes **initial empirical therapy** based on clinical suspicion to ensure patient survival, with subsequent review in the 'Focus' phase. *To ensure antibiotics are only prescribed when there is clear evidence of bacterial infection* - This is a general overarching principle of **antimicrobial stewardship**, but it is not the primary defining purpose of the 'Start Smart' component itself. - In severe sepsis, 'Start Smart' advocates for **empirical antibiotic therapy** to be initiated rapidly, often before definitive bacterial evidence is available. *To promote the use of narrow-spectrum antibiotics as first-line therapy* - 'Start Smart' often requires the initial use of **broad-spectrum antibiotics** to cover potential life-threatening pathogens in critically ill patients. - The process of **narrowing the antibiotic spectrum** is a key objective of the subsequent 'Then Focus' phase, typically performed after 48-72 hours. *To ensure appropriate microbiological sampling before starting antibiotics* - While obtaining **microbiological cultures** before the first antibiotic dose is a crucial recommended action within the 'Start Smart' framework, it serves as an enabling step. - The primary clinical purpose remains the **prompt delivery** of the antibiotic itself to treat the underlying infection effectively. *To document clear indication, choice, dose, route and duration for all antibiotic prescriptions* - These are essential **documentation standards** and elements of good prescribing practice mandated by the toolkit to ensure clarity, safety, and accountability. - Although vital for **clinical governance** and effective stewardship, they are supportive actions rather than the primary clinical objective of rapid antibiotic initiation that 'Start Smart' focuses on.

Question 92: A 51-year-old man with well-controlled HIV (CD4 count 580 cells/μL, undetectable viral load on antiretroviral therapy) presents with a 4-day history of a painful abscess in his right axilla. The abscess is 4cm in diameter, fluctuant, with surrounding erythema extending 6cm beyond the abscess margin. He is pyrexial at 38.2°C with a heart rate of 95 bpm and blood pressure 125/78 mmHg. What is the most appropriate management?

A. Incision and drainage alone
B. Incision and drainage with oral flucloxacillin 500mg four times daily (Correct Answer)
C. Oral flucloxacillin 1g four times daily without drainage
D. Admission for intravenous flucloxacillin 2g four times daily and surgical drainage
E. Oral co-amoxiclav 625mg three times daily and arrange outpatient drainage

Explanation: ***Incision and drainage with oral flucloxacillin 500mg four times daily*** - The patient presents with a **fluctuant abscess** and **significant cellulitis** (erythema >5cm beyond the margin), which requires both **drainage** and **antibiotic therapy**. - Although HIV-positive, his **CD4 count >500** and undetectable viral load allow for outpatient management with oral therapy as he is not severely immunocompromised. *Incision and drainage alone* - While drainage is the primary treatment for an abscess, it is insufficient here due to **systemic features** (fever) and extensive **surrounding cellulitis**. - Guidelines recommend adding antibiotics when there is **erythema >5cm** or signs of systemic illness to prevent further spread. *Oral flucloxacillin 1g four times daily without drainage* - Antibiotics alone cannot penetrate the **fibrous capsule** of a fluctuant abscess effectively; **surgical drainage** is the gold standard of treatment. - Relying solely on medication would likely result in treatment failure and potential worsening of the localized infection. *Admission for intravenous flucloxacillin 2g four times daily and surgical drainage* - **Intravenous therapy** and hospital admission are reserved for patients with severe **sepsis**, rapid progression, or those failing oral therapy. - This patient is hemodynamically stable with a heart rate <100 and a normal blood pressure, making **outpatient management** safe and appropriate. *Oral co-amoxiclav 625mg three times daily and arrange outpatient drainage* - **Flucloxacillin** is the preferred first-line agent for skin and soft tissue infections as it specifically targets **Staphylococcus aureus**. - **Co-amoxiclav** provides unnecessarily broad coverage (including anaerobes and Gram-negatives) which is not typically required for a simple axillary abscess.

Question 93: A hospital trust implements a new antimicrobial stewardship intervention requiring prescribers to document indication, dose, route, and planned duration with review date for all antibiotic prescriptions. Six months post-implementation, audit data shows: documented indication increased from 45% to 92%, documented review dates increased from 12% to 85%, but average antibiotic duration and defined daily doses (DDDs) per 1000 patient-bed days remained unchanged. What does this data primarily indicate?

A. The intervention was ineffective and should be discontinued
B. Documentation improved but this has not yet translated to changes in prescribing behavior (Correct Answer)
C. The hospital's baseline prescribing was already optimal so no reduction is possible
D. The intervention is working and achieving appropriate antimicrobial stewardship goals
E. Prescriber engagement with the intervention is insufficient and requires disciplinary action

Explanation: ***Documentation improved but this has not yet translated to changes in prescribing behavior*** - The data shows a significant increase in **process measures** (documentation of indication and review dates), indicating that the structural requirements of the intervention were adopted. - However, the lack of change in **outcome measures** such as **average antibiotic duration** and **Defined Daily Doses (DDDs)** suggests that clinicians are documenting without actually modifying their clinical decision-making or narrowing therapy. *The intervention was ineffective and should be discontinued* - The improvement in documentation rates is a positive **process outcome**, showing that prescribers are engaging with the administrative requirements of the intervention. - A lack of immediate change in **prescribing outcomes** at six months often indicates a need for refinement or additional components to the stewardship program, rather than complete abandonment. *The hospital's baseline prescribing was already optimal so no reduction is possible* - It is highly improbable that antibiotic prescribing was **optimally low** given the initial documentation rates for review dates were only 12%, implying significant room for improvement in prescribing practices. - **Antimicrobial stewardship programs** are typically initiated to address suboptimal prescribing, aiming for reductions in duration and DDDs to minimize resistance. *The intervention is working and achieving appropriate antimicrobial stewardship goals* - While documentation is a component of good stewardship, the ultimate goal is to optimize antibiotic use, which includes reducing **unnecessary prescriptions** and **minimizing overall consumption**. - Since **antibiotic duration** and **DDDs** remained unchanged, the core objective of improving clinical prescribing behavior and reducing **antimicrobial resistance** has not yet been met. *Prescriber engagement with the intervention is insufficient and requires disciplinary action* - The substantial increases in documented indication (from 45% to 92%) and review dates (from 12% to 85%) clearly demonstrate **high prescriber engagement** with the documentation requirements. - The issue is not a lack of engagement with the process, but rather that the documentation itself has not yet translated into desired **changes in clinical practice** regarding antibiotic use.

Question 94: A 59-year-old woman with breast cancer receiving chemotherapy (day 12 post-cycle) presents with a 24-hour history of fever (38.8°C) and a painful, erythematous rash on her left lower leg with well-demarcated borders and bullae formation. Her blood results show: WCC 1.2 × 10⁹/L (neutrophils 0.4 × 10⁹/L), CRP 156 mg/L. Blood pressure is 105/65 mmHg, heart rate 108 bpm. What is the most appropriate immediate management?

A. Oral flucloxacillin 1g four times daily and close outpatient monitoring
B. Intravenous flucloxacillin 2g four times daily
C. Intravenous piperacillin-tazobactam 4.5g three times daily (Correct Answer)
D. Intravenous co-amoxiclav 1.2g three times daily and gentamicin
E. Intravenous vancomycin 1g twice daily and metronidazole

Explanation: ***Intravenous piperacillin-tazobactam 4.5g three times daily***- The patient has **neutropenic sepsis**, defined as a temperature >38°C and an absolute neutrophil count (ANC) **<0.5 × 10⁹/L**, which is a medical emergency requiring immediate broad-spectrum antibiotics.- **Piperacillin-tazobactam** (Tazocin) is the first-line empirical monotherapy recommended by guidelines because it provides essential **anti-pseudomonal** coverage and broad-spectrum Gram-positive activity.*Oral flucloxacillin 1g four times daily and close outpatient monitoring*- **Outpatient management** and oral antibiotics are inappropriate for a patient with sepsis symptoms (hypotension, tachycardia) and a neutrophil count this low.- **Oral flucloxacillin** lacks the necessary Gram-negative coverage required to treat empirical neutropenic sepsis.*Intravenous flucloxacillin 2g four times daily*- While suitable for standard cellulitis, flucloxacillin is insufficient for **neutropenic sepsis** as it does not cover **Pseudomonas aeruginosa** or other enteric Gram-negative rods.- Patients on chemotherapy are at high risk for **rapidly progressive infection**, necessitating broader spectrum coverage than what a narrow-spectrum penicillin offers.*Intravenous co-amoxiclav 1.2g three times daily and gentamicin*- This combination is not the gold-standard empirical regimen for neutropenic sepsis and does not provide the reliable **anti-pseudomonal** monotherapy recommended as first-line.- **Gentamicin** is generally avoided as a routine empirical first-line choice in neutropenic sepsis due to risks of **nephrotoxicity** unless there is a specific suspicion of resistant organisms.*Intravenous vancomycin 1g twice daily and metronidazole*- **Vancomycin** lacks coverage for Gram-negative organisms, which are the most life-threatening pathogens in the setting of **neutropenia**.- This regimen would be inadequate as an initial monotherapy; vancomycin is typically reserved for patients who remain **hemodynamically unstable** or have suspected **MRSA** infection after starting first-line agents.

Question 95: What is the recommended first-line antibiotic for treatment of acute human bite wound infection according to current UK guidelines?

A. Flucloxacillin
B. Co-amoxiclav (Correct Answer)
C. Doxycycline
D. Metronidazole
E. Ciprofloxacin

Explanation: ***Co-amoxiclav***- **Co-amoxiclav** is the first-line treatment as it provides broad-spectrum coverage against the **polymicrobial flora** of the human mouth, including **aerobes** and **anaerobes**.- It specifically targets organisms like **Eikenella corrodens**, **Streptococcus** species, and **Staphylococcus aureus** which are common in human bite infections.*Flucloxacillin*- While effective against *Staphylococci*, **flucloxacillin** lacks sufficient activity against **Gram-negative aerobes** like *Eikenella corrodens*.- It does not provide the necessary anaerobic coverage required for the complex infections resulting from human bites.*Doxycycline*- **Doxycycline** is typically reserved as an alternative for patients with a **penicillin allergy**, often in combination with metronidazole.- It is not considered first-line therapy according to **UK guidelines** for the initial management of human bite wounds.*Metronidazole*- **Metronidazole** provides excellent coverage for **anaerobes**, but it has no activity against **aerobic bacteria**.- It must be used in combination with other agents and is never appropriate as a **monotherapy** for bite wounds.*Ciprofloxacin*- **Ciprofloxacin** has poor activity against **Gram-positive cocci** (like *Streptococci*) and virtually no activity against **anaerobes**.- It is generally unsuitable for human bite infections unless combined with other specific antibiotics for broader coverage.

Question 96: A 37-year-old man who works as a commercial diver presents with a 10-day history of a slowly progressive, painless nodular lesion on his right hand following a minor abrasion sustained while working underwater in a marine environment. The lesion has a violaceous appearance with some ulceration. He is systemically well. What is the most likely causative organism?

A. Vibrio vulnificus
B. Aeromonas hydrophila
C. Mycobacterium marinum (Correct Answer)
D. Pseudomonas aeruginosa
E. Erysipelothrix rhusiopathiae

Explanation: ***Mycobacterium marinum***- This pathogen is a **non-tuberculous mycobacterium** typically associated with exposure to **aquatic environments** (e.g., marine, fresh, aquariums), causing a **slowly progressive**, **painless nodular** or granulomatous lesion.- The classic presentation, often called **"swimming pool granuloma"** or **"fish tank granuloma,"** involves a **violaceous lesion** with potential ulceration, developing after skin trauma in contaminated water.*Vibrio vulnificus*- *Vibrio vulnificus* typically causes **fulminant**, rapidly progressive infections characterized by **severe pain**, **hemorrhagic bullae**, and a high risk of **sepsis**.- These infections are often seen in individuals with **underlying liver disease** or **immunocompromise**, and the onset is usually much faster than the 10-day slow progression described.*Aeromonas hydrophila*- *Aeromonas hydrophila* is typically associated with **freshwater exposure** and causes **rapidly progressive cellulitis** or necrotizing fasciitis, often with an acute onset within 24-48 hours.- The lesion in the question is slowly progressive and occurred in a marine environment, which differentiates it from the typical *Aeromonas* presentation.*Pseudomonas aeruginosa*- *Pseudomonas aeruginosa* can cause skin infections like **folliculitis** (e.g., "hot tub folliculitis") or **ecthyma gangrenosum**, which have different clinical appearances and progression than a slowly enlarging, painless nodule.- While it thrives in moist environments, it is less likely to present as a chronic, **violaceous, ulcerated nodule** following minor trauma in a healthy host compared to *M. marinum*.*Erysipelothrix rhusiopathiae*- *Erysipelothrix rhusiopathiae* causes **erysipeloid**, which is characterized by a **painful**, well-demarcated, purplish-red skin lesion, often with raised borders.- Unlike the painless, nodular lesion described, erysipeloid is typically **painful** and does not usually progress to a chronic ulcerating nodule.

Question 97: Which of the following prescribing scenarios represents the most significant breach of antimicrobial stewardship principles?

A. Prescribing a 7-day course of antibiotics for cellulitis that improves after 5 days
B. Continuing empirical broad-spectrum antibiotics despite negative cultures at 72 hours in a clinically improving patient (Correct Answer)
C. Using intravenous antibiotics for the first 24 hours of severe pneumonia before switching to oral
D. Prescribing prophylactic antibiotics for a patient with recurrent UTIs and structural urinary tract abnormality
E. Starting empirical antibiotics before obtaining blood cultures in a patient with suspected sepsis

Explanation: ***Continuing empirical broad-spectrum antibiotics despite negative cultures at 72 hours in a clinically improving patient*** - This represents a failure to **de-escalate** or **focalize** therapy, which is a core pillar of **antimicrobial stewardship** that aims to reduce **antibiotic resistance**. - Systematic review at **48-72 hours** is mandatory; if cultures are negative and the patient is stable, therapy should be narrowed or discontinued to prevent **superinfections** like *C. difficile*. *Prescribing a 7-day course of antibiotics for cellulitis that improves after 5 days* - While shorter courses are increasingly preferred, completing a **7-day course** is a common clinical standard and does not represent a major breach compared to broad-spectrum misuse. - This scenario reflects a minor variation in **treatment duration** rather than a failure of fundamental stewardship principles. *Using intravenous antibiotics for the first 24 hours of severe pneumonia before switching to oral* - This is actually an example of **good stewardship**, demonstrating an appropriate **IV-to-oral switch** once the patient is clinically stable. - Early oral conversion reduces **complications** related to IV lines and decreases **length of hospital stay**. *Prescribing prophylactic antibiotics for a patient with recurrent UTIs and structural urinary tract abnormality* - Antibiotic **prophylaxis** is a recognized strategy in patients with documented **structural abnormalities** who suffer from high morbidity due to recurrent infections. - This is a targeted clinical decision based on **patient-specific risk factors** rather than an indiscriminate misuse of antimicrobials. *Starting empirical antibiotics before obtaining blood cultures in a patient with suspected sepsis* - In **sepsis**, minimizing **time-to-antibiotics** is a critical, life-saving intervention that takes priority over waiting for culture collection in emergent situations. - While obtaining cultures first is ideal, prioritizing **rapid administration** of empirical drugs in hemodynamic instability aligns with **Surviving Sepsis Campaign** guidelines.

Question 98: A 41-year-old woman who recently started boxing training at a new gym presents with multiple painful, pustular lesions on her forearms and neck. The lesions began 3 days ago after using the gym's shared equipment mats. Several other gym members have developed similar lesions. Swabs grow methicillin-resistant Staphylococcus aureus (MRSA). She is otherwise well with no systemic symptoms. What is the most appropriate antibiotic treatment?

A. Oral flucloxacillin 500mg four times daily
B. Topical fusidic acid three times daily
C. Oral doxycycline 100mg twice daily (Correct Answer)
D. Intravenous vancomycin 1g twice daily
E. Oral co-trimoxazole 960mg three times daily

Explanation: ***Oral doxycycline 100mg twice daily***- **Doxycycline** is recommended as a first-line oral antibiotic for uncomplicated **community-acquired MRSA (CA-MRSA)** skin and soft tissue infections in the UK.- This patient has localized but **multiple pustular lesions** without systemic symptoms, making an oral agent with **MRSA activity** the most appropriate choice.*Oral flucloxacillin 500mg four times daily*- **Flucloxacillin** is ineffective against **MRSA** because the organism carries the **mecA gene**, which alters the penicillin-binding protein (PBP2a).- While it is standard treatment for methicillin-sensitive Staphylococcus aureus (MSSA), it will result in **treatment failure** in this confirmed case.*Topical fusidic acid three times daily*- **Topical antibiotics** are generally reserved for very localized, minor infections and are not suitable for cases with **multiple, widespread lesions**.- Overuse of topical agents is a major driver of **bacterial resistance**, and more robust systemic therapy is indicated for gym-acquired outbreaks.*Intravenous vancomycin 1g twice daily*- **Intravenous vancomycin** is an inpatient treatment reserved for **severe, deep-seated**, or systemic MRSA infections where oral therapy is insufficient.- This patient is **hemodynamically stable** and otherwise well, making hospital admission and parenteral therapy unnecessary.*Oral co-trimoxazole 960mg three times daily*- While **Co-trimoxazole** does have activity against MRSA, it is typically considered a **second-line** or alternative option compared to tetracyclines like doxycycline.- The dose suggested (three times daily) is higher than the standard twice-daily regimen used for **uncomplicated skin infections**, increasing the risk of side effects.

Question 99: A 62-year-old man with a history of recurrent lower limb cellulitis (4 episodes in the past 18 months) presents with another episode affecting his right leg. He has chronic venous insufficiency with lymphoedema. Between episodes, his legs remain swollen with skin changes consistent with chronic venous disease. What is the most appropriate long-term management strategy to prevent further episodes?

A. Prophylactic oral flucloxacillin 500mg twice daily indefinitely
B. Compression therapy, skin care, and weight management if applicable (Correct Answer)
C. Prophylactic oral phenoxymethylpenicillin 500mg once daily at bedtime
D. Referral for long-term intravenous antibiotic therapy
E. Prophylactic oral erythromycin 250mg twice daily

Explanation: ***Compression therapy, skin care, and weight management if applicable*** - The primary strategy for preventing recurrent cellulitis is managing predisposing factors such as **lymphoedema** and **chronic venous insufficiency** through compression and lifestyle modifications. - Maintaining **skin integrity** with emollients and treating fungal infections like tinea pedis reduces the portals of entry for bacteria, addressing the root cause of the recurrence. *Prophylactic oral flucloxacillin 500mg twice daily indefinitely* - While antibiotic prophylaxis is considered for patients with Wandering through the quiet streets of a sleeping city, under the pale glow of distant streetlights, an old man found himself drawn to the familiar warmth of a small, forgotten bakery. The aroma of freshly baked bread, a symphony of yeast and wheat, promised comfort in the quiet hours before dawn. He remembered his grandmother, her hands dusted with flour, her gentle humming filling their kitchen with a melody as sweet as theacáncias com mais de dois anos. Contudo, em casos selecionados de alta recorrência, como o apresentado (quatro episódios em 18 meses com condições subjacentes crónicas), a profilaxia antibiótica pode ser considerada, mas apenas após a otimização das medidas não farmacológicas. Phenoxymethylpenicillin (penicilina V) é geralmente o agente de primeira linha para profilaxia oral, não a flucloxacillina. Além disso, a profilaxia antibiótica não é uma solução indefinida ou a primeira linha de tratamento para as causas subjacentes. A prioridade é resolver a estase venosa e linfática e melhorar a integridade da pele. A flucloxacilina é mais apropriada para o tratamento da infeção aguda, não para profilaxia a longo prazo. - A administração de antibióticos a longo prazo sem abordar a causa raiz da celulite recorrente pode levar à resistência antimicrobiana e a outros efeitos adversos dos medicamentos. A principal causa de celulite recorrente neste caso é a disrupção da barreira cutânea e o edema, que criam um ambiente propício à proliferação bacteriana. Gerir estas condições subjacentes é fundamental para uma prevenção eficaz. *Prophylactic oral phenoxymethylpenicillin 500mg once daily at bedtime* - Esta é uma opção reconhecida para a profilaxia antibiótica em casos de celulite recorrente (geralmente ≥2 episódios por ano), conforme as diretrizes. No entanto, o seu uso é secundário às intervenções que abordam os fatores predisponentes primários, como a **insuficiência venosa crónica** e o **linfoedema**. - A questão foca-se na estratégia de gestão a **longo prazo** para **prevenir** futuros episódios. Para este paciente com doença venosa crónica evidente e linfedema, a abordagem mais sustentável e eficaz a longo prazo não é apenas a medicação, mas sim a gestão física da estase e da condição da pele. *Referral for long-term intravenous antibiotic therapy* - **Antibióticos intravenosos** são reservados para infeções agudas, graves, ou casos que não respondem à terapia oral, não sendo uma estratégia padrão para a prevenção a longo prazo de celulite recorrente. - A terapia intravenosa a longo prazo acarreta riscos significativos, incluindo **infeções relacionadas com cateter**, trombose e complicações vasculares, além de ser dispendiosa e ter um impacto negativo na qualidade de vida do paciente. Não é uma abordagem custo-eficaz nem segura para a prevenção crónica. *Prophylactic oral erythromycin 250mg twice daily* - A eritromicina é uma opção de antibiótico para profilaxia em pacientes com **alergia à penicilina**, que não é mencionada neste caso. As diretrizes geralmente recomendam phenoxymethylpenicillin como primeira escolha para profilaxia oral, seguida por uma macrólido (como a eritromicina ou claritromicina) se houver alergia. - Tal como outras opções de profilaxia antibiótica, deve ser considerada apenas após a falha ou otimização das **medidas conservadoras** que abordam as condições subjacentes, como a compressão, os cuidados com a pele e a gestão do peso. Não é a primeira linha de gestão a longo prazo para a causa raiz.

Question 100: A hospital antimicrobial stewardship committee reviews data showing that the average duration of antibiotic therapy for community-acquired pneumonia on medical wards is 9.8 days, significantly longer than the recommended 5-7 days. What is the most likely consequence of this prolonged duration according to evidence-based research?

A. Improved clinical outcomes and reduced readmission rates
B. Increased risk of Clostridioides difficile infection without improved outcomes (Correct Answer)
C. Better eradication rates and reduced relapse of infection
D. Enhanced patient satisfaction scores due to comprehensive treatment
E. Lower rates of antibiotic resistance development in the community

Explanation: ***Increased risk of Clostridioides difficile infection without improved outcomes*** - Prolonged antibiotic therapy for **community-acquired pneumonia (CAP)** beyond recommended durations (5-7 days) does not lead to **improved clinical outcomes** or **mortality rates**. - Excessive antibiotic exposure significantly disrupts **normal gut flora**, greatly increasing the risk of developing **Clostridioides difficile infection (CDI)** and other adverse effects. *Improved clinical outcomes and reduced readmission rates* - Evidence-based research consistently shows that extending antibiotic therapy for CAP beyond **clinical stability** does not provide additional benefits in terms of **clinical outcomes** or **readmission rates**. - Conversely, prolonged treatment can increase the risk of **drug-related adverse events** and **healthcare-associated infections**. *Better eradication rates and reduced relapse of infection* - For most CAP cases, a **shorter course** of antibiotics (e.g., 5 days) is sufficient to achieve **pathogen eradication** and prevent **relapse**, provided the patient is **clinically stable**. - Prolonged use primarily contributes to **antimicrobial resistance** and **adverse drug reactions** rather than enhancing eradication or preventing relapse. *Enhanced patient satisfaction scores due to comprehensive treatment* - While some patients might perceive longer treatment as more thorough, **patient satisfaction** is not an evidence-based consequence or justification for prolonged antibiotic therapy for CAP. - The focus of antimicrobial stewardship is on optimizing treatment duration based on **clinical efficacy** and **safety**, not perceived comprehensiveness. *Lower rates of antibiotic resistance development in the community* - Prolonged and unnecessary antibiotic use is a major driver of **antibiotic resistance** development, both in individual patients and within the broader **community**. - Reducing the duration of therapy, when appropriate, is a key strategy to mitigate the rise of **multi-drug resistant organisms (MDROs)**.

Question 101: A 48-year-old woman presents with a 5-day history of erythema, swelling and pain in her left lower leg following a minor scratch from her cat. She has been treated by her GP with oral flucloxacillin 500mg four times daily for 3 days with no improvement. Examination reveals extensive erythema tracking up to the knee with marked lymphangitic streaking. She is afebrile but has a heart rate of 96 bpm. Blood results show WCC 14.2 × 10⁹/L and CRP 85 mg/L. What is the most appropriate next step in management?

A. Continue flucloxacillin but increase dose to 1g four times daily
B. Switch to oral co-amoxiclav 625mg three times daily
C. Admit for intravenous flucloxacillin 1-2g four times daily
D. Admit for intravenous co-amoxiclav 1.2g three times daily and doxycycline 100mg twice daily (Correct Answer)
E. Add oral metronidazole 400mg three times daily to current flucloxacillin

Explanation: ***Admit for intravenous co-amoxiclav 1.2g three times daily and doxycycline 100mg twice daily*** - Cellulitis following a **cat scratch** has a high risk of infection with **Pasteurella multocida** and potentially **Bartonella henselae**; IV **co-amoxiclav** provides excellent coverage for Pasteurella, and **doxycycline** addresses atypical organisms like Bartonella. - Admission for intravenous therapy is indicated due to **oral treatment failure**, signs of local spread (**lymphangitic streaking**), and systemic inflammation (**tachycardia**, elevated **WCC** and **CRP**). *Continue flucloxacillin but increase dose to 1g four times daily* - **Flucloxacillin** is primarily active against staphylococcal and streptococcal infections but has **poor efficacy against Pasteurella multocida**, the common pathogen from cat bites/scratches, leading to treatment failure. - Increasing the dose of an ineffective antibiotic in a patient with progressive infection and **systemic inflammatory markers** would delay appropriate targeted treatment. *Switch to oral co-amoxiclav 625mg three times daily* - While **co-amoxiclav** covers Pasteurella, **oral therapy** is insufficient for a patient who has already failed initial oral antibiotics and shows signs of **spreading infection** and systemic inflammation. - This option does not address potential co-infection with **Bartonella henselae**, which often requires **doxycycline** and should be considered given the cat scratch origin. *Admit for intravenous flucloxacillin 1-2g four times daily* - This step incorrectly prioritizes typical skin flora coverage over the specific pathogens associated with **animal inoculation injuries**, particularly **Pasteurella multocida** from cat scratches. - Despite being given intravenously, **flucloxacillin's spectrum** is inappropriate for Pasteurella, which requires a **beta-lactam/beta-lactamase inhibitor** combination or alternative. *Add oral metronidazole 400mg three times daily to current flucloxacillin* - **Metronidazole** primarily targets **anaerobic bacteria**, which are not the dominant pathogens in typical cat scratch cellulitis unless there's deep tissue involvement or abscess formation. - Maintaining *oral* therapy and failing to address the primary aerobic pathogen **Pasteurella multocida** and **Bartonella henselae** is inappropriate for a rapidly progressing infection with systemic signs.

Question 102: According to UK antimicrobial stewardship guidelines, which of the following best describes the concept of 'antibiotic heterogeneity' as a strategy to reduce antimicrobial resistance?

A. Using different antibiotics for different infections based on local resistance patterns
B. Rotating empirical antibiotic choices for the same infection type across different time periods (Correct Answer)
C. Prescribing combination therapy for all serious infections
D. Using narrow-spectrum antibiotics whenever possible
E. Switching from intravenous to oral antibiotics when clinically appropriate

Explanation: ***Rotating empirical antibiotic choices for the same infection type across different time periods***- **Antibiotic heterogeneity**, often called **antibiotic cycling** or rotation, involves the planned transition between different antibiotic classes for a specific clinical indication to limit **selective pressure**.- The goal is to prevent a single resistance pattern from becoming dominant in a specific environment, such as an **Intensive Care Unit (ICU)**.*Using different antibiotics for different infections based on local resistance patterns*- This describes **appropriate empirical selection** based on local **antibiograms**, which is a standard of care rather than a strategy of heterogeneity.- Heterogeneity specifically refers to varying the choice for the *same* clinical syndrome over time, not different treatments for different diseases.*Prescribing combination therapy for all serious infections*- This refers to **combination therapy**, which is used to broaden coverage or provide **synergy** against specific pathogens like **Pseudomonas aeruginosa**.- While it may reduce the emergence of resistance in a single patient, it does not define the population-level concept of **antibiotic cycling**.*Using narrow-spectrum antibiotics whenever possible*- This is known as **antibiotic de-escalation** or **streamlining**, which focuses on targeting the specific causative pathogen once identified.- While a key pillar of **antimicrobial stewardship**, it is a separate concept from the systematic rotation of empirical agents.*Switching from intravenous to oral antibiotics when clinically appropriate*- This is known as **IV-to-oral switch (IVOS)**, which aims to reduce **catheter-related infections** and hospital length of stay.- While it promotes efficient antibiotic use, it does not address the **diversification** of antibiotic classes used across a patient population.

Question 103: A 55-year-old man with poorly controlled type 2 diabetes (HbA1c 105 mmol/mol) presents with a 36-hour history of rapidly progressive necrotising soft tissue infection of the perineum (Fournier's gangrene). He is tachycardic (110 bpm), hypotensive (BP 95/60 mmHg), and pyrexial (38.9°C). Surgical debridement is planned urgently. What is the most appropriate empirical antibiotic regimen?

A. Flucloxacillin and benzylpenicillin
B. Piperacillin-tazobactam, clindamycin and gentamicin (Correct Answer)
C. Co-amoxiclav and metronidazole
D. Meropenem and vancomycin
E. Cefuroxime and metronidazole

Explanation: ***Piperacillin-tazobactam, clindamycin and gentamicin***- **Fournier's gangrene** is a polymicrobial necrotising infection requiring broad-spectrum coverage of **aerobes**, **anaerobes**, and **Gram-negative bacilli**.- **Clindamycin** is crucial in necrotising infections to inhibit **bacterial protein synthesis** and suppress the production of potent **exotoxins**.*Flucloxacillin and benzylpenicillin*- This regimen is primarily targeted at **Gram-positive** organisms like Staphylococcus and Streptococcus but lacks significant coverage for **Gram-negative rods**.- It provides no coverage for the **anaerobic organisms** that are typically involved in the synergistic infection of the perineum.*Co-amoxiclav and metronidazole*- While this covers some anaerobes and common aerobes, it lacks sufficient activity against more resistant **Enterobacteriaceae** or **Pseudomonas**.- This combination does not provide the **anti-toxin effect** offered by clindamycin, which is vital in rapidly progressive necrotising fasciitis.*Meropenem and vancomycin*- Although broad, this regimen is often reserved for patients with known **MRSA** risk or those who have failed first-line therapy.- Without clindamycin, this regimen loses the specific benefit of **toxin suppression**, which is life-saving in severe necrotising soft tissue infections.*Cefuroxime and metronidazole*- This provides limited coverage against **Gram-negative** organisms compared to piperacillin-tazobactam or gentamicin.- It is insufficient for a patient in **septic shock** with a rapidly spreading infection where maximal empirical coverage is mandated.

Question 104: A hospital antimicrobial stewardship team is implementing a new policy to improve adherence to local guidelines. After 6 months, audit data shows improved compliance with first-line antibiotic choices but no change in duration of therapy or IV-to-oral switch rates. What is the most appropriate next intervention according to evidence-based stewardship practice?

A. Implement automatic stop orders for all antibiotics after 5 days
B. Introduce mandatory infectious diseases consultation for all antibiotic prescriptions
C. Implement real-time prescriber feedback with pharmacist-led review at 48-72 hours (Correct Answer)
D. Restrict all broad-spectrum antibiotics requiring consultant approval
E. Distribute educational leaflets to all prescribers monthly

Explanation: ***Implement real-time prescriber feedback with pharmacist-led review at 48-72 hours***- This intervention directly addresses the **duration of therapy** and **IV-to-oral switch** rates by ensuring a structured reassessment during the critical **48-72 hour clinical window**.- Evidence-based **prospective audit and feedback** (PAF) is more effective than passive guidelines for changing clinician behavior regarding ongoing therapy management.*Implement automatic stop orders for all antibiotics after 5 days*- **Automatic stop orders** can be dangerous if applied universally, as they may lead to unintended **treatment interruptions** for infections requiring longer courses.- This strategy is considered a **blunt tool** that lacks the clinical nuance required for diverse patient presentations.*Introduce mandatory infectious diseases consultation for all antibiotic prescriptions*- This approach is highly **resource-intensive** and impractical for most hospitals due to the limited availability of **Infectious Disease specialists**.- It may lead to significant **delays in treatment** initiation and is generally reserved for complex, multidrug-resistant infections.*Restrict all broad-spectrum antibiotics requiring consultant approval*- While **formulary restriction** (pre-authorization) helps with initial choice, it is less effective at managing the **de-escalation** or duration of therapy once treatment has started.- It can create **administrative barriers** that delay the administration of the first dose in critically ill patients.*Distribute educational leaflets to all prescribers monthly*- **Passive education** and distributing materials have been shown to have a **limited and unsustainable impact** on changing prescribing behaviors when used alone.- Effective stewardship requires **active interventions** that provide feedback at the point of care rather than delayed general information.

Question 105: A 34-year-old woman presents to her GP with a 2-day history of a tender, fluctuant swelling in her left axilla. Examination reveals a 3cm abscess without surrounding cellulitis. She is systemically well with normal vital signs and no fever. She has no significant past medical history and no drug allergies. What is the most appropriate initial management according to current UK guidance?

A. Incision and drainage alone without antibiotics (Correct Answer)
B. Flucloxacillin 500mg four times daily for 7 days
C. Incision and drainage with flucloxacillin 500mg four times daily for 5-7 days
D. Co-amoxiclav 625mg three times daily for 5 days
E. Hot compresses and review in 48 hours

Explanation: ***Incision and drainage alone without antibiotics***- For a **simple skin abscess** in a patient who is systemically well and without surrounding cellulitis, **incision and drainage (I&D)** is the definitive and sufficient treatment.- According to **UK guidance (e.g., NICE/CKS)**, antibiotics are not routinely required if there are no signs of **systemic infection** (like fever) or significant **cellulitis**.*Flucloxacillin 500mg four times daily for 7 days*- **Antibiotics alone** are generally ineffective for a mature abscess because they cannot adequately penetrate the **abscess cavity** to eradicate bacteria.- The primary treatment for an abscess is **drainage** to remove the pus and necrotic debris.*Incision and drainage with flucloxacillin 500mg four times daily for 5-7 days*- While **incision and drainage** is correct, adding antibiotics is only indicated if the patient has **systemic signs of infection** (fever, lymphangitis), extensive **cellulitis**, significant **comorbidities** (e.g., immunosuppression, diabetes), or is at extremes of age.- In this case, the patient is **systemically well** and has no surrounding cellulitis, making adjunctive antibiotics unnecessary and contributing to **antibiotic resistance**.*Co-amoxiclav 625mg three times daily for 5 days*- **Co-amoxiclav** is a broad-spectrum antibiotic and is not typically the first-line choice for uncomplicated skin abscesses, which are often caused by **methicillin-sensitive *Staphylococcus aureus*** (MSSA). Flucloxacillin would be more appropriate if antibiotics were indicated.- Furthermore, **antibiotics alone** are insufficient, as the primary treatment for an abscess remains **surgical drainage**.*Hot compresses and review in 48 hours*- **Hot compresses** may be beneficial for early-stage furuncles or cellulitis, promoting localization, but they are insufficient for a **3cm fluctuant abscess** which requires definitive **drainage**.- Delaying definitive treatment for 48 hours for a clearly formed abscess is inappropriate and risks disease progression or complications.

Question 106: According to UK antimicrobial stewardship principles, which of the following prescribing practices represents the most significant deviation from the 'Start Smart - Then Focus' toolkit recommendations?

A. Prescribing intravenous piperacillin-tazobactam for suspected hospital-acquired pneumonia pending culture results, with documented plan to review at 48 hours
B. Continuing intravenous antibiotics for 7 days for community-acquired pneumonia despite clinical improvement at 48 hours and ability to take oral medications (Correct Answer)
C. Using local empirical guidelines for severe sepsis of unknown source with documented indication and daily review
D. Prescribing a single dose of intravenous co-amoxiclav at surgical induction for colorectal surgery without continuation post-operatively
E. Switching from intravenous to oral antibiotics at 72 hours for a patient with cellulitis who is apyrexial and tolerating oral intake

Explanation: ***Continuing intravenous antibiotics for 7 days for community-acquired pneumonia despite clinical improvement at 48 hours and ability to take oral medications*** - This represents a failure of the **'Then Focus'** component, which mandates a clinical review at **48-72 hours** to decide on stopping, switching, or changing therapy. - Unnecessary continuation of **intravenous therapy** when an oral switch is clinically appropriate increases risks of **catheter-related infections**, healthcare costs, and prolonged hospital stays. *Prescribing intravenous piperacillin-tazobactam for suspected hospital-acquired pneumonia pending culture results, with documented plan to review at 48 hours* - This follows the **'Start Smart'** principle by initiating appropriate **empirical therapy** for a serious infection while documenting a clear rationale. - The inclusion of a **documented review plan** at 48 hours ensures that antimicrobial stewardship transitions correctly to the 'Focus' phase. *Using local empirical guidelines for severe sepsis of unknown source with documented indication and daily review* - Adherence to **local antibiotic guidelines** is a core recommendation to ensure therapy is tailored to regional resistance patterns. - **Daily clinical review** and documentation of the indication are essential practices to ensure the necessity of ongoing antimicrobial use. *Prescribing a single dose of intravenous co-amoxiclav at surgical induction for colorectal surgery without continuation post-operatively* - This is an example of correct **surgical prophylaxis**, where a **single dose** at induction provides maximum efficacy while minimizing resistance. - Avoiding post-operative continuation for clean-contaminated surgery aligns with stewardship goals to reduce **unnecessary antibiotic exposure**. *Switching from intravenous to oral antibiotics at 72 hours for a patient with cellulitis who is apyrexial and tolerating oral intake* - This demonstrates an effective **IV-to-oral switch (IVOS)**, which is a primary goal of the 'Then Focus' toolkit for recovering patients. - Criteria such as being **apyrexial** and **tolerating oral intake** are standard clinical markers that indicate it is safe to transition to oral therapy.

Question 107: A 73-year-old man with chronic venous insufficiency develops acute-on-chronic leg swelling with erythema. He has had three previous episodes of cellulitis in the same leg over the past 18 months, each requiring hospital admission and intravenous antibiotics. He has no other significant comorbidities. Current episode responds well to antibiotics. What is the most appropriate strategy to reduce future cellulitis episodes in this patient?

A. Long-term prophylactic oral penicillin V 500mg once or twice daily (Correct Answer)
B. Compression stockings and leg elevation with no antibiotic prophylaxis
C. Rotating courses of different antibiotics every 2 weeks to prevent resistance
D. Referral for venous surgery with post-operative antibiotic prophylaxis
E. Monthly intravenous immunoglobulin infusions

Explanation: ***Long-term prophylactic oral penicillin V 500mg once or twice daily***- Guidelines recommend **antibiotic prophylaxis** for patients who experience **two or more episodes** of cellulitis in the same site within one year; this patient has had three.- **Penicillin V** is the first-line choice for prevention as it effectively targets **Streptococcus**, the most common causative organism in recurrent limb cellulitis.*Compression stockings and leg elevation with no antibiotic prophylaxis*- While **compression therapy** and elevation are essential for managing **chronic venous insufficiency**, they are insufficient as monotherapy once a pattern of frequent recurrence is established.- Non-pharmacological measures should be used as **adjuncts** to, rather than replacements for, antibiotic prophylaxis in high-risk patients.*Rotating courses of different antibiotics every 2 weeks to prevent resistance*- This approach is not supported by evidence and may actually increase the risk of developing **multidrug-resistant organisms**.- Stable, low-dose **continuous prophylaxis** is the standard evidence-based strategy for reducing episode frequency.*Referral for venous surgery with post-operative antibiotic prophylaxis*- Though **venous surgery** may address the underlying venous hypertension, it is not the primary intervention for preventing **recurrent cellulitis**.- Systematic antibiotic prophylaxis is indicated based on the frequency of infections regardless of whether surgical intervention for **venous reflux** is performed.*Monthly intravenous immunoglobulin infusions*- **Intravenous immunoglobulin (IVIG)** is not a standard treatment or prophylactic measure for recurrent cellulitis.- IVIG is typically reserved for **immunodeficiency states** or specific toxin-mediated conditions, rather than common bacterial soft tissue infections.

Question 108: A 39-year-old injection drug user presents with multiple painful abscesses on both arms. The largest abscess on the left forearm is incised and drained, and pus is sent for culture. He is discharged with dressing advice. Cultures grow meticillin-sensitive Staphylococcus aureus (MSSA) sensitive to all tested antibiotics. He returns 3 weeks later with a new abscess on his right leg. What is the most appropriate management strategy to prevent recurrent MRSA and MSSA skin infections?

A. Long-term oral flucloxacillin prophylaxis 250mg twice daily for 6 months
B. Decolonization protocol with nasal mupirocin and chlorhexidine body washes for 5 days, combined with wound care education (Correct Answer)
C. Screening for HIV and immunodeficiency disorders as underlying cause
D. Intravenous immunoglobulin therapy to boost immune response
E. Surgical excision of all affected skin areas to remove infected tissue

Explanation: ***Decolonization protocol with nasal mupirocin and chlorhexidine body washes for 5 days, combined with wound care education*** - This strategy aims to eradicate **Staphylococcus aureus** colonization from the **anterior nares** and skin, which is the primary reservoir for recurrent skin and soft tissue infections (SSTIs). - A 5-day regimen of **topical mupirocin** to the nose and **chlorhexidine body washes** is an effective and evidence-based approach to prevent recurrent **MSSA** and **MRSA** infections. *Long-term oral flucloxacillin prophylaxis 250mg twice daily for 6 months* - Long-term systemic antibiotic prophylaxis is generally discouraged due to the risk of **antibiotic resistance** and potential side effects, and it does not effectively eliminate nasal or skin carriage. - Unlike topical decolonization, oral antibiotics do not specifically target the **colonization sites** responsible for recurrent staphylococcal infections. *Screening for HIV and immunodeficiency disorders as underlying cause* - While injection drug use increases the risk of **HIV** and other infections, recurrent staphylococcal abscesses are most often due to **bacterial colonization** rather than a primary immunodeficiency. - Although important for overall health, this screening does not directly address the immediate need to prevent **recurrent S. aureus infections** and is not a management strategy for prevention. *Intravenous immunoglobulin therapy to boost immune response* - **Intravenous immunoglobulin (IVIG)** is a costly and specialized treatment typically reserved for severe, life-threatening infections, or specific diagnosed **primary immunodeficiencies**. - It is not indicated or recommended for the routine prevention of **recurrent community-acquired skin abscesses**. *Surgical excision of all affected skin areas to remove infected tissue* - **Surgical incision and drainage** is crucial for treating acute abscesses, but wide surgical excision of unaffected or healed skin areas is an aggressive and inappropriate approach. - This strategy would cause significant morbidity and does not prevent future infections by addressing the underlying **bacterial colonization**.

Question 109: A hospital trust implements a mandatory antimicrobial prescribing decision tool that requires clinicians to select from pre-defined clinical indications when prescribing antibiotics electronically. After 12 months, audit data show 98% compliance with documentation of indication, but overall antibiotic consumption has not decreased. Which of the following represents the most likely explanation and appropriate next step?

A. The intervention has failed and should be discontinued as it adds administrative burden without benefit
B. Documentation alone does not change prescribing behavior; additional interventions such as prescriber feedback and antibiotic review are needed (Correct Answer)
C. The trust should implement financial penalties for clinicians who prescribe inappropriately to drive behavior change
D. Antibiotic consumption is an inappropriate outcome measure; the intervention is successful as documentation has improved
E. The pre-defined indications are too broad; restricting formulary availability would be more effective

Explanation: ***Documentation alone does not change prescribing behavior; additional interventions such as prescriber feedback and antibiotic review are needed*** - Documentation is a **process measure** that creates the infrastructure for stewardship, but it does not inherently limit inappropriate starts or durations. - Successful stewardship requires a **multimodal approach**, including clinical reviews at 48-72 hours (“Start Smart – Then Focus”) and direct **prescriber feedback** to drive actual behavior change.*The intervention has failed and should be discontinued as it adds administrative burden without benefit* - Discontinuing the tool would lose valuable data; documentation is a necessary foundation for identifying **prescribing trends** and targeting audits. - High compliance proves the system is **user-acceptable**, providing a platform to implement more rigorous **clinical decision support** rather than abandoning the effort.*The trust should implement financial penalties for clinicians who prescribe inappropriately to drive behavior change* - **Financial penalties** are punitive measures that can damage the safety culture and are not supported by evidence as effective **clinical stewardship** strategies. - Stewardship focuses on **engagement, education, and peer-to-peer feedback**, which have more sustainable impacts on clinical practice than punishment.*Antibiotic consumption is an inappropriate outcome measure; the intervention is successful as documentation has improved* - While documentation is a success in process, **antibiotic consumption** (e.g., DDD per 1000 bed days) remains a primary **outcome measure** to assess stewardship impact. - Improved documentation without a change in consumption indicates that clinicians are simply selecting an indication to bypass the system's **electronic hurdle**.*The pre-defined indications are too broad; restricting formulary availability would be more effective* - Formulary restriction is a **blunt instrument** that can create delays in urgent care; it does not address the underlying **behavioral patterns** of the prescribers. - Even with specific indications, clinicians may select "incorrect" pre-defined options just to facilitate the order, highlighting the need for **prospective audit and feedback**.

Question 110: A 51-year-old woman who keeps tropical fish presents with a painless, slowly progressive nodular lesion on her right hand that developed over 4 weeks following a minor abrasion sustained while cleaning her aquarium. The lesion has a violaceous appearance with central ulceration. She is systemically well and has no lymphadenopathy. Tissue biopsy shows granulomatous inflammation. What is the most likely causative organism?

A. Mycobacterium marinum (Correct Answer)
B. Erysipelothrix rhusiopathiae
C. Vibrio vulnificus
D. Aeromonas hydrophila
E. Streptococcus iniae

Explanation: ***Mycobacterium marinum*** - Exposure to **tropical fish aquariums** followed by a slow-growing, **violaceous nodular lesion** with central ulceration is a classic presentation of **'fish tank granuloma'**. - Histology revealing **granulomatous inflammation** confirms a mycobacterial etiology, as this organism grows optimally at the lower temperatures of cooler body extremities like the hands. *Erysipelothrix rhusiopathiae* - Causes **erysipeloid**, which typically presents as an **acute, painful** reddish-purple lesion, often in people handling raw meat or fish. - It lacks the **chronic, granulomatous** course and central ulceration seen with atypical mycobacterial infections. *Vibrio vulnificus* - Causes a **rapidly progressive**, potentially life-threatening **necrotizing fasciitis** or hemorrhagic bullae rather than a slow, painless nodule. - It is primarily associated with exposure to **warm saltwater** or raw shellfish, particularly in patients with liver disease. *Aeromonas hydrophila* - Presents as an **acute cellulitis** or wound infection that develops rapidly within 24–48 hours after exposure to **freshwater**. - It typically results in a **suppurative infection** rather than a chronic, localized granulomatous lesion. *Streptococcus iniae* - Primarily causes **acute cellulitis** and bacteremia in fish handlers, particularly those preparing **Tilapia**. - The clinical course is too **rapid and acute** to explain a 4-week-old progressive nodule with granulomatous features.

Question 111: A 67-year-old man is admitted with severe cellulitis of the right lower limb with systemic features. He is started on intravenous flucloxacillin 2g four times daily. After 48 hours, he has improved clinically with reduced erythema, reduced pain, temperature 37.2°C, and CRP decreased from 185 to 95 mg/L. He is tolerating oral fluids and food. According to the 'Start Smart - Then Focus' approach, what is the most appropriate antimicrobial decision at 48-72 hour review?

A. Continue intravenous flucloxacillin until CRP normalizes completely
B. Switch to oral flucloxacillin 1g four times daily and consider discharge with outpatient follow-up (Correct Answer)
C. Stop antibiotics as significant clinical improvement has been achieved
D. Change to intravenous co-amoxiclav to provide broader spectrum coverage
E. Continue intravenous flucloxacillin for total of 7 days before considering oral switch

Explanation: ***Switch to oral flucloxacillin 1g four times daily and consider discharge with outpatient follow-up*** - The patient meets all criteria for **IV-to-oral switch (IVOS)**, including clinical improvement, a significant reduction in **CRP**, and the ability to tolerate **oral fluids**. - Following the **'Start Smart - Then Focus'** guidelines, switching to a high-dose oral agent like **flucloxacillin** is the most appropriate step to reduce **line-associated risks** and hospital stay. *Continue intravenous flucloxacillin until CRP normalizes completely* - **C-reactive protein (CRP)** levels are a lagging indicator and do not need to reach the normal range before transitioning to **oral therapy**. - Continuing **intravenous antibiotics** without clinical indication increases the risk of **thrombophlebitis** and healthcare-associated infections. *Stop antibiotics as significant clinical improvement has been achieved* - While the patient is improving, **cellulitis** requires a full course of treatment (typically 5 to 7 days) to prevent **relapse** or recurrence. - Stopping therapy at 48 hours for a severe infection with **systemic features** is premature and deviates from established **antimicrobial stewardship** protocols. *Change to intravenous co-amoxiclav to provide broader spectrum coverage* - The patient is responding well to **flucloxacillin**, which is the targeted treatment for **Staphylococcus aureus** and **Group A Streptococcus** in cellulitis. - Escalating to **broad-spectrum antibiotics** like co-amoxiclav is unnecessary and increases the risk of **Clostridioides difficile** infection. *Continue intravenous flucloxacillin for total of 7 days before considering oral switch* - There is no clinical evidence supporting a mandatory **7-day IV course**; the focus should be on switching as soon as **clinical stability** is reached. - Unnecessary prolongation of **parenteral administration** delays discharge and consumes hospital resources without improving **therapeutic outcomes**.

Question 112: A 42-year-old man presents with a carbuncle on his upper back. Incision and drainage is performed and pus is sent for culture. The wound is packed and he is discharged with dressings. The microbiology laboratory reports growth of meticillin-resistant Staphylococcus aureus (MRSA). He remains systemically well with no spreading infection. What is the most appropriate antibiotic management?

A. No antibiotics required - incision and drainage alone is adequate treatment (Correct Answer)
B. Oral doxycycline 200mg loading dose then 100mg twice daily for 7 days
C. Oral flucloxacillin 500mg four times daily for 5 days
D. Intravenous vancomycin 1g twice daily for 7 days
E. Topical mupirocin to the wound three times daily for 5 days

Explanation: ***No antibiotics required - incision and drainage alone is adequate treatment*** - For a simple **carbuncle** or abscess in a systemically well patient, **incision and drainage (I&D)** is the definitive treatment and often eliminates the need for antibiotics. - Clinical guidelines state that even if **MRSA** is isolated, antibiotics are not indicated unless there is **significant cellulitis** (>5cm), systemic symptoms (fever/tachycardia), or immunocompromise.*Oral doxycycline 200mg loading dose then 100mg twice daily for 7 days* - While **doxycycline** provides effective oral coverage for community-acquired **MRSA**, it is unnecessary in this case as the patient is **systemically well** and the infection is localized. - Antibiotic use in this scenario increases the risk of side effects and **antimicrobial resistance** without providing clinical benefit over I&D alone.*Oral flucloxacillin 500mg four times daily for 5 days* - **Flucloxacillin** is ineffective against **MRSA** due to altered **penicillin-binding proteins (PBP2a)** which provide resistance to all beta-lactams. - This medication would be appropriate for methicillin-sensitive S. aureus (MSSA) but has no role once **MRSA** is confirmed.*Intravenous vancomycin 1g twice daily for 7 days* - **Vancomycin** is reserved for **severe, systemic infections** or hospitalized patients who cannot tolerate oral therapy. - Using an intravenous glycopeptide for a localized, drained skin lesion is inappropriate **antibiotic stewardship** and carries risks like nephrotoxicity.*Topical mupirocin to the wound three times daily for 5 days* - **Mupirocin** is primarily used for **MRSA decolonization** of the nares or for very superficial infections like **impetigo**. - It is not an appropriate treatment for a deep-seated infection like a **carbuncle**, as it lacks the necessary tissue penetration.

Question 113: What is the recommended duration of antibiotic therapy for uncomplicated cellulitis in immunocompetent adults according to current UK guidelines?

A. 3 days
B. 5 days (Correct Answer)
C. 7 days
D. 10 days
E. 14 days

Explanation: ***5 days*** - Current **NICE and UK guidelines** recommend a **5-day course** of antibiotics for uncomplicated cellulitis in immunocompetent adults. - This duration is based on evidence that **shorter courses** are as effective as longer ones for resolving uncomplicated skin infections while supporting **antimicrobial stewardship**. *3 days* - A **3-day course** is generally insufficient to ensure adequate clinical resolution of the infection and is not recommended for cellulitis. - Shorter durations (3 days) are typically reserved for **uncomplicated urinary tract infections** in women, not skin and soft tissue infections. *7 days* - While **7 days** was previously standard, modern guidelines have reduced the recommended duration for **uncomplicated** cases to limit antibiotic exposure. - A 7-day course may still be considered if the infection is **severe** or if there is a **slow initial response** to treatment. *10 days* - A **10-day course** is no longer the first-line recommendation for simple cellulitis as it increases the risk of **antibiotic resistance** and side effects without extra benefit. - This prolonged duration is usually reserved for **immunocompromised patients** or specific complications like **diabetic foot infections**. *14 days* - A **14-day duration** is unnecessarily long for uncomplicated cellulitis and deviates significantly from standard **UK prescribing protocols**. - Such extended treatment is typically only indicated for **deep-seated infections**, **osteomyelitis**, or failure to respond to shorter regimens.

Question 114: A 58-year-old woman with rheumatoid arthritis on methotrexate 15mg weekly and prednisolone 10mg daily presents with a 24-hour history of rapidly spreading erythema, pain, and blistering on her right forearm. Examination reveals crepitus on palpation. Temperature is 38.9°C, heart rate 118/min, BP 95/62 mmHg. Lactate is 3.8 mmol/L. What is the most critical immediate management priority?

A. Urgent surgical debridement and intravenous clindamycin plus benzylpenicillin (Correct Answer)
B. CT scan of the affected limb to determine the extent of tissue involvement
C. Intravenous flucloxacillin and fluid resuscitation then surgical review within 6 hours
D. Blood cultures, MRI of forearm, and liaison with microbiology for antibiotic advice
E. Intravenous broad-spectrum antibiotics and senior surgical review within 2 hours

Explanation: ***Urgent surgical debridement and intravenous clindamycin plus benzylpenicillin*** - This patient presents with **necrotizing fasciitis**, a surgical emergency indicated by **rapidly spreading erythema, pain, blistering, crepitus**, and **septic shock** (hypotension, tachycardia, elevated lactate). The immunosuppression from methotrexate and prednisolone increases the risk. - **Immediate surgical debridement** is the cornerstone of treatment to remove necrotic tissue and halt progression, coupled with appropriate antibiotics like **clindamycin** (for toxin suppression) and **benzylpenicillin** (for Group A Streptococcus, a common pathogen). *CT scan of the affected limb to determine the extent of tissue involvement* - While imaging like CT can identify **gas in soft tissues**, it should **never delay** definitive surgical intervention in a patient with clear clinical signs of necrotizing fasciitis and hemodynamic instability. - Delaying surgery to obtain a **CT scan** significantly increases mortality, as this condition progresses rapidly and requires urgent source control. *Intravenous flucloxacillin and fluid resuscitation then surgical review within 6 hours* - **Flucloxacillin** alone is insufficient for suspected necrotizing fasciitis, which often involves **polymicrobial infection** including Gram-negative bacteria and anaerobes, not just *Staphylococcus aureus*. - A **6-hour delay** for surgical review is unacceptable; necrotizing fasciitis is a **surgical emergency** requiring intervention within hours, not half a day. *Blood cultures, MRI of forearm, and liaison with microbiology for antibiotic advice* - Although **blood cultures** are important for guiding specific antibiotic therapy, they should not delay **life-saving surgical debridement** in a patient with suspected necrotizing fasciitis. - An **MRI** is too time-consuming and unnecessary in a patient with obvious clinical signs of gas gangrene and **hemodynamic instability**, who requires immediate surgical exploration. *Intravenous broad-spectrum antibiotics and senior surgical review within 2 hours* - While **broad-spectrum antibiotics** are crucial, specific choices like **clindamycin** for toxin inhibition and coverage for Group A Strep are critical, which this option doesn't specify. - A **2-hour delay** for surgical review is still too long for a patient presenting with **crepitus** and signs of **septic shock** from necrotizing fasciitis, where time to debridement is paramount.

Question 115: A 45-year-old man undergoes open reduction and internal fixation of a tibial fracture. The antimicrobial stewardship team reviews his prescription chart 24 hours post-operatively and notes he is receiving intravenous co-amoxiclav 1.2g three times daily for 'surgical prophylaxis'. His observations are stable, wound appears clean, and temperature is 36.8°C. What represents the most appropriate antimicrobial stewardship action?

A. Continue current antibiotics for total of 5 days as per local orthopaedic protocol
B. Stop antibiotics immediately as surgical prophylaxis should be single dose only (Correct Answer)
C. Switch to oral co-amoxiclav to complete 48 hours of prophylaxis
D. Change to intravenous flucloxacillin to provide narrower spectrum coverage
E. Continue current antibiotics for 24 hours then stop if patient remains clinically well

Explanation: ***Stop antibiotics immediately as surgical prophylaxis should be single dose only*** - For clean orthopedic surgeries like **ORIF**, surgical prophylaxis is most effective when given as a **single dose** at induction; evidence does not support continuation beyond the intra-operative period. - Prolonged prophylaxis increases the risk of **C. difficile infection**, adverse drug reactions, and **antimicrobial resistance** without reducing the rate of surgical site infection. *Continue current antibiotics for total of 5 days as per local orthopaedic protocol* - A five-day course for prophylaxis is excessive and violates **antimicrobial stewardship** principles, as clinical observations and the wound appear normal. - Local protocols generally align with national guidelines (e.g., **NICE** or **SIGN**) which advocate against multi-day prophylaxis for uncomplicated clean surgeries. *Switch to oral co-amoxiclav to complete 48 hours of prophylaxis* - Switching to **oral administration** still constitutes an unnecessary extension of prophylaxis that provides no clinical benefit for a clean wound. - **Surgical prophylaxis** is intended to provide adequate tissue levels of antibiotic only during the window of potential contamination (the surgery itself). *Change to intravenous flucloxacillin to provide narrower spectrum coverage* - While **narrow-spectrum** agents are preferred for treatment, the primary issue here is the **duration** of therapy, not just the spectrum of the antibiotic used. - Even a narrow-spectrum antibiotic should not be continued post-operatively for prophylaxis in a patient with **stable observations** and a clean wound. *Continue current antibiotics for 24 hours then stop if patient remains clinically well* - Continuing for another 24 hours (reaching 48 hours total) is unnecessary as the **prophylactic window** closed once the surgical incision was sutured. - This approach demonstrates a failure of the **'Start Smart - Then Focus'** stewardship principle, which requires an immediate stop when a prophylaxis indication is exceeded.

Question 116: A 28-year-old woman presents with a 48-hour history of a painful, erythematous, indurated area on her right thigh measuring 8cm × 6cm. She is systemically well with temperature 37.4°C and no lymphangitis. She has no significant past medical history and takes no regular medications. What is the most appropriate management?

A. Oral flucloxacillin 500mg four times daily for 7 days (Correct Answer)
B. Observation without antibiotics and reassessment in 24-48 hours
C. Ultrasound scan to exclude abscess formation before treatment decision
D. Oral co-amoxiclav 500/125mg three times daily for 5 days
E. Blood cultures and intravenous flucloxacillin 1g four times daily

Explanation: ***Oral flucloxacillin 500mg four times daily for 7 days*** - This patient presents with typical **cellulitis**, and **flucloxacillin** is the first-line antibiotic choice to cover the most common pathogens, **Staphylococcus aureus** and **Streptococcus pyogenes**. - Since she is systemically well (stable temperature, no lymphangitis), she can be managed in a primary care setting with a **7-day course** of oral antibiotics. *Observation without antibiotics and reassessment in 24-48 hours* - Delaying treatment is inappropriate as the patient already shows a clear 8cm × 6cm area of **erythema and induration** consistent with active infection. - Untreated **cellulitis** can rapidly progress to systemic illness, sepsis, or necrotizing fasciitis, necessitating prompt antibiotic initiation. *Ultrasound scan to exclude abscess formation before treatment decision* - An **ultrasound scan** is not routinely indicated for simple cellulitis unless there is clinical evidence of **fluctuance** or failure to respond to initial therapy. - Waiting for imaging would unnecessarily delay the administration of effective **empiric antibiotics** for this uncomplicated skin infection. *Oral co-amoxiclav 500/125mg three times daily for 5 days* - **Co-amoxiclav** is broader spectrum than required and is generally reserved for animal bites, facial cellulitis, or infections involving **anaerobes**. - Using a broader-spectrum agent for simple cellulitis contributes to **antibiotic resistance** and provides no additional clinical benefit over flucloxacillin. *Blood cultures and intravenous flucloxacillin 1g four times daily* - **Intravenous antibiotics** and blood cultures are reserved for patients with signs of **systemic toxicity**, significant comorbidities, or Eron Class III/IV infections. - This patient is **hemodynamically stable** and systemically well, making outpatient oral therapy the most appropriate and cost-effective management strategy.

Question 117: A hospital antimicrobial stewardship committee reviews data showing that the median duration of antibiotic treatment for uncomplicated community-acquired pneumonia has decreased from 7 days to 5 days following implementation of a new guideline. However, 30-day readmission rates have remained unchanged at 8%. What is the most appropriate interpretation of these findings?

A. The intervention has failed as readmission rates have not decreased, indicating inadequate treatment duration
B. The intervention is successful as it demonstrates that shorter duration therapy is safe without increasing readmissions (Correct Answer)
C. The data are inconclusive as patient-reported outcomes and quality of life measures were not assessed
D. The intervention should be reversed as maintaining readmission rates while reducing treatment duration suggests emerging resistance
E. The intervention requires modification as 5 days is too short for community-acquired pneumonia regardless of readmission data

Explanation: ***The intervention is successful as it demonstrates that shorter duration therapy is safe without increasing readmissions*** - The primary goal of **antimicrobial stewardship** for **uncomplicated community-acquired pneumonia (CAP)** is to optimize antibiotic use by safely reducing unnecessary exposure, which this intervention achieved by shortening treatment from 7 to 5 days. - The fact that **30-day readmission rates** remained stable (8%) indicates that the shorter 5-day therapy was **clinically safe** and did not compromise patient outcomes or lead to treatment failures. *The intervention has failed as readmission rates have not decreased, indicating inadequate treatment duration* - The objective of this **stewardship intervention** was to reduce **antibiotic exposure**, not necessarily to lower existing **readmission rates**, which can be influenced by numerous other patient-specific and systemic factors. - Stable **readmission rates** actually confirm that the reduced duration of therapy was *not* inadequate and did not result in increased treatment failures or relapses. *The data are inconclusive as patient-reported outcomes and quality of life measures were not assessed* - While **patient-reported outcomes (PROs)** and **quality of life** are valuable metrics, they are not primary indicators required to assess the success of an **antimicrobial stewardship program** focused on **safety** (readmission rates) and process measures (antibiotic duration). - The objective finding of reduced antibiotic duration with maintained **patient safety** (stable readmission rates) provides sufficient evidence for a positive conclusion regarding the intervention's success. *The intervention should be reversed as maintaining readmission rates while reducing treatment duration suggests emerging resistance* - Shortening antibiotic duration, when appropriate, is a key strategy to *reduce* **antimicrobial resistance** by decreasing **selective pressure** on bacteria, rather than contributing to it. - **Emerging resistance** is typically identified through microbiological surveillance, culture data, and resistance patterns, not inferred from stable **30-day hospital readmission rates**. *The intervention requires modification as 5 days is too short for community-acquired pneumonia regardless of readmission data* - Current **evidence-based guidelines** from leading organizations like the **Infectious Diseases Society of America (IDSA)** and **American Thoracic Society (ATS)** recommend a minimum of 5 days of therapy for **uncomplicated CAP** in clinically stable patients. - Dismissing objective clinical data showing maintained patient safety (stable readmission rates) for a 5-day course contradicts principles of **antimicrobial stewardship** and **evidence-based medicine**.

Question 118: A 62-year-old man with type 2 diabetes presents with a 5-day history of progressive swelling, erythema, and pain affecting his left leg from ankle to mid-calf. His temperature is 38.2°C. He is allergic to penicillin (previous anaphylaxis). Blood tests show WCC 15.2 × 10⁹/L, CRP 145 mg/L, creatinine 98 μmol/L. What is the most appropriate antibiotic therapy?

A. Oral doxycycline 200mg loading dose, then 100mg twice daily
B. Intravenous clarithromycin 500mg twice daily (Correct Answer)
C. Oral clindamycin 300mg four times daily
D. Intravenous vancomycin 1g twice daily
E. Oral ciprofloxacin 500mg twice daily

Explanation: ***Intravenous clarithromycin 500mg twice daily*** - This patient has **cellulitis** with **systemic inflammation** (fever, elevated WCC and CRP), necessitating **intravenous (IV)** antibiotics for effective treatment. - **Clarithromycin** is a suitable **macrolide** alternative for patients with a history of **penicillin anaphylaxis**, providing good coverage against common causes of cellulitis like *Streptococcus pyogenes* and *Staphylococcus aureus*. *Oral doxycycline 200mg loading dose, then 100mg twice daily* - **Doxycycline** is effective against common skin pathogens but the **oral route** is generally insufficient for a patient with **systemic signs of infection** and high inflammatory markers. - Initial management of **severe cellulitis** or cellulitis with systemic features usually requires **intravenous antibiotics** to achieve adequate tissue concentrations rapidly. *Oral clindamycin 300mg four times daily* - While **clindamycin** has activity against Gram-positive skin pathogens and is an alternative for penicillin allergy, the **oral route** is inappropriate for systemic infection. - For severe infections, **intravenous clindamycin** at higher doses would be considered, but oral therapy is reserved for milder cases or step-down treatment. *Intravenous vancomycin 1g twice daily* - **Vancomycin** is primarily used for serious infections, especially those caused by **methicillin-resistant *Staphylococcus aureus* (MRSA)**. - In community-acquired cellulitis without specific risk factors for MRSA or failure of first-line therapy, **vancomycin** is typically **overkill** and contributes to antimicrobial resistance. *Oral ciprofloxacin 500mg twice daily* - **Ciprofloxacin** is a fluoroquinolone primarily targeting **Gram-negative bacteria**, with limited activity against the most common causes of cellulitis, such as *Streptococcus* species. - Its use in uncomplicated cellulitis without a specific Gram-negative indication would likely result in **treatment failure** due to inadequate coverage of typical Gram-positive pathogens.

Question 119: According to UK antimicrobial stewardship principles, what is the primary purpose of documenting an 'indication' when prescribing antimicrobials in the 'Start Smart - Then Focus' toolkit?

A. To facilitate accurate billing and coding for hospital reimbursement
B. To enable antimicrobial stewardship teams to audit prescribing appropriateness and review decisions at 48-72 hours (Correct Answer)
C. To provide medico-legal protection for the prescribing clinician in case of adverse outcomes
D. To ensure compliance with Care Quality Commission inspection requirements
E. To allow pharmacists to substitute alternative antimicrobials based on local formulary availability

Explanation: ***To enable antimicrobial stewardship teams to audit prescribing appropriateness and review decisions at 48-72 hours***- Clear documentation of the **indication** is a core component of the **'Start Smart'** phase, ensuring all clinical staff understand the rationale for the initial treatment.- It is essential for the **'Then Focus'** phase, allowing for a structured review at **48-72 hours** to decide whether to stop, de-escalate, or switch the antimicrobial.*To facilitate accurate billing and coding for hospital reimbursement*- While documentation is used for clinical coding, the **'Start Smart - Then Focus'** toolkit is a clinical safety and effectiveness framework, not a financial tool.- UK hospital reimbursement via the **NHS** does not rely on antimicrobial indications in the same way as private insurance-based systems.*To provide medico-legal protection for the prescribing clinician in case of adverse outcomes*- Good documentation inherently provides a **medico-legal record**, but this is a secondary benefit rather than the primary stewardship objective.- Stewardship focuses on **patient outcomes** and reducing **antimicrobial resistance** rather than clinician liability protection.*To ensure compliance with Care Quality Commission inspection requirements*- The **Care Quality Commission (CQC)** does look for evidence of stewardship, but compliance is the result of good practice, not the primary clinical goal of the documentation.- Clinical documentation is intended to drive **patient safety** and effective treatment transitions at the bedside.*To allow pharmacists to substitute alternative antimicrobials based on local formulary availability*- Identifying the **indication** helps the pharmacist verify appropriateness, but they generally cannot substitute agents without a **local protocol** or clinician consultation.- The primary goal of recording the indication is to facilitate the **prescriber's review** of the treatment plan once more clinical data is available.

Question 120: A 35-year-old woman presents to her GP with a 3-day history of increasing pain, redness, and swelling around her thumbnail. She works as a dental hygienist and reports frequent exposure to water. On examination, there is erythema and swelling of the nail fold with absence of the cuticle. No pus is visible. What is the most appropriate initial management?

A. Oral flucloxacillin for 7 days
B. Topical antifungal cream with avoidance of moisture (Correct Answer)
C. Incision and drainage under local anaesthetic
D. Oral clarithromycin for 5 days
E. Oral metronidazole for 7 days

Explanation: ***Topical antifungal cream with avoidance of moisture*** - This patient's presentation of **erythema**, **swelling of the nail fold**, and **absence of the cuticle** due to frequent **water exposure** is classic for **chronic paronychia**. - The absence of pus and the occupational risk factors strongly suggest a **Candida** infection as the primary driver, making a **topical antifungal** and keeping the area dry the appropriate first-line treatment. *Oral flucloxacillin for 7 days* - **Flucloxacillin** is typically indicated for **acute bacterial paronychia**, which presents with rapid onset, severe pain, and often a **purulent collection**. - This patient's history and examination (no visible pus, chronic nature, water exposure) are more consistent with a fungal or irritant cause, not a primary bacterial infection requiring systemic antibiotics. *Incision and drainage under local anaesthetic* - **Incision and drainage** is the treatment of choice for **acute paronychia** when a visible **abscess** or **fluctuance** is present, indicating a collection of pus. - In this clinical scenario, there is **no visible pus**, and the underlying pathology is inflammatory/fungal rather than a localized bacterial collection requiring surgical intervention. *Oral clarithromycin for 5 days* - **Clarithromycin** is a macrolide antibiotic used for bacterial infections, often as an alternative for patients with **penicillin allergies**. - It does not address the likely **fungal etiology** of chronic paronychia and is not indicated as a primary treatment for nail fold inflammation without clear evidence of bacterial cellulitis. *Oral metronidazole for 7 days* - **Metronidazole** is primarily effective against **anaerobic bacteria** and certain parasites. - These are not the typical pathogens involved in chronic paronychia, which is commonly caused by **Candida species** or persistent irritation from **moisture exposure**.

Question 121: A 52-year-old woman with a BMI of 42 kg/m² undergoes emergency laparotomy for perforated diverticulitis with peritoneal contamination. She receives appropriate surgical prophylaxis with co-amoxiclav 1.2g at induction. Post-operatively, the surgical team plans to continue co-amoxiclav 1.2g three times daily for 5 days as 'therapeutic' antibiotics. As the antimicrobial stewardship pharmacist, which of the following represents the most evidence-based recommendation?

A. Support continuation of co-amoxiclav 1.2g three times daily for 5 days as this represents appropriate treatment for intra-abdominal infection
B. Recommend increasing to co-amoxiclav 2.4g three times daily due to obesity and severity of infection, continuing for 7 days
C. Recommend stopping antibiotics at 24 hours if source control achieved and no evidence of ongoing infection, as this is adequate for Hinchey grade III diverticulitis with successful source control (Correct Answer)
D. Recommend changing to piperacillin-tazobactam for broader coverage and continuing for minimum 5 days post-operatively
E. Recommend continuing antibiotics until inflammatory markers normalize (typically 7-10 days)

Explanation: ***Recommend stopping antibiotics at 24 hours if source control achieved and no evidence of ongoing infection, as this is adequate for Hinchey grade III diverticulitis with successful source control*** - Evidence from the **STOP-IT trial** and modern guidelines suggest that when **source control** (e.g., resection and washout) is successful, prolonged antibiotic courses do not improve outcomes. - For cases of **peritoneal contamination** (Hinchey III), antibiotics function more as extended prophylaxis; continuing them for only **24 hours** post-operatively is safe and reduces the risk of resistance and side effects like *C. difficile*. *Support continuation of co-amoxiclav 1.2g three times daily for 5 days as this represents appropriate treatment for intra-abdominal infection* - Traditional **5-day courses** are increasingly considered unnecessary for intra-abdominal infections where the source of contamination has been surgically removed. - This approach overlooks **antimicrobial stewardship** principles that prioritize minimizing exposure once the clinical focus of infection is eliminated. *Recommend increasing to co-amoxiclav 2.4g three times daily due to obesity and severity of infection, continuing for 7 days* - While **obesity** affects drug distribution, there is no clinical evidence that doubling the standard dose to 2.4g improves outcomes in this surgical context. - A **7-day duration** is excessively long for a patient with achieved source control and increases the risk of **drug-induced toxicity** and healthcare-associated infections. *Recommend changing to piperacillin-tazobactam for broader coverage and continuing for minimum 5 days post-operatively* - **Piperacillin-tazobactam** provides broader anti-pseudomonal coverage which is generally not required for community-acquired **perforated diverticulitis** unless the patient is at high risk for resistant organisms. - Escalating to a broader spectrum without clinical or **microbiological justification** violates core stewardship goals and promotes the selection of multi-drug resistant pathogens. *Recommend continuing antibiotics until inflammatory markers normalize (typically 7-10 days)* - **Inflammatory markers** like CRP often remain elevated for several days due to the trauma of **emergency laparotomy**, making them an unreliable sole indicator for stopping antibiotics. - Relying on these markers leads to inappropriately **prolonged antibiotic therapy**, which does not correlate with a reduced rate of surgical site infections or abscess formation.

Question 122: A hospital trust implements a quality improvement initiative where all patients started on broad-spectrum antibiotics (piperacillin-tazobactam, carbapenems, or quinolones) must have a documented review decision within 48 hours, selecting from: stop, step-down to narrow spectrum, continue, or escalate. Six months post-implementation, audits show 85% compliance with documentation, mean duration of broad-spectrum therapy decreased from 6.2 to 4.1 days, and C. difficile rates decreased by 18%. However, there is significant variation between specialties (compliance 95% in respiratory medicine vs 68% in general surgery). What is the most appropriate next step to optimize and sustain this intervention?

A. Replace the intervention with automatic antibiotic stop orders at 48 hours across all specialties
B. Mandate immediate discontinuation of broad-spectrum antibiotics in surgery if review not documented within 48 hours
C. Conduct targeted education sessions with surgical teams, identify barriers to compliance, and implement specialty-specific solutions with ongoing feedback (Correct Answer)
D. Remove access to broad-spectrum antibiotics for surgical teams until compliance improves to 90%
E. Introduce financial penalties for consultants whose teams have <80% compliance with review documentation

Explanation: ***Conduct targeted education sessions with surgical teams, identify barriers to compliance, and implement specialty-specific solutions with ongoing feedback*** - Successful **antimicrobial stewardship** requires identifying specific **barriers to compliance** (e.g., surgical workflow or theatre time) and using **audit and feedback** to drive behavioral change. - Tailoring interventions to specific clinical contexts through **stakeholder engagement** is more sustainable and effective than imposing rigid, top-down mandates. *Replace the intervention with automatic antibiotic stop orders at 48 hours across all specialties* - **Automatic stop orders** can be clinically dangerous as they may interrupt treatment for patients with legitimate needs for continued **broad-spectrum therapy**. - This approach removes **clinical judgment** and does not address the underlying reasons for poor documentation compliance. *Mandate immediate discontinuation of broad-spectrum antibiotics in surgery if review not documented within 48 hours* - This is a **punitive measure** that risks **patient safety** by potentially stopping necessary treatment for severe surgical infections. - It fails to foster a **safety culture** and instead creates friction between the stewardship team and surgical staff. *Remove access to broad-spectrum antibiotics for surgical teams until compliance improves to 90%* - Restricting access to essential medicines like **carbapenems** or **piperacillin-tazobactam** prevents clinicians from treating life-threatening conditions like **sepsis**. - This strategy is counterproductive and damages the **collaborative relationship** essential for effective hospital-wide quality improvement. *Introduce financial penalties for consultants whose teams have <80% compliance with review documentation* - **Financial penalties** focuses on punishment rather than **process improvement**, often leading to "gaming the system" or inaccurate documentation just to meet targets. - Sustainable **quality improvement (QI)** relies on intrinsic motivation and demonstrating clinical benefits, such as the observed reduction in **C. difficile rates**.

Question 123: A 67-year-old man with type 2 diabetes and chronic kidney disease stage 4 (eGFR 24 mL/min/1.73m²) presents with cellulitis of the right leg. He weighs 95kg. Blood tests show creatinine 245 μmol/L (baseline 220 μmol/L) and CRP 156 mg/L. He has a documented severe penicillin allergy (previous anaphylaxis). According to current UK guidance, what is the most appropriate antibiotic regimen?

A. Intravenous clarithromycin 500mg twice daily
B. Intravenous teicoplanin loading dose 800mg, then 400mg once daily (Correct Answer)
C. Intravenous vancomycin 1g twice daily
D. Oral doxycycline 200mg loading dose, then 100mg twice daily
E. Intravenous clindamycin 600mg four times daily

Explanation: ***Intravenous teicoplanin loading dose 800mg, then 400mg once daily*** - In patients with **severe penicillin allergy** (anaphylaxis) requiring IV therapy, **teicoplanin** is preferred over vancomycin due to lower nephrotoxicity risk and simpler dosing in **stage 4 CKD**. - A loading dose of **800-1200mg** (based on weight) followed by a reduced maintenance dose is appropriate to ensure rapid therapeutic levels while preventing accumulation in **renal impairment**. *Intravenous clarithromycin 500mg twice daily* - Macrolides like clarithromycin have **poor coverage** against certain strains of **Staphylococcus aureus**, which is a primary pathogen in cellulitis. - It is generally not the first-line choice for severe cellulitis requiring hospitalization and IV therapy in a complex patient. *Intravenous vancomycin 1g twice daily* - Vancomycin carries a significant risk of **nephrotoxicity**, which is a major concern in a patient with a baseline **eGFR of 24 mL/min/1.73m²**. - The dosing frequency (twice daily) would be excessive for this level of renal function and would require intensive **therapeutic drug monitoring (TDM)**. *Oral doxycycline 200mg loading dose, then 100mg twice daily* - **Oral therapy** is inappropriate in this scenario given the patient's age, comorbidities (Diabetes, CKD), and high **CRP (156 mg/L)** suggesting severe infection. - Doxycycline is typically reserved for **mild cellulitis** managed in the outpatient setting for patients with penicillin allergies. *Intravenous clindamycin 600mg four times daily* - While effective against Gram-positive cocci, clindamycin is associated with a high risk of **Clostridioides difficile-associated diarrhea**, especially in elderly patients. - High-dose frequent administration is less practical compared to the **once-daily maintenance** regimen provided by glycopeptides like teicoplanin.

Question 124: A 38-year-old man who returned from visiting relatives in rural India 3 weeks ago presents with a 5-day history of a painless ulcer on his right forearm. The ulcer has raised, violaceous borders and a necrotic base. He recalls being bitten by an insect during his trip. He is systemically well with no fever or lymphadenopathy. The lesion has not responded to 3 days of oral flucloxacillin. What is the most likely diagnosis?

A. Cutaneous leishmaniasis (Correct Answer)
B. Mycobacterium ulcerans infection (Buruli ulcer)
C. Cutaneous anthrax
D. Ecthyma gangrenosum
E. Chromoblastomycosis

Explanation: ***Cutaneous leishmaniasis***- This diagnosis is strongly suggested by the patient's travel to **rural India**, the history of a **sandfly bite**, and the development of a **painless ulcer** with **violaceous borders**.- The **incubation period** of several weeks and the lack of response to standard antibiotics like **flucloxacillin** are characteristic of this parasitic infection caused by **Leishmania species**.*Mycobacterium ulcerans infection (Buruli ulcer)*- While it causes painless ulcers, it is typically characterized by **undermined borders** rather than raised violaceous ones and is not common in **India**.- It progresses more slowly than cutaneous leishmaniasis and often presents initially as a **subcutaneous nodule**.*Cutaneous anthrax*- Although it presents as a painless lesion, it usually features a characteristic **black eschar** surrounded by extensive **perilesional edema**.- The progression is much more rapid (days) and is typically associated with **livestock exposure** rather than an insect bite.*Ecthyma gangrenosum*- This is a cutaneous manifestation of **Pseudomonas aeruginosa bacteremia** and occurs almost exclusively in **immunocompromised patients**.- It is associated with severe **systemic toxicity** and rapid progression, which contrasts with this patient's systemically well status.*Chromoblastomycosis*- This is a **chronic fungal infection** that typically presents as slow-growing, **verrucous (warty) plaques** rather than an acute ulcerative lesion.- It has a much more prolonged course over **months to years** and usually involves traumatic inoculation from soil or vegetation in outdoor workers.

Question 125: A hospital antimicrobial stewardship team implements a new intervention requiring pharmacist-led review of all antimicrobial prescriptions within 72 hours of initiation. After 6 months, audit data shows a 22% reduction in defined daily doses of antibiotics and a 15% reduction in mean duration of therapy, with no increase in 30-day mortality or readmission rates. However, the intervention requires 1.5 full-time equivalent pharmacists and costs £120,000 annually. Which framework is most appropriate to evaluate the overall value of this intervention?

A. Structure-Process-Outcome model to assess quality of care delivery
B. Cost-effectiveness analysis comparing costs per quality-adjusted life year gained
C. Interrupted time-series analysis to demonstrate causal relationship with outcomes
D. Balanced scorecard approach incorporating clinical, economic, and process measures (Correct Answer)
E. Root cause analysis to identify factors contributing to antibiotic overuse

Explanation: ***Balanced scorecard approach incorporating clinical, economic, and process measures*** - A **balanced scorecard** integrates various performance perspectives, making it ideal for evaluating this intervention's **clinical outcomes** (reduced antibiotic use, no increased mortality), **process efficiency** (pharmacist review, duration of therapy), and **economic costs** (£120,000, 1.5 FTE). - It allows for a holistic assessment of the **overall value** by considering both the financial investment and the multi-faceted benefits in antibiotic stewardship. *Structure-Process-Outcome model to assess quality of care delivery* - The **Donabedian model** focuses on assessing the quality of care through structure (resources), process (activities), and outcome (results). - While relevant for quality, it does not explicitly provide a framework to integrate and weigh the **economic costs** against the benefits to determine overall

Question 126: A 44-year-old woman presents with a painful swelling in her right axilla. She underwent wide local excision of breast cancer with sentinel lymph node biopsy 10 days ago. On examination, there is a 5cm fluctuant, tender swelling in the axilla with surrounding erythema extending 8cm from the wound. Her temperature is 38.1°C. Ultrasound confirms a 4cm fluid collection. What is the most appropriate management?

A. Start oral flucloxacillin and arrange outpatient review in 48 hours
B. Aspirate the collection with needle and syringe, send fluid for culture, and start oral antibiotics
C. Perform incision and drainage, send pus for culture, and start intravenous antibiotics (Correct Answer)
D. Start intravenous co-amoxiclav and request CT chest to exclude necrotising infection
E. Refer urgently to breast surgery for wound exploration under general anaesthesia

Explanation: ***Perform incision and drainage, send pus for culture, and start intravenous antibiotics***- The patient presents with a post-operative **surgical site infection (SSI)** and a confirmed **abscess** (fluctuance, 4cm fluid on ultrasound), which mandates **source control** via drainage.- **Intravenous antibiotics** are indicated due to systemic symptoms (**fever**) and significant spreading **cellulitis** (8cm erythema) beyond the immediate wound site.*Start oral flucloxacillin and arrange outpatient review in 48 hours*- Oral antibiotics alone are insufficient for an **established abscess** because they cannot penetrate the collection effectively to achieve sterilization.- Outpatient management is inappropriate given the systemic features and the need for immediate **surgical intervention** to drain the pus.*Aspirate the collection with needle and syringe, send fluid for culture, and start oral antibiotics*- **Needle aspiration** has a high failure rate for a 4cm collection and is often insufficient to provide complete **drainage and decompression**.- Oral antibiotics are inadequate here as the presence of fever and extensive erythema suggests the need for **systemic IV therapy**.*Start intravenous co-amoxiclav and request CT chest to exclude necrotising infection*- A **CT chest** is not routinely required as the diagnosis of a superficial **post-surgical abscess** is clearly established by clinical exam and **ultrasound**.- While IV coverage is correct, the management must prioritize **mechanical drainage** (source control) over advanced imaging unless there is evidence of crepitus or rapid systemic collapse.*Refer urgently to breast surgery for wound exploration under general anaesthesia*- Most superficial axillary abscesses can be managed with **incision and drainage** at the bedside or in a procedure room under **local anesthesia**.- **General anesthesia** and formal wound exploration are typically reserved for deep-seated infections or when there is concern for **necrotizing fasciitis**.

Question 127: A 56-year-old woman with end-stage renal failure on peritoneal dialysis presents with fever, abdominal pain, and cloudy dialysate fluid. Peritoneal fluid analysis shows WCC 420 cells/μL (>50% neutrophils). Gram stain shows no organisms. Empirical therapy is started. After 48 hours, culture grows coagulase-negative staphylococci sensitive to all antibiotics tested. What is the most appropriate management?

A. Remove peritoneal dialysis catheter immediately and switch to haemodialysis
B. Continue antibiotics for 14 days and reassess catheter removal if not improving
C. Add rifampicin to current antibiotic regimen and continue for 21 days
D. Continue antibiotics for 14-21 days, maintain catheter if clinical improvement within 5 days (Correct Answer)
E. Switch to oral antibiotics and arrange outpatient follow-up in one week

Explanation: ***Continue antibiotics for 14-21 days, maintain catheter if clinical improvement within 5 days***- For **coagulase-negative staphylococci (CoNS)** peritonitis, the standard course is **14 days** of appropriate antibiotics, provided there is a prompt clinical response.- **Catheter retention** is the goal; removal is only necessary if the infection is **refractory** (no improvement after 5 days), relapsing, or caused by fungi/mycobacteria.*Remove peritoneal dialysis catheter immediately and switch to haemodialysis*- **Immediate catheter removal** is typically reserved for severe cases such as **fungal peritonitis**, **mycobacterial peritonitis**, or **peritonitis refractory to initial antibiotic therapy**.- For common bacterial peritonitis like CoNS, an initial attempt to treat with **antibiotics while preserving the catheter** is the preferred approach.*Continue antibiotics for 14 days and reassess catheter removal if not improving*- While 14 days is a correct duration for CoNS, this option lacks the specific **early reassessment** (within 3-5 days) for clinical response, which is crucial for decision-making regarding catheter salvage.- Guidelines emphasize monitoring for **clinical improvement** (e.g., clear effluent, resolution of pain/fever) within the first few days of therapy.*Add rifampicin to current antibiotic regimen and continue for 21 days*- **Rifampicin** is not a first-line agent for CoNS peritonitis and is generally considered for **refractory Staphylococcus aureus** infections or specific tunnel infections.- A **21-day course** is often longer than necessary for sensitive CoNS, which usually responds well to a **14-day** regimen.*Switch to oral antibiotics and arrange outpatient follow-up in one week*- **Peritoneal dialysis peritonitis** requires adequate drug concentrations in the peritoneal cavity, best achieved with **intraperitoneal (IP)** or intravenous antibiotics initially.- Switching to **oral antibiotics** too early or using them as sole therapy for active peritonitis carries a high risk of **treatment failure** and catheter loss.

Question 128: A 72-year-old man with chronic obstructive pulmonary disease is admitted with an infective exacerbation and started on intravenous co-amoxiclav. On day 3 of admission, he develops watery diarrhoea (6 episodes in 24 hours). Clostridioides difficile toxin is positive. His temperature is 37.8°C, heart rate 88 bpm, and blood pressure 128/76 mmHg. Blood tests show WCC 13.2 × 10⁹/L and creatinine 98 μmol/L. What is the most appropriate management?

A. Stop co-amoxiclav, start oral vancomycin 125mg four times daily for 10 days (Correct Answer)
B. Continue co-amoxiclav, add oral metronidazole 400mg three times daily for 10 days
C. Stop co-amoxiclav, start oral fidaxomicin 200mg twice daily for 10 days
D. Stop co-amoxiclav, start intravenous metronidazole 500mg three times daily for 10 days
E. Stop co-amoxiclav, start oral vancomycin 500mg four times daily for 14 days

Explanation: ***Stop co-amoxiclav, start oral vancomycin 125mg four times daily for 10 days***- This patient has a first episode of **non-severe Clostridioides difficile infection (CDI)**, as evidenced by a white cell count (WCC) < 15 x 10⁹/L and no significant creatinine rise.- Current guidelines recommend **oral vancomycin 125mg QID for 10 days** as the first-line treatment for an initial episode of non-severe CDI, along with **discontinuation of the precipitating antibiotic** (co-amoxiclav).*Continue co-amoxiclav, add oral metronidazole 400mg three times daily for 10 days*- **Metronidazole** is less effective than oral vancomycin for CDI and is no longer considered first-line for non-severe cases in many guidelines.- **Continuing the inciting antibiotic**, co-amoxiclav, will worsen the CDI and potentially lead to treatment failure and prolonged symptoms.*Stop co-amoxiclav, start oral fidaxomicin 200mg twice daily for 10 days*- **Fidaxomicin** is highly effective but is typically reserved for **recurrent CDI** or patients at very high risk of recurrence due to its higher cost.- While a valid option, **oral vancomycin** remains the standard first-line and more cost-effective choice for a first episode of non-severe CDI in most clinical protocols.*Stop co-amoxiclav, start intravenous metronidazole 500mg three times daily for 10 days*- **Intravenous metronidazole** is ineffective for typical CDI because it does not achieve sufficient therapeutic concentrations within the colonic lumen, where the infection is located.- This route is only indicated for **fulminant or severe CDI** when oral intake is compromised (e.g., ileus) or as an adjunct to oral therapy for systemic effects.*Stop co-amoxiclav, start oral vancomycin 500mg four times daily for 14 days*- A **higher dose of oral vancomycin** (500mg) is reserved for **severe or complicated CDI**, sometimes in combination with other agents or for recurrent disease.- For non-severe CDI, the standard **125mg dose** is equally effective, safer, and recommended for a 10-day duration.

Question 129: A 33-year-old chef presents with a 10-day history of a slowly enlarging, painless nodule on his right hand following a minor cut while preparing seafood. The lesion is now 2cm in diameter with central ulceration and violaceous edges. He is systemically well with no fever. A swab taken 5 days ago showed no growth on standard culture media. What is the most appropriate next investigation?

A. Repeat wound swab for extended bacterial culture
B. Tissue biopsy with culture in Lowenstein-Jensen medium at 30-32°C (Correct Answer)
C. Blood cultures for aerobic and anaerobic organisms
D. Serology for Bartonella henselae
E. Patch testing for allergic contact dermatitis

Explanation: ***Tissue biopsy with culture in Lowenstein-Jensen medium at 30-32°C***- The clinical presentation (chef, minor cut while preparing seafood, slowly enlarging painless nodule with central ulceration and violaceous edges, no fever, no growth on standard culture) is classic for **Mycobacterium marinum** infection (Fish Tank Granuloma).- Diagnosis of **M. marinum** requires specialized culture conditions, including **Lowenstein-Jensen medium** (for mycobacteria) and incubation at a cooler temperature of **30-32°C**, which mimics the temperature of the skin surface where it thrives. A **tissue biopsy** provides adequate material.*Repeat wound swab for extended bacterial culture*- Standard wound swabs and conventional bacterial cultures are inadequate for detecting **atypical mycobacteria** like M. marinum due to their specific growth requirements and **acid-fast** nature.- A previous swab already yielded **no growth**, suggesting that a standard bacterial pathogen is not the cause, and merely repeating the same investigation is unlikely to be diagnostic.*Blood cultures for aerobic and anaerobic organisms*- The patient is **systemically well** and **afebrile**, which strongly indicates a localized skin infection rather than a systemic or disseminated process.- **Mycobacterium marinum** is typically a cutaneous infection and rarely causes bacteremia; it also would not grow in standard aerobic or anaerobic blood culture media.*Serology for Bartonella henselae*- While **Bartonella henselae** (Cat Scratch Disease) can cause skin lesions and regional lymphadenopathy, it is primarily associated with **cat exposure**, not seafood-related injuries.- The specific history of a cut during **seafood preparation** is a highly specific clue pointing towards **M. marinum** rather than Bartonella.*Patch testing for allergic contact dermatitis*- **Allergic contact dermatitis** typically manifests as an intensely **pruritic, erythematous, vesicular, or papular rash** in response to an allergen, often with well-demarcated borders.- The lesion described is a **painless, slowly enlarging nodule with central ulceration** following a penetrating injury, which is inconsistent with the presentation of allergic contact dermatitis.

Question 130: A 41-year-old woman with systemic lupus erythematosus on prednisolone 15mg daily and mycophenolate mofetil presents with a 5-day history of a painful red nodule on her left shin. The lesion has not responded to a 3-day course of oral flucloxacillin prescribed by her GP. On examination, there is a 4cm violaceous nodule with central ulceration and a surrounding halo of erythema. She is apyrexial with normal inflammatory markers. What is the most likely diagnosis?

A. Cellulitis with partial antibiotic response
B. Cutaneous abscess requiring incision and drainage
C. Pyoderma gangrenosum (Correct Answer)
D. Mycobacterium marinum infection
E. Cutaneous vasculitis secondary to SLE

Explanation: ***Pyoderma gangrenosum*** - This diagnosis is strongly suggested by the description of a **painful, violaceous nodule with central ulceration** and a surrounding **halo of erythema** on the shin, which is classic for a **neutrophilic dermatosis**. - The patient's history of **SLE** and being on immunosuppressants, combined with the **failure to respond to oral flucloxacillin** and **normal inflammatory markers** (apyrexial), makes an infectious etiology unlikely and supports an inflammatory cause. *Cellulitis with partial antibiotic response* - **Cellulitis** typically presents with diffuse, spreading erythema, warmth, and tenderness, often accompanied by systemic signs like **fever** or elevated **CRP**, none of which are present here. - The discrete **violaceous nodule with central ulceration** is not characteristic of a typical bacterial cellulitis, and the lack of improvement after a standard course of antibiotics further argues against it. *Cutaneous abscess requiring incision and drainage* - An **abscess** is usually a localized collection of pus, often fluctuant. The described **violaceous nodule with central ulceration** is morphologically distinct from a simple abscess. - Surgical intervention like **incision and drainage** is generally contraindicated in **pyoderma gangrenosum** due to the risk of **pathergy**, where trauma can exacerbate the lesion. *Mycobacterium marinum infection* - **M. marinum** infections typically occur after exposure to **contaminated water** and usually manifest as **slow-growing papules, nodules, or ulcers**, often with a **sporotrichoid spread** over weeks to months. - A 5-day history is too acute for **M. marinum** infection, which has a much more indolent course. *Cutaneous vasculitis secondary to SLE* - **Cutaneous vasculitis** in SLE typically presents as **palpable purpura**, livedo reticularis, splinter hemorrhages, or small punctate infarcts, reflecting inflammation of small blood vessels. - The isolated **large, violaceous, ulcerating nodule with an undermined border** is not the typical presentation for cutaneous vasculitis, which usually involves multiple lesions or a different morphology.

Question 131: A hospital antimicrobial stewardship committee reviews quarterly prescribing data and identifies that the consumption of piperacillin-tazobactam has increased by 35% over the past year, while the incidence of Clostridioides difficile infection has risen by 28%. The increase in piperacillin-tazobactam use is primarily on medical wards for lower respiratory tract infections. Which intervention is most likely to address both concerns effectively?

A. Replace piperacillin-tazobactam with meropenem as first-line therapy for pneumonia
B. Implement automatic stop dates for all piperacillin-tazobactam prescriptions at 48 hours
C. Develop and implement evidence-based guidelines promoting narrower spectrum antibiotics for community-acquired pneumonia with regular audit and feedback (Correct Answer)
D. Introduce mandatory infectious diseases consultation for all patients prescribed piperacillin-tazobactam
E. Restrict piperacillin-tazobactam to intensive care units only

Explanation: ***Develop and implement evidence-based guidelines promoting narrower spectrum antibiotics for community-acquired pneumonia with regular audit and feedback*** - This intervention directly targets the **root cause** of inappropriate broad-spectrum prescribing by promoting **narrower spectrum agents** sufficient for most lower respiratory tract infections, thereby reducing overall antibiotic pressure. - Combining **evidence-based guidelines** with **prospective audit and feedback** is a core antimicrobial stewardship strategy proven to effectively reduce broad-spectrum antibiotic consumption and the incidence of **Clostridioides difficile infection**. *Replace piperacillin-tazobactam with meropenem as first-line therapy for pneumonia* - Replacing one broad-spectrum antibiotic with an **even broader-spectrum carbapenem** like meropenem would exacerbate the problem, leading to increased selection pressure for **multi-drug resistant organisms (MDROs)**. - Carbapenems are associated with a **higher risk of C. difficile infection** and gut dysbiosis compared to piperacillin-tazobactam, worsening both concerns identified in the question. *Implement automatic stop dates for all piperacillin-tazobactam prescriptions at 48 hours* - While **automatic stop dates** are a useful antimicrobial stewardship tool for limiting duration, a universal 48-hour stop date for piperacillin-tazobactam is often too short for many legitimate indications, potentially leading to **under-treatment** or frequent manual overrides. - This approach primarily addresses the **duration of therapy** but does not address the fundamental issue of **inappropriate initial selection** of a broad-spectrum antibiotic when a narrower agent might have been sufficient for a lower respiratory tract infection. *Introduce mandatory infectious diseases consultation for all patients prescribed piperacillin-tazobactam* - Mandating **infectious diseases (ID) consultation** for every piperacillin-tazobactam prescription is **impractical and not scalable** given the high volume of prescriptions and limited ID specialist resources. - This strategy could lead to significant **delays in initiating appropriate therapy** and is not the most efficient population-level intervention for general medical wards. *Restrict piperacillin-tazobactam to intensive care units only* - Such a **drastic restriction** is overly rigid and could compromise care for patients on general medical wards with legitimate indications for piperacillin-tazobactam, such as severe **hospital-acquired pneumonia** or **neutropenic sepsis**. - This approach often leads to **antibiotic displacement** or "squeezing the balloon," where clinicians switch to other equally broad or inappropriate antibiotics without addressing the underlying issue of rational prescribing.

Question 132: A 48-year-old man with recurrent methicillin-sensitive Staphylococcus aureus (MSSA) skin abscesses presents for his third episode in six months. Previous episodes required incision and drainage. He works in healthcare and lives with his partner and two children. What is the most appropriate strategy to prevent further recurrence?

A. Prescribe prophylactic oral flucloxacillin for 6 months
B. Offer decolonisation therapy with nasal mupirocin and chlorhexidine body wash, and screen household contacts (Correct Answer)
C. Prescribe prophylactic oral clindamycin for 3 months
D. Advise improved hand hygiene only and reassure that recurrence is uncommon
E. Recommend surgical excision of affected skin areas and hair follicles

Explanation: ***Offer decolonisation therapy with nasal mupirocin and chlorhexidine body wash, and screen household contacts*** - Recurrent **Staphylococcus aureus** infections, especially skin abscesses, often indicate persistent **colonization**, typically in the **nares** and on the skin. Decolonization therapy aims to eradicate this reservoir. - The patient's **healthcare profession** and **household contacts** increase the risk of both acquiring and transmitting **S. aureus**, making screening and decolonization of contacts crucial to prevent re-colonization. *Prescribe prophylactic oral flucloxacillin for 6 months* - Long-term **oral antibiotic prophylaxis** like flucloxacillin is generally not recommended for recurrent MSSA skin infections due to the high risk of **antibiotic resistance** development and potential adverse effects. - Systemic antibiotics are less effective than topical decolonization regimens at eradicating superficial **nasal and skin carriage** which drives recurrent infections. *Prescribe prophylactic oral clindamycin for 3 months* - Similar to other oral antibiotics, **clindamycin prophylaxis** for recurrent S. aureus is discouraged due to risks like **Clostridioides difficile infection** and fostering resistance. - Its use is typically reserved for treatment of active infections, often in cases of **beta-lactam allergy** or specific susceptibilities, not as a primary decolonization strategy. *Advise improved hand hygiene only and reassure that recurrence is uncommon* - While **hand hygiene** is important, it is usually insufficient on its own to eliminate established **S. aureus colonization** in individuals with recurrent infections. - Reassuring that recurrence is uncommon is incorrect; individuals who are **colonized** with S. aureus are at a significantly **higher risk** for recurrent infections. *Recommend surgical excision of affected skin areas and hair follicles* - **Surgical excision** is a treatment for active or complicated abscesses, but it is an overly invasive and impractical strategy for preventing recurrent widespread skin abscesses related to colonization. - This approach would not address the **nasal carriage** or other colonized skin sites that are the primary source of recurrent infections.

Question 133: A 55-year-old woman presents with a 24-hour history of severe pain and swelling of her right forearm following a minor scratch from her cat. On examination, the forearm is markedly swollen, erythematous, and exquisitely tender with crepitus palpable in the soft tissues. Her temperature is 38.9°C, heart rate 118 bpm, and blood pressure 98/65 mmHg. Blood tests show WCC 18.5 × 10⁹/L, CRP 245 mg/L, and lactate 3.2 mmol/L. What is the most important immediate management step?

A. Start intravenous co-amoxiclav and refer for urgent surgical assessment (Correct Answer)
B. Start oral co-amoxiclav and arrange outpatient follow-up in 48 hours
C. Perform incision and drainage under local anaesthesia in the Emergency Department
D. Obtain blood cultures and await results before starting antibiotics
E. Start intravenous flucloxacillin and request ultrasound of the forearm

Explanation: ***Start intravenous co-amoxiclav and refer for urgent surgical assessment***- The presence of **crepitus**, severe pain, and **systemic toxicity** (hypotension, raised lactate, fever, tachycardia) strongly indicates **necrotising fasciitis**, which is a surgical emergency.- Immediate **surgical debridement** is crucial, and IV **co-amoxiclav** provides appropriate broad-spectrum coverage, including for **Pasteurella multocida** and anaerobic organisms associated with cat scratches.*Start oral co-amoxiclav and arrange outpatient follow-up in 48 hours*- The patient is in **septic shock** with high inflammatory markers and signs of organ dysfunction, making oral therapy and outpatient management life-threateningly inappropriate.- **Necrotising fasciitis** progresses rapidly (within hours) and requires urgent hospitalization for aggressive **intravenous resuscitation** and definitive surgical intervention.*Perform incision and drainage under local anaesthesia in the Emergency Department*- **Necrotising fasciitis** involves the deep fascial planes and requires extensive exploration and **wide radical debridement** in an operating theatre under general anesthesia.- Localized incision and drainage is insufficient for the widespread tissue necrosis and **gas-forming infection** indicated by the crepitus.*Obtain blood cultures and await results before starting antibiotics*- While blood cultures are essential, delaying antibiotic administration in a septic patient with suspected **necrotising fasciitis** significantly increases morbidity and mortality.- Empiric **broad-spectrum antibiotics** should be initiated immediately after cultures are drawn as part of the **Sepsis Six** protocol.*Start intravenous flucloxacillin and request ultrasound of the forearm*- **Flucloxacillin** is primarily active against staphylococci and streptococci but lacks reliable coverage for **Pasteurella multocida**, which is a common pathogen in cat bite/scratch infections.- Clinical diagnosis of **necrotising fasciitis** is paramount; requesting an **ultrasound** causes a dangerous delay in essential **surgical intervention**, which is time-critical.

Question 134: According to the UK 'Start Smart - Then Focus' antimicrobial stewardship framework, which of the following represents the correct timeframe for the 'Review and Focus' stage of antimicrobial prescribing?

A. Within 24 hours of starting antibiotics
B. Within 48-72 hours of starting antibiotics (Correct Answer)
C. Within 5-7 days of starting antibiotics
D. At the point of hospital discharge
E. Within 12 hours of starting antibiotics

Explanation: ***Within 48-72 hours of starting antibiotics*** - This timeframe is the critical window where **clinical response** and **microbiology results** are typically available to guide professional judgment. - It facilitates one of the five mandatory decisions: **stop**, **switch to oral**, **change (narrow/broaden)**, **continue**, or **outpatient parenteral antibiotic therapy (OPAT)**. *Within 24 hours of starting antibiotics* - This is generally too early for complete **culture and sensitivity results** to return and influence a definitive management change. - The 'Start Smart' toolkit focuses on the first 24 hours for initial **empirical therapy** and high-quality documentation rather than the 'Focus' review. *Within 5-7 days of starting antibiotics* - Waiting this long to review therapy risks unnecessary exposure to **broad-spectrum antibiotics** and increases the risk of **Clostridioides difficile** or resistance. - A review should have already occurred to determine if a **shorter course** or **de-escalation** was appropriate long before day 5. *At the point of hospital discharge* - Reviewing only at discharge is reactive rather than proactive; the **'Focus' stage** must happen during the inpatient stay to optimize clinical outcomes. - The framework requires a documented clinical review at **48-72 hours** regardless of the patient's immediate discharge status. *Within 12 hours of starting antibiotics* - This period is part of the **'Start Smart'** phase, emphasizing rapid delivery of antibiotics for sepsis within the **'Golden Hour'**. - Clinical signs of improvement and **pathogen identification** are rarely established within 12 hours to allow for a comprehensive focus review.

Question 135: A 65-year-old man with type 2 diabetes presents to the Emergency Department with a 3-day history of a painful, swollen left lower leg. On examination, there is erythema, warmth, and tenderness extending from the ankle to mid-calf with a clearly demarcated edge. His temperature is 38.2°C, heart rate 95 bpm, and blood pressure 135/82 mmHg. Blood tests show WCC 14.2 × 10⁹/L and CRP 78 mg/L. Which of the following is the most appropriate first-line antibiotic treatment according to current UK guidance?

A. Intravenous flucloxacillin (Correct Answer)
B. Oral flucloxacillin
C. Oral co-amoxiclav
D. Intravenous vancomycin
E. Oral doxycycline

Explanation: ***Intravenous flucloxacillin***- This patient presents with signs of **systemic infection** (fever, tachycardia, raised WCC and CRP) in addition to localized cellulitis, which indicates severe cellulitis, often classified as **Eron Class III** or higher, requiring **intravenous antibiotics**.- **Flucloxacillin** is the recommended first-line agent in the UK for cellulitis as it effectively covers the most common causative bacteria: **Streptococcus pyogenes** and **methicillin-sensitive Staphylococcus aureus**.*Oral flucloxacillin*- Oral flucloxacillin is appropriate for **mild cellulitis** (Eron Class I) without systemic features, but this patient's **fever** and elevated inflammatory markers necessitate the more rapid and higher tissue concentrations achieved with **intravenous administration**.- The presence of **systemic inflammatory response** suggests a need for hospital admission and parenteral therapy, making oral treatment insufficient.*Oral co-amoxiclav*- Co-amoxiclav is a **broader-spectrum antibiotic** typically reserved for specific types of cellulitis, such as **facial cellulitis**, **animal/human bites**, or when **anaerobic infection** is suspected.- Its use as first-line for uncomplicated limb cellulitis is discouraged to minimize the development of **antimicrobial resistance** without providing additional clinical benefit.*Intravenous vancomycin*- Intravenous vancomycin is primarily indicated for suspected or confirmed **MRSA infections** or in patients with a **severe penicillin allergy**.- There is no clinical indication for MRSA in this case, and flucloxacillin is superior for typical **methicillin-sensitive Gram-positive cocci**.*Oral doxycycline*- Oral doxycycline is an alternative for cellulitis in patients with **penicillin allergy** or for specific atypical pathogens, but it is not the standard first-line treatment for severe cellulitis.- For a patient with significant **systemic signs of infection**, an oral antibiotic alone would be inadequate, and intravenous therapy is required.

Question 136: A hospital trust implements a comprehensive antimicrobial stewardship program including: electronic prescribing with decision support, weekly antimicrobial ward rounds, automatic 48-hour review prompts, and quarterly prescriber feedback. After 18 months, total antimicrobial consumption has decreased by 25%, but rates of Clostridioides difficile infection have remained unchanged. What is the most likely explanation for this finding?

A. The intervention has failed as reduced antimicrobial use should decrease C. difficile rates
B. The reduction in antimicrobial use is insufficient to impact C. difficile rates which require >40% reduction
C. Other factors such as infection control practices, patient case mix, or environmental contamination may be more important determinants of C. difficile rates than antimicrobial consumption alone (Correct Answer)
D. There is a lag period of at least 3 years before changes in antimicrobial consumption affect C. difficile rates
E. C. difficile rates are increasing in the community and offsetting any hospital reduction

Explanation: ***Other factors such as infection control practices, patient case mix, or environmental contamination may be more important determinants of C. difficile rates than antimicrobial consumption alone*** - Successful reduction in total **antimicrobial consumption** does not guarantee clinical improvement in CDI rates if other transmission factors like **hand hygiene** or **environmental cleaning** are suboptimal. - The specific **antibiotic class** targeted matters; a 25% reduction in low-risk agents may not impact CDI rates as much as reducing high-risk "4C" antibiotics (**Clindamycin, Cephalosporins, Co-amoxiclav, Ciprofloxacin**). *The intervention has failed as reduced antimicrobial use should decrease C. difficile rates* - The intervention was successful in its primary goal of reducing **antimicrobial consumption** by 25%, demonstrating effective **stewardship** processes. - Stewardship success is multifaceted and cannot be deemed a failure based on a single variable like **C. difficile** incidence when other local factors are at play. *The reduction in antimicrobial use is insufficient to impact C. difficile rates which require >40% reduction* - There is no evidence-based "threshold" such as a **40% reduction** required to see a shift in CDI incidence; improvements can often be seen with smaller, more targeted shifts. - Focus should be on the **quality of prescribing** and the reduction of **high-risk agents** rather than just a quantitative percentage of total volume. *There is a lag period of at least 3 years before changes in antimicrobial consumption affect C. difficile rates* - Hospital CDI rates typically respond to significant shifts in **antibiotic policy** or **infection control** much faster than a **3-year lag** period. - Changes in **gut microbiome** susceptibility and environmental spore load can reflect in hospital outcomes within months of implementing effective **stewardship**. *C. difficile rates are increasing in the community and offsetting any hospital reduction* - While **community-associated CDI** is rising, it does not explain static rates in a hospital setting if **nosocomial transmission** and stewardship are being addressed correctly. - This explanation ignores the critical role of the **hospital environment** and internal **infection prevention** measures in managing institutional outbreaks.

Question 137: A 71-year-old man with type 2 diabetes and chronic kidney disease stage 3b (eGFR 38 mL/min/1.73m²) presents with cellulitis of his right lower leg. He weighs 110 kg. You decide to prescribe intravenous flucloxacillin. What is the most appropriate dose?

A. Flucloxacillin 1g four times daily
B. Flucloxacillin 2g four times daily (Correct Answer)
C. Flucloxacillin 500mg four times daily
D. Flucloxacillin 1g twice daily
E. Flucloxacillin 2g twice daily

Explanation: ***Flucloxacillin 2g four times daily*** - For severe **cellulitis** requiring intravenous therapy, the standard adult dose is 2g four times daily to ensure adequate tissue penetration and efficacy against **Staphylococcus aureus** and **Streptococci**. - Although the patient has **CKD stage 3b**, flucloxacillin does not require dose adjustment in renal impairment as it is primarily **metabolized by the liver**. *Flucloxacillin 1g four times daily* - This is the standard dose for **mild to moderate** infections, but it is insufficient for a severe case of cellulitis in a patient weighing **110 kg** with **diabetes**. - Lower doses increase the risk of **treatment failure** and antibiotic resistance in significant skin and soft tissue infections. *Flucloxacillin 500mg four times daily* - This is typically an **oral dose** for mild skin infections and is inappropriate for a patient requiring **intravenous therapy** for cellulitis. - The volume of distribution in a **110 kg patient** would lead to sub-therapeutic plasma concentrations at this dosage. *Flucloxacillin 1g twice daily* - Flucloxacillin is a **time-dependent antibiotic** with a short half-life, requiring **frequent dosing** (usually four times daily) to maintain concentrations above the MIC. - Twice-daily dosing would result in periods where the drug concentration is too low to be effective, leading to **poor clinical outcomes**. *Flucloxacillin 2g twice daily* - Even with a higher individual dose, the **dosing interval** is too long to sustain the antimicrobial effect required for cellulitis. - Correct management of **severe cellulitis** always prioritizes the frequency of administration (QDS) over reduced intervals, regardless of renal function at this eGFR level.

Question 138: A hospital antimicrobial stewardship team reviews prescribing for surgical site infections (SSIs) following colorectal surgery. Current practice is to prescribe intravenous co-amoxiclav and metronidazole for 7-10 days. Evidence-based guidelines recommend 3-5 days for uncomplicated SSIs. The team proposes reducing the default duration to 5 days. Which additional measure would most effectively support implementation of this change?

A. Send a one-time email to all surgical consultants informing them of the new policy
B. Update the hospital antimicrobial formulary guidelines on the intranet
C. Implement electronic prescribing alerts prompting review at 5 days with default stop date (Correct Answer)
D. Conduct a teaching session for surgical junior doctors during their induction
E. Place posters in surgical wards highlighting the recommended duration

Explanation: ***Implement electronic prescribing alerts prompting review at 5 days with default stop date***- This intervention leverages **electronic prescribing systems** to provide **point-of-care decision support**, actively guiding prescribers towards the recommended duration.- A **default stop date** at 5 days acts as a powerful **behavioral nudge**, requiring prescribers to consciously override the recommendation if a longer duration is deemed necessary, thereby improving compliance with stewardship goals.*Send a one-time email to all surgical consultants informing them of the new policy*- **Passive communication** methods like one-time emails often have limited impact, as they can be easily overlooked, forgotten, or not prioritized by busy clinicians.- This approach lacks **active reinforcement** at the time of prescribing, offering no direct prompting or feedback when decisions are being made.*Update the hospital antimicrobial formulary guidelines on the intranet*- While necessary for official documentation, simply updating **intranet guidelines** relies on clinicians actively seeking out and remembering the information, which is not an effective strategy for changing established prescribing habits.- It is a **passive dissemination** method that doesn't provide **real-time alerts** or decision support, making it less effective in influencing immediate prescribing behavior compared to active interventions.*Conduct a teaching session for surgical junior doctors during their induction*- Educational sessions are valuable for **knowledge transfer** but often have limited success in changing ingrained practice behaviors on their own, especially in dynamic clinical environments.- Junior doctors may be influenced more by senior colleagues' habits, and the impact of a single induction session can fade, especially given **staff rotation** and the lack of continuous reinforcement.*Place posters in surgical wards highlighting the recommended duration*- **Posters** are a form of **visual reminder** but are often subject to "banner blindness" and do not provide an active prompt or intervention at the crucial moment of prescribing.- This method offers no **direct feedback loop** or mechanism to ensure that the information is acted upon by individual prescribers, making its impact on behavioral change minimal.

Question 139: A 43-year-old woman who works in a nail salon presents with acute paronychia of her right middle finger. She reports frequent exposure to water and nail products. Examination reveals erythema, swelling, and purulent discharge from the lateral nail fold. What is the most likely causative organism?

A. Staphylococcus aureus (Correct Answer)
B. Candida albicans
C. Pseudomonas aeruginosa
D. Streptococcus pyogenes
E. Herpes simplex virus

Explanation: ***Staphylococcus aureus*** - **Staphylococcus aureus** is the most common cause of **acute paronychia**, typically following minor trauma to the cuticle or nail fold and presenting with rapid onset of **purulent discharge**. - While the patient's occupation involves water exposure, the presence of **acute erythema, swelling, and pus** strongly points to a bacterial etiology over fungal causes. *Candida albicans* - **Candida albicans** is the primary cause of **chronic paronychia** (lasting >6 weeks), especially in those with frequent water exposure like nail salon workers. - It usually presents with **proximal nail fold** thickening and episodes of inflammation rather than acute, localized **purulent abscess** formation. *Pseudomonas aeruginosa* - **Pseudomonas aeruginosa** is associated with **chloronychia** (green nail syndrome) due to the production of **pyocyanin** pigment. - It tends to colonize the space between the nail plate and bed in **moist environments** but is not the standard cause of acute bacterial paronychia. *Streptococcus pyogenes* - **Streptococcus pyogenes** (Group A Strep) can cause acute paronychia but is clinically less frequent than **Staphylococcus aureus**. - It is more commonly associated with rapidly spreading **cellulitis** or lymphangitis if the infection extends beyond the nail fold. *Herpes simplex virus* - **Herpes simplex virus** causes **herpetic whitlow**, which is characterized by the presence of small, clear **vesicles** on an erythematous base. - It typically produces **tingling or burning pain** and should not be incised and drained, unlike the purulent discharge associated with bacterial paronychia.

Question 140: According to current UK antimicrobial guidance, what is the first-line empirical antibiotic for treatment of uncomplicated cellulitis in a patient with no drug allergies?

A. Oral flucloxacillin (Correct Answer)
B. Oral co-amoxiclav
C. Oral clarithromycin
D. Intravenous benzylpenicillin
E. Oral doxycycline

Explanation: ***Oral flucloxacillin*** - **Flucloxacillin** is the recommended first-line agent for uncomplicated cellulitis because it provides excellent coverage against **Staphylococcus aureus** and **Streptococcus pyogenes**. - It has high **oral bioavailability** and a targeted spectrum, making it the most appropriate choice for patients with no known drug allergies. *Oral co-amoxiclav* - This provides unnecessarily broad coverage against anaerobic and Gram-negative organisms, which is not required for **uncomplicated cellulitis**. - It is typically reserved for cellulitis following **animal bites** or facial involvement where different pathogens are suspected. *Oral clarithromycin* - This is a macrolide usually reserved as a second-line option for patients with a **penicillin allergy**. - It is not first-line because **flucloxacillin** is superior in its narrow-spectrum targeting of skin flora in non-allergic patients. *Intravenous benzylpenicillin* - **Benzylpenicillin** has poor activity against **Staphylococcus aureus** and is primarily effective against Streptococci, making it insufficient as mono-therapy for cellulitis. - The **intravenous route** is inappropriate for uncomplicated cases that can be managed effectively with oral outpatient treatment. *Oral doxycycline* - **Doxycycline** is considered an alternative treatment for patients with a **penicillin allergy** or when **MRSA** is a specific concern. - It is not the preferred first-line agent for common **Staphylococcal** or **Streptococcal** skin infections in the general population.

Question 141: A 58-year-old man with well-controlled HIV (CD4 count 450 cells/μL, undetectable viral load) presents with a 10-day history of multiple painful ulcers on his lower legs. The ulcers have violaceous, undermined borders and purulent bases. He has a history of ulcerative colitis. Swabs grow mixed skin flora. What is the most appropriate next step in management?

A. Start intravenous flucloxacillin and metronidazole
B. Arrange skin biopsy to exclude vasculitis or malignancy
C. Start high-dose oral prednisolone
D. Refer to dermatology for consideration of pyoderma gangrenosum (Correct Answer)
E. Perform wound debridement and arrange tissue culture

Explanation: ***Refer to dermatology for consideration of pyoderma gangrenosum*** - The presence of multiple painful ulcers with **violaceous, undermined borders** and **purulent bases**, combined with a history of **ulcerative colitis**, is highly characteristic of **pyoderma gangrenosum (PG)**. - PG is a **neutrophilic dermatosis** and an inflammatory condition, not a primary infection, requiring specialized dermatological expertise for accurate diagnosis and management with immunosuppressive therapy. *Start intravenous flucloxacillin and metronidazole* - The growth of **mixed skin flora** from swabs suggests colonization of the ulcers rather than an active, primary bacterial infection that would necessitate systemic antibiotics. - PG is an **auto-inflammatory** condition, and antibiotics are generally ineffective in addressing its underlying pathophysiology. *Arrange skin biopsy to exclude vasculitis or malignancy* - While biopsy can be considered, **pyoderma gangrenosum is a diagnosis of exclusion**, and the biopsy site itself can be subject to **pathergy**, where trauma causes the ulcer to worsen or expand. - A specialist consultation is crucial to guide the diagnostic process, including the timing and necessity of a biopsy, to avoid exacerbating the condition. *Start high-dose oral prednisolone* - Although **systemic corticosteroids** are a cornerstone of PG treatment, initiating such potent therapy without a definitive diagnosis by a specialist can mask other conditions. - High-dose steroid use in an **HIV-positive patient**, even with a well-controlled viral load, requires careful consideration and coordinated care between dermatology and infectious disease specialists. *Perform wound debridement and arrange tissue culture* - **Surgical debridement is strictly contraindicated** in suspected pyoderma gangrenosum due to the phenomenon of **pathergy**, which leads to the enlargement and worsening of the ulcers with any traumatic intervention. - Tissue culture would likely confirm the presence of commensal flora, similar to the swabs, and would not address the inflammatory nature of the lesions.

Question 142: A 32-year-old woman with no significant past medical history presents with a 4-day history of a painful, red, swollen area on her left breast. She is 6 weeks postpartum and breastfeeding. Examination reveals a 5 cm area of erythema and induration in the upper outer quadrant of the left breast. Temperature is 38.2°C. There is no fluctuance. What is the most appropriate initial management?

A. Advise to stop breastfeeding and prescribe oral flucloxacillin
B. Continue breastfeeding and prescribe oral flucloxacillin (Correct Answer)
C. Arrange urgent ultrasound of the breast before starting antibiotics
D. Continue breastfeeding, prescribe oral co-amoxiclav and regular breast massage
E. Refer urgently to breast surgery for incision and drainage

Explanation: ***Continue breastfeeding and prescribe oral flucloxacillin***- **Lactational mastitis** is most commonly caused by **Staphylococcus aureus**, and **flucloxacillin** is the first-line antibiotic treatment as it is safe during breastfeeding.- Maintaining **milk drainage** by continuing breastfeeding or expression is essential to resolve **milk stasis** and prevent the progression to a breast abscess.*Advise to stop breastfeeding and prescribe oral flucloxacillin*- Stopping breastfeeding is contraindicated as it promotes **milk stasis**, which significantly increases the risk of **abscess formation**.- Emptying the breast is a critical component of treatment to help clear the **bacterial load** and inflammatory debris.*Arrange urgent ultrasound of the breast before starting antibiotics*- Clinical diagnosis of mastitis is sufficient for starting antibiotics; an **ultrasound** is only indicated if an **abscess** is suspected due to **fluctuance** or failure to respond to treatment.- Delaying antibiotics in the presence of **systemic symptoms** like fever (38.2°C) can lead to worsening infection.*Continue breastfeeding, prescribe oral co-amoxiclav and regular breast massage*- **Flucloxacillin** is preferred over **co-amoxiclav** because it specifically targets the commonest pathogen, **Staph. aureus**, without providing unnecessary broad-spectrum coverage.- While breastfeeding and massage are helpful, **co-amoxiclav** is usually reserved for second-line treatment or suspected anaerobic involvement.*Refer urgently to breast surgery for incision and drainage*- Surgical intervention is only required for a **breast abscess**, which is typically characterized by **fluctuance** on examination.- This patient presents with **induration** only, which is characteristic of cellulitis of the breast tissue and should be managed medically first.

Question 143: A hospital trust implements a new antimicrobial stewardship policy requiring indication and planned duration to be documented for all antimicrobial prescriptions. Six months post-implementation, audit data shows documentation rates have increased from 35% to 88%. However, antimicrobial consumption (measured in defined daily doses per 1000 patient-bed days) remains unchanged. What does this finding suggest?

A. The intervention has failed and should be discontinued
B. Documentation alone is insufficient to change prescribing behavior without active review and feedback (Correct Answer)
C. The antimicrobial consumption was already optimal before the intervention
D. The audit methodology is flawed and cannot detect changes in consumption
E. Six months is too short a period to detect changes in antimicrobial consumption

Explanation: ***Documentation alone is insufficient to change prescribing behavior without active review and feedback*** - Passive interventions like documentation of indication improve **accountability and process measures** but do not directly challenge the clinical decision-making involved in antimicrobial use. - Effective antimicrobial stewardship requires **active interventions**, such as prospective audit and feedback or clinical pharmacist review, to translate documentation into actual **consumption reduction**. *The intervention has failed and should be discontinued* - The intervention successfully achieved its primary process goal of increasing **documentation rates** from 35% to 88%, which provides a better baseline for future audits. - Rather than discontinuation, this stage indicates a need to **evolve the strategy** by adding active clinical reviews to the existing documentation framework. *The antimicrobial consumption was already optimal before the intervention* - A documentation rate of 35% historically correlates with **suboptimal prescribing habits**, and a lack of change in DDDs suggests substantial **opportunities for optimization** remain. - Achieving "optimal" consumption usually results in a shift toward **narrow-spectrum agents**, which would still reflect a change in specific consumption metrics not seen here. *The audit methodology is flawed and cannot detect changes in consumption* - **Defined Daily Dose (DDD)** per 1000 patient-bed days is a standardized global metric that is highly sensitive to changes in total antimicrobial volume. - The methodology successfully detected a change in **process measures** (documentation); the lack of change in consumption is a result of prescribing behavior, not a measurement failure. *Six months is too short a period to detect changes in antimicrobial consumption* - Six months provides **sufficient time** for prescription cycles to turn over and for changes in hospital-wide prescribing patterns to manifest in the data. - Stewardship interventions that include **active feedback** typically show significant reductions in consumption within three to six months of implementation.

Question 144: A 69-year-old man with peripheral vascular disease and atrial fibrillation on warfarin presents with cellulitis of his right lower leg. Blood cultures are pending. He has a documented severe penicillin allergy (anaphylaxis). His INR is 2.8. Which antibiotic regimen is most appropriate for initial empirical therapy?

A. Intravenous clindamycin
B. Intravenous teicoplanin (Correct Answer)
C. Intravenous meropenem
D. Oral doxycycline
E. Intravenous clarithromycin

Explanation: ***Intravenous teicoplanin*** - **Teicoplanin** is a **glycopeptide** with excellent activity against **Group A Streptococcus** and **Staphylococcus aureus**, the most common causes of cellulitis, and is suitable for systemic therapy in this setting. - It is safe for patients with **anaphylactic penicillin allergy** as it lacks cross-reactivity with beta-lactams and does not significantly interact with **warfarin**, making it a suitable choice for a patient with an INR of 2.8. *Intravenous clindamycin* - While effective against Gram-positives, **clindamycin** can significantly increase the **INR/warfarin effect** by inhibiting CYP enzymes, posing a bleeding risk for a patient already on warfarin. - There are increasing rates of **resistance** among staphylococci and streptococci, making it less reliable for empirical monotherapy in severe cases like this. *Intravenous meropenem* - **Meropenem** is a **carbapenem** and carries a **1-2% cross-reactivity risk** in patients with documented **penicillin anaphylaxis**, making it contraindicated due to the severe allergy history. - It provides unnecessarily broad coverage (including Gram-negatives and anaerobes) for a typical case of simple **cellulitis**, where targeted Gram-positive coverage is usually sufficient. *Oral doxycycline* - **Oral doxycycline** is generally reserved for **mild cellulitis** or as part of a step-down regimen; intravenous therapy is indicated for a patient with risk factors like peripheral vascular disease and requiring hospital admission. - It has inconsistent or poor activity against **Group A Streptococcus**, which is a primary pathogen in rapidly spreading skin infections and would not be appropriate as initial monotherapy for severe cellulitis. *Intravenous clarithromycin* - **Clarithromycin** is a macrolide that frequently interacts with **warfarin** via CYP3A4 inhibition, leading to a dangerous rise in **prothrombin time/INR**, similar to clindamycin, and is thus unsuitable for this patient. - Resistance among common skin pathogens is a concern, and it is not considered first-line for **severe cellulitis** compared to glycopeptides, especially with a severe penicillin allergy.

Question 145: A 38-year-old woman presents with a 5-day history of painful bilateral shin lesions. She has been feeling unwell for 2 weeks with a sore throat and low-grade fever. Examination reveals multiple tender, raised, erythematous nodules on both shins without ulceration. Chest X-ray shows bilateral hilar lymphadenopathy. What is the most likely diagnosis?

A. Erysipelas
B. Cellulitis
C. Erythema nodosum secondary to sarcoidosis (Correct Answer)
D. Necrotizing fasciitis
E. Pyoderma gangrenosum

Explanation: ***Erythema nodosum secondary to sarcoidosis***- The presentation of **tender, erythematous nodules** on the shins, systemic symptoms like **sore throat** and **low-grade fever**, and crucially, **bilateral hilar lymphadenopathy (BHL)** on chest X-ray, is pathognomonic for **Löfgren's syndrome**, an acute manifestation of sarcoidosis.- Erythema nodosum is a form of **septal panniculitis** that typically presents as non-ulcerated, painful nodules on the extensor surfaces of the lower legs, often triggered by various conditions including sarcoidosis.*Erysipelas*- This is a superficial cutaneous infection characterized by a **well-demarcated**, raised, and fiery red plaque, which is usually **unilateral** and caused by bacterial pathogens.- It does not typically involve **bilateral hilar lymphadenopathy** or present as multiple discrete nodules.*Cellulitis*- Cellulitis involves deeper dermis and subcutaneous fat, presenting as an **ill-defined, unilateral** area of warmth and erythema, rather than discrete nodules.- It is an acute bacterial infection that lacks the characteristic **distribution** and radiological findings (BHL) of sarcoidosis.*Necrotizing fasciitis*- This is a surgical emergency characterized by **rapidly progressing** tissue destruction, severe systemic toxicity, and "pain out of proportion" to clinical findings.- It typically features **crepitus**, skin necrosis, or hemorrhagic bullae, which are absent in this patient who presents with non-ulcerating nodules.*Pyoderma gangrenosum*- This condition presents as a rapidly enlarging, **painful ulcer** with a **purulent base** and **violaceous, undermined borders**, often associated with inflammatory bowel disease.- The lesions in this patient are described as **non-ulcerating nodules**, which differentiates them from the typical ulcerative progression of pyoderma gangrenosum.

Question 146: A 47-year-old man who is a fish tank enthusiast presents with a 3-week history of a slowly progressive papulonodular lesion on his right index finger following a minor injury while cleaning his aquarium. The lesion has a violaceous appearance with superficial ulceration. He is systemically well. What is the most appropriate antimicrobial treatment?

A. Flucloxacillin 500mg four times daily for 7 days
B. Clarithromycin 500mg twice daily for 4-6 weeks (Correct Answer)
C. Co-amoxiclav 625mg three times daily for 2 weeks
D. Doxycycline 100mg twice daily for 2 weeks
E. Ciprofloxacin 500mg twice daily for 10 days

Explanation: ***Clarithromycin 500mg twice daily for 4-6 weeks***- The clinical presentation with a **slowly progressive papulonodular lesion** on the hand of a **fish tank enthusiast** following an injury is highly characteristic of **Mycobacterium marinum** infection, often called "fish tank granuloma."- **Clarithromycin** is a recommended first-line agent for *M. marinum* infections, and a prolonged treatment course of **4-6 weeks** (or even longer, typically until 1-2 months after lesion resolution) is necessary due to the slow-growing nature of **atypical mycobacteria**.*Flucloxacillin 500mg four times daily for 7 days*- This antibiotic is primarily used for **Gram-positive bacterial infections** like *Staphylococcus aureus* or *Streptococcus pyogenes*, common causes of acute cellulitis or skin abscesses.- Flucloxacillin is ineffective against **Mycobacterium marinum**, and the 7-day duration is far too short for **mycobacterial infections**, which require prolonged therapy.*Co-amoxiclav 625mg three times daily for 2 weeks*- Co-amoxiclav is a broad-spectrum antibiotic effective against many common bacterial skin pathogens, including some anaerobes, but it does not cover **atypical mycobacteria** like *M. marinum*.- A 2-week course is insufficient for **mycobacterial infections**, which typically demand treatment durations of several weeks to months for successful eradication.*Doxycycline 100mg twice daily for 2 weeks*- While **Doxycycline** is an effective agent against **Mycobacterium marinum**, often used as a first-line or alternative therapy, the specified **2-week duration** is inadequate.- Treatment with tetracyclines like doxycycline for *M. marinum* typically requires a minimum of **3 to 6 months** or until 1-2 months after the lesion has fully resolved to prevent recurrence.*Ciprofloxacin 500mg twice daily for 10 days*- While some fluoroquinolones like **Ciprofloxacin** may show *in vitro* activity against *M. marinum*, they are generally not considered first-line monotherapy, particularly for cutaneous infections.- The **10-day course** is drastically too short for a **granulomatous mycobacterial skin infection**, which necessitates prolonged treatment.

Question 147: A hospital antimicrobial stewardship committee is implementing a new intervention to reduce inappropriate antimicrobial use. Data shows that the average duration of intravenous antibiotics for community-acquired pneumonia is 6.2 days despite most patients meeting criteria for IV to oral switch by day 3. What intervention is most likely to achieve sustained reduction in IV antibiotic duration?

A. Monthly email reminders to all prescribers about switching guidelines
B. Automatic stop orders for all IV antibiotics after 72 hours
C. Implementation of a daily multidisciplinary antimicrobial ward round with real-time feedback (Correct Answer)
D. Annual mandatory e-learning module on IV to oral switching
E. Poster campaigns in clinical areas highlighting switch criteria

Explanation: ***Implementation of a daily multidisciplinary antimicrobial ward round with real-time feedback*** - This approach utilizes **prospective audit and feedback**, which is one of the most effective and **sustained interventions** in antimicrobial stewardship for changing clinician behavior. - Providing **point-of-care education** and direct engagement with the clinical team allows for nuanced decision-making while consistently reinforcing **IV-to-oral switch** guidelines. *Monthly email reminders to all prescribers about switching guidelines* - This is considered a **passive intervention**, which has limited impact on long-term clinical practice and often suffers from **information overload**. - Educational materials without **active engagement** or specific patient-level feedback are rarely effective in achieving significant reductions in antibiotic duration. *Automatic stop orders for all IV antibiotics after 72 hours* - While this creates a hard stop, it can be **clinically unsafe** as it may interrupt critical treatment for complex patients who genuinely require extended IV therapy. - Such systems often lead to **work-around behaviors**, such as clinicians reflexively renewing orders without a proper clinical review, defeating the purpose of the intervention. *Annual mandatory e-learning module on IV to oral switching* - One-time or infrequent **educational modules** lack the real-time reinforcement necessary to alter daily prescribing habits in a dynamic hospital environment. - **Knowledge acquisition** through e-learning does not consistently translate into permanent clinical **behavioral change** compared to daily clinical bedside practice. *Poster campaigns in clinical areas highlighting switch criteria* - Visual aids and posters are **passive alerts** that are easily ignored by busy clinical staff and do not provide the necessary drive for clinical action. - These tools are best used as **adjuncts** to active strategies rather than standalone interventions for achieving a sustained reduction in antibiotic use.

Question 148: A 55-year-old woman with chronic lymphocytic leukaemia on ibrutinib presents with a 48-hour history of a rapidly expanding painful lesion on her right forearm following a cat scratch. Examination reveals a 6 cm area of erythema with central necrosis and violaceous bullae. Temperature is 38.7°C, BP 110/70 mmHg, HR 105 bpm. Which organism is most likely responsible for this presentation?

A. Pasteurella multocida (Correct Answer)
B. Capnocytophaga canimorsus
C. Bartonella henselae
D. Streptococcus pyogenes
E. Staphylococcus aureus

Explanation: ***Pasteurella multocida*** - **Pasteurella multocida** is a commensal in the oral cavity of cats and is the most common organism isolated from infections following **cat scratches or bites**, especially with rapid onset. - This pathogen is known for its **rapid clinical progression** (often within 24-48 hours) and can cause severe, necrotic cellulitis with **erythema, central necrosis, and violaceous bullae**, particularly in **immunocompromised** patients like those with CLL on ibrutinib. *Capnocytophaga canimorsus* - While it can cause severe sepsis and skin necrosis in immunocompromised hosts, it is much more frequently associated with **dog bites** rather than cat scratches. - The clinical presentation usually features overwhelming **sepsis or meningitis** rather than a localized rapidly expanding necrotizing skin lesion within 48 hours of a scratch. *Bartonella henselae* - This organism is the causative agent of **Cat Scratch Disease**, which typically presents with a subacute course involving **regional lymphadenopathy** weeks after a scratch. - It does not present as an acute, **rapidly expanding necrotizing lesion** with systemic toxicity and violaceous bullae as seen in this localized cellulitis case. *Streptococcus pyogenes* - While a common cause of **necrotizing fasciitis** and cellulitis, it is less specifically associated with the initial inoculation event of a **feline scratch** compared to a zoonotic organism. - The rapid onset immediately following feline contact makes a pathogen directly linked to animal oral flora a more statistically likely primary driver of the infection. *Staphylococcus aureus* - **Staphylococcus aureus** typically presents with a more localized, purulent infection or **abscess formation** rather than the rapid, widespread erythema with central necrosis and violaceous bullae described. - Like Streptococcus, while it can complicate skin trauma, it lacks the specific **epidemiological link** to feline oral flora that defines the high-risk period immediately following a cat scratch.

Question 149: According to the UK 'Start Smart - Then Focus' antimicrobial stewardship toolkit, what is the recommended timeframe for reviewing all antimicrobial prescriptions after initiation to assess the need for continuation, modification, or cessation?

A. Within 24 hours of initiation
B. Within 48-72 hours of initiation (Correct Answer)
C. Within 5 days of initiation
D. Within 7 days of initiation
E. At the end of the prescribed course

Explanation: ***Within 48-72 hours of initiation*** - The UK **'Start Smart - Then Focus'** toolkit mandates a clinical review at **48-72 hours** to make a clear decision: stop, switch to oral, change (de-escalate/escalate), or continue. - This timeframe is critical as **microbiology results** and the patient's initial clinical response are typically available, allowing for more targeted therapy. *Within 24 hours of initiation* - While early review is beneficial, 24 hours is often **too soon** for definitive culture results or to observe a full clinical response to antibiotics. - The toolkit emphasizes the **second phase ('Then Focus')** specifically starting at the 48-hour mark to ensure data-driven decisions. *Within 5 days of initiation* - Waiting five days to review an antimicrobial can lead to **unnecessary broad-spectrum exposure**, increasing the risk of resistance and side effects like C. difficile. - The **five rights** (right drug, dose, etc.) should be confirmed much earlier than five days to optimize patient safety. *Within 7 days of initiation* - A seven-day review window is far beyond the **stewardship goal** of early de-escalation and prompt IV-to-oral conversion. - Delayed review at this stage is associated with **prolonged hospital stays** and inappropriate antimicrobial utilization. *At the end of the prescribed course* - Reviewing only at the end of a course fails to implement **antimicrobial stewardship**, as the opportunity to refine therapy based on clinical progress is missed. - This approach risks **over-treating** the patient and does not allow for potential cessation of ineffective or unnecessary treatment.

Question 150: A 62-year-old man with type 2 diabetes presents with a 3-day history of a red, tender swelling on his upper back. Examination reveals a 4 cm fluctuant mass with multiple pustular heads and surrounding erythema. He is systemically well with normal observations. What is the most appropriate initial management for this condition?

A. Incision and drainage with oral flucloxacillin
B. Oral flucloxacillin alone for 7 days
C. Incision and drainage alone without antibiotics (Correct Answer)
D. Intravenous flucloxacillin and metronidazole
E. Warm compresses and review in 48 hours

Explanation: ***Incision and drainage alone without antibiotics*** - The patient presents with a **carbuncle**, characterized by a cluster of boils with **multiple pustular heads** and a **fluctuant mass**, for which **incision and drainage (I&D)** is the definitive treatment. - In **systemically well** patients with a simple localized abscess or carbuncle, clinical guidelines recommend I&D alone, as antibiotics provide no additional benefit for a drainable focus. *Incision and drainage with oral flucloxacillin* - While **flucloxacillin** is effective against **Staphylococcus aureus**, it is not routinely required for a localized carbuncle in a **systemically well** patient after adequate drainage. - The patient's **normal observations** and lack of systemic symptoms indicate that surgical drainage alone is sufficient without empirical antibiotics. *Oral flucloxacillin alone for 7 days* - Antibiotics alone are often ineffective for treating abscesses or carbuncles because they cannot achieve therapeutic concentrations within the **walled-off necrotic core** of the lesion. - Surgical intervention via **drainage** is essential to evacuate the pus and allow for resolution of the infection. *Intravenous flucloxacillin and metronidazole* - **Intravenous antibiotics** are reserved for patients with signs of **systemic sepsis**, extensive cellulitis, or rapid progression, none of which are present in this case. - **Metronidazole** specifically targets anaerobic bacteria and is not indicated for carbuncles, which are predominantly caused by aerobic **Staphylococcus aureus**. *Warm compresses and review in 48 hours* - While warm compresses can sometimes aid in the spontaneous drainage of smaller boils, a **4 cm fluctuant mass with multiple pustular heads** represents a significant infection requiring active intervention. - Delaying definitive treatment like **incision and drainage** for such a lesion can lead to increased pain, further tissue damage, and potentially more complicated infection.

Question 151: A hospital antimicrobial stewardship committee reviews audit data showing that 68% of patients with uncomplicated community-acquired pneumonia receive dual therapy (beta-lactam plus macrolide) versus 32% receiving beta-lactam monotherapy. Mortality rates are equivalent between groups (3.2% vs 3.4%). Length of stay and costs are significantly higher in the dual therapy group. Microbiological data shows only 8% of isolates are atypical pathogens. Which recommendation best demonstrates evidence-based antimicrobial stewardship?

A. Continue current practice as mortality rates are acceptable
B. Implement guidelines recommending beta-lactam monotherapy for non-severe CAP in absence of specific atypical pathogen risk factors (Correct Answer)
C. Add fluoroquinolone monotherapy as a third option for all CAP patients
D. Mandate PCR testing for atypical pathogens before prescribing macrolides
E. Extend macrolide duration from 3 to 7 days to improve outcomes

Explanation: ***Implement guidelines recommending beta-lactam monotherapy for non-severe CAP in absence of specific atypical pathogen risk factors*** - Evidence shows that for **non-severe community-acquired pneumonia (CAP)**, beta-lactam monotherapy offers equivalent clinical outcomes to dual therapy with fewer side effects. - Over-prescription of macrolides is discouraged when **atypical pathogen** prevalence is low (8% here), as it increases **costs**, **length of stay**, and antimicrobial resistance without lowering mortality. *Continue current practice as mortality rates are acceptable* - Stewardship aims to optimize therapy; since **dual therapy** shows no mortality benefit but carries higher costs and risks, continuing it is poor practice. - Failing to address the 68% rate of dual therapy ignores the **unnecessary antibiotic exposure** and the lack of clinical superiority shown in the audit data. *Add fluoroquinolone monotherapy as a third option for all CAP patients* - Fluoroquinolones are generally reserved as second-line agents due to risks of **Clostridioides difficile** infection and significant **collateral damage** involving resistance. - Adding broad-spectrum options for all patients contradicts **stewardship principles** of using the narrowest spectrum agent effective for the clinical scenario. *Mandate PCR testing for atypical pathogens before prescribing macrolides* - Routine **PCR testing** for atypicals in non-severe CAP is often not cost-effective and may lack the turnaround time needed to guide initial empiric therapy. - Stewardship should focus first on **risk stratification** and guideline adherence rather than mandating expensive diagnostic bundles for low-risk patients. *Extend macrolide duration from 3 to 7 days to improve outcomes* - Extending duration increases **drug exposure** and potential for adverse events without any evidence of improved mortality or clinical success in this cohort. - This action would worsen the identified issues of **increased costs** and **longer length of stay** highlighted by the committee's audit.

Question 152: A 51-year-old woman presents with a 6-day history of progressive pain and swelling of her right index finger. She had a manicure 10 days ago. Examination shows a tense, fluctuant swelling along the flexor aspect of the finger extending into the palm, with the finger held in slight flexion. There is severe pain on passive extension. Temperature 38.3°C. What is the most critical aspect of immediate management?

A. Refer urgently to hand surgery for surgical drainage within hours - this is a surgical emergency (Correct Answer)
B. Perform bedside incision and drainage in the Emergency Department
C. Splint the hand, start IV flucloxacillin, and review in 12 hours
D. Start oral co-amoxiclav and arrange hand surgery review within 24 hours
E. Arrange ultrasound imaging to confirm abscess before surgical referral

Explanation: ***Refer urgently to hand surgery for surgical drainage within hours - this is a surgical emergency*** - The clinical presentation, including tense fluctuant swelling, flexed posture, tenderness along the flexor aspect, and severe pain on passive extension, represents **Kanavel's four cardinal signs**, pathognomonic for **infectious flexor tenosynovitis**. - This condition is a **surgical emergency** due to the risk of high pressure within the closed tendon sheath leading to **tendon ischemia**, **necrosis**, and permanent functional loss if not drained promptly. *Perform bedside incision and drainage in the Emergency Department* - Bedside drainage is typically **insufficient** for infectious flexor tenosynovitis, as it often requires formal **surgical irrigation and debridement** in an operating room to adequately clear the entire tendon sheath. - Attempting inadequate drainage risks incomplete pus removal and potential iatrogenic injury to critical structures like **neurovascular bundles**. *Splint the hand, start IV flucloxacillin, and review in 12 hours* - While **IV antibiotics** are crucial, they are not effective as a sole treatment for a significant pus collection within a high-pressure, closed space like the flexor tendon sheath. - A **12-hour delay** in surgical intervention is unacceptable for infectious flexor tenosynovitis and significantly increases the risk of irreversible **tendon damage** and **functional impairment**. *Start oral co-amoxiclav and arrange hand surgery review within 24 hours* - **Oral antibiotics** are inadequate for treating a severe deep-space infection with systemic signs such as **fever** and significant local inflammation. - A **24-hour delay** in surgical referral and treatment is too long for this time-sensitive condition, potentially leading to **widespread infection** or digit loss. *Arrange ultrasound imaging to confirm abscess before surgical referral* - Infectious flexor tenosynovitis is primarily a **clinical diagnosis** based on the characteristic physical findings (Kanavel's signs). - Delaying urgent surgical intervention for **imaging studies** can unnecessarily prolong the time to definitive treatment and worsen the patient's prognosis.

Question 153: A 63-year-old man is admitted with severe community-acquired pneumonia and started on IV co-amoxiclav and clarithromycin. On day 3, he develops watery diarrhoea (6 episodes in 24 hours), abdominal cramping, and low-grade fever. White cell count rises from 12 to 19 x 10⁹/L. Which of the following management steps best represents optimal antimicrobial stewardship in this situation?

A. Switch pneumonia treatment to IV levofloxacin and start oral vancomycin
B. Continue current antibiotics and add oral metronidazole 400mg three times daily
C. Send stool for C. difficile testing, stop clarithromycin, continue co-amoxiclav at minimum effective duration (Correct Answer)
D. Stop all antibiotics immediately and await stool culture results
E. Add IV metronidazole and vancomycin while continuing pneumonia treatment

Explanation: ***Send stool for C. difficile testing, stop clarithromycin, continue co-amoxiclav at minimum effective duration*** - Optimal **antimicrobial stewardship** involves reviewing the clinical need for current antibiotics; after 72 hours, the macrolide (**clarithromycin**) can often be stopped if the patient is stable, reducing the risk of further **C. difficile** provocation. - Immediate **C. difficile toxin testing** is essential, while maintaining the minimum necessary coverage for the primary infection (**pneumonia**) to prevent clinical relapse. *Switch pneumonia treatment to IV levofloxacin and start oral vancomycin* - **Fluoroquinolones** like levofloxacin are high-risk triggers for **Clostridioides difficile** infection and should be avoided when a patient already has diarrhea. - Starting **oral vancomycin** empirically without a confirmed diagnosis or signs of severe toxicity (like megacolon) violates stewardship principles by contributing to antibiotic overuse. *Continue current antibiotics and add oral metronidazole 400mg three times daily* - Continuing the inciting antibiotics (**co-amoxiclav and clarithromycin**) without review prolongs the disruption of gut flora, making the **C. difficile** harder to treat. - **Oral metronidazole** is no longer the first-line recommendation for confirmed CDI in many guidelines and shouldn't be added before a stool test result is obtained. *Stop all antibiotics immediately and await stool culture results* - Stopping treatment for **severe community-acquired pneumonia** prematurely on day 3 is dangerous and could lead to respiratory failure or clinical deterioration. - While stewardship aims to minimize unnecessary use, it does not advocate for withdrawing **life-saving therapy** for an active, severe infection. *Add IV metronidazole and vancomycin while continuing pneumonia treatment* - **IV metronidazole** is typically reserved for **fulminant CDI** with ileus; it is less effective than oral routes for standard C. difficile infection. - Adding multiple potent antibiotics without diagnostic confirmation or narrowing the current regimen represents poor **polypharmacy** and stewardship practice.

Question 154: A 42-year-old woman with rheumatoid arthritis on methotrexate 20mg weekly and prednisolone 10mg daily presents with a 3-day history of a painful erythematous nodule on her shin. It has now developed into a rapidly expanding ulcer with a violaceous undermined border. The base shows purulent exudate. Temperature 37.4°C. She is otherwise systemically well. What is the most appropriate next step in management?

A. Start oral flucloxacillin for staphylococcal cellulitis
B. Start IV piperacillin-tazobactam for presumed necrotising infection
C. Take bacterial and fungal cultures, consider biopsy, and refer to dermatology (Correct Answer)
D. Arrange urgent surgical debridement
E. Start oral prednisolone 40mg daily for presumed pyoderma gangrenosum

Explanation: ***Take bacterial and fungal cultures, consider biopsy, and refer to dermatology***- This patient's presentation with a **violaceous undermined border** and a rapidly expanding ulcer is classic for **pyoderma gangrenosum (PG)**, which is strongly associated with **rheumatoid arthritis**.- Since PG is a **diagnosis of exclusion**, it is crucial to first perform **bacterial and fungal cultures** and a skin biopsy to rule out infections and malignancy, especially in an **immunosuppressed patient**.*Start oral flucloxacillin for staphylococcal cellulitis*- While cellulitis causes erythema, it typically lacks the characteristic **undermined borders** and rapid, necrotizing ulceration seen here.- Empiric antibiotics alone are inappropriate as they do not address the likely **inflammatory pathology** and delay a tissue-proven diagnosis.*Start IV piperacillin-tazobactam for presumed necrotising infection*- Although the ulcer is rapid, the patient is **systemically well** with a temperature of only 37.4°C, making a life-threatening **necrotizing fasciitis** less likely.- IV antibiotics do not treat the underlying **neutrophilic dermatosis** of pyoderma gangrenosum and have limited role unless secondary infection is confirmed.*Arrange urgent surgical debridement*- Surgical debridement is highly contraindicated in suspected pyoderma gangrenosum due to **pathergy**, where trauma leads to worsening of the lesion.- Debridement can cause significant and rapid **extension of the ulcer**, potentially leading to severe tissue loss and poor outcomes.*Start oral prednisolone 40mg daily for presumed pyoderma gangrenosum*- Although high-dose steroids are the treatment for PG, starting them before **ruling out infection** can be dangerous in an immunocompromised host on **methotrexate**.- A formal diagnosis following **dermatology referral** and biopsy is required to ensure that systemic immunosuppression is safe and appropriate.

Question 155: A hospital trust reviews antimicrobial consumption data over 12 months following implementation of a new stewardship programme. Total antibiotic defined daily doses (DDDs) per 1000 bed-days decreased from 850 to 720. However, rates of Gram-negative bacteraemia with carbapenem-resistant organisms increased from 0.8 to 2.1 per 10,000 bed-days. What is the most likely explanation for this paradoxical finding?

A. The stewardship programme was ineffective at reducing overall antibiotic use
B. Increased use of carbapenems or other broad-spectrum agents despite reduced total DDDs, causing selection pressure (Correct Answer)
C. Natural variation in resistance patterns unrelated to antibiotic use
D. Reduced infection control measures coinciding with stewardship implementation
E. Contamination of surveillance cultures rather than true bacteraemia

Explanation: ***Increased use of carbapenems or other broad-spectrum agents despite reduced total DDDs, causing selection pressure*** - A reduction in **total Defined Daily Doses (DDDs)** does not preclude a shift towards increased use of **specific broad-spectrum antibiotics** like carbapenems, which exert strong **selection pressure**. - This selective increase in **carbapenem** use, even if overall antibiotic consumption declines, directly drives the proliferation of **carbapenem-resistant organisms (CROs)** by favoring their survival and spread. *The stewardship programme was ineffective at reducing overall antibiotic use* - This option is contradicted by the data provided, which explicitly states that total antibiotic DDDs **decreased** from 850 to 720 per 1000 bed-days, indicating some effectiveness in reducing volume. - The ineffectiveness lies not in reducing volume, but potentially in failing to target the **quality or spectrum** of antibiotics that drive specific resistance. *Natural variation in resistance patterns unrelated to antibiotic use* - While some background **epidemiological variation** occurs, such a significant and specific increase in **carbapenem resistance** coinciding with a new stewardship program strongly suggests a causal link to the intervention or local prescribing practices. - Antimicrobial resistance in a hospital setting is largely influenced by **antimicrobial selection pressure**, making a direct link to antibiotic use more probable than unrelated natural variation for such a rapid rise. *Reduced infection control measures coinciding with stewardship implementation* - Poor **infection control** could contribute to the spread of resistant organisms, but it wouldn't directly explain a paradoxical increase in resistance **despite decreased overall antibiotic consumption**. - A general breakdown in infection control would typically lead to an increase in various healthcare-associated infections, not specifically a focused rise in **carbapenem-resistant Gram-negative bacteraemia** linked to antibiotic usage patterns. *Contamination of surveillance cultures rather than true bacteraemia* - **Bacteraemia** implies the presence of bacteria in the blood, confirmed by **blood cultures**, which are typically collected under strict aseptic conditions to minimize contamination risk. - A substantial and consistent increase in documented **bacteraemia rates** across a hospital trust is highly unlikely to be attributed solely to widespread **culture contamination**; it generally signifies a true increase in infection.

Question 156: A 57-year-old man with poorly controlled diabetes (HbA1c 102 mmol/mol) presents with malaise and a tender swelling in his left upper back over 5 days. Examination reveals a 5cm fluctuant, erythematous mass with multiple pustular points. Temperature 38.1°C, HR 95/min, BP 128/78 mmHg. White cell count 14.2 x 10⁹/L, CRP 87 mg/L. Ultrasound confirms a multiloculated abscess. What is the most appropriate management?

A. Oral flucloxacillin 500mg four times daily for 7 days
B. Incision and drainage with oral flucloxacillin 500mg four times daily for 5-7 days (Correct Answer)
C. IV flucloxacillin 2g four times daily for 14 days
D. Needle aspiration and oral co-amoxiclav 625mg three times daily
E. Hot compresses and reassess in 48 hours

Explanation: ***Incision and drainage with oral flucloxacillin 500mg four times daily for 5-7 days*** - The patient presents with a **carbuncle**, characterized by a deep, **multiloculated abscess** with multiple pustular points, which requires surgical **incision and drainage** for definitive source control. - **Antibiotics** are indicated in this case because of the lesion's size (>2cm), the presence of **systemic symptoms** (fever, tachycardia), and the patient's **immunocompromised state** due to poorly controlled diabetes. *Oral flucloxacillin 500mg four times daily for 7 days* - Antibiotics alone are insufficient for treating a **fluctuant abscess** or carbuncle as the medication cannot effectively penetrate the abscess cavity. - Failure to perform **drainage** increases the risk of treatment failure, recurrence, and worsening of the infection in a diabetic patient. *IV flucloxacillin 2g four times daily for 14 days* - While the patient has a minor fever, he is **hemodynamically stable** with a BP of 128/78 mmHg, meaning **oral antibiotics** are typically sufficient following drainage. - **Intravenous therapy** is usually reserved for patients with severe sepsis, rapidly progressing cellulitis, or those unable to tolerate oral medications. *Needle aspiration and oral co-amoxiclav 625mg three times daily* - **Needle aspiration** is inadequate for a **multiloculated collection** where multiple septations prevent complete evacuation of pus. - **Flucloxacillin** is the preferred narrow-spectrum choice for **Staphylococcus aureus**, which is the most common causative organism in carbuncles. *Hot compresses and reassess in 48 hours* - **Hot compresses** are only appropriate for very small, simple furuncles or folliculitis to encourage spontaneous drainage. - Delaying active treatment in a patient with **poorly controlled diabetes** and systemic features of infection significantly increases the risk of **necrotizing fasciitis** or sepsis.

Question 157: A 29-year-old woman with no past medical history presents with a 24-hour history of severe pain in her right thigh following minor trauma 3 days ago. On examination, she appears toxic (temperature 39.2°C, BP 95/55 mmHg, HR 125/min). The thigh is swollen, tense, with dusky discolouration and bullae. There is crepitus on palpation and severe pain disproportionate to physical signs. Lactate 4.2 mmol/L. What is the most important immediate management step?

A. Arrange urgent MRI to define tissue planes involved
B. Start IV benzylpenicillin and clindamycin and arrange immediate surgical exploration (Correct Answer)
C. Take deep tissue cultures and start IV co-amoxiclav
D. Perform urgent CT imaging to assess extent of infection
E. Arrange surgical debridement within 6 hours and start broad-spectrum antibiotics

Explanation: ***Start IV benzylpenicillin and clindamycin and arrange immediate surgical exploration*** - The presentation of **pain disproportionate to physical signs**, **crepitus**, **bullae**, **dusky discolouration**, and **septic shock** (temperature 39.2°C, BP 95/55 mmHg, HR 125/min, lactate 4.2 mmol/L) is highly indicative of **necrotizing fasciitis**, a surgical emergency. - **Immediate surgical debridement** is critical to remove necrotic tissue and halt progression, complemented by **broad-spectrum IV antibiotics** including **clindamycin** for its vital **antitoxin effect** against Group A Strep and other toxin-producing bacteria. *Arrange urgent MRI to define tissue planes involved* - **MRI**, while detailed for soft tissue, should **never delay emergent surgical intervention** for suspected necrotizing fasciitis, especially in a patient exhibiting signs of **septic shock**. - Time-consuming diagnostic imaging would unacceptably postpone **life-saving debridement**, worsening patient outcomes in this rapidly progressive infection. *Take deep tissue cultures and start IV co-amoxiclav* - **Co-amoxiclav** alone may not provide adequate coverage for severe necrotizing fasciitis (e.g., against MRSA or certain anaerobes) and, crucially, **lacks the antitoxin effect** provided by clindamycin, which is vital in toxin-mediated infections. - While cultures are important for guiding definitive antibiotic therapy, they should be obtained **intraoperatively** without delaying the initiation of empiric antibiotics and **immediate surgery**. *Perform urgent CT imaging to assess extent of infection* - **CT imaging** can reveal gas in tissues but is **not required to diagnose** necrotizing fasciitis clinically and should **not delay immediate surgical exploration**. - Spending time on imaging for a condition requiring **immediate surgical debridement** in a patient with **septic shock** significantly increases morbidity and mortality. *Arrange surgical debridement within 6 hours and start broad-spectrum antibiotics* - A delay of "**within 6 hours**" for surgical debridement is **unacceptable and dangerous** in necrotizing fasciitis, which requires **immediate** surgical intervention to prevent rapid spread and systemic deterioration. - The infection spreads aggressively, and even short delays in **surgical debridement**, which is the primary treatment, significantly increase mortality and morbidity.

Question 158: A 68-year-old man with end-stage renal failure on peritoneal dialysis presents with abdominal pain and cloudy dialysate effluent. Dialysate cell count shows 450 white cells/μL (90% neutrophils). Gram stain shows no organisms. He is haemodynamically stable. According to International Society for Peritoneal Dialysis guidelines, what is the most appropriate empirical antimicrobial regimen?

A. Intraperitoneal vancomycin and gentamicin (Correct Answer)
B. Intravenous flucloxacillin and gentamicin
C. Intraperitoneal cefazolin and ceftazidime
D. Oral co-amoxiclav and remove peritoneal dialysis catheter
E. Intravenous meropenem monotherapy

Explanation: ***Intraperitoneal vancomycin and gentamicin*** - Empirical therapy for **peritoneal dialysis-associated peritonitis** must provide broad cover against both **Gram-positive** (e.g., Staphylococci) and **Gram-negative** (e.g., Pseudomonas, E. coli) organisms. - The **intraperitoneal (IP)** route is superior to intravenous administration because it achieves higher drug concentrations at the site of infection and correlates with better clinical outcomes. *Intravenous flucloxacillin and gentamicin* - This regimen uses the **intravenous route**, which fails to achieve the high local dialysate concentrations required for optimal treatment of peritonitis. - **Flucloxacillin** provides poor coverage against **MRSA**, which is a common pathogen in long-term dialysis patients, making vancomycin a safer empirical choice. *Intraperitoneal cefazolin and ceftazidime* - While this combination is a valid alternative per **ISPD guidelines**, vancomycin is preferred in settings with high **MRSA prevalence** or for patients with penicillin allergies. - This patient's stability and the lack of Gram stain results make the **vancomycin/aminoglycoside** combination the traditional and highly reliable first-line choice in many clinical practices. *Oral co-amoxiclav and remove peritoneal dialysis catheter* - **Oral antibiotics** are inappropriate as initial therapy because they cannot match the efficacy of **intraperitoneal administration** in acute PD peritonitis. - **Catheter removal** is not indicated at presentation and is typically reserved for cases that are **refractory**, fungal, or involve the exit site/tunnel infection. *Intravenous meropenem monotherapy* - **Meropenem** is an unnecessarily broad-spectrum carbapenem for initial empirical therapy and contributes to increased **antimicrobial resistance**. - Like other **intravenous options**, it is less effective than intraperitoneal delivery for treating the peritoneal membrane and effluent infection.

Question 159: A 35-year-old man who recently returned from visiting family in Bangladesh presents with a 5-day history of a painless ulcer with a necrotic centre on his forearm, where he recalls an insect bite. He has fever (38.4°C) and tender axillary lymphadenopathy. The ulcer is 2cm diameter with a black eschar surrounded by erythema and oedema. He works in a textile warehouse. What is the most likely diagnosis?

A. Cutaneous anthrax (Correct Answer)
B. Cutaneous leishmaniasis
C. Ecthyma gangrenosum
D. Rickettsial spotted fever
E. Buruli ulcer

Explanation: ***Cutaneous anthrax***- The classic presentation of a **painless ulcer** that develops into a **black necrotic eschar** (malignant pustule) surrounded by **erythema and significant non-pitting edema**, along with **fever** and **tender regional lymphadenopathy**, is highly characteristic of *Bacillus anthracis* infection.- Occupational exposure in a **textile warehouse** (handling animal fibers or products) and recent travel to **Bangladesh** (an area where anthrax is endemic) significantly increase the risk of contact with anthrax spores.*Cutaneous leishmaniasis*- While it can cause a painless ulcer, **cutaneous leishmaniasis** typically has a much **slower progression** over weeks to months, rather than the acute 5-day history presented here.- The lesions are often more nodular or plaque-like, eventually ulcerating, but generally lack the acute systemic symptoms and the specific **black eschar** surrounded by marked edema.*Ecthyma gangrenosum*- This condition is primarily associated with **immunocompromised patients**, especially those with **severe neutropenia**, and is typically caused by **Pseudomonas aeruginosa** bacteremia.- The lesions are often multiple and rapidly progressive, but the patient's general health and the specific occupational and travel history do not align with the typical risk factors for ecthyma gangrenosum.*Rickettsial spotted fever*- Some rickettsial infections can cause an **eschar (tache noire)** at the bite site, but this is usually accompanied by a **widespread maculopapular rash**, which is not mentioned in this case.- While fever and lymphadenopathy can be present, the distinctive **black eschar** with extensive surrounding **edema** and the strong epidemiological links point more strongly to anthrax.*Buruli ulcer*- Caused by *Mycobacterium ulcerans*, **Buruli ulcer** presents as a **chronic, slow-growing, painless ulcer** with **undermined edges** and typically lacks the acute onset of fever and tender lymphadenopathy.- The rapid progression over 5 days and the distinct **black eschar** are not characteristic features of Buruli ulcer.

Question 160: A hospital antimicrobial stewardship team identifies that 55% of surgical prophylaxis for colorectal surgery continues beyond 24 hours post-operatively. Surgical site infection rates are within national benchmarks. Which intervention is most likely to improve compliance with single-dose prophylaxis without increasing infection rates?

A. Extend prophylaxis to 48 hours for all patients undergoing colorectal surgery
B. Implement automatic stop orders for surgical prophylaxis at 24 hours post-operatively (Correct Answer)
C. Require approval from microbiology consultants for prophylaxis continuation
D. Replace current prophylaxis with broader spectrum agents for longer duration
E. Provide educational sessions only without changing prescribing systems

Explanation: ***Implement automatic stop orders for surgical prophylaxis at 24 hours post-operatively*** - **Automatic stop orders** are highly effective system-based interventions that reduce unnecessary antibiotic exposure by defaulting to the standard of care. - This approach improves compliance with **prophylaxis guidelines** without requiring individual manual intervention, minimizing the risk of **antimicrobial resistance** and C. difficile infections. *Extend prophylaxis to 48 hours for all patients undergoing colorectal surgery* - Evidence indicates that extending prophylaxis beyond 24 hours does not further reduce **surgical site infection** rates but does increase side effects. - This intervention contradicts the goal of **antimicrobial stewardship** and promotes the development of multi-drug resistant organisms. *Require approval from microbiology consultants for prophylaxis continuation* - While effective for high-cost or broad-spectrum drugs, requiring **consultant approval** for routine prophylaxis creates excessive administrative barriers and delays in care. - This method is less sustainable for high-volume surgical procedures compared to **systemized stop orders**. *Replace current prophylaxis with broader spectrum agents for longer duration* - Increasing the **spectrum of activity** and duration is clinically unnecessary given that infection rates are already within benchmarks. - This strategy would significantly increase **selective pressure** for resistant bacteria without providing additional clinical benefits. *Provide educational sessions only without changing prescribing systems* - Although important, **passive education** alone has been shown to have limited long-term impact on prescribing habits in the absence of **structural changes**. - Educational sessions lack the immediate and reliable impact that **clinical decision support tools** or stop orders provide.

Question 161: A 44-year-old woman with breast cancer receiving chemotherapy (last cycle 8 days ago) presents with fever of 38.9°C and a 2-day history of erythema and tenderness around her Hickman line exit site. Neutrophil count is 0.3 x 10⁹/L. Blood pressure 105/65 mmHg, heart rate 108/min. There is a 4cm area of erythema and purulent discharge at the line site. What is the most appropriate initial antimicrobial management?

A. Remove line and start IV vancomycin and gentamicin
B. Take blood cultures via line and peripherally, start IV piperacillin-tazobactam (Correct Answer)
C. Start oral co-amoxiclav and arrange line removal within 24 hours
D. Take blood cultures and await results before starting antibiotics
E. Start IV teicoplanin alone and attempt line salvage

Explanation: ***Take blood cultures via line and peripherally, start IV piperacillin-tazobactam*** - This patient presents with **febrile neutropenia** (neutrophil count 0.3 x 10⁹/L and fever 38.9°C), a medical emergency requiring **immediate broad-spectrum IV antibiotics** (ideally within one hour) to cover both Gram-positive and Gram-negative organisms, such as **piperacillin-tazobactam**. - **Blood cultures** from both the central venous catheter and a peripheral site are crucial to help diagnose a **catheter-related bloodstream infection (CRBSI)** by comparing the differential time to positivity, guiding subsequent management. *Remove line and start IV vancomycin and gentamicin* - While the Hickman line is a likely source of infection and may need removal, **initial management** prioritizes stabilizing the patient with prompt **broad-spectrum IV antibiotics** before definitive line management. - **Gentamicin** provides good Gram-negative coverage but lacks adequate Gram-positive coverage, and combined with vancomycin (primarily Gram-positive), it doesn't offer the immediate broad empirical spectrum, including anti-pseudomonal activity, that a single agent like piperacillin-tazobactam provides for **neutropenic sepsis**. *Start oral co-amoxiclav and arrange line removal within 24 hours* - **Oral antibiotics** are insufficient for managing **febrile neutropenia** with a suspected central line infection and signs of systemic compromise; **IV antimicrobial therapy** is essential for rapid systemic delivery. - Delaying definitive treatment for a procedure like line removal is inappropriate in a rapidly progressing condition like **neutropenic sepsis**; immediate broad-spectrum antibiotics are paramount. *Take blood cultures and await results before starting antibiotics* - Delaying antibiotic administration until **blood culture results** are available is contraindicated in **febrile neutropenia** due to the high risk of rapid clinical deterioration, **septic shock**, and mortality. - **Empiric broad-spectrum antibiotics** must be initiated immediately after blood cultures are drawn, without waiting for pathogen identification or susceptibility results. *Start IV teicoplanin alone and attempt line salvage* - **Teicoplanin** is a glycopeptide that primarily covers **Gram-positive organisms** (including MRSA) but provides no coverage for **Gram-negative bacteria**, which are major pathogens in **neutropenic sepsis**, especially Pseudomonas species. - **Monotherapy** with a glycopeptide is therefore inadequate for initial empiric treatment of **febrile neutropenia**; comprehensive Gram-negative coverage is mandatory, and line salvage attempts are secondary to effective antimicrobial therapy.

Question 162: A 76-year-old man with type 2 diabetes and peripheral arterial disease presents with a 3-day history of a painful, warm, erythematous area on his shin following minor trauma. Temperature is 37.8°C. There is a 10cm x 8cm area of erythema with a well-demarcated border but no crepitus, blistering, or skin necrosis. CRP 45 mg/L. What is the most appropriate initial management?

A. Oral flucloxacillin 500mg four times daily (Correct Answer)
B. Oral co-amoxiclav 625mg three times daily
C. IV flucloxacillin 2g four times daily
D. Oral doxycycline 200mg loading then 100mg twice daily
E. Arrange urgent surgical debridement

Explanation: ***Oral flucloxacillin 500mg four times daily*** - This patient presents with **cellulitis**, characterized by a painful, warm, erythematous area with a **well-demarcated border** and mild systemic symptoms (low-grade fever, elevated CRP) but no signs of severe infection. - **Flucloxacillin** is the first-line oral antibiotic for uncomplicated cellulitis, providing effective coverage against the most common causative organisms, **Staphylococcus aureus** and **Streptococci**. *Oral co-amoxiclav 625mg three times daily* - **Co-amoxiclav** offers a broader spectrum of activity, including anaerobes, which is generally not required for typical uncomplicated cellulitis following minor trauma. - It is usually reserved for specific scenarios such as **animal/human bites**, diabetic foot infections, or when polymicrobial infection is highly suspected. *IV flucloxacillin 2g four times daily* - **Intravenous antibiotics** are typically indicated for severe cellulitis (e.g., Eron Class III or IV) with signs of **sepsis**, rapid progression, or inability to tolerate oral medications. - The patient's condition, with only mild fever and no signs of systemic toxicity or rapid spread, allows for **oral antibiotic therapy** as the initial approach. *Oral doxycycline 200mg loading then 100mg twice daily* - **Doxycycline** is primarily used as an alternative agent for cellulitis in patients with a confirmed **penicillin allergy** or when **MRSA** (Methicillin-resistant Staphylococcus aureus) infection is suspected. - Since there is no mention of penicillin allergy or specific risk factors for MRSA, **flucloxacillin** remains the preferred first-line treatment. *Arrange urgent surgical debridement* - **Surgical debridement** is reserved for severe infections like **necrotizing fasciitis**, deep abscesses, or significant tissue necrosis. - The absence of **crepitus**, blistering, or skin necrosis explicitly rules out necrotizing fasciitis in this case, making surgical intervention unnecessary.

Question 163: According to UK antimicrobial prescribing guidance, which of the following statements about documenting antimicrobial prescriptions is correct?

A. Indication must be documented within 48 hours of starting treatment
B. Review date is optional for oral antibiotics in primary care
C. Clinical indication, dose, route and duration/review date must all be documented at time of prescribing (Correct Answer)
D. Duration can be determined later once microbiological results are available
E. Only the consultant responsible needs to document the indication in medical notes

Explanation: ***Clinical indication, dose, route and duration/review date must all be documented at time of prescribing*** - According to 'Start Smart - Then Focus' guidelines, this documentation is essential at the **point of prescribing** to ensure patient safety and effective **antimicrobial stewardship**. - Clear documentation allows for **timely clinical review** and prevents unnecessary prolonged courses of antibiotics. *Indication must be documented within 48 hours of starting treatment* - The **clinical indication** must be documented **immediately** when the prescription is written, not delayed by 48 hours. - The **48-72 hour** window is reserved for the **clinical review** and decision to stop, switch, or continue treatment based on culture results. *Review date is optional for oral antibiotics in primary care* - Including a **review date or duration** is a mandatory requirement for all antimicrobial prescriptions to prevent **inappropriate long-term use**. - This applies across all healthcare settings, including **primary care**, to maintain safety and reduce **antibiotic resistance**. *Duration can be determined later once microbiological results are available* - An initial **duration or review date** must be specified at the start of treatment based on **empirical guidelines**. - While treatment may be adjusted after **microbiology results** are available, it cannot be left open-ended at the initial prescribing stage. *Only the consultant responsible needs to document the indication in medical notes* - It is the responsibility of the **individual prescriber**, regardless of grade, to ensure all details are documented correctly in the **medical records**. - **Contemporaneous documentation** by the prescriber ensures that the rationale for therapy is transparent to all members of the multidisciplinary team.

Question 164: A 52-year-old woman with community-acquired pneumonia has been receiving intravenous co-amoxiclav for 48 hours. She is now apyrexial, haemodynamically stable, able to eat and drink, and her inflammatory markers are improving (CRP down from 185 to 78 mg/L). Chest examination reveals reduced crackles. What is the most appropriate antimicrobial stewardship action at this stage?

A. Continue IV co-amoxiclav for a total of 7 days
B. Switch to oral co-amoxiclav and consider early discharge (Correct Answer)
C. Stop antibiotics as she is now clinically improved
D. Change to oral clarithromycin monotherapy
E. Continue IV co-amoxiclav for 5 days then switch to oral

Explanation: ***Switch to oral co-amoxiclav and consider early discharge*** - The patient meets criteria for **IV-to-oral switch (IVOS)**, demonstrating **clinical stability** (apyrexial, haemodynamically stable, tolerating oral intake) and **improving inflammatory markers** (CRP decreasing). - This action represents good **antimicrobial stewardship**, minimizing risks associated with intravenous access (e.g., phlebitis, line infections) and facilitating **early hospital discharge**. *Continue IV co-amoxiclav for a total of 7 days* - Continuing intravenous therapy when a patient is clinically stable and able to take oral medication is an example of **over-prescribing IV medications**. - Prolonged IV access increases the risk of **cannula-related complications** and **hospital-acquired infections**, which is contrary to stewardship principles. *Stop antibiotics as she is now clinically improved* - While the patient is improving, stopping antibiotics prematurely can lead to **relapse** of the infection and potentially foster the development of **antibiotic resistance**. - Community-acquired pneumonia typically requires a course of 5-7 days, and 48 hours is usually insufficient for complete **bacterial eradication**. *Change to oral clarithromycin monotherapy* - Switching to a different **antibiotic class** like a macrolide without a specific indication (e.g., proven atypical pathogen, allergy to penicillin) is not appropriate when co-amoxiclav is effective. - This action could broaden the **antibiotic spectrum** unnecessarily or lead to treatment failure if the initial pathogen is not susceptible to clarithromycin. *Continue IV co-amoxiclav for 5 days then switch to oral* - Delaying the switch to oral therapy for an additional 3 days when the patient is already stable and meeting IVOS criteria is **unnecessary intravenous use**. - Antimicrobial stewardship emphasizes transitioning to oral therapy as soon as clinically appropriate to reduce complications and **hospital stay**.

Question 165: A hospital antimicrobial stewardship committee reviews audit data on community-acquired pneumonia (CAP) management. They find that 78% of patients admitted with low-severity CAP (CURB-65 score 0-1) receive dual antibiotic therapy (amoxicillin plus clarithromycin), while national guidelines recommend monotherapy with amoxicillin for this group unless specific indications exist. When the data is presented to the medical teams, several consultants express concern that monotherapy might miss atypical organisms. What evidence-based response best addresses this concern while supporting antimicrobial stewardship?

A. Agree to continue dual therapy as consultant concerns about clinical risk should take precedence over stewardship guidelines
B. Present evidence that macrolide addition in low-severity CAP shows no mortality benefit and increases antibiotic exposure and C. difficile risk without clear clinical benefit (Correct Answer)
C. Propose a compromise of using monotherapy for CURB-65 0 but continuing dual therapy for CURB-65 1 patients
D. Suggest that all patients should have atypical serology tested on admission to guide whether to add a macrolide
E. Recommend switching to fluoroquinolone monotherapy (levofloxacin) which covers both typical and atypical organisms

Explanation: ***Present evidence that macrolide addition in low-severity CAP shows no mortality benefit and increases antibiotic exposure and C. difficile risk without clear clinical benefit*** - In patients with **low-severity CAP (CURB-65 0-1)**, randomized trials and meta-analyses demonstrate that **macrolide** addition does not improve outcomes compared to **beta-lactam monotherapy**. - Prioritizing evidence helps address clinician fear while reducing **collateral damage**, such as **C. difficile** risk, adverse drug reactions, and the selection of **resistant organisms**. *Agree to continue dual therapy as consultant concerns about clinical risk should take precedence over stewardship guidelines* - This approach ignores **evidence-based guidelines** and fails to fulfill the primary mission of the **Antimicrobial Stewardship (AMS)** committee. - Deferring to clinical preference without reviewing data leads to **excessive antibiotic use** and does not mitigate the actual risks of antibiotic resistance or side effects. *Propose a compromise of using monotherapy for CURB-65 0 but continuing dual therapy for CURB-65 1 patients* - There is no clinical evidence to support this compromise, as patients with a **CURB-65 score of 1** are still categorized as **low risk** with low mortality. - National guidelines (like **BTS** and **NICE**) consistently recommend **monotherapy** for the entire 0-1 score group unless specific contraindications exist. *Suggest that all patients should have atypical serology tested on admission to guide whether to add a macrolide* - **Atypical serology** is generally not useful for acute management because it often requires **convalescent samples** (taken weeks later) to confirm a diagnosis. - These tests have poor sensitivity and specificity in the acute setting and do not provide the **rapid results** needed to guide initial antibiotic selection. *Recommend switching to fluoroquinolone monotherapy (levofloxacin) which covers both typical and atypical organisms* - This represents unnecessary use of **broad-spectrum** agents, which should be reserved for those with **beta-lactam allergies** or more severe disease. - **Fluoroquinolones** carry significant risks, including **tendon rupture**, QT prolongation, and high associations with **C. difficile** infection.

Question 166: A 63-year-old man with type 2 diabetes and end-stage renal failure on haemodialysis three times weekly presents with fever (38.7°C) and a painful, erythematous tunnelled haemodialysis catheter exit site with purulent discharge. Blood cultures drawn from the catheter and peripheral vein both grow Gram-positive cocci in clusters at 14 hours. He is haemodynamically stable. The renal team plans catheter removal and temporary femoral line insertion tomorrow. His last dialysis session was yesterday. What is the most appropriate empirical antimicrobial therapy pending identification and sensitivities?

A. Intravenous flucloxacillin 2g four times daily with dose adjustment for renal function
B. Intravenous vancomycin 15-20mg/kg loading dose, then subsequent dosing guided by levels and dialysis schedule (Correct Answer)
C. Intravenous teicoplanin 800mg loading dose, then 400mg after each dialysis session
D. Intravenous daptomycin 6mg/kg after each dialysis session
E. Oral doxycycline 100mg twice daily as outpatient with catheter left in situ

Explanation: ***Intravenous vancomycin 15-20mg/kg loading dose, then subsequent dosing guided by levels and dialysis schedule*** - This patient presents with a **catheter-related bloodstream infection (CRBSI)**, indicated by the infected catheter exit site and positive blood cultures with **Gram-positive cocci in clusters** in a haemodialysis patient. - **Vancomycin** is the recommended empirical therapy for suspected CRBSI in this population, providing crucial coverage against **MRSA**, and requires a **loading dose** followed by level-guided dosing adjusted for **dialysis**. *Intravenous flucloxacillin 2g four times daily with dose adjustment for renal function* - While effective against **MSSA**, flucloxacillin lacks coverage for **MRSA**, which is a prevalent and serious pathogen in **haemodialysis patients** with catheter infections. - Empirical treatment of CRBSI in this high-risk group mandates coverage for **MRSA** until sensitivities are known, making flucloxacillin insufficient. *Intravenous teicoplanin 800mg loading dose, then 400mg after each dialysis session* - Although **teicoplanin** is effective against **MRSA**, **vancomycin** is often preferred as first-line empirical therapy in CRBSI due to more established dosing protocols and extensive clinical experience in **dialysis patients**. - The suggested maintenance dose may be suboptimal, as ensuring adequate **trough levels** can be challenging, often requiring more aggressive initial dosing strategies for serious infections. *Intravenous daptomycin 6mg/kg after each dialysis session* - **Daptomycin** is typically reserved for specific situations like **vancomycin-resistant organisms** or in cases of glycopeptide intolerance/failure, to preserve its efficacy and prevent resistance. - For a serious **Staphylococcus aureus bacteraemia** in dialysis patients, a higher dose (often 8-10 mg/kg) is usually indicated, making 6 mg/kg potentially **subtherapeutic**. *Oral doxycycline 100mg twice daily as outpatient with catheter left in situ* - **Oral antibiotics** are inappropriate for treating a suspected **bloodstream infection** with systemic signs like fever and purulent discharge from a central venous catheter. - The presence of a **tunnelled catheter infection** with bacteraemia mandates **catheter removal** and inpatient intravenous antimicrobial therapy to prevent severe complications such as **endocarditis**.

Question 167: A 39-year-old woman with well-controlled HIV (CD4 count 520 cells/μL, undetectable viral load on antiretroviral therapy) presents with a 3-day history of a painful, red, swollen area on her right buttock. Examination reveals a 4cm fluctuant, tender swelling consistent with a subcutaneous abscess. Temperature 37.6°C, otherwise systemically well. Incision and drainage is performed in the Emergency Department with good drainage of pus. The sample is sent for culture. What is the most appropriate antimicrobial management following drainage?

A. Intravenous vancomycin 1g twice daily for 7 days as inpatient due to HIV status
B. Oral flucloxacillin 1g four times daily for 7 days and outpatient follow-up
C. No antibiotics; drainage alone is adequate, arrange wound review in 48 hours (Correct Answer)
D. Oral co-amoxiclav 625mg three times daily for 10 days due to immunosuppression
E. Oral doxycycline 100mg twice daily for 14 days pending culture results

Explanation: ***No antibiotics; drainage alone is adequate, arrange wound review in 48 hours*** - For a **simple cutaneous abscess**, the definitive treatment is **incision and drainage** (I&D); antibiotics do not improve outcomes in patients without systemic signs or extensive cellulitis. - Despite her HIV status, a **CD4 count >500** and undetectable viral load mean she is managed as an **immunocompetent** host for this minor soft tissue infection. *Intravenous vancomycin 1g twice daily for 7 days as inpatient due to HIV status* - **Inpatient admission** and **intravenous MRSA coverage** are not indicated for an otherwise healthy, systemically well patient with a localized infection. - Vancomycin is reserved for severe infections, suspected **MRSA**, or situations where oral therapy is not feasible. *Oral flucloxacillin 1g four times daily for 7 days and outpatient follow-up* - While flucloxacillin is standard for cellulitis, it is unnecessary here as **source control** (drainage) has already been established and there is no mention of spreading **surrounding cellulitis**. - Routine use of antibiotics for drained abscesses increases the risk of side effects like **C. difficile** and antibiotic resistance. *Oral co-amoxiclav 625mg three times daily for 10 days due to immunosuppression* - **Immunosuppression** is not a mandate for antibiotics if the immune profile (CD4 count) is high and the infection is localized and drained. - **Co-amoxiclav** provides broader coverage than necessary for typical skin flora like *Staphylococcus aureus* or *Streptococcus pyogenes*. *Oral doxycycline 100mg twice daily for 14 days pending culture results* - **Doxycycline** is an alternative for community-acquired MRSA, but antibiotics remain unnecessary since the abscess has been successfully **drained**. - A **14-day course** is excessively long for a simple skin and soft tissue infection that has already received primary surgical management.

Question 168: A hospital pharmacy department implements a new antimicrobial stewardship intervention requiring pharmacist review and approval for all restricted antibiotics (carbapenems, glycopeptides, anti-pseudomonal agents) within 24 hours of initiation. The pharmacist reviews microbiology results, therapeutic drug monitoring, and can recommend modifications or discontinuation. Which of the following represents the primary mechanism by which this intervention supports antimicrobial stewardship?

A. It creates an administrative barrier that reduces inappropriate initiation of restricted antibiotics
B. It ensures optimal dosing of expensive antibiotics to reduce pharmacy costs
C. It provides prospective audit with intervention and feedback to prescribers, enabling targeted therapy optimization (Correct Answer)
D. It transfers prescribing responsibility from medical staff to pharmacy staff, improving accountability
E. It standardizes antibiotic prescribing across the hospital by enforcing protocol compliance

Explanation: ***It provides prospective audit with intervention and feedback to prescribers, enabling targeted therapy optimization*** - This intervention represents a core strategy in **antimicrobial stewardship**, where pharmacists review ongoing therapy *after* initiation but *within 24 hours*, providing **prospective audit and feedback**. - The review of **microbiology results** and **therapeutic drug monitoring** enables **targeted therapy optimization**, including de-escalation, dose adjustments, or discontinuation, improving patient outcomes and reducing resistance. *It creates an administrative barrier that reduces inappropriate initiation of restricted antibiotics* - While some **AMS** interventions, like preauthorization, create barriers, this specific model focuses on **post-initiation review** and optimization rather than simply preventing the initial prescription. - The intent is clinical refinement based on evolving data, not solely an administrative deterrent to antibiotic use. *It ensures optimal dosing of expensive antibiotics to reduce pharmacy costs* - **Cost reduction** is a secondary benefit of appropriate antimicrobial use, but the primary mechanism of stewardship is to improve **patient safety** and combat **antimicrobial resistance**. - Emphasizing only cost overlooks the critical clinical and public health goals of **antimicrobial stewardship programs**. *It transfers prescribing responsibility from medical staff to pharmacy staff, improving accountability* - **Antimicrobial stewardship** is a **collaborative process** where pharmacists offer recommendations and expert guidance, but the **prescribing physician** maintains ultimate responsibility for patient care decisions. - The intervention facilitates **interprofessional communication** and shared decision-making rather than a complete transfer of clinical authority. *It standardizes antibiotic prescribing across the hospital by enforcing protocol compliance* - While protocols are valuable, this intervention highlights **individualized patient review** based on specific **microbiology** and **therapeutic drug monitoring**, allowing for tailored therapy. - It moves beyond mere **protocol enforcement** by providing dynamic, patient-specific recommendations that optimize treatment for each unique clinical scenario.

Question 169: A 52-year-old man presents to the Emergency Department with a 2-day history of painful swelling of his left hand following a cat bite 4 days ago. He did not seek initial medical attention. Examination reveals a hot, swollen, tender hand with limited range of movement at the MCP joints and wrist. There is purulent discharge from the bite wound. Temperature 38.1°C, pulse 94 bpm. He has no known drug allergies. Plain radiograph shows no evidence of foreign body or gas in tissues. What is the most appropriate antibiotic regimen?

A. Oral flucloxacillin 1g four times daily
B. Intravenous co-amoxiclav 1.2g three times daily (Correct Answer)
C. Oral doxycycline 100mg twice daily and metronidazole 400mg three times daily
D. Intravenous ceftriaxone 2g once daily
E. Oral co-trimoxazole 960mg twice daily

Explanation: ***Intravenous co-amoxiclav 1.2g three times daily*** - **Co-amoxiclav** is the first-line treatment for cat bites because it covers common pathogens like **Pasteurella multocida**, **Staphylococcus aureus**, and anaerobes. - In this case, **intravenous** administration is necessary due to systemic symptoms (fever), purulent discharge, and risk of deep tissue involvement like **septic arthritis** or **tenosynovitis**. *Oral flucloxacillin 1g four times daily* - **Flucloxacillin** is ineffective as a monotherapy for cat bites because it lacks sufficient activity against **Pasteurella multocida**. - Oral therapy is inappropriate here due to the severity of the infection and the patient's **systemic inflammatory response**. *Oral doxycycline 100mg twice daily and metronidazole 400mg three times daily* - This combination is typically reserved for patients with a **penicillin allergy**, which this patient does not have. - Even if used for allergy, the severe clinical presentation and potential **deep space infection** require parenteral (IV) broad-spectrum therapy rather than oral. *Intravenous ceftriaxone 2g once daily* - While **ceftriaxone** provides good coverage for **Pasteurella species**, it does not provide adequate coverage for the **anaerobes** frequently found in feline oral flora. - It is not considered the standard empirical first-line choice compared to the broader coverage offered by **co-amoxiclav**. *Oral co-trimoxazole 960mg twice daily* - **Co-trimoxazole** has unreliable and variable activity against **Pasteurella multocida**, making it an unsafe empirical choice. - It lacks the necessary **anaerobic coverage** and the clinical potency required to treat an established, severe infection in the hand.

Question 170: A 67-year-old man with a history of chronic venous insufficiency develops cellulitis of his right lower leg and is treated with oral flucloxacillin. This is his fourth episode in 18 months, all affecting the same leg. Between episodes, he has no fever or active infection but has persistent leg swelling and varicose eczema. What is the most appropriate long-term antimicrobial stewardship-aligned strategy to reduce recurrence?

A. Prophylactic oral flucloxacillin 250mg twice daily indefinitely
B. Prophylactic oral phenoxymethylpenicillin 500mg twice daily for 12 months with review (Correct Answer)
C. Rotating courses of different antibiotics (flucloxacillin, doxycycline, clarithromycin) every 3 months to prevent resistance
D. Topical fusidic acid to the affected leg applied daily as long-term prophylaxis
E. No antibiotic prophylaxis; focus on compression therapy, skin care, and management of venous insufficiency with antibiotic treatment only for acute episodes

Explanation: ***Prophylactic oral phenoxymethylpenicillin 500mg twice daily for 12 months with review*** - Antibiotic prophylaxis is indicated for patients who experience **two or more episodes** of cellulitis per year, particularly when underlying risk factors like **chronic venous insufficiency** are present. This patient has had four episodes in 18 months. - **Phenoxymethylpenicillin** (Penicillin V) is the preferred agent because it is **narrow-spectrum** and primarily targets **Streptococci**, which are the most common causative organisms for recurrent cellulitis, aligning with **antimicrobial stewardship** principles. The duration of 12 months with a review is also standard practice. *Prophylactic oral flucloxacillin 250mg twice daily indefinitely* - While **flucloxacillin** is effective for acute cellulitis (often due to *Staphylococcus aureus* or *Streptococcus pyogenes*), its use for long-term prophylaxis is less preferred due to its **broader spectrum** compared to phenoxymethylpenicillin, which may lead to unnecessary impact on normal flora and increased resistance risk. - Indefinite therapy without review is generally discouraged for antibiotic prophylaxis. Guidelines typically recommend a periodic **clinical review** (e.g., every 6–12 months) to assess the continued need and potential for discontinuation. *Rotating courses of different antibiotics (flucloxacillin, doxycycline, clarithromycin) every 3 months to prevent resistance* - There is no clinical evidence to support **rotating antibiotics** for cellulitis prophylaxis; this practice is more likely to increase the selection pressure for **multi-drug resistant** organisms rather than prevent resistance. - **Antimicrobial stewardship** principles emphasize using the **narrowest-spectrum** agent consistently when prophylaxis is indicated, rather than cycling through various broad-spectrum antibiotics. *Topical fusidic acid to the affected leg applied daily as long-term prophylaxis* - **Topical antibiotics** like fusidic acid are not indicated for the prevention of systemic infections like cellulitis, which originates from deeper tissue layers. They have poor penetration and do not achieve therapeutic levels systemically. - Long-term topical antibiotic use significantly increases the risk of developing **bacterial resistance** (especially to *Staphylococcus aureus* leading to MRSA) and can also cause **contact dermatitis** or sensitization. *No antibiotic prophylaxis; focus on compression therapy, skin care, and management of venous insufficiency with antibiotic treatment only for acute episodes* - While **compression therapy**, meticulous **skin care**, and aggressive management of **venous insufficiency** are crucial in preventing cellulitis recurrence by addressing underlying predisposing factors, this patient's history of **four episodes in 18 months** clearly meets the threshold for recommending **antibiotic prophylaxis**. - For patients with frequent recurrent cellulitis, relying solely on reactive treatment for acute episodes is insufficient and can lead to repeated hospitalizations, increased morbidity, and cumulative **lymphatic damage**.

Question 171: A 46-year-old man undergoes elective inguinal hernia repair as a day case procedure. He receives a single dose of intravenous co-amoxiclav 1.2g at induction of anaesthesia at 09:00. The procedure lasts 45 minutes and is uncomplicated with primary closure. He is recovering well post-operatively and due for discharge at 16:00. The surgical team writes him a prescription for co-amoxiclav 625mg three times daily for 5 days 'to complete the course and prevent wound infection'. From an antimicrobial stewardship perspective, what is the most appropriate action?

A. Support the prescription as it ensures adequate prophylaxis coverage and patient compliance
B. Suggest extending to 7 days to ensure complete prevention of surgical site infection
C. Recommend no further antibiotics as single-dose prophylaxis is adequate for clean elective surgery (Correct Answer)
D. Suggest switching to flucloxacillin for narrower spectrum coverage but continue the 5-day course
E. Recommend reducing to 3 days of oral antibiotics as a compromise between prophylaxis and stewardship

Explanation: ***Recommend no further antibiotics as single-dose prophylaxis is adequate for clean elective surgery*** - For **clean-contaminated** or **clean elective surgery** like an inguinal hernia repair, a single pre-operative dose of antibiotics is considered sufficient to prevent **Surgical Site Infection (SSI)**. - **Antimicrobial stewardship** principles advocate against prolonged antibiotic courses when not clinically indicated, as this contributes to **antimicrobial resistance** and potential adverse effects such as *Clostridioides difficile* infection. *Support the prescription as it ensures adequate prophylaxis coverage and patient compliance* - This approach is contrary to **antimicrobial stewardship** guidelines for clean surgical procedures, as extended antibiotic courses for uncomplicated cases are not evidence-based and offer no additional benefit. - Unnecessary antibiotic use increases the risk of **adverse drug reactions**, **C. difficile infection**, and fosters the development of **antibiotic-resistant bacteria**. *Suggest extending to 7 days to ensure complete prevention of surgical site infection* - There is no evidence that longer courses of antibiotics are more effective at preventing infection in **uncomplicated elective surgery**. - This action significantly increases the selection pressure for **multi-drug resistant organisms** and unnecessary healthcare costs. *Suggest switching to flucloxacillin for narrower spectrum coverage but continue the 5-day course* - While **narrower-spectrum antibiotics** are generally preferred, no antibiotic course is required post-operatively for this specific procedure, making any continuation inappropriate. - Continuing any antibiotic for 5 days post-discharge in this scenario is considered **inappropriate prescribing** regardless of the spectrum, for a **clean elective surgery**. *Recommend reducing to 3 days of oral antibiotics as a compromise between prophylaxis and stewardship* - A "compromise" duration is not **evidence-based**; if prophylaxis is only needed at induction, any further doses are redundant. - Stewardship focuses on the **optimal duration** of antibiotic use, which in this case is zero further doses once the surgical incision is closed and the patient is stable.

Question 172: What is the recommended first-line oral antibiotic for the treatment of uncomplicated cellulitis in adults according to current UK national guidance?

A. Co-amoxiclav 625mg three times daily
B. Flucloxacillin 500mg-1g four times daily (Correct Answer)
C. Doxycycline 200mg loading dose then 100mg daily
D. Clarithromycin 500mg twice daily
E. Cefalexin 500mg three times daily

Explanation: ***Flucloxacillin 500mg-1g four times daily***- **Flucloxacillin** is the recommended first-line agent for uncomplicated cellulitis in the UK (NICE/PHE) as it effectively targets **Staphylococcus aureus** and **Group A Streptococcus**.- Using a narrow-spectrum agent like flucloxacillin promotes **antimicrobial stewardship** by limiting unnecessary coverage and reducing resistance.*Co-amoxiclav 625mg three times daily*- This is a broad-spectrum antibiotic generally reserved for **bites (human or animal)** or cellulitis with specific contamination from soil or water.- It is not recommended for routine uncomplicated cellulitis because it extends coverage to **anaerobes** and gram-negative bacilli unnecessarily.*Doxycycline 200mg loading dose then 100mg daily*- This is usually considered a **second-line** option or an alternative for patients with **penicillin allergy**.- It provides moderate coverage but is not the primary empirical choice for otherwise healthy adults in the UK.*Clarithromycin 500mg twice daily*- Clarithromycin is an alternative treatment option specifically for patients who have a **penicillin allergy**.- While effective against common skin pathogens, it is not first-line due to the preferred efficacy and narrow spectrum of **penicillins**.*Cefalexin 500mg three times daily*- Cefalexin is a **first-generation cephalosporin** that may be used as an alternative, but it is not the gold-standard first-line therapy.- It is often reserved for those with non-severe penicillin allergies or as a second-line oral agent.

Question 173: A hospital trust antimicrobial stewardship team reviews prescribing practices on surgical wards and identifies that 68% of patients receive surgical antibiotic prophylaxis extending beyond 24 hours post-operatively, despite evidence that single-dose prophylaxis is adequate for most procedures. Which quality improvement intervention has the strongest evidence base for reducing inappropriate prolonged surgical prophylaxis?

A. Monthly educational emails to surgical consultants highlighting guidelines on appropriate prophylaxis duration
B. Automatic stop orders embedded in electronic prescribing systems that discontinue surgical prophylaxis after 24 hours unless actively renewed with documented indication (Correct Answer)
C. Quarterly audit and feedback reports sent to surgical departments showing their prophylaxis prescribing patterns
D. Poster campaigns in surgical areas displaying guidelines for surgical antibiotic prophylaxis
E. Annual mandatory e-learning modules on antimicrobial stewardship for all surgical staff

Explanation: ***Automatic stop orders embedded in electronic prescribing systems that discontinue surgical prophylaxis after 24 hours unless actively renewed with documented indication***- **Automatic stop orders** are high-leverage interventions that change the **default behavior**, requiring clinicians to actively justify deviations from evidence-based guidelines.- This approach is part of **Computerized Clinical Decision Support (CCDS)**, which has the strongest evidence base for achieving significant and sustained reductions in inappropriate prolonged prophylaxis.*Monthly educational emails to surgical consultants highlighting guidelines on appropriate prophylaxis duration*- Educational emails are considered **passive interventions** and are generally weak at changing long-term clinical behavior when used in isolation.- They do not address the **point-of-care decision-making** process where prescribing errors frequently occur.*Quarterly audit and feedback reports sent to surgical departments showing their prophylaxis prescribing patterns*- While **audit and feedback** is a recognized strategy, its effectiveness is often delayed as it identifies past behaviors rather than preventing errors in real-time.- It is less effective than **structural changes** like electronic stops because it relies on the clinician's motivation to review and act upon old data.*Poster campaigns in surgical areas displaying guidelines for surgical antibiotic prophylaxis*- Posters are a form of **visual aid** with very low evidence for changing complex prescribing habits; they are easily ignored in busy clinical environments.- They lack the **forcing function** needed to stop a clinician from continuing a prophylaxis course unnecessarily.*Annual mandatory e-learning modules on antimicrobial stewardship for all surgical staff*- **E-learning** increases theoretical knowledge but often fails to translate into improved **clinical practice** due to the gap between learning and bedside application.- **Antimicrobial stewardship** guidelines are better implemented through workflow integration rather than periodic mandatory training sessions.

Question 174: A 58-year-old woman with poorly controlled type 2 diabetes (HbA1c 98 mmol/mol) presents with a 24-hour history of rapidly progressive pain, swelling, and discolouration of her left foot following a minor injury 3 days ago. On examination, the foot is grossly swollen, dusky purple with areas of blistering, and there is crepitus on palpation. She appears unwell with temperature 38.9°C, pulse 118 bpm, blood pressure 98/62 mmHg. Blood tests show: WBC 22.4 × 10⁹/L, lactate 4.8 mmol/L, creatinine 156 μmol/L, CK 2,840 U/L. What is the most critical immediate antimicrobial therapy in addition to urgent surgical consultation?

A. Intravenous flucloxacillin 2g six-hourly and metronidazole 500mg eight-hourly
B. Intravenous piperacillin-tazobactam 4.5g eight-hourly, clindamycin 600mg six-hourly, and vancomycin 1g twelve-hourly (Correct Answer)
C. Intravenous co-amoxiclav 1.2g eight-hourly and ciprofloxacin 400mg twelve-hourly
D. Intravenous meropenem 1g eight-hourly and teicoplanin 400mg twelve-hourly
E. Intravenous ceftriaxone 2g daily and metronidazole 500mg eight-hourly

Explanation: ***Intravenous piperacillin-tazobactam 4.5g eight-hourly, clindamycin 600mg six-hourly, and vancomycin 1g twelve-hourly*** - This regimen provides comprehensive **broad-spectrum coverage** essential for necrotizing fasciitis, targeting **Gram-positive**, **Gram-negative**, **anaerobic**, and **MRSA** pathogens. - **Clindamycin** is crucial for its ability to inhibit **bacterial toxin production**, which is a significant factor in the rapid tissue destruction seen in necrotizing fasciitis. *Intravenous flucloxacillin 2g six-hourly and metronidazole 500mg eight-hourly* - This combination lacks adequate coverage for **Gram-negative bacteria** and **MRSA**, both of which are common in severe soft tissue infections, especially in diabetic patients. - **Flucloxacillin** primarily covers MSSA and Streptococcus but is insufficient for the broad range of potential pathogens in necrotizing fasciitis. *Intravenous co-amoxiclav 1.2g eight-hourly and ciprofloxacin 400mg twelve-hourly* - This regimen lacks reliable coverage for **MRSA** and may not be sufficient for severe **Pseudomonas aeruginosa** infections or certain resistant Gram-negative organisms. - The anti-toxin effect of **clindamycin** is also missing, which is important in necrotizing infections. *Intravenous meropenem 1g eight-hourly and teicoplanin 400mg twelve-hourly* - While **meropenem** provides excellent broad-spectrum Gram-positive, Gram-negative (including Pseudomonas), and anaerobic coverage, and **teicoplanin** covers MRSA, this regimen lacks the crucial **anti-toxin effect of clindamycin**. - The absence of clindamycin might compromise outcomes in severe necrotizing infections where toxin production plays a key role. *Intravenous ceftriaxone 2g daily and metronidazole 500mg eight-hourly* - This combination provides insufficient coverage for **MRSA** and has limited activity against some severe **Gram-positive infections** (e.g., requiring anti-toxin activity) and certain resistant Gram-negative bacteria. - **Ceftriaxone** alone does not offer the broad-spectrum coverage needed for polymicrobial necrotizing fasciitis, particularly for MRSA and some anaerobes.

Question 175: A 26-year-old man presents with a 4-day history of multiple painful pustular lesions on his forearms, chest, and back. He is an amateur rugby player and reports that several teammates have had similar skin problems. Examination reveals multiple 1-2 cm diameter lesions with surrounding erythema and central pustulation. Some lesions have yellow crusting. Temperature 37.4°C, otherwise systemically well. A swab from one lesion grows Staphylococcus aureus resistant to flucloxacillin but sensitive to erythromycin, doxycycline, and co-trimoxazole. What is the most appropriate management?

A. Oral flucloxacillin 1g four times daily for 7 days
B. Topical fusidic acid three times daily for 7 days
C. Oral doxycycline 100mg twice daily for 7 days and recommend decolonisation for close contacts (Correct Answer)
D. Intravenous vancomycin as inpatient due to MRSA infection
E. Oral erythromycin 500mg four times daily and advise wound care only

Explanation: ***Oral doxycycline 100mg twice daily for 7 days and recommend decolonisation for close contacts*** - The patient has **Community-Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA)**, evidenced by flucloxacillin resistance, and doxycycline is an appropriate oral antibiotic for such infections, as confirmed by sensitivity. - Given the cluster of cases in a rugby team, **decolonisation** of close contacts (e.g., with nasal mupirocin and chlorhexidine washes) is essential to prevent further transmission. *Oral flucloxacillin 1g four times daily for 7 days* - The culture results explicitly state the *Staphylococcus aureus* is **resistant to flucloxacillin**, making this antibiotic ineffective for treatment. - Using a resistant antibiotic would lead to treatment failure and potential worsening of the infection. *Topical fusidic acid three times daily for 7 days* - **Topical therapy** is generally insufficient for **multiple, widespread lesions** as seen on this patient's forearms, chest, and back. - In an **outbreak setting** with potentially systemic involvement (mild fever) and community spread, **oral antibiotics** are necessary for effective eradication and control. *Intravenous vancomycin as inpatient due to MRSA infection* - **IV vancomycin** is reserved for severe, invasive, or life-threatening MRSA infections, which is not indicated here as the patient is **systemically well**. - Outpatient management with effective oral antibiotics is appropriate for non-severe CA-MRSA skin and soft tissue infections. *Oral erythromycin 500mg four times daily and advise wound care only* - While sensitive to erythromycin, **macrolide resistance** can develop during treatment with *S. aureus*, making it a less reliable choice than doxycycline in many cases. - Advising **wound care only** is inadequate for widespread CA-MRSA infection and completely ignores the critical need for **decolonisation strategies** in a community outbreak.

Question 176: A hospital antimicrobial stewardship committee is evaluating the impact of a newly implemented antibiotic approval system for restricted antimicrobials. Six months after implementation, audit data shows: total antibiotic prescriptions reduced by 12%, restricted antibiotic use reduced by 35%, mean duration of therapy reduced from 8.2 to 6.4 days, but Clostridioides difficile infection rates increased from 2.1 to 3.8 per 10,000 bed-days. Hospital-acquired bacteraemia rates remain unchanged. What is the most appropriate interpretation of these findings?

A. The intervention is successful and should be continued without modification as the primary outcomes have improved
B. The increase in C. difficile infections is likely coincidental and unrelated to the antibiotic stewardship intervention
C. The intervention requires urgent review and possible modification, as the increase in C. difficile infections suggests unintended consequences that outweigh the benefits (Correct Answer)
D. The intervention should be discontinued immediately as any increase in healthcare-associated infections is unacceptable
E. The data is insufficient to draw conclusions and a further 12 months of data collection is required before making any changes

Explanation: ***The intervention requires urgent review and possible modification, as the increase in C. difficile infections suggests unintended consequences that outweigh the benefits*** - A significant increase in **Clostridioides difficile infection** (CDI) rates serves as a critical safety signal and a likely **unintended consequence** of the new stewardship policy. - While primary metrics like **duration of therapy** improved, the team must investigate if clinicians substituted restricted drugs with high-risk alternatives (e.g., fluoroquinolones) that increase **CDI risk**. *The intervention is successful and should be continued without modification as the primary outcomes have improved* - Success in stewardship is measured not just by **volume reduction**, but by overall patient safety and **clinical outcomes**. - Ignoring a nearly twofold increase in **CDI rates** constitutes a failure to respond to a major **healthcare-associated infection** alert. *The increase in C. difficile infections is likely coincidental and unrelated to the antibiotic stewardship intervention* - Changes in **antibiotic pressure** are the most significant modifiable risk factor for CDI, making a temporal association highly likely to be **causal**. - Assuming the increase is **coincidental** without a thorough investigation or root cause analysis is medically and administratively irresponsible. *The intervention should be discontinued immediately as any increase in healthcare-associated infections is unacceptable* - Complete **discontinuation** ignores the positive data, such as shorter **treatment durations** and reduced antibiotic overuse. - The appropriate response is **modification and optimization** rather than total abandonment of a program that has shown efficacy in other metrics. *The data is insufficient to draw conclusions and a further 12 months of data collection is required before making any changes* - Waiting an additional 12 months while **CDI rates** are rising poses an unacceptable risk to **patient safety**. - Six months of data showing a consistent upward trend in infections is sufficient to trigger a **quality improvement investigation**.

Question 177: A 34-year-old woman with a BMI of 38 kg/m² presents to the Emergency Department with a 3-day history of a painful, red, swollen area on the inner aspect of her right thigh. The affected area measures approximately 15 cm × 10 cm, is warm and tender with overlying shiny skin, but there is no fluctuance, crepitus, or systemic upset. Temperature 37.2°C, pulse 78 bpm, blood pressure 128/82 mmHg. What is the most appropriate immediate management according to current UK guidance?

A. Oral flucloxacillin 500mg four times daily and arrange follow-up in 48 hours (Correct Answer)
B. Incision and drainage under local anaesthetic in the Emergency Department
C. Intravenous flucloxacillin 2g four times daily and admit for observation
D. Oral co-amoxiclav 625mg three times daily and topical fusidic acid
E. Ultrasound imaging to exclude abscess formation before commencing treatment

Explanation: ***Oral flucloxacillin 500mg four times daily and arrange follow-up in 48 hours***- This patient presents with **uncomplicated cellulitis** (Eron Class I) as evidenced by the lack of **systemic upset**, fever, or unstable comorbidities. This warrants outpatient management.- According to current **UK guidelines** (e.g., NICE), first-line treatment for uncomplicated cellulitis in adults is oral **flucloxacillin** to target common Gram-positive pathogens like *Staphylococcus aureus* and *Streptococcus pyogenes*.*Incision and drainage under local anaesthetic in the Emergency Department*- **Incision and drainage** is the primary treatment for **abscesses**, which are characterized by **fluctuance** (a palpable collection of pus). The clinical description explicitly states there is **no fluctuance**.- Attempting to incise and drain **cellulitis** (diffuse soft tissue infection without pus collection) is inappropriate and can potentially worsen the infection or cause unnecessary tissue damage.*Intravenous flucloxacillin 2g four times daily and admit for observation*- **Intravenous antibiotics** and hospital admission are reserved for more severe cases of cellulitis, such as those with **systemic signs of infection** (e.g., high fever, rigors, hemodynamic instability), rapid progression, or failure of oral therapy (Eron Class II or higher).- This patient is **afebrile** and **hemodynamically stable**, indicating that outpatient oral treatment is appropriate and sufficient.*Oral co-amoxiclav 625mg three times daily and topical fusidic acid*- **Co-amoxiclav** (amoxicillin/clavulanic acid) has a broader spectrum, often reserved for cellulitis secondary to **animal/human bites**, facial cellulitis, or where atypical organisms are suspected, which is not indicated here.- **Topical fusidic acid** is ineffective for cellulitis, which is an infection of the deeper dermis and subcutaneous tissue, requiring systemic antibiotic penetration.*Ultrasound imaging to exclude abscess formation before commencing treatment*- While **ultrasound** can identify occult abscesses, it is generally **not necessary** to delay antibiotic treatment for imaging in a clinically clear case of uncomplicated cellulitis with **no signs of fluctuance**.- Clinical examination is typically sufficient for diagnosing uncomplicated cellulitis, and prompt initiation of **antibiotics** is crucial to prevent progression.

Question 178: According to the UK 'Start Smart - Then Focus' antimicrobial stewardship toolkit, which of the following constitutes a key component of the 'Review' decision at 48-72 hours?

A. Discontinue all antimicrobials if the patient is afebrile regardless of other clinical parameters
B. Assess clinical response, microbiology results, and markers of infection to make a documented decision to stop, switch, or continue antibiotics (Correct Answer)
C. Automatically extend treatment duration by another 48-72 hours if any inflammatory markers remain elevated
D. Switch all intravenous antibiotics to oral formulations if the patient can tolerate oral intake
E. Continue current antimicrobial regimen until completion of a minimum 7-day course

Explanation: ***Assess clinical response, microbiology results, and markers of infection to make a documented decision to stop, switch, or continue antibiotics***- The **'Focus'** element of the **'Start Smart - Then Focus'** toolkit mandates a formal review at **48-72 hours** to refine antimicrobial therapy based on evolving clinical and laboratory evidence.- This step ensures a **documented decision** is made among five clinical options: stop, switch (IV to oral), change (narrow/broaden), continue, or move to outpatient parenteral antibiotic therapy (OPAT).*Discontinue all antimicrobials if the patient is afebrile regardless of other clinical parameters*- Fever is only one clinical marker; the decision to stop must also consider **microbiology data**, physical exam findings, and the **site of infection**.- Stopping based solely on temperature ignores the risk of **relapse** or incomplete treatment of deep-seated infections.*Automatically extend treatment duration by another 48-72 hours if any inflammatory markers remain elevated*- Inflammatory markers like **CRP** or **procalcitonin** are non-specific and may remain elevated due to non-infectious inflammation or a lag in physiological recovery.- **Antimicrobial stewardship** discourages automatic extensions, favoring a holistic assessment over reliance on isolated laboratory values.*Switch all intravenous antibiotics to oral formulations if the patient can tolerate oral intake*- While **IV-to-oral switch** is a key component of the 'Review' phase, it is only *one* of the potential decisions, not the *sole* or *defining* component of the entire review process.- The 'Review' decision encompasses a broader assessment to determine whether to stop, switch, change, continue, or move to OPAT, making this option too narrow.*Continue current antimicrobial regimen until completion of a minimum 7-day course*- The 'Start Smart - Then Focus' toolkit emphasizes **individualized treatment duration** based on clinical response and microbiology, not arbitrary minimums.- Continuing for a fixed minimum course without re-evaluation contradicts the **stewardship principle** of optimizing duration to prevent resistance and adverse effects.

Question 179: A 72-year-old man with chronic obstructive pulmonary disease is admitted with an acute exacerbation and started on intravenous co-amoxiclav. On day 4, he develops profuse watery diarrhoea (8 episodes in 24 hours) with cramping abdominal pain. Temperature is 38.3°C, pulse 102 bpm, blood pressure 118/72 mmHg. Examination reveals a diffusely tender abdomen without peritonism. Blood tests show WBC 16.2 × 10⁹/L, CRP 145 mg/L, creatinine 142 μmol/L (baseline 98 μmol/L). According to UK antimicrobial stewardship principles, what is the most appropriate initial management?

A. Continue co-amoxiclav and add loperamide for symptomatic relief
B. Stop co-amoxiclav, send stool for Clostridioides difficile toxin, and start oral vancomycin empirically (Correct Answer)
C. Stop co-amoxiclav, send stool for culture, and await results before starting antibiotics
D. Continue co-amoxiclav and add oral metronidazole as prophylaxis
E. Switch co-amoxiclav to intravenous ciprofloxacin and add probiotics

Explanation: ***Stop co-amoxiclav, send stool for Clostridioides difficile toxin, and start oral vancomycin empirically*** - The patient's presentation with profuse watery diarrhoea, cramping abdominal pain, fever, significantly elevated **WBC (16.2 × 10⁹/L)**, high **CRP (145 mg/L)**, and **acute kidney injury (creatinine 142 μmol/L)**, occurring after **co-amoxiclav** use, is highly suggestive of **Clostridioides difficile infection (CDI)**. - UK antimicrobial stewardship principles mandate stopping the inciting antibiotic and initiating **oral vancomycin** empirically for suspected moderate to severe CDI while awaiting **C. difficile toxin** results, due to the high risk of complications. *Continue co-amoxiclav and add loperamide for symptomatic relief* - **Loperamide** is absolutely contraindicated in suspected or confirmed CDI as it can lead to **toxic megacolon** by reducing gut motility and prolonging toxin exposure. - Continuing **co-amoxiclav**, the suspected causative antibiotic, would perpetuate the dysbiosis and worsen the CDI. *Stop co-amoxiclav, send stool for culture, and await results before starting antibiotics* - While stopping the antibiotic is correct, **stool culture** is not the primary diagnostic test for CDI; a specific **Clostridioides difficile toxin assay** is required. - Awaiting results before starting treatment in a patient with significant systemic signs of infection (fever, elevated WBC, acute kidney injury) and severe diarrhoea risks rapid clinical deterioration and adverse outcomes. *Continue co-amoxiclav and add oral metronidazole as prophylaxis* - **Metronidazole** is no longer the first-line treatment for CDI in the UK, especially for moderate to severe cases, and is never used as prophylaxis for suspected CDI. - Continuing the **co-amoxiclav** directly contributes to the pathogenesis of CDI and prevents resolution of the gut flora imbalance. *Switch co-amoxiclav to intravenous ciprofloxacin and add probiotics* - **Ciprofloxacin**, a fluoroquinolone, is among the antibiotics with the highest risk for inducing and exacerbating **Clostridioides difficile infection**. - There is currently insufficient evidence to recommend **probiotics** for the treatment of active CDI, particularly in severe cases.

Question 180: A hospital audit reveals that 75% of patients receiving IV antibiotics for community-acquired pneumonia have not had renal function checked in the 48 hours prior to prescribing, and 40% of prescriptions do not document stop dates or review dates. The antimicrobial stewardship team proposes implementing mandatory electronic prescribing fields to address these gaps. Which of the following represents the most significant potential benefit of this intervention from a patient safety and antimicrobial stewardship perspective?

A. Improved documentation will reduce medicolegal risk for prescribing clinicians
B. Mandatory fields ensure appropriate dose adjustment and prompt review, reducing toxicity and unnecessary antibiotic duration (Correct Answer)
C. Electronic prescribing creates an audit trail for investigating prescribing errors retrospectively
D. Completion rates for mandatory fields provide data for clinician performance appraisal
E. Standardized prescribing reduces variation between departments and improves consistency

Explanation: ***Mandatory fields ensure appropriate dose adjustment and prompt review, reducing toxicity and unnecessary antibiotic duration***- The mandatory field for **renal function checks** directly facilitates **dose adjustment** for renally-excreted antibiotics, preventing **drug toxicity** and improving patient safety.- Mandatory **stop or review dates** are crucial for ensuring **timely discontinuation** or de-escalation of antibiotics, which directly combats **antimicrobial resistance** and optimizes therapy duration.*Improved documentation will reduce medicolegal risk for prescribing clinicians*- While better documentation offers **medicolegal protection**, this is a secondary benefit and not the primary driver for **antimicrobial stewardship** which focuses on clinical outcomes and public health.- The intervention aims to improve direct patient care and safety, rather than solely reducing **clinician liability**.*Electronic prescribing creates an audit trail for investigating prescribing errors retrospectively*- **Retrospective audit trails** provide data for system learning, but the core benefit of mandatory fields is **prospective error prevention** at the point of prescribing.- The intervention directly addresses the identified gaps by preventing inappropriate dosing and prolonged treatment *before* they occur.*Completion rates for mandatory fields provide data for clinician performance appraisal*- Using completion rates for **performance appraisal** is an administrative outcome, separate from the direct **patient safety** and **antimicrobial stewardship** benefits of the intervention itself.- The primary goal is improving actual patient care processes and outcomes, not merely tracking clinician compliance for evaluation.*Standardized prescribing reduces variation between departments and improves consistency*- While **standardization** is a goal, the most significant benefit here stems from the *specific content* of the mandatory fields, enforcing critical **safety checks** (renal dosing, duration).- The benefit is not just general consistency, but targeted improvement in safe and effective antibiotic prescribing practices.

Question 181: A 44-year-old woman with rheumatoid arthritis on methotrexate 15mg weekly and prednisolone 10mg daily presents with a 2-day history of a painful, rapidly expanding erythematous area on her right thigh. The area is warm, tender, has indistinct margins, and measures approximately 15cm × 10cm. There is associated oedema but no crepitus or bullae. Temperature is 38.7°C, HR 104/min, BP 118/76 mmHg, RR 18/min. Blood tests show WCC 16.8 × 10⁹/L, CRP 178 mg/L, lactate 1.8 mmol/L. Which of the following represents the most appropriate management plan?

A. Commence oral flucloxacillin 1g four times daily and review in 48 hours if not improving
B. Admit for IV flucloxacillin 2g four times daily and regular clinical review (Correct Answer)
C. Arrange urgent surgical review for necrotizing fasciitis and commence IV clindamycin and benzylpenicillin
D. Admit for IV vancomycin and piperacillin-tazobactam pending blood culture results
E. Admit for IV flucloxacillin and temporarily discontinue methotrexate and prednisolone

Explanation: ***Admit for IV flucloxacillin 2g four times daily and regular clinical review*** - This patient presents with **cellulitis** and **systemic inflammatory response syndrome (SIRS)** (fever, tachycardia, leukocytosis), and being **immunocompromised** (methotrexate and steroids) necessitates hospital admission for **intravenous antibiotics**. - **Flucloxacillin** is the appropriate **first-line empirical treatment** for suspected **streptococcal** and **staphylococcal** skin and soft tissue infections, the most common causes of cellulitis. *Commence oral flucloxacillin 1g four times daily and review in 48 hours if not improving* - **Oral antibiotics** are inappropriate in this case due to the presence of clear **systemic features** (fever 38.7°C, tachycardia, raised inflammatory markers) and the patient's **immunosuppressed status**. - Delaying hospital-level care for 48 hours in a patient with **SIRS** and rapidly expanding erythema increases the risk of **sepsis progression** and poor clinical outcomes. *Arrange urgent surgical review for necrotizing fasciitis and commence IV clindamycin and benzylpenicillin* - While a serious consideration, the absence of key features such as **crepitus**, **bullae**, skin necrosis, and a relatively normal **lactate** (1.8 mmol/L) makes **necrotizing fasciitis** less likely than simple cellulitis. - The pain is described as tender but not

Question 182: A hospital trust antimicrobial stewardship committee is evaluating a new point-of-care C-reactive protein (CRP) testing device for use in primary care to guide antibiotic prescribing decisions for respiratory tract infections. Initial pilot data shows a 30% reduction in antibiotic prescribing rates. However, the device costs £15,000 per unit plus £3 per test. Which of the following parameters would be MOST important to evaluate when determining whether this intervention represents good antimicrobial stewardship practice from a healthcare system perspective?

A. Comparison of antibiotic prescribing rates before and after intervention in pilot practices
B. Patient satisfaction scores regarding consultation length and shared decision-making
C. Cost-effectiveness analysis including prevented antibiotic courses, resistance reduction, and adverse events avoided (Correct Answer)
D. Sensitivity and specificity of CRP testing compared to clinical diagnosis for bacterial infections
E. Number of hospital admissions for respiratory infections in areas using the device

Explanation: ***Cost-effectiveness analysis including prevented antibiotic courses, resistance reduction, and adverse events avoided*** - A **cost-effectiveness analysis** is crucial for a **healthcare system perspective** as it evaluates if the device's significant cost is justified by the clinical and economic benefits of reduced antibiotic use. - This analysis quantifies the **return on investment** by considering averted antibiotic courses, reduced **antimicrobial resistance**, and avoided adverse events like **C. difficile infection**. *Comparison of antibiotic prescribing rates before and after intervention in pilot practices* - While a **30% reduction** in prescribing is a positive indicator, this metric alone does not encompass the full **healthcare system impact** or cost-effectiveness of the intervention. - It does not account for the **cost of the device** or the potential long-term savings associated with reduced resistance and avoided complications. *Patient satisfaction scores regarding consultation length and shared decision-making* - **Patient satisfaction** is an important aspect of quality care but is a secondary outcome in evaluating the primary objectives of **antimicrobial stewardship** from a system perspective. - It does not directly assess the **economic viability** of the intervention or its direct impact on **public health challenges** like resistance. *Sensitivity and specificity of CRP testing compared to clinical diagnosis for bacterial infections* - These **diagnostic accuracy** parameters are essential for validating the device's technical reliability but do not address the broader **healthcare system implications** of its implementation. - High accuracy is a prerequisite, but it doesn't quantify the **cost-benefit ratio** or the population-level reduction in **antimicrobial resistance**. *Number of hospital admissions for respiratory infections in areas using the device* - While relevant for **patient safety** and resource use, changes in hospital admissions might be too distal or multifactorial to be the *most* important direct measure of **primary care antimicrobial stewardship** success. - This metric does not directly evaluate the **financial sustainability** or the specific impact on **antibiotic resistance** driven by primary care prescribing patterns.

Question 183: A 37-year-old man who works as a fishmonger presents with a 5-day history of a violaceous, bullous lesion on his left hand that started after sustaining a minor cut while handling shellfish. The lesion has progressed rapidly with surrounding oedema and erythema extending to the wrist. He reports feeling systemically unwell with fever. He has a history of chronic liver disease secondary to alcohol excess. Blood cultures have been sent. What is the most likely causative organism and the most appropriate empirical antibiotic therapy?

A. Staphylococcus aureus; flucloxacillin and doxycycline
B. Vibrio vulnificus; doxycycline and ceftriaxone (Correct Answer)
C. Erysipelothrix rhusiopathiae; benzylpenicillin alone
D. Aeromonas hydrophila; ciprofloxacin and metronidazole
E. Mycobacterium marinum; clarithromycin and rifampicin

Explanation: ***Vibrio vulnificus; doxycycline and ceftriaxone*** - The patient's history of **shellfish handling**, a **minor cut**, rapid progression of a **violaceous, bullous lesion**, **systemic illness (fever)**, and underlying **chronic liver disease** are classic features of severe *Vibrio vulnificus* infection. - Empiric treatment for severe *Vibrio vulnificus* infection, especially in high-risk patients like those with liver disease, requires a combination of **doxycycline** and a **third-generation cephalosporin** (e.g., ceftriaxone) due to the rapid progression and high mortality. *Staphylococcus aureus; flucloxacillin and doxycycline* - While *S. aureus* can cause cellulitis and skin infections, it is less likely to produce rapidly spreading **hemorrhagic bullae** specifically linked to marine exposure and underlying liver disease. - Doxycycline is not a first-line agent for typical *S. aureus* skin infections, and flucloxacillin alone would not adequately cover *Vibrio* if it were the cause. *Erysipelothrix rhusiopathiae; benzylpenicillin alone* - *Erysipelothrix rhusiopathiae* is associated with fish handling and causes **erysipeloid**, a localized, violaceous lesion, but it typically does **not cause systemic symptoms** or rapid bullous necrosis. - This infection is generally milder and more localized, lacking the aggressive, life-threatening systemic features seen in this patient with chronic liver disease. *Aeromonas hydrophila; ciprofloxacin and metronidazole* - *Aeromonas hydrophila* infections are usually associated with **freshwater exposure** or contaminated soil, not typically saltwater shellfish or marine environments like *Vibrio*. - While it can cause aggressive soft tissue infections, the specific epidemiological and clinical context (shellfish exposure, liver disease, bullous lesions) points more strongly to *Vibrio vulnificus*. *Mycobacterium marinum; clarithromycin and rifampicin* - *Mycobacterium marinum* causes **fish tank granuloma** or **swimming pool granuloma**, which presents as chronic, indolent nodular or ulcerative lesions, often with a sporotrichoid pattern of spread. - This infection has a **subacute to chronic course** (weeks to months) and does not typically present as an **acute, rapidly progressing, systemic, bullous illness** within 5 days.

Question 184: A 49-year-old woman undergoes wide local excision of breast cancer with axillary lymph node clearance. She receives cefuroxime 1.5g IV as surgical prophylaxis at induction. Post-operatively, she remains apyrexial and well with normal inflammatory markers. The surgical team plans to prescribe 5 days of prophylactic oral co-amoxiclav citing the extent of axillary dissection. According to antimicrobial stewardship principles and evidence-based practice, what is the most appropriate course of action?

A. Agree with post-operative antibiotic prophylaxis for 5 days given the extent of surgery
B. Recommend extending to 7 days of antibiotics to cover until drain removal
C. Advise against post-operative antibiotics as single-dose prophylaxis is sufficient for clean surgery (Correct Answer)
D. Prescribe 3 days of antibiotics as a compromise between no antibiotics and 5 days
E. Recommend IV antibiotics for 24 hours post-operatively before switching to oral

Explanation: ***Advise against post-operative antibiotics as single-dose prophylaxis is sufficient for clean surgery***- Breast cancer surgery with axillary clearance is classified as **clean surgery**, for which a **single dose** of perioperative antibiotic prophylaxis (like the cefuroxime given) is sufficient according to evidence-based guidelines (e.g., NICE, WHO).- Continuing antibiotics post-operatively for clean surgery violates **antimicrobial stewardship principles** and increases risks such as **antimicrobial resistance**, **Clostridioides difficile infection**, and side effects without providing additional benefit.*Agree with post-operative antibiotic prophylaxis for 5 days given the extent of surgery*- The **extent of axillary dissection** in this context does not transform a clean surgical procedure into one requiring prolonged post-operative antibiotic prophylaxis.- Routine extended post-operative antibiotics for clean surgery do not reduce **surgical site infection** rates and promote antibiotic resistance, contravening **antimicrobial stewardship**.*Recommend extending to 7 days of antibiotics to cover until drain removal*- The **presence of surgical drains** alone is not an indication for extending prophylactic antibiotics beyond the initial perioperative dose in clean surgery.- Prolonged antibiotic use based on drain duration is an **outdated practice** that contributes to the emergence of **antibiotic-resistant bacteria**.*Prescribe 3 days of antibiotics as a compromise between no antibiotics and 5 days*- Prescribing antibiotics based on a **compromise** rather than evidence-based guidelines is inappropriate and goes against best **antimicrobial stewardship** practices.- There is no clinical evidence to support a **3-day course** of post-operative prophylactic antibiotics for clean breast surgery with axillary clearance.*Recommend IV antibiotics for 24 hours post-operatively before switching to oral*- Extending prophylactic antibiotics for **24 hours** post-operatively, whether IV or oral, offers no proven additional benefit over a single induction dose for this type of surgery.- This approach unnecessarily increases **healthcare costs**, patient burden, and the potential for **adverse drug reactions** and **catheter-related complications**.

Question 185: A hospital antimicrobial stewardship team reviews prescribing data for urinary tract infections in elderly patients. They identify that 60% of patients aged over 75 years with asymptomatic bacteriuria (positive urine culture without urinary symptoms) are receiving antibiotic treatment. The team implements an intervention targeting this practice. Which of the following would represent the most effective stewardship intervention to address this issue?

A. Implement automatic laboratory reporting of urine cultures with educational comments about treatment indications (Correct Answer)
B. Restrict access to urine culture requests to consultant-level staff only
C. Introduce mandatory infectious diseases consultation before treating any positive urine culture in elderly patients
D. Automatically prescribe nitrofurantoin for all positive urine cultures in elderly patients unless contraindicated
E. Remove urine culture as an available investigation in patients over 75 years without catheter

Explanation: ***Implement automatic laboratory reporting of urine cultures with educational comments about treatment indications*** - This approach is a **point-of-care intervention**, providing immediate, evidence-based guidance to the prescriber at the time of result interpretation. - It directly addresses the misinterpretation of **asymptomatic bacteriuria** by educating staff that treatment is generally not indicated in the absence of symptoms, thus reducing inappropriate antibiotic use. *Restrict access to urine culture requests to consultant-level staff only* - This creates an **unnecessary administrative barrier** that could delay the diagnosis and treatment of genuine, symptomatic urinary tract infections in elderly patients. - It fails to educate prescribers on the appropriate management of **asymptomatic bacteriuria** and is an inefficient method to curb inappropriate prescribing. *Introduce mandatory infectious diseases consultation before treating any positive urine culture in elderly patients* - This intervention is **resource-intensive** and **impractical** for a common finding like bacteriuria, potentially overwhelming ID services and causing significant delays in patient care. - While valuable for complex cases, making it mandatory for every positive culture is not a scalable or efficient **antimicrobial stewardship strategy** for routine practice. *Automatically prescribe nitrofurantoin for all positive urine cultures in elderly patients unless contraindicated* - This directly violates **antimicrobial stewardship principles** by promoting the widespread, often inappropriate, treatment of **asymptomatic bacteriuria**, which drives antibiotic resistance. - It bypasses essential **clinical judgment**, failing to differentiate between colonization and true infection, and increases the risk of adverse drug events. *Remove urine culture as an available investigation in patients over 75 years without catheter* - This extreme measure would prevent the diagnosis of legitimate **symptomatic urinary tract infections** and **urosepsis** in elderly patients, posing significant risks to patient safety. - Effective stewardship focuses on **optimizing the interpretation and use of diagnostic tests**, not eliminating essential tools, especially when the issue is misapplication of results.

Question 186: A 54-year-old man with morbid obesity (BMI 42 kg/m²) undergoes emergency laparotomy for perforated sigmoid diverticulitis. He receives appropriate intraoperative antibiotic prophylaxis with co-amoxiclav 1.2g IV. The operation lasts 4.5 hours. According to antimicrobial stewardship principles for surgical prophylaxis, which of the following represents best practice for intraoperative antibiotic administration?

A. No further intraoperative doses needed; start therapeutic antibiotics post-operatively
B. Administer a second dose of co-amoxiclav 1.2g IV after 3-4 hours during surgery (Correct Answer)
C. Continue co-amoxiclav infusion throughout surgery and for 24 hours post-operatively
D. Increase initial prophylactic dose to co-amoxiclav 2.4g IV but no repeat dosing
E. Add gentamicin 5mg/kg IV intraoperatively due to prolonged surgical time

Explanation: ***Administer a second dose of co-amoxiclav 1.2g IV after 3-4 hours during surgery*** - Intraoperative **repeat dosing** is recommended when the procedure duration exceeds **two half-lives** of the antibiotic or if there is significant blood loss (>1.5L). - Since **co-amoxiclav** has a half-life of approximately 1 hour, a 4.5-hour surgery requires a second dose to maintain **minimum inhibitory concentrations (MIC)** in the tissues. *No further intraoperative doses needed; start therapeutic antibiotics post-operatively* - While the patient will eventually need **therapeutic antibiotics** for perforated diverticulitis, intraoperative coverage must remain adequate to prevent **surgical site infection (SSI)**. - Failing to repeat the dose during a long surgery leaves the patient with **sub-therapeutic levels** during the most critical period of contamination. *Continue co-amoxiclav infusion throughout surgery and for 24 hours post-operatively* - Antimicrobial stewardship principles emphasize that **prophylaxis** should generally be limited to a single dose or a 24-hour window, but **continuous infusion** is not standard practice for co-amoxiclav. - Extending the duration unnecessarily increases the risk of side effects like **Clostridioides difficile** infection and promotes **antimicrobial resistance**. *Increase initial prophylactic dose to co-amoxiclav 2.4g IV but no repeat dosing* - While **morbid obesity (BMI >40)** may justify a higher initial dose, it does not compensate for the **pharmacokinetic decay** of the drug over 4.5 hours. - A higher starting dose will still fall below the **therapeutic threshold** if the procedure lasts significantly longer than the drug's half-life. *Add gentamicin 5mg/kg IV intraoperatively due to prolonged surgical time* - Adding a different class like **gentamicin** is not a substitute for maintaining the levels of the primary agent used for **prophylaxis**. - Unnecessary addition of broad-spectrum agents increases the risk of **nephrotoxicity** and does not address the lack of **beta-lactam coverage** caused by the delay.

Question 187: A 28-year-old healthcare worker develops a paronychia following a needlestick injury while removing an IV cannula from a patient 4 days ago. She has increasing pain, erythema, and swelling around the right index fingernail with purulent discharge. There is no lymphangitis or systemic features. The source patient is known to have hepatitis B infection (HBsAg positive) but is HIV and hepatitis C negative. What is the most appropriate management of the paronychia?

A. Incision and drainage with oral flucloxacillin 500mg four times daily
B. Oral co-amoxiclav 625mg three times daily without drainage
C. Incision and drainage alone without antibiotic therapy (Correct Answer)
D. IV vancomycin pending wound culture results
E. Topical mupirocin ointment three times daily for 7 days

Explanation: ***Incision and drainage alone without antibiotic therapy*** (Keep the correct option at the top and the incorrect options in the order they are provided in the input) - For an acute paronychia with a **purulent collection** or discharge, physical **drainage** is the definitive treatment to remove the source of infection. - Professional guidelines and **antimicrobial stewardship** suggest that antibiotics are not required for localized infections unless there is spreading **cellulitis**, **lymphangitis**, or systemic symptoms. *Incision and drainage with oral flucloxacillin 500mg four times daily* - Inclusion of **flucloxacillin** is unnecessary in this case because the patient lacks **systemic features** or evidence of spreading soft tissue infection. - While flucloxacillin covers **Staphylococcus aureus**, adding it to a successfully drained localized abscess does not significantly improve healing rates. *Oral co-amoxiclav 625mg three times daily without drainage* - Antibiotics alone are often ineffective for **walled-off collections** like an abscess or paronychia, as they cannot penetrate the purulent cavity effectively. - Management must prioritize **mechanical evacuation** of the pus rather than systemic antimicrobial therapy. *IV vancomycin pending wound culture results* - **Intravenous vancomycin** is an overly aggressive intervention for a localized fingertip infection in a systemically well patient. - This treatment is reserved for candidates with suspected **MRSA** or severe, deep-space infections showing signs of **sepsis**. *Topical mupirocin ointment three times daily for 7 days* - **Topical antibiotics** like mupirocin are suitable for very early, superficial infections or impetigo, but cannot reach the deeper tissue in an established **abscess**. - Once **purulent discharge** and significant swelling are present, topical agents are insufficient compared to definitive **surgical drainage**.

Question 188: A 66-year-old woman with type 2 diabetes and peripheral neuropathy presents with a painless ulcer on the plantar surface of her right foot present for 3 weeks. The ulcer is 3cm diameter, extends to tendon level, and has purulent discharge with surrounding erythema extending 4cm beyond the ulcer margin. There is crepitus on palpation. Temperature is 38.9°C, HR 108/min, BP 128/82 mmHg. X-ray shows soft tissue gas but no obvious bony involvement. What is the most appropriate immediate management?

A. Commence oral co-amoxiclav and arrange outpatient podiatry review within 1 week
B. Obtain wound swab for culture and commence oral antibiotics pending results
C. Arrange urgent surgical review for debridement and commence broad-spectrum IV antibiotics (Correct Answer)
D. Commence IV flucloxacillin and arrange MRI foot within 48 hours
E. Apply negative pressure wound therapy and commence oral metronidazole

Explanation: ***Arrange urgent surgical review for debridement and commence broad-spectrum IV antibiotics*** - The presence of **crepitus** and **soft tissue gas** on X-ray in a diabetic patient, along with systemic signs of infection (fever, tachycardia), are highly indicative of a **necrotizing soft tissue infection (NSTI)**, a surgical emergency. - Immediate and aggressive management involves **urgent surgical debridement** to remove necrotic tissue and **broad-spectrum intravenous antibiotics** to cover the polymicrobial flora, including anaerobes, typically seen in such severe infections. *Commence oral co-amoxiclav and arrange outpatient podiatry review within 1 week* - **Oral antibiotics** are inadequate for a severe, deep-seated infection with systemic symptoms and evidence of tissue gas, which demands immediate, high-dose intravenous therapy. - Arranging an **outpatient review** within a week is dangerously delayed for a rapidly progressing infection that requires emergency hospitalization and intervention to prevent sepsis, limb loss, or mortality. *Obtain wound swab for culture and commence oral antibiotics pending results* - **Wound swabs** are often contaminated with superficial flora and may not accurately reflect the deep tissue pathogens; deep tissue cultures obtained during surgery are more reliable. - Delaying definitive treatment for culture results while only initiating **oral antibiotics** is inappropriate and unsafe given the clinical signs of a severe, potentially necrotizing infection. *Commence IV flucloxacillin and arrange MRI foot within 48 hours* - **Flucloxacillin** provides narrow-spectrum coverage primarily against Gram-positive bacteria, lacking essential coverage for common Gram-negative and anaerobic pathogens in diabetic foot infections with gas. - While MRI is excellent for evaluating **osteomyelitis**, its use should not delay the critical **surgical debridement** required for a necrotizing infection, which is the immediate priority. *Apply negative pressure wound therapy and commence oral metronidazole* - **Negative pressure wound therapy (NPWT)** is typically reserved for wound bed preparation and closure *after* the acute infection has been surgically controlled and necrotic tissue removed, not as an initial treatment for active infection with crepitus. - **Oral metronidazole** alone is insufficient; it only covers anaerobes and fails to address the broad spectrum of aerobic Gram-positive and Gram-negative bacteria often involved in deep diabetic foot infections.

Question 189: A 33-year-old man who recently started attending a gym presents with multiple painful, erythematous pustules and small abscesses on his buttocks and thighs. He reports several gym members have had similar lesions. On examination, there are multiple follicular-based pustules with surrounding erythema, some with small fluctuant areas. Temperature is 37.5°C. What is the most likely causative organism and most appropriate initial management?

A. Candida albicans; prescribe topical clotrimazole cream
B. Staphylococcus aureus; prescribe oral flucloxacillin and advise on hygiene measures (Correct Answer)
C. Pseudomonas aeruginosa; prescribe oral ciprofloxacin
D. Streptococcus pyogenes; prescribe oral phenoxymethylpenicillin
E. Herpes simplex virus; prescribe oral aciclovir

Explanation: ***Staphylococcus aureus; prescribe oral flucloxacillin and advise on hygiene measures*** - The clinical presentation of **follicular-based pustules** and abscesses (furunculosis) in a gym setting is highly characteristic of **Staphylococcus aureus** infection, commonly spread via shared equipment. - **Oral flucloxacillin** is the gold-standard treatment for staphylococcal skin infections, and **hygiene measures** are essential to prevent outbreaks and recurrence. *Candida albicans; prescribe topical clotrimazole cream* - **Candida** typically presents as **satellite lesions** in intertriginous (skin-fold) areas, rather than primary follicular pustules on the thighs. - This patient's presentation and epidemiological link to gym members favor a **bacterial** over a fungal etiology. *Pseudomonas aeruginosa; prescribe oral ciprofloxacin* - Known as **"hot tub folliculitis,"** this usually presents as an itchy rash after exposure to contaminated water rather than deep, painful abscesses. - **Pseudomonas** folliculitis is often self-limiting and does not typically require **ciprofloxacin** unless the patient is immunocompromised or has systemic symptoms. *Streptococcus pyogenes; prescribe oral phenoxymethylpenicillin* - While a common skin pathogen, **Streptococcus pyogenes** more frequently causes spreading **cellulitis** or **erysipelatous** plaques rather than discrete follicular-based pustules. - **Phenoxymethylpenicillin** lacks sufficient coverage for **Staphylococcus aureus**, which is the more likely culprit for furunculosis. *Herpes simplex virus; prescribe oral aciclovir* - **HSV** infections typically present as **grouped vesicles** on an erythematous base rather than widespread pustules and fluctuant abscesses. - Viral folliculitis is less common than bacterial in a gym outbreak and would not respond to the high-temperature **fluctuance** described here.

Question 190: A 71-year-old man with chronic kidney disease stage 4 (eGFR 22 mL/min/1.73m²) develops cellulitis of the left lower leg. He weighs 68kg and has no known drug allergies. The treating physician plans to prescribe oral flucloxacillin. According to antimicrobial stewardship principles and safe prescribing practices, which of the following represents the most appropriate approach?

A. Prescribe standard dose flucloxacillin 1g four times daily without adjustment (Correct Answer)
B. Reduce flucloxacillin dose to 250mg four times daily due to renal impairment
C. Switch to oral doxycycline 200mg loading then 100mg daily due to renal safety profile
D. Admit for intravenous vancomycin with therapeutic drug monitoring
E. Prescribe oral clarithromycin 500mg twice daily to avoid renal complications

Explanation: ***Prescribe standard dose flucloxacillin 1g four times daily without adjustment***- Flucloxacillin is primarily cleared via the **hepatic** route, and therefore, **renal impairment** typically does not necessitate **dose adjustment**.- Maintaining the **standard dose** ensures optimal **therapeutic efficacy** against common cellulitis pathogens like **Staphylococcus aureus** and **Streptococcus pyogenes**, aligning with **antimicrobial stewardship** principles.*Reduce flucloxacillin dose to 250mg four times daily due to renal impairment*- Unnecessary dose reduction based on renal function for a hepatically metabolized drug would result in **subtherapeutic drug levels**.- This could lead to **treatment failure**, persistent infection, and potentially contribute to the development of **antimicrobial resistance**.*Switch to oral doxycycline 200mg loading then 100mg daily due to renal safety profile*- Although **doxycycline** is safe in renal impairment, it is not the first-line choice for typical cellulitis when an appropriate **narrow-spectrum penicillin** can be used.- Flucloxacillin is preferred for its targeted activity against the likely causative organisms of cellulitis, representing better **antimicrobial stewardship**.*Admit for intravenous vancomycin with therapeutic drug monitoring*- **Intravenous vancomycin** is generally reserved for severe infections, suspected **MRSA**, or patients unable to tolerate oral therapy, none of which are indicated here.- Uncomplicated cellulitis can often be safely and effectively managed with **oral antibiotics** in an outpatient setting, reducing hospitalizations.*Prescribe oral clarithromycin 500mg twice daily to avoid renal complications*- **Clarithromycin** is typically considered as an alternative for patients with a confirmed **penicillin allergy**, which is not present in this case.- Using a **macrolide** when a safe and effective **narrow-spectrum penicillin** is available is suboptimal for **antimicrobial stewardship** and can promote broader resistance.

Question 191: A 45-year-old woman with well-controlled type 2 diabetes presents with a superficial surgical site infection following elective laparoscopic cholecystectomy 5 days ago. The wound shows mild erythema extending 2cm around the incision site with serous discharge but no purulence, fluctuance, or systemic features. Temperature is 37.3°C and inflammatory markers are mildly elevated (WCC 10.8 × 10⁹/L, CRP 35 mg/L). What is the most appropriate initial management?

A. Prescribe oral flucloxacillin 500mg four times daily for 7 days
B. Arrange wound swab and commence oral co-amoxiclav pending results
C. Open the wound, perform wound care, and review in 48 hours without antibiotics (Correct Answer)
D. Admit for intravenous antibiotics due to diabetic status
E. Prescribe topical fusidic acid cream twice daily for 5 days

Explanation: ***Open the wound, perform wound care, and review in 48 hours without antibiotics*** - For a **superficial surgical site infection (SSI)** showing only mild, localized erythema and serous discharge, *without* features like **purulence**, **fluctuance**, or **systemic illness** (normal temperature, mildly elevated inflammatory markers), local wound management is the appropriate first step. - This involves **opening the wound** to facilitate drainage of any accumulated fluid, followed by routine **wound care**. Antibiotics are typically not required unless there are clear signs of **spreading cellulitis** or systemic involvement. *Prescribe oral flucloxacillin 500mg four times daily for 7 days* - **Empirical oral antibiotics** are generally unwarranted for minor, superficial SSIs that do not exhibit significant bacterial invasion, such as extensive **cellulitis** (erythema >5cm), pus formation, or features of **systemic inflammatory response syndrome (SIRS)**. - Adhering to **antibiotic stewardship** guidelines, systemic antibiotics should be withheld for simple localized infections effectively managed by local measures, to prevent the emergence of **antibiotic resistance**. *Arrange wound swab and commence oral co-amoxiclav pending results* - **Wound swabs** from superficial infections often yield skin commensals and can lead to unnecessary antibiotic prescriptions; they are best reserved for severe, deep, or unresponsive infections, or when atypical pathogens are suspected. - **Co-amoxiclav** is a broad-spectrum antibiotic, which is inappropriate for a localized, superficial infection manageable with simple mechanical interventions, contributing to the development of **antimicrobial resistance**. *Admit for intravenous antibiotics due to diabetic status* - Admission for **intravenous antibiotics** is typically reserved for severe infections, deep-seated abscesses, or patients displaying significant **systemic compromise** or rapidly deteriorating clinical status, none of which are evident in this case. - Although diabetes is a risk factor for infections, the patient's condition is described as **well-controlled**, and the infection remains superficial without any signs of **sepsis** or widespread involvement, making inpatient IV antibiotics unnecessary. *Prescribe topical fusidic acid cream twice daily for 5 days* - **Topical antibiotics** have limited effectiveness in treating surgical site infections as they often lack sufficient penetration into the wound bed to eradicate deep-seated bacteria. - The widespread use of topical agents like **fusidic acid** is a significant driver of **antibiotic resistance**, particularly in common skin pathogens such as **Staphylococcus aureus**.

Question 192: A 62-year-old woman is admitted with severe community-acquired pneumonia and started on intravenous co-amoxiclav and clarithromycin. Blood and sputum cultures are sent on admission. At 72 hours, she has clinically improved with reduced oxygen requirements, and cultures remain negative. Temperature is 37.1°C, respiratory rate 16/min, oxygen saturation 96% on 2L/min oxygen. Which antimicrobial stewardship principle should guide the next management decision?

A. Continue current IV antibiotics until day 7 to complete standard pneumonia course
B. Switch to oral antibiotics and consider early discharge with community follow-up (Correct Answer)
C. Stop all antibiotics immediately as cultures are negative
D. Add intravenous levofloxacin for broader atypical coverage
E. Continue IV antibiotics until all inflammatory markers normalize

Explanation: ***Switch to oral antibiotics and consider early discharge with community follow-up*** - This patient meets criteria for an **IV-to-oral switch (IVOS)**, as she is clinically stable, improving, and able to tolerate oral intake at the 72-hour review. - Transitioning to oral therapy reduces the risk of **cannula-associated infections**, lowers healthcare costs, and promotes earlier patient mobilization and **discharge**. *Continue current IV antibiotics until day 7 to complete standard pneumonia course* - Prolonged **intravenous therapy** after clinical stabilization increases the risk of **phlebitis** and hospital-acquired complications without providing additional clinical benefit. - Antimicrobial stewardship guidelines advocate for **early de-escalation** rather than adhering to a fixed IV duration when the patient is suitable for oral medication. *Stop all antibiotics immediately as cultures are negative* - A **negative culture** in community-acquired pneumonia does not rule out bacterial infection, as many causative organisms are difficult to grow or are suppressed by early antibiotic therapy. - Stopping treatment prematurely before completing a **standard course** (typically 5 days for moderate pneumonia) risks a clinical **relapse** or treatment failure. *Add intravenous levofloxacin for broader atypical coverage* - The patient is already showing significant **clinical improvement**, indicating that the current regimen of co-amoxiclav and clarithromycin is effectively treating the pathogens. - Adding a **fluoroquinolone** without clinical necessity represents inappropriate **antimicrobial escalation**, increasing the risk of side effects like C. difficile infection or antibiotic resistance. *Continue IV antibiotics until all inflammatory markers normalize* - Treatment decisions should be guided by **clinical stability** (temperature, heart rate, respiration) rather than waiting for laboratory **inflammatory markers** like CRP to fully normalize. - **CRP levels** often lag behind clinical improvement, and waiting for them to reach baseline would result in unnecessary, prolonged **intravenous antibiotic** exposure.

Question 193: A hospital antimicrobial stewardship team is developing a policy for empirical antibiotic therapy. According to UK antimicrobial stewardship principles, which of the following timeframes represents the recommended maximum duration before antibiotic therapy should be reviewed and either stopped, switched to oral therapy, or continued based on clinical evidence?

A. 24 hours after initiation
B. 48-72 hours after initiation (Correct Answer)
C. 5 days after initiation
D. 7 days after initiation
E. When microbiology results become available

Explanation: ***48-72 hours after initiation*** - According to the **'Start Smart - Then Focus'** toolkit, all empirical antibiotic prescriptions must be formally reviewed between **48 to 72 hours**. - This timeframe allows for the integration of **microbiology results** and clinical response to decide on **IV-to-oral switch**, narrowing the spectrum, or stopping therapy. *24 hours after initiation* - Evaluating at **24 hours** is often too early to accurately judge **clinical improvement** or receive comprehensive culture sensitivities. - While monitoring is continuous, the **standardized review mandate** for policy development is specifically set later to capture diagnostic data. *5 days after initiation* - Waiting **5 days** increases the risk of **adverse effects**, such as Clostridioides difficile infection, if the therapy remains unnecessarily broad. - UK stewardship guidelines emphasize earlier intervention to promote **antimicrobial precision** and prevent resistance. *7 days after initiation* - **Seven days** is often the total duration of a complete course for many common infections, making it too late for a meaningful **clinical review**. - Relying on this window fails the **'Then Focus'** principle, which aims to optimize therapy as soon as evidence is available. *When microbiology results become available* - While culture results are vital, a review should happen within the **48-72 hour window** even if no organism is grown (**culture-negative** cases). - Clinical assessment of the patient's **hemodynamic stability** and symptoms is an independent trigger for review, regardless of lab timing.

Question 194: A 58-year-old man with chronic venous insufficiency presents with a 4-day history of painful erythema of the right lower leg. The affected area is warm, tender, and has a sharply demarcated border extending from the ankle to mid-calf. Temperature is 38.2°C. He has no history of recent trauma or skin breaks. Blood tests show WCC 14.2 × 10⁹/L and CRP 85 mg/L. Which of the following is the most appropriate first-line antibiotic according to current UK guidelines?

A. Oral amoxicillin 500mg three times daily
B. Oral flucloxacillin 500-1000mg four times daily (Correct Answer)
C. Oral co-amoxiclav 625mg three times daily
D. Oral clarithromycin 500mg twice daily
E. Intravenous vancomycin 1g twice daily

Explanation: ***Oral flucloxacillin 500-1000mg four times daily*** - According to **NICE guidelines**, this is the first-line treatment for **cellulitis** and **erysipelas** as it provides excellent coverage against **Staphylococcus aureus** and **Group A Streptococcus**. - The patient presents with classic signs of soft tissue infection (erythema, warmth, tenderness) and systemic inflammatory response (**fever**, raised **WCC/CRP**) without signs of sepsis requiring IV therapy. *Oral amoxicillin 500mg three times daily* - **Amoxicillin** is ineffective against most strains of **Staphylococcus aureus** due to the production of **beta-lactamases**. - While it covers **Streptococcus**, it is not used as monotherapy for cellulitis because coverage for both common pathogens is essential. *Oral co-amoxiclav 625mg three times daily* - This is often reserved for **human/animal bites**, facial cellulitis, or infections with suspected **anaerobic** or **Gram-negative** involvement. - Using it for simple lower limb cellulitis contributes to **antimicrobial resistance** by providing unnecessarily broad-spectrum coverage. *Oral clarithromycin 500mg twice daily* - This is a **macrolide** antibiotic typically reserved for patients with a **penicillin allergy**. - Since there is no documentation of allergy in this patient, a **beta-lactam** like flucloxacillin is preferred for its superior efficacy in skin infections. *Intravenous vancomycin 1g twice daily* - This is reserved for severe infections, suspected **MRSA**, or patients who have failed oral therapy and require **intravenous** administration. - The patient's condition is currently manageable with **oral antibiotics**, and vancomycin requires intensive **serum level monitoring**.

Question 195: Which of the following scenarios represents an appropriate indication for the use of topical antibiotics in primary care according to current UK antimicrobial prescribing guidance?

A. Acute bacterial conjunctivitis in an immunocompetent adult with purulent discharge and no visual impairment
B. Impetigo affecting a limited area (<2% body surface area) in a 5-year-old child who is systemically well (Correct Answer)
C. Small superficial abrasion on the forearm of a 30-year-old woman with no signs of infection
D. Acute otitis externa in a 45-year-old man with marked canal oedema and purulent discharge
E. Mild eczema with secondary bacterial infection in a 12-year-old child

Explanation: ***Impetigo affecting a limited area (<2% body surface area) in a 5-year-old child who is systemically well***- For **localized impetigo**, UK (NICE/PHE) antimicrobial stewardship guidelines recommend **topical fusidic acid** or **mupirocin** as first-line treatment if the patient is systemically well.- This approach avoids unnecessary **systemic antibiotic exposure** while effectively treating the infection and reducing transmission.*Acute bacterial conjunctivitis in an immunocompetent adult with purulent discharge and no visual impairment*- Most cases are **self-limiting**, and guidance recommends **conservative management** (cleaning the eye with cotton wool and water) rather than immediate topical antibiotics.- Topical antibiotics are usually only considered if symptoms are **severe** or persist beyond **7 days**.*Small superficial abrasion on the forearm of a 30-year-old woman with no signs of infection*- Prophylactic use of **topical antibiotics** on uninfected minor wounds is strongly discouraged to prevent **antimicrobial resistance**.- Routine cleaning and simple dressings are the standard of care for preventing infection in **clean abrasions**.*Acute otitis externa in a 45-year-old man with marked canal oedema and purulent discharge*- While topical drops are used, **marked canal oedema** may block the application of medication, necessitating an **ear wick** or **microsuction**.- Severe cases with significant swelling or systemic features may require **systemic antibiotics** as topical penetration is limited in a closed canal.*Mild eczema with secondary bacterial infection in a 12-year-old child*- Guidance typically recommends **oral (systemic) antibiotics** for secondary infections of eczema to ensure adequate coverage and efficacy across the affected skin areas.- Topical antibiotics are generally avoided in eczema due to the high risk of developing **bacterial resistance** and the potential for **contact sensitization**.

Question 196: A 52-year-old man with liver cirrhosis (MELD score 18) presents with fever and right upper quadrant pain. Ultrasound shows a 6cm liver abscess. Blood cultures grow Klebsiella pneumoniae which is extended-spectrum beta-lactamase (ESBL) producing. The microbiology laboratory reports sensitivity to meropenem, gentamicin, and tigecycline, but resistance to all cephalosporins and co-amoxiclav. Which antibiotic represents the best choice according to antimicrobial stewardship principles?

A. Meropenem (Correct Answer)
B. Gentamicin
C. Tigecycline
D. Combination of gentamicin and tigecycline
E. Piperacillin-tazobactam based on susceptibility testing

Explanation: ***Meropenem*** - **Carbapenems** are the treatment of choice for invasive **ESBL-producing Enterobacterales** infections as they provide superior mortality outcomes compared to other agents. - Meropenem has excellent **abscess penetration** and stability against beta-lactamases, making it the most reliable option for this clinical scenario while adhering to stewardship principles by selecting the most effective agent for a severe, resistant infection. *Gentamicin* - This drug has poor efficacy in the **acidic environment** of an abscess and is generally unsuitable as **monotherapy** for systemic or deep-seated infections like a liver abscess. - There is a high risk of **nephrotoxicity** and ototoxicity, especially in a patient with cirrhosis and a high MELD score who may already have compromised renal perfusion, making it a less safe first-line option. *Tigecycline* - It is a **bacteriostatic** agent that achieves low serum concentrations, making it suboptimal for treating **bacteremia** or deep-seated invasive infections, especially as monotherapy. - Current guidelines recommend avoiding its use as primary therapy for serious infections when more effective and bactericidal alternatives like carbapenems are available due to concerns over higher mortality in severe infections. *Combination of gentamicin and tigecycline* - **Combination therapy** with these agents is not indicated here as meropenem monotherapy is highly effective and carries a lower risk of cumulative toxicity and poorer penetration into the abscess. - Using this combination increases the risk of adverse effects, such as **acute kidney injury** from gentamicin and overall concerns with tigecycline, without providing a proven clinical benefit over a single appropriate carbapenem. *Piperacillin-tazobactam based on susceptibility testing* - While some ESBL strains may appear sensitive to piperacillin-tazobactam in vitro, clinical outcomes are often poor for invasive infections due to the **inoculum effect** and instability against certain ESBL enzymes. - In this specific case, the lab reports **resistance to all cephalosporins and co-amoxiclav**, which are also beta-lactam/beta-lactamase inhibitor combinations or beta-lactams, making piperacillin-tazobactam a high-risk and likely clinically ineffective choice for an ESBL-producing Klebsiella pneumoniae.

Question 197: A 43-year-old woman presents with a 2-day history of a painful red eye with purulent discharge. She wears soft contact lenses daily and continued wearing them despite developing symptoms. Visual acuity is reduced to 6/36 in the affected eye. Slit-lamp examination reveals a central corneal ulcer with surrounding infiltrate and hypopyon. What is the most important initial step in management?

A. Commence topical chloramphenicol immediately and arrange ophthalmology review within 24 hours
B. Immediate ophthalmology referral, corneal scraping for microscopy and culture, and intensive topical fortified antibiotics (Correct Answer)
C. Commence topical fusidic acid and arrange ophthalmology review within 48 hours
D. Immediate ophthalmology referral and commence topical aciclovir for presumed herpetic keratitis
E. Commence oral ciprofloxacin and topical dexamethasone with routine ophthalmology referral

Explanation: ***Immediate ophthalmology referral, corneal scraping for microscopy and culture, and intensive topical fortified antibiotics*** - The clinical presentation of a **painful red eye**, **purulent discharge**, significant **visual acuity reduction (6/36)**, **central corneal ulcer** with surrounding infiltrate, and **hypopyon** in a contact lens wearer strongly indicates severe **microbial keratitis**, a sight-threatening emergency. - **Immediate ophthalmology referral** for **corneal scraping** to identify the causative organism (often **Pseudomonas aeruginosa** or other Gram-negative bacteria in contact lens wearers) and initiation of **intensive topical fortified antibiotics** (e.g., fortified cephalosporin and aminoglycoside, or a broad-spectrum fluoroquinolone) are critical to prevent permanent vision loss. *Commence topical chloramphenicol immediately and arrange ophthalmology review within 24 hours* - **Chloramphenicol** is a broad-spectrum but bacteriostatic antibiotic typically used for milder conjunctivitis and is wholly inadequate for a severe, vision-threatening **corneal ulcer** with hypopyon. - A delay of **24 hours** for ophthalmology review in a case of presumed **microbial keratitis** with hypopyon is unacceptable and significantly increases the risk of severe complications like **corneal perforation** or endophthalmitis. *Commence topical fusidic acid and arrange ophthalmology review within 48 hours* - **Fusidic acid** has a narrow spectrum primarily effective against Gram-positive bacteria, particularly **Staphylococcus aureus**, and would not cover common pathogens like **Pseudomonas** often associated with contact lens-related keratitis. - Waiting **48 hours** for ophthalmology review in such a severe presentation of keratitis is dangerously prolonged and would lead to significant worsening of the condition. *Immediate ophthalmology referral and commence topical aciclovir for presumed herpetic keratitis* - While immediate ophthalmology referral is correct, the clinical features (purulent discharge, hypopyon, central ulcer) are highly suggestive of **bacterial keratitis**, not typical **herpetic keratitis**, which usually presents with a **dendritic ulcer** and less purulence. - Empiric use of **aciclovir** without confirmation of viral etiology would delay appropriate treatment for the likely bacterial infection, leading to progression and potential loss of vision. *Commence oral ciprofloxacin and topical dexamethasone with routine ophthalmology referral* - **Topical corticosteroids** like **dexamethasone** are absolutely **contraindicated** in undiagnosed infectious keratitis, as they can suppress the immune response, exacerbate the infection, and lead to rapid progression and **corneal perforation**. - Oral antibiotics have **poor corneal penetration** and are generally ineffective as primary treatment for severe keratitis, which requires high concentrations of **topical antibiotics** directly on the ocular surface; routine referral is also insufficient for an emergency.

Question 198: A hospital trust analyses antimicrobial consumption data and identifies that carbapenem use has increased by 40% over 12 months despite no change in case mix or hospital admissions. Investigation reveals that 60% of carbapenem prescriptions are empirical therapy for suspected healthcare-associated infections. Which antimicrobial stewardship intervention would be most appropriate to address this?

A. Complete ban on carbapenem prescribing except with infectious diseases approval
B. Implementing local antimicrobial resistance surveillance and antibiogram-guided empirical therapy guidance (Correct Answer)
C. Reducing duration of all carbapenem courses to maximum 5 days
D. Replacing carbapenems with alternative broad-spectrum agents such as piperacillin-tazobactam
E. Mandatory screening for carbapenem-resistant organisms in all patients before carbapenem prescription

Explanation: ***Implementing local antimicrobial resistance surveillance and antibiogram-guided empirical therapy guidance***- This approach directly addresses the problem of increased empirical carbapenem use by providing **local epidemiological data** to guide appropriate **antibiotic selection**.- By utilizing **antibiograms**, clinicians can make informed decisions, opting for narrower-spectrum agents when possible and thereby reducing unnecessary carbapenem consumption and **antibiotic resistance**.*Complete ban on carbapenem prescribing except with infectious diseases approval*- A **complete ban** is an overly restrictive measure that can significantly delay critical treatment, especially in **unstable patients** with suspected severe infections.- While infectious diseases consultation is valuable, a blanket ban does not empower prescribers with the knowledge to make **data-driven decisions** and may lead to resistance to policy rather than adherence.*Reducing duration of all carbapenem courses to maximum 5 days*- This intervention focuses on the **duration of therapy** rather than the initial **empirical selection** of the antibiotic, which is the primary driver of increased carbapenem use identified.- An arbitrary **5-day limit** may be insufficient for certain severe or deep-seated infections, potentially leading to **treatment failure** or recurrence.*Replacing carbapenems with alternative broad-spectrum agents such as piperacillin-tazobactam*- Simply substituting one **broad-spectrum antibiotic** for another does not address the underlying issue of inappropriate empirical escalation and could merely shift the **resistance pressure** to the alternative agent.- Effective **antimicrobial stewardship** aims to optimize therapy by using the **narrowest effective spectrum** possible, not just rotating broad-spectrum drugs.*Mandatory screening for carbapenem-resistant organisms in all patients before carbapenem prescription*- While important for **infection control**, screening for **carbapenem-resistant organisms (CROs)** identifies colonization and is not typically used to guide immediate empirical therapy for acute infections due to **turnaround times**.- The primary issue is the high rate of empirical carbapenem use, not necessarily the presence of **known CROs** in the patient population.

Question 199: A 59-year-old man with poorly controlled type 2 diabetes (HbA1c 92 mmol/mol) is admitted with a moderate diabetic foot ulcer (Wagner grade 2) with surrounding cellulitis extending 3cm beyond the ulcer margin. Temperature is 38.1°C. Plain radiograph shows no evidence of osteomyelitis. He has a documented severe penicillin allergy (anaphylaxis). According to current guidelines, what is the most appropriate empirical antibiotic regimen?

A. Oral doxycycline and oral metronidazole
B. Intravenous teicoplanin and intravenous ciprofloxacin and intravenous metronidazole (Correct Answer)
C. Intravenous clindamycin and intravenous gentamicin
D. Oral clarithromycin and oral metronidazole
E. Intravenous meropenem

Explanation: ***Intravenous teicoplanin and intravenous ciprofloxacin and intravenous metronidazole***- This combination provides broad-spectrum coverage against common pathogens in diabetic foot infections, targeting **Gram-positive** (teicoplanin), **Gram-negative** (ciprofloxacin), and **anaerobic** (metronidazole) bacteria, suitable for a moderate infection with systemic signs.- It is a crucial choice for patients with a **severe penicillin allergy (anaphylaxis)** as it completely avoids all beta-lactam antibiotics, minimizing the risk of cross-reactivity. *Oral doxycycline and oral metronidazole*- This **oral regimen** is generally insufficient for a **moderate diabetic foot infection** accompanied by fever (38.1°C) and cellulitis extending 3cm, indicating systemic involvement.- **Moderate to severe infections** typically necessitate **intravenous antibiotics** to achieve adequate drug concentrations and ensure effective tissue penetration in compromised diabetic feet. *Intravenous clindamycin and intravenous gentamicin*- While clindamycin provides some Gram-positive and anaerobic coverage, this regimen offers less comprehensive **anaerobic coverage** compared to metronidazole, which is vital in polymicrobial diabetic foot infections.- **Gentamicin** carries a significant risk of **nephrotoxicity** and ototoxicity, making it a less preferred option, especially in diabetic patients who are often prone to renal impairment. *Oral clarithromycin and oral metronidazole*- **Clarithromycin**, a macrolide, often lacks sufficient spectrum against the diverse aerobic Gram-negative and some Gram-positive pathogens commonly found in **diabetic foot infections**.- This **oral regimen** is inadequate for treating a **moderate infection** with systemic features that requires hospitalization and **parenteral antibiotic therapy** according to current guidelines. *Intravenous meropenem*- **Meropenem** is a carbapenem, a class of **beta-lactam antibiotics**, and thus carries a risk of cross-reactivity in patients with a history of **severe penicillin allergy (anaphylaxis)**.- Despite its broad spectrum, carbapenems are generally contraindicated in patients with documented **anaphylactic reactions to penicillin** to avoid potentially life-threatening allergic responses.

Question 200: A 28-year-old woman presents with a 3-day history of painful swelling in her right axilla. She has no fever. Examination reveals a 2cm tender, erythematous, fluctuant nodule in the axilla with surrounding induration. There is no lymphadenopathy and no evidence of ascending lymphangitis. She has a past medical history of similar lesions in both axillae over the past 2 years. What is the most likely diagnosis?

A. Hidradenitis suppurativa (Correct Answer)
B. Furunculosis
C. Cat scratch disease
D. Lymph node abscess
E. Mycobacterial lymphadenitis

Explanation: ***Hidradenitis suppurativa*** - This chronic inflammatory condition is characterized by **recurrent painful nodules**, abscesses, and sinus tracts in **apocrine gland-bearing areas** like the axillae, groin, and gluteal cleft. - The history of similar lesions over **2 years** in both axillae, presenting as a tender, erythematous, fluctuant nodule without fever or significant lymphadenopathy, is classic for **hidradenitis suppurativa**. *Furunculosis* - These are acute deep-seated **follicular infections** (boils) caused by *Staphylococcus aureus* and typically resolve without recurrence in the same specific locations. - While presenting as a tender nodule, furuncles lack the **chronic, relapsing-remitting course** and specific involvement of **apocrine gland-rich areas** seen in this patient. *Cat scratch disease* - Caused by **Bartonella henselae**, it typically presents with **regional lymphadenopathy** proximal to a cat scratch or bite, not recurrent primary skin nodules. - The enlarged lymph nodes are usually tender, firm, and often solitary, distinct from the **fluctuant, recurring axillary skin lesions** described. *Lymph node abscess* - This involves a suppurative infection of a **lymph node itself**, often secondary to a draining infection, and is typically accompanied by systemic signs like **fever** and significant lymphadenopathy. - The presentation here is a primary **skin lesion** with no lymphadenopathy and a history of recurrence, which differentiates it from a single, deep-seated lymph node abscess. *Mycobacterial lymphadenitis* - Also known as **scrofula**, this condition presents as an **indolent, non-tender,

Question 201: A 67-year-old man with type 2 diabetes presents with a 4-day history of severe pain, swelling, and erythema of his left foot following a minor cut. Examination reveals a dusky, violaceous discolouration with bullae containing dark fluid, crepitus on palpation, and anaesthesia of the overlying skin. Temperature is 38.9°C, heart rate 118/min, blood pressure 98/62 mmHg. Blood tests show lactate 4.2 mmol/L, creatinine 178 μmol/L (baseline 92), and creatine kinase 3,420 U/L. What is the single most important immediate management step?

A. Urgent surgical referral for debridement/amputation and broad-spectrum antibiotics including clindamycin (Correct Answer)
B. CT imaging of the foot to delineate extent of infection before surgical intervention
C. Intravenous flucloxacillin and metronidazole with close observation for 24 hours
D. Ultrasound of the foot to confirm presence of gas and guide antibiotic selection
E. Blood cultures, commence broad-spectrum antibiotics, and arrange MRI within 6 hours

Explanation: ***Urgent surgical referral for debridement/amputation and broad-spectrum antibiotics including clindamycin***- The patient's presentation with **dusky skin**, **bullae**, **crepitus**, **skin anaesthesia**, and signs of **septic shock** (hypotension, tachycardia, elevated lactate) is highly indicative of **necrotizing fasciitis**, a surgical emergency requiring immediate debridement.- **Broad-spectrum antibiotics** covering Gram-positive, Gram-negative, and anaerobic organisms are essential, with **clindamycin** specifically included for its ability to inhibit bacterial **toxin production** and modulate the severe inflammatory response. *CT imaging of the foot to delineate extent of infection before surgical intervention*- While CT imaging can confirm the presence of **fascial fluid** or **gas**, it must **never delay urgent surgical exploration and debridement**, which is the definitive diagnostic and therapeutic step.- In a patient with clear clinical signs of necrotizing fasciitis and **hemodynamic instability**, delaying surgery for imaging significantly increases morbidity and mortality. *Intravenous flucloxacillin and metronidazole with close observation for 24 hours*- This antibiotic regimen is **insufficient**, as flucloxacillin primarily covers *Staphylococcus* and *Streptococcus*, and it lacks adequate **broad-spectrum coverage** for potential polymicrobial infections including Gram-negative bacteria, and it does not include an agent for **toxin suppression**.- **Close observation for 24 hours** is inappropriate and dangerous; necrotizing fasciitis progresses rapidly, and a delay of even a few hours can lead to extensive tissue loss, limb amputation, or death. *Ultrasound of the foot to confirm presence of gas and guide antibiotic selection*- Ultrasound has **limited sensitivity** for detecting subtle **subcutaneous gas** and may not reliably define the extent of fascial involvement, making it an unreliable primary diagnostic tool in this context.- Antibiotic selection for suspected necrotizing fasciitis must be **empiric and broad-spectrum** and initiated immediately; waiting for imaging to guide this decision is a critical delay. *Blood cultures, commence broad-spectrum antibiotics, and arrange MRI within 6 hours*- While **blood cultures** and **broad-spectrum antibiotics** are important initial steps, arranging an **MRI within 6 hours** will cause an unacceptable delay in definitive surgical management.- MRI, though sensitive for soft tissue infection, often **overestimates the extent** and is not indicated when the clinical picture is clear and demands immediate surgical intervention.

Question 202: According to current UK antimicrobial guidance, what is the recommended duration of antibiotic therapy for an immunocompetent adult with uncomplicated cellulitis of the lower limb showing good clinical response?

A. 3 days
B. 5 days (Correct Answer)
C. 7 days
D. 10 days
E. 14 days

Explanation: ***5 days*** - Current **NICE** and **PHE** guidance recommends a **5-day course** of antibiotics for uncomplicated cellulitis in immunocompetent adults who show a **good clinical response**. - Evidence demonstrates that shorter courses are **non-inferior** to longer treatments, effectively reducing antibiotic exposure and the risk of **antimicrobial resistance**. *3 days* - A **3-day duration** is generally insufficient for the eradication of bacteria in skin and soft tissue infections like **cellulitis**. - This short duration is more commonly associated with uncomplicated **urinary tract infections** in women, not skin infections. *7 days* - While previously common, a **7-day course** is now reserved for cases where there has been a **slow clinical response** by day 5. - For an immunocompetent patient responding well, extending treatment to 7 days provides no additional benefit over **5 days**. *10 days* - A **10-day course** represents outdated practice for uncomplicated infections and increases the risk of **antibiotic-associated side effects**. - This duration might only be considered in **complicated infections** or cases involving specific pathogens like **Group A Streptococcus** with associated complications. *14 days* - **14 days** of therapy is unnecessarily long for simple cellulitis and significantly increases the likelihood of **Clostridioides difficile** infection. - Such prolonged courses are typically reserved for **immunocompromised patients** or deep-seated infections like **osteomyelitis**.

Question 203: A 36-year-old woman with systemic lupus erythematosus on prednisolone 20mg daily and mycophenolate mofetil presents with a 5-day history of painful vesicular rash in a dermatomal distribution on the right side of her chest. Several vesicles have coalesced and there is involvement crossing the midline anteriorly. She has no visual symptoms. Temperature is 37.8°C. What is the most appropriate management?

A. Oral aciclovir 800mg five times daily for 7 days
B. Intravenous aciclovir 10mg/kg three times daily (Correct Answer)
C. Oral valaciclovir 1g three times daily for 7 days
D. Topical aciclovir cream five times daily with oral analgesia
E. Oral famciclovir 500mg three times daily for 7 days

Explanation: ***Intravenous aciclovir 10mg/kg three times daily*** - This patient is **severely immunocompromised** due to systemic lupus erythematosus, moderate-dose **prednisolone** (20mg daily), and **mycophenolate mofetil**, which warrants intravenous therapy for Herpes Zoster. - Features such as **crossing the midline** and coalescing vesicles in an immunocompromised host indicate a high risk of **disseminated disease** or visceral involvement, requiring high-bioavailability systemic treatment. *Oral aciclovir 800mg five times daily for 7 days* - While a standard dose for **immunocompetent** patients, oral aciclovir has poor **bioavailability** compared to the intravenous route. - In this scenario, the severity of immunosuppression and the clinical presentation require the higher serum levels provided by **IV aciclovir**. *Oral valaciclovir 1g three times daily for 7 days* - Valaciclovir offers better absorption than oral aciclovir but is still insufficient for an immunocompromised patient with **extensive dermatomal involvement** or risk of dissemination. - Guidelines prioritize **parenteral therapy** in patients receiving multiple immunosuppressants or showing signs of severe local disease. *Topical aciclovir cream five times daily with oral analgesia* - **Topical therapy** is completely inadequate for the treatment of **Herpes Zoster** and does not prevent post-herpetic neuralgia or systemic spread. - Management must involve **systemic antiviral agents** to inhibit viral replication within the nervous system and skin. *Oral famciclovir 500mg three times daily for 7 days* - Famciclovir is an alternative oral prodrug, but like other oral agents, it is reserved for **uncomplicated shingles** in the immunocompetent. - The presence of **systemic lupus** and current medication use (Mycophenolate) makes the patient too high-risk for **oral-only** therapeutic strategies.

Question 204: A hospital antimicrobial stewardship team reviews audit data showing that 45% of patients receiving antimicrobials for more than 5 days lack documented indication, review dates, or stop/review dates in their medical records. Which intervention, according to evidence-based antimicrobial stewardship practice, would most effectively address this documentation deficiency?

A. Implementing mandatory infectious diseases consultation for all patients on antibiotics for >5 days
B. Introducing antimicrobial prescription charts with mandatory fields for indication, review date, and duration (Correct Answer)
C. Sending weekly email reminders to all prescribers about documentation requirements
D. Restricting antibiotic prescribing to consultants and registrars grade ST4 and above
E. Conducting monthly teaching sessions for junior doctors on antimicrobial prescribing

Explanation: ***Introducing antimicrobial prescription charts with mandatory fields for indication, review date, and duration*** - This is a system-level **structural intervention** that creates a 'hard stop' at the point of prescribing, ensuring compliance with **antimicrobial stewardship (AMS)** guidelines. - Evidence shows that forcing the inclusion of **indication and stop/review dates** significantly improves documentation compared to passive reminders or education alone. *Implementing mandatory infectious diseases consultation for all patients on antibiotics for >5 days* - This approach is **resource-intensive** and impractical for most hospital environments due to the high volume of antibiotic use. - It acts more as a **clinical review mechanism** rather than a solution for the specific documentation deficiency identified in the audit. *Sending weekly email reminders to all prescribers about documentation requirements* - Email reminders are considered a **weak, passive intervention** that does not integrate into the clinical workflow or force a change in habit. - Prescribers often experience **notification fatigue**, leading to these reminders being ignored without improving documentation accuracy. *Restricting antibiotic prescribing to consultants and registrars grade ST4 and above* - Such restrictions are typically reserved for **broad-spectrum or high-cost antibiotics** and are not an appropriate solution for general documentation issues. - This intervention could lead to **treatment delays** and does not address the underlying lack of structure in the documentation process itself. *Conducting monthly teaching sessions for junior doctors on antimicrobial prescribing* - While **education** is a core component of AMS, it is rarely sufficient as a standalone strategy to ensure long-term behavioral change in documentation. - Teaching sessions address **knowledge gaps** but fail to provide the **system enablers** required to facilitate routine clinical documentation tasks.

Question 205: A 41-year-old man who works as a fishmonger presents with a 48-hour history of a painful, rapidly spreading erythematous swelling on his right hand following a puncture injury from a fish bone. The affected area has violaceous bullae and is exquisitely tender. He is systemically well with temperature 37.4°C. Blood tests show WCC 11.2 × 10⁹/L and CRP 28 mg/L. Which organism is most likely responsible?

A. Vibrio vulnificus
B. Pasteurella multocida
C. Streptococcus pyogenes
D. Staphylococcus aureus
E. Erysipelothrix rhusiopathiae (Correct Answer)

Explanation: ***Erysipelothrix rhusiopathiae*** - This organism causes **erysipeloid**, a localized skin infection classic in **fishmongers** and meat handlers following a **puncture injury** from fish bones or scales. - It typically presents as a painful, **violaceous (purplish)**, spreading erythema on the hands, often with mild systemic symptoms and a lack of significant suppuration.*Vibrio vulnificus* - While associated with seawater and shellfish, it typically causes much more **severe, necrotizing soft tissue infections** and hemorrhagic bullae. - Usually presents in patients with **liver disease** or immunosuppression with profound **systemic toxicity** and sepsis.*Pasteurella multocida* - This organism is classically associated with **animal bites or scratches**, particularly from **cats and dogs**, rather than fish-related injuries. - It typically presents with a very rapid onset of infection, often within **24 hours** of the injury.*Streptococcus pyogenes* - Commonly causes cellulitis and erysipelas, but these are typically associated with **high fever**, significant systemic toxicity, and bright red rather than **violaceous** erythema. - While it can cause necrotizing fasciitis, the occupational link to a fish bone and the patient's **systemically well** status makes it less likely.*Staphylococcus aureus* - A frequent cause of skin infections, it primarily leads to **localized abscess formation** or impetigo rather than broad, violaceous spreading lesions. - It lacks the specific **occupational association** with raw fish and sea life compared to Erysipelothrix.

Question 206: Which of the following antimicrobial prescribing practices best demonstrates the 'Start Smart - Then Focus' antimicrobial stewardship principle of 'review and revise' at 48-72 hours?

A. Continuing intravenous meropenem for hospital-acquired pneumonia despite clinical improvement and negative cultures because the patient remains pyrexial
B. Switching from intravenous co-amoxiclav to oral amoxicillin for community-acquired pneumonia following clinical improvement and ability to tolerate oral intake (Correct Answer)
C. Extending a 5-day course of ciprofloxacin to 10 days for uncomplicated urinary tract infection because the patient had microscopic haematuria
D. Adding azithromycin to amoxicillin for community-acquired pneumonia despite clinical improvement to 'cover atypical organisms'
E. Continuing flucloxacillin for cellulitis despite complete resolution of erythema because the baseline creatine kinase was mildly elevated

Explanation: ***Switching from intravenous co-amoxiclav to oral amoxicillin for community-acquired pneumonia following clinical improvement and ability to tolerate oral intake*** - This demonstrates **antimicrobial de-escalation**, a core component of the "Focus" step, which involves switching from **IV to oral (IVOS)** therapy when clinical criteria are met. - By narrowing the spectrum (removing anaerobic coverage of clavulanate) and switching route, it reduces **antibiotic resistance**, side effects, and costs. *Continuing intravenous meropenem for hospital-acquired pneumonia despite clinical improvement and negative cultures because the patient remains pyrexial* - This describes **inappropriate broad-spectrum misuse**; pyrexia alone without other markers of infection does not justify continuing a carbapenem if cultures are negative. - Stewardship guidelines advise **narrowing the spectrum** or stopping therapy if infection is unlikely after 72 hours of review. *Extending a 5-day course of ciprofloxacin to 10 days for uncomplicated urinary tract infection because the patient had microscopic haematuria* - **Microscopic haematuria** is common in cystitis and does not warrant extending therapy beyond the standard evidence-based duration. - Proper stewardship focuses on **shorter durations** of therapy to minimize the selection of resistant bacteria. *Adding azithromycin to amoxicillin for community-acquired pneumonia despite clinical improvement to 'cover atypical organisms'* - Adding a second agent when a patient is already improving is an **unnecessary escalation** of therapy and violates the "review and revise" principle. - Stewardship encourages **rationalizing therapy** based on microbiology and clinical response rather than adding unnecessary empirical coverage. *Continuing flucloxacillin for cellulitis despite complete resolution of erythema because the baseline creatine kinase was mildly elevated* - Antibiotics should be stopped when the **clinical infection has resolved**; an isolated mildly elevated CK is not an indication for continued antimicrobial therapy. - This practice leads to **unnecessary antibiotic exposure**, increasing the risk of healthcare-associated infections like C. difficile.

Question 207: A 33-year-old woman presents to the Emergency Department with a 12-hour history of severe pain and swelling of her left breast. She is 3 weeks postpartum and exclusively breastfeeding. On examination, there is a 4cm fluctuant, erythematous, tender mass in the upper outer quadrant of the left breast. Temperature is 38.7°C. What is the most appropriate management?

A. Oral flucloxacillin and advise to continue breastfeeding from both breasts
B. Intravenous flucloxacillin and advise to stop breastfeeding from the affected breast
C. Ultrasound-guided aspiration or incision and drainage, plus oral flucloxacillin (Correct Answer)
D. Oral co-amoxiclav and advise complete cessation of breastfeeding
E. Oral erythromycin and advise to express and discard milk from the affected breast

Explanation: ***Ultrasound-guided aspiration or incision and drainage, plus oral flucloxacillin*** - The presence of a **fluctuant mass** and fever in the context of mastitis indicates a **breast abscess**, which requires surgical or needle **drainage** for resolution. - **Flucloxacillin** is the first-line antibiotic choice to cover **Staphylococcus aureus**, and patients should be encouraged to **continue breastfeeding** to prevent further engorgement. *Oral flucloxacillin and advise to continue breastfeeding from both breasts* - While antibiotics and continuing breastfeeding are vital, they are insufficient for an **abscess**; antibiotics cannot effectively penetrate a **walled-off collection** of pus. - This management is appropriate for simple **lactational mastitis** without a fluctuant mass or collection. *Intravenous flucloxacillin and advise to stop breastfeeding from the affected breast* - Stopping breastfeeding on the affected side is contraindicated as it leads to **milk stasis**, which can worsen the infection and exacerbate the **abscess**. - Intravenous antibiotics may be required for severe systemic sepsis, but the definitive treatment for the localized mass remains **drainage**. *Oral co-amoxiclav and advise complete cessation of breastfeeding* - **Co-amoxiclav** provides unnecessarily broad coverage (including anaerobes) for a typical **S. aureus** breast infection and is not first-line. - **Cessation of breastfeeding** is unnecessary and harmful, as it increases the risk of further abscess formation and compromises the **milk supply**. *Oral erythromycin and advise to express and discard milk from the affected breast* - **Erythromycin** has less predictable efficacy against **Staphylococcus aureus** compared to penicillinase-resistant penicillins like flucloxacillin. - There is no clinical indication to **discard milk**, as the milk remains safe for the infant and expressing is essential to **decompress** the breast tissue.

Question 208: A 54-year-old man with known cirrhosis (Child-Pugh class B) presents with a 3-day history of fever, abdominal pain, and confusion. He has tense ascites. Diagnostic paracentesis reveals ascitic fluid with neutrophil count of 320 cells/mm³, protein 18 g/L, and glucose 3.8 mmol/L. Blood cultures are pending. According to antimicrobial stewardship principles and current evidence, what is the most appropriate initial antibiotic regimen?

A. Intravenous cefotaxime 2g three times daily (Correct Answer)
B. Intravenous piperacillin-tazobactam 4.5g three times daily
C. Intravenous meropenem 1g three times daily
D. Oral ciprofloxacin 500mg twice daily
E. Intravenous co-amoxiclav 1.2g three times daily

Explanation: ***Intravenous cefotaxime 2g three times daily***- Third-generation cephalosporins are the **gold-standard empirical treatment** for community-acquired **spontaneous bacterial peritonitis (SBP)**, effectively covering common pathogens like **E. coli, Klebsiella**, and **S. pneumoniae**.- This patient's ascitic fluid **neutrophil count of 320 cells/mm³** (>250 threshold) confirms SBP, and cefotaxime provides excellent **ascitic fluid penetration** and a proven mortality benefit.*Intravenous piperacillin-tazobactam 4.5g three times daily*- This provides an unnecessarily broad spectrum including **Pseudomonas** coverage, which is generally not required for **community-acquired SBP**.- According to **antimicrobial stewardship**, it should be reserved for **healthcare-associated infections** or patients with recent broad-spectrum antibiotic exposure.*Intravenous meropenem 1g three times daily*- Carbapenems are **ultra-broad-spectrum antibiotics** and are inappropriate as first-line therapy for non-refractory, community-acquired SBP.- Overuse of meropenem promotes the development of **carbapenem-resistant Enterobacteriaceae (CRE)** and should be avoided unless **multidrug-resistant organisms** are highly suspected.*Oral ciprofloxacin 500mg twice daily*- Oral fluoroquinolones are primarily used for **SBP prophylaxis** (primary or secondary) rather than the treatment of an acute, symptomatic infection with systemic features like **fever** and **confusion**.- There is increasing **bacterial resistance** to quinolones among enteric gram-negative bacilli, making them less reliable for initial empiric therapy in severe cases.*Intravenous co-amoxiclav 1.2g three times daily*- While it covers some gram-negatives and anaerobes, it has **inferior clinical evidence** and penetration compared to third-generation cephalosporins for treating SBP.- In many regions, **resistance rates** for common enteric bacteria to amoxicillin-clavulanate are higher than to **cefotaxime**, reducing its effectiveness for empiric SBP treatment.

Question 209: A 78-year-old woman with chronic obstructive pulmonary disease is admitted with acute exacerbation. She is started on amoxicillin 500mg three times daily. On day 5 of admission, she develops watery diarrhoea (5 episodes in 24 hours). Temperature is 38.2°C. Abdominal examination reveals mild lower abdominal tenderness but no peritonism. Blood tests show WCC 16.8 × 10⁹/L (neutrophils 14.2 × 10⁹/L). What is the most appropriate next step in management?

A. Continue amoxicillin and send stool for culture and Clostridioides difficile testing
B. Stop amoxicillin, start oral metronidazole, and send stool for C. difficile testing
C. Stop amoxicillin, start oral vancomycin, and send stool for C. difficile testing (Correct Answer)
D. Continue amoxicillin, start loperamide, and send stool for culture
E. Stop amoxicillin, start intravenous metronidazole and vancomycin immediately

Explanation: ***Stop amoxicillin, start oral vancomycin, and send stool for C. difficile testing*** - The patient presents with classic symptoms of **Clostridioides difficile infection (CDI)** following antibiotic use, including **watery diarrhoea**, fever, and **leukocytosis** (WCC 16.8 × 10⁹/L). - Current clinical guidelines recommend **oral vancomycin** as first-line treatment for an initial episode of CDI, especially with indicators of severity like high WCC, and the causative antibiotic (**amoxicillin**) should be discontinued immediately. *Continue amoxicillin and send stool for culture and Clostridioides difficile testing* - Continuing the inciting antibiotic significantly increases the risk of **disease progression** and treatment failure in CDI. - Management must begin with the removal of the **precipitating factor** (amoxicillin) alongside diagnostic testing, not before. *Stop amoxicillin, start oral metronidazole, and send stool for C. difficile testing* - **Oral metronidazole** is no longer recommended as first-line therapy for CDI due to its inferiority to vancomycin in achieving clinical cure. - Metronidazole is now typically reserved for scenarios where vancomycin is unavailable or contraindicated in **non-severe** cases, or as an adjunct in fulminant disease. *Continue amoxicillin, start loperamide, and send stool for culture* - **Loperamide** and other anti-motility agents are generally **contraindicated** in suspected CDI as they can precipitate **toxic megacolon** by inhibiting toxin clearance. - Stool culture is non-specific for CDI; specific **C. difficile toxin** or PCR testing is required for diagnosis. *Stop amoxicillin, start intravenous metronidazole and vancomycin immediately* - **Intravenous metronidazole** in combination with **oral/rectal vancomycin** is reserved for **life-threatening (fulminant)** CDI with ileus, hypotension, or other signs of systemic toxicity. - This patient's symptoms represent severe CDI but do not indicate fulminant disease, and intravenous vancomycin has poor penetration into the gut lumen.

Question 210: A 31-year-old woman presents with a diffuse, painful erythematous rash on her left lower leg that developed over 12 hours. She has a temperature of 38.7°C and feels generally unwell. On examination, the affected area is bright red, well-demarcated, raised above surrounding skin, and has an 'orange peel' appearance. There is associated tender inguinal lymphadenopathy. She reports having had similar episodes twice before in the same location. What is the most important prophylactic measure to discuss with this patient?

A. Long-term prophylactic oral flucloxacillin 250 mg twice daily
B. Long-term prophylactic oral phenoxymethylpenicillin 250-500 mg twice daily (Correct Answer)
C. Regular application of emollients to prevent skin fissuring
D. Compression stockings to improve venous drainage
E. Prophylactic benzathine penicillin injections every 3 weeks

Explanation: ***Long-term prophylactic oral phenoxymethylpenicillin 250-500 mg twice daily***- The patient presents with **erysipelas**, suggested by the **well-demarcated**, raised, bright red rash and **'peau d'orange'** appearance, typically caused by **Group A Streptococcus**.- Since she has had **two or more episodes** at the same site, long-term prophylaxis with **phenoxymethylpenicillin** is indicated to prevent further recurrence and potential **lymphedema**.*Long-term prophylactic oral flucloxacillin 250 mg twice daily*- **Flucloxacillin** is primarily used for its **anti-staphylococcal** activity; however, streptococci are the dominant cause of recurrent erysipelas.- **Phenoxymethylpenicillin** is preferred as a more targeted agent to prevent resistance and specifically cover **Streptococcus pyogenes**.*Regular application of emollients to prevent skin fissuring*- **Emollients** are important for maintaining **skin integrity** and preventing entry points for bacteria, but they are considered an **adjunctive measure**.- In the case of **recurrent infections** (2+ episodes), pharmacological prophylaxis with antibiotics takes priority over topical skin care alone.*Compression stockings to improve venous drainage*- **Compression therapy** can help manage underlying **venous insufficiency** or chronic edema which are risk factors, but it is not the primary treatment for preventing infection recurrence.- Use of stockings must be avoided during the **acute phase** of infection due to pain and the potential to worsen the inflammatory response.*Prophylactic benzathine penicillin injections every 3 weeks*- **Benzathine penicillin injections** are the standard of care for secondary prophylaxis of **Rheumatic Fever**, not for preventing soft tissue infections.- While effective against streptococci, **oral dosing** is the first-line and less invasive prophylactic strategy recommended for **recurrent cellulitis** or erysipelas.

Question 211: A 64-year-old woman with recurrent MRSA skin and soft tissue infections has undergone three successful decolonization attempts over the past year, but surveillance swabs consistently become positive again within 3 months. She lives with her husband who has chronic leg ulcers, and they have two dogs that sleep in their bedroom. Despite adherence to decolonization protocols, she develops another MRSA abscess requiring drainage. Which management strategy represents the most evidence-based approach to prevent future recurrence?

A. Extend decolonization regimen to 14 days and repeat monthly for 6 months
B. Perform environmental decontamination, screen and treat household contacts, and consider pet screening (Correct Answer)
C. Prescribe long-term suppressive oral doxycycline 100 mg daily
D. Implement twice-daily chlorhexidine body washes indefinitely
E. Arrange for immunological assessment for underlying immune deficiency

Explanation: ***Perform environmental decontamination, screen and treat household contacts, and consider pet screening*** - Recurrent **MRSA colonization** after successful decolonization, despite adherence to protocols, strongly indicates **re-exposure** from the immediate environment or close contacts. - An evidence-based strategy involves simultaneously addressing potential reservoirs such as **household contacts** (especially those with chronic wounds like leg ulcers) and **pet screening**, alongside environmental cleaning to break the cycle of transmission. *Extend decolonization regimen to 14 days and repeat monthly for 6 months* - Prolonged use of topical decolonization agents, like **mupirocin**, significantly increases the risk of developing **antibiotic resistance** without addressing the underlying sources of reinfection. - Standard 5-day decolonization protocols are generally effective; repeated failures usually point to **recolonization** from external reservoirs rather than insufficient duration. *Prescribe long-term suppressive oral doxycycline 100 mg daily* - **Long-term systemic antibiotic suppression** is not a standard or recommended strategy for MRSA decolonization due to concerns about the emergence of **multidrug-resistant organisms** and potential side effects. - This approach does not eliminate the primary **colonization reservoir** on the patient's skin or nares, or within their household environment and contacts. *Implement twice-daily chlorhexidine body washes indefinitely* - While **chlorhexidine body washes** can effectively reduce skin colonization, they do not eradicate **nasal carriage**, which is a significant reservoir for MRSA. - **Indefinite use** can lead to skin irritation or sensitization and, more importantly, does not address the crucial **environmental reservoirs** or colonized household contacts. *Arrange for immunological assessment for underlying immune deficiency* - While recurrent infections can sometimes indicate an underlying **immune deficiency**, the detailed history points strongly to **exogenous re-exposure** from identified risk factors (husband's ulcers, pets). - Immunological testing should generally be considered only after **environmental and household transmission factors** have been thoroughly controlled and recurrent infections persist.

Question 212: A hospital trust implements a quality improvement initiative requiring antimicrobial prescriptions to include documentation of: indication, drug choice, dose, route, duration, and review date. Six months after implementation, audit shows 78% compliance for indication, 81% for drug/dose/route, but only 42% for review date and 38% for intended duration. Antimicrobial consumption has not decreased. Which additional intervention would most effectively improve outcomes and reduce inappropriate antimicrobial use?

A. Introduce mandatory 48-72 hour antimicrobial prescribing review by senior clinician (Correct Answer)
B. Implement electronic prescribing system alerts for missing documentation fields
C. Increase frequency of audit and feedback cycles to monthly intervals
D. Provide individual feedback to prescribers with lowest compliance rates
E. Develop antimicrobial prescribing competency framework for junior doctors

Explanation: ***Introduce mandatory 48-72 hour antimicrobial prescribing review by senior clinician*** - The **Start Smart – Then Focus** framework emphasizes that the **48-72 hour review** is the most critical intervention for deciding to stop, switch, or de-escalate antimicrobial therapy. - Since antimicrobial consumption did not decrease despite some documentation improvements, a **mandatory senior review** ensures timely clinical action to reduce inappropriate or prolonged use, rather than just administrative compliance. *Implement electronic prescribing system alerts for missing documentation fields* - While alerts can improve **documentation compliance** rates for fields like review date and duration, they do not guarantee appropriate clinical decision-making or the subsequent action to stop or de-escalate. - This intervention primarily addresses the **symptom of incomplete record-keeping** rather than the underlying clinical issue of continued inappropriate antimicrobial use. *Increase frequency of audit and feedback cycles to monthly intervals* - **Audit and feedback** are valuable tools for monitoring trends and identifying areas for improvement, but increasing their frequency alone does not provide a direct, real-time clinical intervention to stop unnecessary treatments. - Monthly cycles still involve a **time lag** that may not influence the immediate management of a patient currently on antibiotics, thus failing to promptly reduce consumption. *Provide individual feedback to prescribers with lowest compliance rates* - Targeted feedback can address **behavioral outliers** or specific knowledge gaps but does not implement a systemic process for proactive clinical review at the crucial 48-72 hour mark. - This approach focuses on **retrospective accountability** rather than the prospective, active stewardship required to change prescribing decisions in real-time and reduce overall consumption. *Develop antimicrobial prescribing competency framework for junior doctors* - Education and **competency frameworks** are crucial for building foundational knowledge and skills for long-term improvement in prescribing practices. - However, they often lack the immediate impact needed to change existing prescribing patterns or ensure timely de-escalation decisions, which frequently require **senior oversight** and institutional policy enforcement.

Question 213: A 39-year-old man who injects performance-enhancing drugs presents with a 5-day history of severe pain in his left thigh with fever and malaise. Examination reveals a tense, swollen thigh with woody induration, purple discolouration of overlying skin, and multiple small areas of necrosis. Crepitus is present. He is tachycardic (128 bpm), hypotensive (88/52 mmHg), and has acute kidney injury (creatinine 298 μmol/L from baseline 76 μmol/L). CT shows extensive gas within muscle compartments. Which statement best describes the optimal management approach?

A. Urgent surgical debridement combined with IV benzylpenicillin and clindamycin (Correct Answer)
B. IV piperacillin-tazobactam monotherapy with 24-hour surgical review
C. Hyperbaric oxygen therapy as primary treatment with delayed surgery
D. IV vancomycin and meropenem pending blood culture results
E. Immediate fasciotomy followed by IV flucloxacillin and metronidazole

Explanation: ***Urgent surgical debridement combined with IV benzylpenicillin and clindamycin***- The patient's presentation with **crepitus**, **woody induration**, **purple discoloration**, **necrosis**, and **gas in muscle compartments** in an intravenous drug user is highly suggestive of **clostridial myonecrosis** (gas gangrene).- **Urgent surgical debridement** is critical for source control and removal of necrotic tissue, while **benzylpenicillin** targets *Clostridium perfringens* and **clindamycin** provides an essential **antitoxin effect**, inhibiting bacterial protein synthesis and toxin production.*IV piperacillin-tazobactam monotherapy with 24-hour surgical review*- A 24-hour delay for surgical review is unacceptable in **gas gangrene**, which is a rapidly progressive, life-threatening emergency requiring **immediate surgical intervention**.- While piperacillin-tazobactam has broad-spectrum activity, it lacks the specific **antitoxin effect** of clindamycin, which is crucial for managing the severe systemic toxicity of clostridial infections.*Hyperbaric oxygen therapy as primary treatment with delayed surgery*- **Hyperbaric oxygen therapy** (HBO) can be a useful *adjunctive* treatment by inhibiting toxin production and bacterial growth in anaerobic conditions, but it is **not a primary treatment** and should never delay urgent surgical debridement.- The priority in **necrotizing soft tissue infections** is the immediate removal of necrotic tissue and source control, which only surgery can achieve.*IV vancomycin and meropenem pending blood culture results*- This regimen is broad but may not be optimal for *Clostridium perfringens*, and more importantly, **waiting for blood culture results** is dangerously delayed given the patient's presentation of **septic shock** and rapidly progressing infection.- **Empiric antibiotic therapy** for necrotizing soft tissue infection must be initiated immediately, targeting likely pathogens including anaerobes.*Immediate fasciotomy followed by IV flucloxacillin and metronidazole*- **Fasciotomy** primarily addresses compartment syndrome by relieving pressure; however, in **myonecrosis**, the muscle itself is necrotic, requiring **extensive surgical debridement** or amputation, not just incision of the fascia.- **Flucloxacillin** primarily covers Staphylococcus, which is not the main pathogen for gas gangrene, and while metronidazole covers anaerobes, it lacks the specific **antitoxin effect** of clindamycin.

Question 214: A hospital antimicrobial stewardship team reviews prescribing data and identifies that 35% of patients receiving carbapenems for Gram-negative infections have organisms that are susceptible to narrower-spectrum agents such as piperacillin-tazobactam or third-generation cephalosporins. Despite availability of culture results showing susceptibility patterns, prescribers continue broad-spectrum therapy. Which antimicrobial stewardship intervention would most effectively address this issue?

A. Implement automatic stop dates for all carbapenem prescriptions after 72 hours
B. Introduce mandatory infectious diseases consultation for all carbapenem prescriptions
C. Develop an automatic de-escalation alert system triggered by culture sensitivities (Correct Answer)
D. Restrict carbapenem prescribing to consultant-level authorization only
E. Provide annual antimicrobial stewardship training to all prescribers

Explanation: ***Develop an automatic de-escalation alert system triggered by culture sensitivities***- This intervention directly targets the specific problem identified by providing **real-time, point-of-care decision support** when culture results become available.- **De-escalation** is a core antimicrobial stewardship principle that reduces the selection pressure for **multi-drug resistant organisms** while maintaining clinical efficacy.*Implement automatic stop dates for all carbapenem prescriptions after 72 hours*- While **automatic stop dates** encourage the review of therapy, they do not provide specific guidance on which **narrower-spectrum agent** to switch to based on results.- This approach carries a risk of **treatment gaps** if the prescriber is busy and fails to manually re-order or adjust the antibiotic promptly.*Introduce mandatory infectious diseases consultation for all carbapenem prescriptions*- Mandatory consultations are highly effective but are **resource-intensive** and may cause significant delays in starting or adjusting therapy in a large hospital setting.- This intervention is often reserved for complex infections like **Staphylococcus aureus bacteremia** rather than routine de-escalation based on simple susceptibility.*Restrict carbapenem prescribing to consultant-level authorization only*- **Restrictive authorization** (front-end stewardship) primarily controls the initial empirical use of broad-spectrum drugs rather than the **back-end de-escalation** process.- It does not address the behavioral issue where clinicians continue broad-spectrum therapy even after meeting the criteria for **narrow-spectrum alternatives**.*Provide annual antimicrobial stewardship training to all prescribers*- **Educational interventions** are considered "passive" and are generally less effective at changing physician behavior compared to "active" clinical decision support systems.- Training lacks the **immediacy** required to prompt action at the specific moment a culture result is published and a decision needs to be made.

Question 215: A 53-year-old man with end-stage renal failure on haemodialysis presents with fever, rigors, and hypotension. His tunnelled dialysis catheter exit site shows erythema and purulent discharge. Blood cultures are taken and he is started on empirical antibiotics. The next day, blood cultures grow coagulase-negative Staphylococcus with intermediate glycopeptide resistance (vancomycin MIC 4 mg/L). The catheter is essential for dialysis access. What is the most appropriate definitive management?

A. Continue vancomycin and treat through the catheter for 14 days
B. Remove the catheter and treat with daptomycin for 14 days (Correct Answer)
C. Treat with linezolid orally for 14 days while retaining the catheter
D. Antibiotic lock therapy with vancomycin plus systemic gentamicin
E. Remove the catheter and treat with high-dose vancomycin for 6 weeks

Explanation: ***Remove the catheter and treat with daptomycin for 14 days*** - **Catheter removal** is mandatory due to **sepsis** (fever, rigors, hypotension) and local infection, indicating the catheter is the source and **source control** is critical. - **Daptomycin** is the appropriate bactericidal agent for treating bloodstream infections with **coagulase-negative Staphylococcus** that show **intermediate glycopeptide resistance** (vancomycin MIC 4 mg/L), as vancomycin is likely ineffective. *Continue vancomycin and treat through the catheter for 14 days* - Continuing **vancomycin** is inappropriate because an **MIC of 4 mg/L** indicates intermediate resistance, making clinical failure highly probable, especially in a severe infection. - Attempting to "treat through" a **tunneled catheter** is contraindicated in the presence of severe sepsis, hypotension, and purulent discharge at the exit site. *Treat with linezolid orally for 14 days while retaining the catheter* - **Linezolid** is generally bacteriostatic, and for severe **catheter-related bloodstream infections** with systemic signs, a bactericidal agent like daptomycin is often preferred. - **Retaining the catheter** prevents source control, which is essential for managing sepsis from an infected device, significantly increasing the risk of treatment failure and complications. *Antibiotic lock therapy with vancomycin plus systemic gentamicin* - **Antibiotic lock therapy** is typically reserved for uncomplicated infections where catheter salvage is attempted and is unsuitable for patients with **systemic instability** or purulent exit site infection. - The elevated **vancomycin MIC** makes vancomycin an ineffective choice for the lock, and systemic **gentamicin** carries a high risk of **ototoxicity** and nephrotoxicity in hemodialysis patients. *Remove the catheter and treat with high-dose vancomycin for 6 weeks* - High-dose **vancomycin** is unlikely to overcome an **MIC of 4 mg/L** and carries increased risk of toxicity without significantly improved efficacy against intermediate strains. - A **6-week duration** of antibiotics is excessive for an uncomplicated catheter-related bloodstream infection once the source is removed; it is reserved for complications like endocarditis or osteomyelitis.

Question 216: A 68-year-old man on a surgical ward develops hospital-acquired pneumonia and is started on IV piperacillin-tazobactam. After 3 days of treatment, sputum culture results become available showing Pseudomonas aeruginosa sensitive to piperacillin-tazobactam (MIC 8 mg/L), meropenem, gentamicin, and ciprofloxacin, but resistant to co-amoxiclav and ceftriaxone. The patient is clinically improving with decreasing oxygen requirements and falling inflammatory markers. According to antimicrobial stewardship principles, what is the most appropriate action?

A. Continue current therapy with piperacillin-tazobactam (Correct Answer)
B. Switch to meropenem as it has better pseudomonal activity
C. Switch to oral ciprofloxacin to facilitate earlier discharge
D. Add gentamicin to piperacillin-tazobactam for synergistic effect
E. Stop antibiotics as the patient is clinically improving

Explanation: ***Continue current therapy with piperacillin-tazobactam*** - The patient is showing **clinical improvement** and the organism is confirmed as **susceptible** to the current regimen, fulfilling core antimicrobial stewardship goals. - **Piperacillin-tazobactam** is a narrow-spectrum choice relative to carbapenems, and continuing it prevents unnecessary use of broader-spectrum agents. *Switch to meropenem as it has better pseudomonal activity* - **Meropenem** is a carbapenem that should be **reserved** for multi-drug resistant organisms or patients failing first-line therapy to prevent the development of resistance. - Escalating therapy when the patient is already improving on a susceptible agent violates **stewardship principles**. *Switch to oral ciprofloxacin to facilitate earlier discharge* - While **IV-to-oral switch** is a stewardship goal, it is premature as the patient still has **oxygen requirements**, indicating he is not yet stable for discharge. - Ciprofloxacin is a potent **fluoroquinolone** and its premature use can drive resistance in *Pseudomonas* populations if the infection is not adequately controlled. *Add gentamicin to piperacillin-tazobactam for synergistic effect* - **Double coverage** for *Pseudomonas* is generally not recommended once sensitivities are known and the patient is showing signs of **clinical recovery**. - Adding an **aminoglycoside** like gentamicin increases the risk of **nephrotoxicity** and ototoxicity without providing additional clinical benefit in this scenario. *Stop antibiotics as the patient is clinically improving* - Stopping therapy after only **3 days** for *Pseudomonas aeruginosa* pneumonia is inadequate; standard courses usually last **7 days** or more depending on severity. - Premature cessation of antibiotics in a confirmed Gram-negative pneumonia carries a high risk of **relapse** and treatment failure.

Question 217: A 42-year-old woman presents to A&E with a 2-day history of pain, swelling, and redness around a cat bite on her right hand sustained 48 hours ago. The wound was initially cleaned at home. On examination, the dorsum of the hand is swollen, erythematous, and tender with purulent discharge from the bite wound. She is apyrexial but has reduced range of movement in her fingers due to swelling. What is the most appropriate antibiotic choice?

A. Flucloxacillin 500 mg four times daily
B. Co-amoxiclav 625 mg three times daily (Correct Answer)
C. Doxycycline 100 mg twice daily
D. Clarithromycin 500 mg twice daily
E. Metronidazole 400 mg three times daily

Explanation: ***Co-amoxiclav 625 mg three times daily***- This is the first-line treatment for **cat bites** as it provides broad-spectrum coverage against **Pasteurella multocida**, **Staphylococcus aureus**, and **anaerobes** found in feline oral flora.- It is highly effective in preventing and treating the rapid-onset cellulitis often seen with **Pasteurella**, which is a common pathogen in over 50% of cat bite infections.*Flucloxacillin 500 mg four times daily*- This antibiotic is excellent for typical skin infections caused by **Staphylococcus** or **Streptococcus** but lacks activity against **Pasteurella multocida**.- Using this alone in a cat bite scenario significantly increases the risk of treatment failure and progression to deep-tissue infection.*Doxycycline 100 mg twice daily*- While it has activity against **Pasteurella**, it is typically reserved as an alternative for patients with a **penicillin allergy**.- It has inferior efficacy compared to co-amoxiclav for the mixed aerobic and anaerobic populations common in animal bites.*Clarithromycin 500 mg twice daily*- This macrolide has variable and often inadequate activity against **Pasteurella multocida** and common oral anaerobes.- It is not recommended as a first-line or primary monotherapy for hand infections resulting from animal bites.*Metronidazole 400 mg three times daily*- This provides excellent coverage for **strict anaerobes** but has no activity against **aerobic organisms** like Pasteurella or Staphylococcus.- It must be used in combination with another agent (like doxycycline) if a penicillin allergy is present, but is inappropriate as monotherapy here.

Question 218: A 51-year-old man with poorly controlled type 2 diabetes (HbA1c 96 mmol/mol) presents to the Emergency Department with a 3-day history of severe pain, swelling, and discharge from his right foot. Examination reveals a deep ulcer on the plantar surface with visible bone, surrounding erythema extending 5 cm from the wound edge, and purulent discharge. X-ray shows soft tissue gas and bony destruction. Temperature is 38.6°C, heart rate 104 bpm, and blood pressure 118/72 mmHg. What is the most appropriate initial antibiotic regimen?

A. Oral co-amoxiclav 625 mg three times daily
B. IV flucloxacillin 2 g four times daily plus IV metronidazole 500 mg three times daily
C. IV piperacillin-tazobactam 4.5 g three times daily (Correct Answer)
D. IV teicoplanin 400 mg twice daily plus oral ciprofloxacin 500 mg twice daily
E. Oral doxycycline 100 mg twice daily plus oral metronidazole 400 mg three times daily

Explanation: ***IV piperacillin-tazobactam 4.5 g three times daily***- This patient presents with a **severe diabetic foot infection (DFI)** complicated by **osteomyelitis** (visible bone) and systemic inflammatory response; broad-spectrum IV antibiotics covering **Gram-positives, Gram-negatives, and anaerobes** are essential.- **Piperacillin-tazobactam** provides the necessary empirical coverage for multi-organism infections common in deep diabetic ulcers, including **Pseudomonas** and the gas-forming anaerobes suggested by the X-ray.*Oral co-amoxiclav 625 mg three times daily*- **Oral therapy** is inadequate for a severe infection with **systemic symptoms** (fever, tachycardia) and underlying bone involvement.- While co-amoxiclav has broad activity, the severity and depth of the infection necessitate **intravenous** administration to ensure adequate tissue penetration.*IV flucloxacillin 2 g four times daily plus IV metronidazole 500 mg three times daily*- This regimen lacks sufficient **Gram-negative coverage**, which is required for complex, chronic diabetic foot ulcers.- **Flucloxacillin** is excellent for Staphylococcus, but severe DFIs are often **polymicrobial**, requiring broader agents like piperacillin-tazobactam.*IV teicoplanin 400 mg twice daily plus oral ciprofloxacin 500 mg twice daily*- While this combination offers MRSA and Gram-negative coverage, **ciprofloxacin** provides unreliable **anaerobic coverage**, which is crucial when soft tissue gas is present.- This is generally reserved as a second-line option for patients with **penicillin allergies** rather than first-line empirical therapy.*Oral doxycycline 100 mg twice daily plus oral metronidazole 400 mg three times daily*- This **low-potency oral regimen** is entirely inappropriate for a limb-threatening infection with **radiological evidence of bone destruction**.- Severe infections with **hemodynamic changes** or SIRS criteria require immediate hospitalization and **high-dose parenteral** antibiotics.

Question 219: A 29-year-old woman with no past medical history presents to her GP with a painful red lump on her inner thigh that has been present for 3 days. On examination, there is a 3 cm fluctuant, erythematous swelling with a central punctum. She is apyrexial with no signs of spreading infection. She asks if she needs antibiotics. What is the most appropriate initial management?

A. Prescribe flucloxacillin 500 mg four times daily for 7 days
B. Arrange same-day referral for incision and drainage without antibiotics (Correct Answer)
C. Prescribe warm compress application and safety-netting advice only
D. Prescribe topical fusidic acid three times daily for 5 days
E. Prescribe co-amoxiclav 625 mg three times daily for 5 days

Explanation: ***Arrange same-day referral for incision and drainage without antibiotics*** - The presence of a **fluctuant swelling** with a **central punctum** indicates a localized abscess (e.g., a furuncle), for which **incision and drainage** is the definitive treatment to remove the source of infection. - In a systemically well patient without signs of **spreading infection** or fever, antibiotics are generally not required, as they poorly penetrate the walled-off abscess cavity. *Prescribe flucloxacillin 500 mg four times daily for 7 days* - Antibiotics cannot effectively penetrate a **walled-off abscess cavity**, making medical management alone insufficient for a fluctuant lesion requiring **source control**. - Prescribing antibiotics for simple abscesses without systemic features contributes to **antimicrobial resistance** and is not recommended by stewardship guidelines. *Prescribe warm compress application and safety-netting advice only* - While warm compresses may help early-stage boils, they are inadequate once the lesion is **fluctuant** and 3 cm in size, indicating a mature abscess. - Delaying drainage of a confirmed abscess can lead to increased pain and potential complications such as **spontaneous rupture** or further spread. *Prescribe topical fusidic acid three times daily for 5 days* - **Topical antibiotics** are indicated for superficial infections like **impetigo** but lack the penetration to treat deep-seated dermal abscesses. - Management of a furuncle requires physical evacuation of the **purulent material**, which a topical cream cannot achieve. *Prescribe co-amoxiclav 625 mg three times daily for 5 days* - Co-amoxiclav is an unnecessarily **broad-spectrum** antibiotic for a common skin infection typically caused by *Staphylococcus aureus* in a healthy individual. - Like flucloxacillin, it is not a substitute for **surgical drainage** when fluctuance is clinically evident, as antibiotics alone are often ineffective for established abscesses.

Question 220: A 70-year-old man with type 2 diabetes presents with a rapidly spreading erythematous rash on his left leg associated with haemorrhagic bullae. The infection started 18 hours ago following a minor abrasion sustained while fishing in coastal waters. He appears toxic with temperature 38.9°C, heart rate 118 bpm, and blood pressure 92/58 mmHg. The affected area has crepitus on palpation. Which organism is most likely responsible for this presentation?

A. Vibrio vulnificus (Correct Answer)
B. Clostridium perfringens
C. Streptococcus pyogenes
D. Aeromonas hydrophila
E. Staphylococcus aureus

Explanation: ***Vibrio vulnificus***- This organism is strongly associated with **coastal waters** and marine environments, causing rapid, fulminant **necrotizing soft tissue infections** following minor skin abrasions.- Classic clinical hallmarks include **haemorrhagic bullae**, rapid progression to **sepsis**, and a higher risk in patients with **type 2 diabetes** or liver disease.*Clostridium perfringens*- While it causes **gas gangrene** and **crepitus** due to gas production, it is typically associated with **dirty traumatic wounds** or soil exposure rather than coastal water.- It progresses rapidly but lacks the specific epidemiological link to **marine environments** seen in this case.*Streptococcus pyogenes*- A common cause of **necrotizing fasciitis** (Type II), it usually presents with severe pain out of proportion to exam findings and rapid erythema.- Unlike this patient's presentation, it rarely produces **crepitus** because it is not a gas-forming organism.*Aeromonas hydrophila*- This pathogen causes aggressive soft tissue infections and **necrotizing fasciitis** specifically following exposure to **freshwater** or brackish water.- Although it presents similarly to Vibrio, the patient's exposure to **coastal waters** makes Vibrio vulnificus the more likely diagnosis.*Staphylococcus aureus*- Typically causes localized infections like **abscesses**, cellulitis, or **scalded skin syndrome**, rather than sudden-onset necrotizing infection with gas formation.- It does not usually present with **crepitus** or follow a specific pattern of **marine water** exposure.

Question 221: A 56-year-old woman is being treated for hospital-acquired pneumonia on the medical ward. She has been on intravenous co-amoxiclav for 4 days and shows clinical improvement with defervescence, improving inflammatory markers (CRP decreased from 185 to 62 mg/L), and no oxygen requirement. She is eating and drinking normally. According to the 'Start Smart - Then Focus' antimicrobial stewardship strategy, what is the most appropriate next step in her management?

A. Continue IV co-amoxiclav until CRP normalizes completely
B. Switch to oral co-amoxiclav and plan discharge with community follow-up (Correct Answer)
C. Stop antibiotics as she has completed 4 days of therapy
D. Continue IV co-amoxiclav for a total of 10 days as per protocol
E. Switch to IV ceftriaxone for improved tissue penetration

Explanation: ***Switch to oral co-amoxiclav and plan discharge with community follow-up*** - The patient exhibits clear **clinical improvement**, including defervescence, no oxygen requirement, and normal oral intake, which are key criteria for an **IV-to-oral switch (IVOS)** under the 'Start Smart - Then Focus' strategy. - Her **inflammatory markers are declining**, indicating a positive response to therapy, making it safe to step down to oral antibiotics and plan for **hospital discharge** with appropriate follow-up. *Continue IV co-amoxiclav until CRP normalizes completely* - It is not necessary to wait for **CRP to fully normalize** before switching to oral therapy; significant clinical improvement and a **downward trend** are usually sufficient. - Prolonging **intravenous access** unnecessarily increases the risk of **catheter-related complications** like phlebitis or infection. *Stop antibiotics as she has completed 4 days of therapy* - Hospital-acquired pneumonia typically requires a **longer course** of antibiotics, generally 5-7 days or more, and stopping at 4 days is often **premature** and risks treatment failure or relapse. - The 'Focus' part of antimicrobial stewardship involves optimizing therapy, not necessarily stopping it early without clinical justification for a completed course. *Continue IV co-amoxiclav for a total of 10 days as per protocol* - Modern antimicrobial stewardship guidelines advocate for the **shortest effective course** of antibiotics, and a fixed 10-day IV course for a clinically improving patient with uncomplicated HAP is often **excessive**. - Maintaining **IV therapy** longer than necessary delays discharge and contributes to **antimicrobial resistance** and healthcare costs. *Switch to IV ceftriaxone for improved tissue penetration* - The patient is already responding well to **IV co-amoxiclav**, making a switch to another IV antibiotic unnecessary and unjustified without new clinical deterioration or specific microbiological indications. - Co-amoxiclav provides a **broad spectrum** of activity, including against beta-lactamase-producing bacteria, which is appropriate for HAP, and changing to ceftriaxone may not offer additional benefit or could even be less appropriate depending on local epidemiology.

Question 222: A 47-year-old homeless patient presents with an abscess on the left buttock. Following incision and drainage, Gram stain shows Gram-positive cocci in clusters, and culture subsequently grows methicillin-resistant Staphylococcus aureus (MRSA). The patient is systemically well with no fever. What is the most appropriate antimicrobial management according to current UK guidelines?

A. No antibiotics required; incision and drainage is sufficient (Correct Answer)
B. Oral doxycycline 100 mg twice daily for 7 days
C. Intravenous vancomycin for 2 weeks
D. Oral co-trimoxazole 960 mg twice daily for 14 days
E. Topical mupirocin applied three times daily for 5 days

Explanation: ***No antibiotics required; incision and drainage is sufficient*** - For a simple, localized **skin abscess** in a patient who is **systemically well** with no signs of spreading infection, **incision and drainage (I&D)** is the definitive and often sufficient treatment. - UK guidelines (e.g., NICE/PHE) emphasize that routine antibiotic use is **not recommended** for simple abscesses, even if **MRSA** is isolated, unless there are signs of **systemic illness**, extensive **cellulitis**, or **immunocompromise**. *Oral doxycycline 100 mg twice daily for 7 days* - While **doxycycline** is an effective oral antibiotic against many strains of **community-acquired MRSA**, it is unnecessary for a simple, drained abscess in an otherwise healthy patient. - Prescribing antibiotics in such cases contributes to **antimicrobial resistance** and is contrary to antimicrobial stewardship principles. *Intravenous vancomycin for 2 weeks* - **Intravenous vancomycin** is a powerful antibiotic reserved for **severe MRSA infections**, such as **sepsis**, **osteomyelitis**, or deep-seated infections that require parenteral therapy. - Using such a potent agent for a localized, drained skin lesion is inappropriate, carries risks of **adverse effects** (e.g., nephrotoxicity), and promotes **vancomycin resistance**. *Oral co-trimoxazole 960 mg twice daily for 14 days* - **Co-trimoxazole (trimethoprim/sulfamethoxazole)** is active against many **MRSA strains** and can be used for skin and soft tissue infections when indicated. - However, as with other oral antibiotics, it is not required for a simple, drained abscess in a systemically well patient, and a **14-day course** is an excessive duration for this condition. *Topical mupirocin applied three times daily for 5 days* - **Topical mupirocin** is primarily used for **MRSA decolonization** (e.g., nasal carriage) or for superficial skin infections like impetigo. - It is **ineffective for treating an abscess** as it does not achieve adequate **tissue penetration** to treat the deep-seated infection within the walled-off cavity.

Question 223: A 63-year-old man with chronic kidney disease (eGFR 28 mL/min/1.73m²) is admitted with community-acquired pneumonia. The medical team prescribes gentamicin as part of his treatment regimen. According to antimicrobial stewardship principles, what is the most important monitoring requirement for this patient?

A. Daily serum creatinine and pre-dose gentamicin levels (Correct Answer)
B. Liver function tests every 48 hours
C. Audiometry before and after treatment course
D. Daily full blood count monitoring
E. Twice-weekly electrocardiogram monitoring

Explanation: ***Daily serum creatinine and pre-dose gentamicin levels*** - **Aminoglycosides** like **gentamicin** are primarily excreted by the kidneys and have a narrow **therapeutic index**, making daily **serum creatinine** monitoring vital in patients with **chronic kidney disease** (CKD). - **Trough (pre-dose) levels** must be measured to prevent accumulation and minimize the risk of dose-dependent **nephrotoxicity** and ototoxicity. *Liver function tests every 48 hours* - Gentamicin is not metabolized by the liver, so it does not typically cause **hepatotoxicity**. - Routine **liver function tests** are not a standard stewardship requirement for aminoglycoside therapy unless other hepatotoxic drugs are being administered. *Audiometry before and after treatment course* - While **ototoxicity** is a known side effect of gentamicin, **audiometry** is rarely practical or routinely required in acute clinical settings like community-acquired pneumonia. - Monitoring **drug levels** is the primary method used to mitigate the risk of vestibular and cochlear damage. *Daily full blood count monitoring* - Gentamicin does not commonly cause **bone marrow suppression** or significant changes in the **full blood count** (FBC). - FBC may be monitored to track the resolution of the **infection** (e.g., white cell count), but it is not specific to gentamicin safety monitoring. *Twice-weekly electrocardiogram monitoring* - Unlike fluoroquinolones or macrolides, gentamicin is not associated with **QTc prolongation** or other significant cardiac conduction issues. - Routine **ECG monitoring** is not indicated for patients receiving aminoglycoside therapy.

Question 224: A 34-year-old woman presents to the Emergency Department with a 5-day history of worsening pain and redness on her right shin following a minor cut while gardening. On examination, there is a well-demarcated area of erythema measuring 15×10 cm with associated warmth and tenderness. Her temperature is 37.8°C, heart rate 92 bpm, and blood pressure 128/76 mmHg. Blood tests show WCC 11.2×10⁹/L and CRP 45 mg/L. Which antibiotic is the most appropriate first-line treatment for this condition?

A. Flucloxacillin 500 mg four times daily (Correct Answer)
B. Co-amoxiclav 625 mg three times daily
C. Ciprofloxacin 500 mg twice daily
D. Clindamycin 300 mg four times daily
E. Cefuroxime 500 mg twice daily

Explanation: ***Flucloxacillin 500 mg four times daily*** - **Flucloxacillin** is the recommended first-line treatment for uncomplicated **cellulitis** as it provides narrow-spectrum coverage against the most common pathogens, **Staphylococcus aureus** and **Streptococcus pyogenes**. - The clinical presentation of **erythema**, warmth, and tenderness following a minor skin break is classic for cellulitis, and flucloxacillin effectively targets the **penicillinase-producing staphylococci** involved. *Co-amoxiclav 625 mg three times daily* - This provides broad-spectrum coverage, including **anaerobes** and **Gram-negative bacilli**, which is unnecessary for simple, uncomplicated cellulitis. - It is typically reserved for cellulitis caused by **animal/human bites** or infections in the vicinity of the **facial sinuses**. *Ciprofloxacin 500 mg twice daily* - This fluoroquinolone has excellent activity against **Gram-negative organisms** but has notoriously poor coverage against **Gram-positive cocci** like staphylococci and streptococci. - It is not indicated for skin and soft tissue infections unless **Pseudomonas aeruginosa** is suspected, usually in specific contexts like chronic ulcers. *Clindamycin 300 mg four times daily* - This is an appropriate alternative for patients with a **penicillin allergy**, but it is not the first-line choice for the general population. - It carries a higher risk of associated **Clostridioides difficile** infection compared to narrow-spectrum penicillins. *Cefuroxime 500 mg twice daily* - This is a **second-generation cephalosporin** that is generally considered second-line for skin infections compared to flucloxacillin. - While it has some efficacy, narrow-spectrum agents are preferred to promote **antimicrobial stewardship** and reduce the development of resistance.

Question 225: A hospital implements a new antimicrobial stewardship policy requiring all prescriptions of meropenem to be reviewed by the microbiology team within 48 hours of initiation. Three months post-implementation, audit data shows meropenem consumption has decreased by 35%, with no increase in mortality or clinical deterioration rates. However, compliance with the 48-hour review remains at only 55%. Analyzing this data, what conclusion can be most reasonably drawn?

A. The intervention has failed as compliance is below 60%
B. The 48-hour review requirement should be abandoned due to poor compliance
C. The intervention is successful but requires measures to improve compliance further (Correct Answer)
D. Meropenem prescribing should be completely restricted to infectious diseases consultants
E. The reduction in meropenem use suggests patients are being undertreated

Explanation: ***The intervention is successful but requires measures to improve compliance further*** - A **35% reduction** in meropenem consumption without an increase in **mortality or clinical deterioration** demonstrates that the policy is achieving its intended stewardship goals and improving safety. - Since the outcome measures are positive despite only **55% compliance**, the intervention is effective but needs process optimization to reach its full potential and ensure **sustainability**. *The intervention has failed as compliance is below 60%* - Failure in quality improvement is defined by a lack of **improved clinical or process outcomes**, whereas this case shows a significant **reduction in antibiotic use**. - Low **compliance rates** indicate a need for process refinement, not that the entire intervention is unsuccessful or clinically ineffective. *The 48-hour review requirement should be abandoned due to poor compliance* - Abandoning the policy would likely revert **meropenem consumption** back to high levels, losing the **antimicrobial stewardship** benefits achieved. - Quality improvement focuses on **iterative cycles** (PDSA) to address barriers to compliance rather than discarding effective clinical policies. *Meropenem prescribing should be completely restricted to infectious diseases consultants* - While **complete restriction** might lower consumption further, the current data shows the policy is already working well with a **collaborative review model**. - This approach may be **unnecessary** and could cause dangerous delays in treating critically ill patients who require immediate broad-spectrum coverage. *The reduction in meropenem use suggests patients are being undertreated* - The audit data specifically mentions there was **no increase in mortality** or clinical deterioration, which directly refutes the concern of **undertreatment**. - Successful stewardship aims to reduce **inappropriate broad-spectrum use**, and these results suggest that the saved doses were likely unnecessary for clinical recovery.

Question 226: A 41-year-old man with recurrent skin abscesses presents for the fourth time in 8 months. Previous swabs have grown methicillin-sensitive Staphylococcus aureus (MSSA). Each abscess has been incised and drained successfully. He has no underlying medical conditions. Screening reveals he is a nasal carrier of MSSA. Which intervention is most likely to reduce recurrence?

A. Long-term prophylactic oral flucloxacillin
B. Decolonization regimen with nasal mupirocin and chlorhexidine body washes (Correct Answer)
C. Monthly intramuscular benzathine penicillin
D. Four-week course of oral rifampicin and fusidic acid
E. Excision of all previous abscess sites

Explanation: ***Decolonization regimen with nasal mupirocin and chlorhexidine body washes*** - Recurrent **Staphylococcus aureus** infections are strongly associated with **nasal carriage**, where the nares act as a reservoir for self-infection. - **Mupirocin** nasal ointment and **chlorhexidine** washes are the first-line intervention to eliminate colonization and significantly reduce the frequency of future abscesses. *Long-term prophylactic oral flucloxacillin* - Long-term use of oral antibiotics is generally avoided due to the significant risk of developing **antimicrobial resistance**. - This approach treats the symptoms rather than addressing the root cause of **colonization** in the nasal passages. *Monthly intramuscular benzathine penicillin* - This treatment is primarily used for **rheumatic fever prophylaxis** to prevent recurrent Group A Streptococcus infections. - It is ineffective against **methicillin-sensitive Staphylococcus aureus (MSSA)**, which produces beta-lactamases that degrade penicillin. *Four-week course of oral rifampicin and fusidic acid* - These medications are typically reserved for **MRSA decolonization** or as specialized therapy for deep-seated infections after primary methods fail. - Using them for simple MSSA skin infections promotes **resistance** and is not recommended as an initial recurrence prevention strategy. *Excision of all previous abscess sites* - This surgical approach is used for conditions like **hidradenitis suppurativa**, not for simple recurrent staphylococcal abscesses. - Recurrence in this patient is due to **bacterial carriage** on the skin and nares, so removing scar tissue from healed sites provides no benefit.

Question 227: A 59-year-old diabetic man is admitted with a severe diabetic foot infection involving the plantar aspect of his left foot with tracking infection along tendon sheaths. MRI confirms osteomyelitis of the 2nd and 3rd metatarsals. Deep tissue samples are sent for culture. He undergoes surgical debridement. Which antibiotic duration is most appropriate for definitive treatment of his osteomyelitis following adequate surgical debridement?

A. 2 weeks of intravenous antibiotics only
B. 4 weeks of oral antibiotics following initial IV therapy
C. 6 weeks total antibiotic therapy (IV followed by oral) (Correct Answer)
D. 3 months of oral suppressive therapy
E. 12 weeks of combination intravenous therapy

Explanation: ***6 weeks total antibiotic therapy (IV followed by oral)***- A minimum of **6 weeks** of antibiotic therapy is the standard recommended duration for **osteomyelitis** to ensure resolution and prevent recurrence, especially when adequate surgical debridement is performed.- Current guidelines, including those from the **Infectious Diseases Society of America (IDSA)**, support an initial course of IV therapy followed by a transition to **oral antibiotics** with high bioavailability once the patient is clinically stable.*2 weeks of intravenous antibiotics only*- A duration of **2 weeks** is generally insufficient for treating **bone infections**, as it is associated with a high rate of treatment failure and **relapse**.- This short duration is only typically considered if the entire infected bone has been completely removed (e.g., via **amputation** or complete **resection**) with clear margins.*4 weeks of oral antibiotics following initial IV therapy*- While the route (initial IV followed by oral) is appropriate, the total duration would likely fall short of the required **6-week minimum** necessary for deep-seated **metatarsal osteomyelitis**.- Inadequate duration increases the risk of developing **chronic osteomyelitis** and the need for subsequent surgical interventions or amputations.*3 months of oral suppressive therapy*- **Suppressive therapy** is usually reserved for complex cases where **surgical debridement** is not possible or residual infection remains, which is not the primary approach for a curable initial episode.- Standard treatment for an initial episode of diabetic foot osteomyelitis with adequate debridement focuses on **curative intent** rather than long-term suppression.*12 weeks of combination intravenous therapy*- **12 weeks** of therapy is unnecessarily long for a standard case of osteomyelitis following adequate debridement and increases the risk of **antibiotic-associated complications** (e.g., *C. difficile* infection, nephrotoxicity) or catheter-related infections.- Continuous **intravenous therapy** for this duration is typically not required as studies like the **OVIVA trial** have demonstrated that oral therapy is non-inferior to IV therapy for complex orthopedic infections after initial stabilization.

Question 228: A 37-year-old woman develops a perianal abscess. She undergoes incision and drainage, and tissue culture grows mixed anaerobes including Bacteroides fragilis and Peptostreptococcus species. She is systemically well post-procedure. Her consultant questions whether post-drainage antibiotics are indicated. Which factor would most strongly support the use of post-operative antibiotics in this case?

A. Growth of anaerobic organisms on culture
B. Female gender and perianal location
C. Presence of surrounding cellulitis or systemic signs of infection (Correct Answer)
D. Age under 40 years
E. Mixed growth of multiple organisms

Explanation: ***Presence of surrounding cellulitis or systemic signs of infection***- Antibiotics are indicated when infection extends beyond the abscess cavity into adjacent tissues, as evidenced by **cellulitis**, or if there are systemic signs like **fever**, **tachycardia**, or **sepsis**.- Incision and drainage (**I&D**) is the primary treatment for abscesses; antibiotics are an adjunct only in high-risk patients, those with spreading **tissue infection**, or systemic inflammatory response. *Growth of anaerobic organisms on culture*- The presence of **Bacteroides fragilis** and other anaerobes is expected in the perianal region due to proximity to normal **gastrointestinal flora**.- Culture results alone do not justify antibiotics if **source control** (drainage) has been successfully achieved and the patient is **systemically well**. *Female gender and perianal location*- Neither **gender** nor the anatomical location of a **simple perianal abscess** are independent indications for post-operative antimicrobial therapy.- Treatment protocols depend on the **clinical severity** and the patient's overall **immune status** rather than demographic factors. *Age under 40 years*- Age is not a primary determinant for antibiotic use in skin and soft tissue infections unless the patient is at the **extremes of age** or has significant **comorbidities**.- Younger, otherwise healthy patients typically have more robust immune responses, making them **less likely** to require antibiotics after successful drainage. *Mixed growth of multiple organisms*- **Polymicrobial growth** is a hallmark of perianal infections and does not inherently change the management if the patient is **systemically well** and the abscess has been drained.- Antibiotic stewardship guidelines emphasize treating the patient's **clinical presentation** and ensuring source control rather than solely focusing on **microbiological findings** from an abscess cavity.

Question 229: A 48-year-old man presents with a painful, red, swollen right lower leg. The affected area has a well-demarcated, raised border that is advancing rapidly. He reports fever and rigors. Examination reveals a bright red, indurated area with a sharply defined, elevated edge on the anterior shin. His temperature is 38.9°C. He has a history of chronic lymphoedema affecting both legs. What is the most likely diagnosis?

A. Cellulitis
B. Erysipelas (Correct Answer)
C. Superficial thrombophlebitis
D. Necrotising fasciitis
E. Contact dermatitis

Explanation: ***Erysipelas***- Erysipelas is a superficial skin infection of the dermis and **upper lymphatics** characterized by a **well-demarcated**, raised, bright red border.- It is most commonly caused by **Streptococcus pyogenes** (Group A Streptococcus) and frequently presents with systemic symptoms like **high fever and rigors**.*Cellulitis*- Unlike erysipelas, cellulitis involves the **deeper dermis** and subcutaneous fat, resulting in a **poorly defined**, non-raised border.- The absence of a **sharply demarcated** edge in cellulitis is the primary clinical feature used to distinguish it from the case described.*Superficial thrombophlebitis*- This condition typically presents as a **palpable, tender, cord-like** structure along the distribution of a superficial vein.- While it causes localized redness and pain, it lacks the **raised, rapidly advancing border** and systemic toxicity seen in erysipelas.*Necrotising fasciitis*- This is a surgical emergency characterized by systemic toxicity, **pain out of proportion** to clinical findings, and potential **crepitus** or skin necrosis.- While serious, it does not typically present with the **well-demarcated, superficial bright red** appearance characteristic of erysipelas.*Contact dermatitis*- This is an inflammatory reaction to an allergen or irritant that usually presents with **intense pruritus** (itching) and localized vesicles rather than fever.- It lacks the **systemic inflammatory response** (high fever, rigors) and the rapidly spreading bacterial infection pattern seen in this patient.

Question 230: According to Public Health England guidance on antimicrobial stewardship, which of the following interventions has the strongest evidence base for reducing antimicrobial resistance in secondary care settings?

A. Automatic stop dates on all antimicrobial prescriptions
B. Educational outreach visits to prescribers
C. Restriction of carbapenem use to infectious diseases specialists only
D. Multifaceted antimicrobial stewardship programmes incorporating audit, formulary restriction, and clinical decision support (Correct Answer)
E. Monthly feedback of individual prescriber data compared to peers

Explanation: ***Multifaceted antimicrobial stewardship programmes incorporating audit, formulary restriction, and clinical decision support*** - Evidence from **Public Health England** and systematic reviews shows that **multifaceted interventions** are the most effective way to reduce resistance and improve prescribing in hospitals. - Combining approaches like **prospective audit**, **formulary restriction**, and **clinical decision support** creates reinforcing mechanisms that yield stronger, more sustainable outcomes than single interventions. *Automatic stop dates on all antimicrobial prescriptions* - While **automatic stop dates** help prevent unnecessarily prolonged courses, they are considered a single-component structural intervention. - On their own, they are less effective than **comprehensive programmes** that include clinical review and evidence-based feedback. *Educational outreach visits to prescribers* - **Educational outreach** can improve knowledge and individual practice but is often insufficient to change long-term institutional prescribing patterns in isolation. - These visits are most effective when integrated into a broader **clinical decision support** strategy rather than standing alone. *Restriction of carbapenem use to infectious diseases specialists only* - **Formulary restriction** is a powerful tool for controlling specific high-risk drugs, but focusing on a single class does not address systemic resistance issues broadly. - Restrictive policies work best when supported by **audit and feedback** rather than acting as a solo administrative hurdle. *Monthly feedback of individual prescriber data compared to peers* - **Peer-comparison feedback** is a behavioral nudge that can reduce prescriptions, but its impact in secondary care is often limited without **guideline support**. - This intervention is a component of a stewardship programme but lacks the **multifaceted synergy** required for the strongest evidence base.

Question 231: A 73-year-old care home resident develops urinary symptoms and is found to have 10⁵ CFU/mL of Escherichia coli sensitive to trimethoprim, nitrofurantoin, and ciprofloxacin but resistant to co-amoxiclav on urine culture. She was treated with co-amoxiclav by her GP two weeks ago for a chest infection. She is clinically well with no fever. According to antimicrobial stewardship principles, what is the most appropriate management?

A. Prescribe oral trimethoprim based on sensitivities
B. No antibiotic treatment required as she is asymptomatic (Correct Answer)
C. Prescribe ciprofloxacin as first-line therapy
D. Repeat urine culture in one week before deciding on treatment
E. Prescribe nitrofurantoin despite care home residence

Explanation: ***No antibiotic treatment required as she is asymptomatic*** - This patient presents with **asymptomatic bacteriuria** (ASB), characterized by significant bacterial counts in urine without clinical symptoms like fever or dysuria. - According to **antimicrobial stewardship** principles, ASB in elderly non-pregnant individuals should not be treated with antibiotics to prevent **antimicrobial resistance** and potential side effects such as **C. difficile infection**. *Prescribe oral trimethoprim based on sensitivities* - While the organism is sensitive, initiating antibiotics for **asymptomatic bacteriuria** is inappropriate and contrary to **antimicrobial stewardship** guidelines. - Unnecessary antibiotic use increases the risk of selecting for **resistant organisms** and potential adverse drug reactions, especially in an elderly patient with recent antibiotic exposure. *Prescribe ciprofloxacin as first-line therapy* - **Ciprofloxacin** is a **broad-spectrum fluoroquinolone** generally reserved for severe or complicated infections due to its potential for **collateral damage** and promotion of **resistance**. - Using it for asymptomatic bacteriuria is a misuse of a vital antibiotic class and carries a higher risk of adverse effects in the elderly. *Repeat urine culture in one week before deciding on treatment* - Repeating the culture is unlikely to change management as **asymptomatic bacteriuria** often persists, and the key determinant for treatment is the presence of **clinical symptoms**, which are absent here. - This approach delays appropriate management (no treatment) and does not align with the principle of avoiding unnecessary investigations and interventions in an asymptomatic patient. *Prescribe nitrofurantoin despite care home residence* - **Nitrofurantoin** is an appropriate choice for symptomatic uncomplicated UTIs, but this patient is **asymptomatic**. - **NICE guidelines** specifically advise against screening for and treating bacteriuria in **care home residents** without symptoms, as it does not improve outcomes and contributes to antibiotic resistance.

Question 232: A 56-year-old man with a history of intravenous drug use presents with painful swelling and erythema of his left hand following injection into the dorsum. X-ray shows soft tissue swelling and subcutaneous gas. Blood tests reveal WCC 22 × 10⁹/L, CRP 312 mg/L, and creatine kinase 4,500 U/L. On examination, the hand is tense, dusky in colour, and exquisitely tender. Which combination of organisms is most likely responsible?

A. Staphylococcus aureus and Streptococcus pyogenes (Correct Answer)
B. Clostridium perfringens and Clostridium septicum
C. Pseudomonas aeruginosa and Acinetobacter baumannii
D. Escherichia coli and Klebsiella pneumoniae
E. Bacteroides fragilis and Peptostreptococcus species

Explanation: ***Staphylococcus aureus and Streptococcus pyogenes*** - This presentation of rapidly progressing, severe soft tissue infection with **subcutaneous gas**, markedly elevated **creatine kinase (CK)**, and high inflammatory markers in an **intravenous drug user (IVDU)** is highly suggestive of **Type II necrotising fasciitis**. - **S. aureus** and **S. pyogenes** (Group A Streptococcus) are the most common causative organisms in **Type II necrotising fasciitis**, often entering through skin breaches like injection sites. *Clostridium perfringens and Clostridium septicum* - These are the classic causes of **gas gangrene (clostridial myonecrosis)**, which involves deep muscle necrosis and significant gas production. - While they cause gas, their primary association is with deep traumatic wounds contaminated with soil or gut perforation, rather than typical IVDU-related superficial soft tissue infections. *Pseudomonas aeruginosa and Acinetobacter baumannii* - These are **gram-negative organisms** often associated with **nosocomial infections**, contaminated water sources, or infections in immunocompromised patients. - They are less common as primary agents in **community-acquired necrotising fasciitis** or acute IVDU-related infections, especially with this specific presentation of subcutaneous gas and high CK. *Escherichia coli and Klebsiella pneumoniae* - These are common **Enterobacteriaceae** associated with **Type I necrotising fasciitis**, which is typically **polymicrobial** and often occurs in the trunk, perineum (**Fournier's gangrene**), or in patients with underlying conditions. - While Type I can produce gas, this patient's presentation with a clear injection site and specific clinical picture (rapid onset, dusky hand, high CK) is more characteristic of Type II, which is typically monomicrobial or involves skin flora. *Bacteroides fragilis and Peptostreptococcus species* - These are **anaerobic bacteria** commonly involved in **polymicrobial infections** and are major components of **Type I necrotising fasciitis**, often originating from gut flora. - They are unlikely to be the sole or primary pathogens in an acute infection following an injection into the dorsum of the hand, which is more prone to contamination with skin flora.

Question 233: A hospital's antimicrobial stewardship committee notes that 40% of antibiotic prescriptions in the medical assessment unit lack documented indication or review dates. They implement a new intervention requiring a mandatory electronic field for indication and planned review date before prescriptions can be authorized. Three months later, compliance increases to 85%. Which antimicrobial stewardship intervention type best describes this approach?

A. Prospective audit with intervention and feedback
B. Formulary restriction with prior authorization
C. Front-end restriction requiring pre-approval
D. Structural intervention with decision support (Correct Answer)
E. Post-prescription review and feedback

Explanation: ***Structural intervention with decision support*** - A **structural intervention** modifies the **prescribing system** (like adding mandatory electronic fields) to enforce appropriate antimicrobial use. - By incorporating these fields into the **electronic health record (EHR)**, the system provides **decision support** that ensures essential data (indication, review date) is captured at the point of care. *Prospective audit with intervention and feedback* - This approach involves **external experts** (e.g., pharmacists, ID physicians) reviewing active antibiotic orders and providing personalized recommendations to the prescriber. - It is a **post-prescription backend strategy** that occurs after the initial order, unlike the built-in mandatory fields described. *Formulary restriction with prior authorization* - This strategy limits the use of **specific high-cost** or broad-spectrum antibiotics by requiring approval from an infectious disease expert before the drug is dispensed. - It focuses on **drug selection and access** rather than systematically ensuring documentation of indications for all antibiotic prescriptions. *Front-end restriction requiring pre-approval* - This is synonymous with **prior authorization**, where a prescriber must receive **clinical clearance** (often from a specialist) before initiating a specific therapy. - This intervention is typically **drug-specific** and involves a human consultation, rather than an automated, mandatory field within the prescribing software. *Post-prescription review and feedback* - Also known as PPRF, this typically occurs **48-72 hours** after an initial empiric prescription to adjust therapy based on microbiology results and patient response. - It is a **retrospective audit** of an ongoing patient's therapy to improve appropriateness, not a proactive, structural requirement at the moment of initial computer entry.

Question 234: A 61-year-old woman with poorly controlled type 2 diabetes (HbA1c 89 mmol/mol) presents with a 3-day history of pain and swelling around her right eye. On examination, she has periorbital erythema, chemosis, proptosis, and restricted eye movements with diplopia. Her temperature is 38.7°C. CT scan shows preseptal and orbital soft tissue inflammation with evidence of ethmoid sinusitis but no abscess formation. Which antibiotic regimen is most appropriate?

A. Oral co-amoxiclav alone
B. Intravenous ceftriaxone and metronidazole (Correct Answer)
C. Intravenous flucloxacillin and benzylpenicillin
D. Intravenous vancomycin, ceftazidime, and metronidazole
E. Oral doxycycline and metronidazole

Explanation: ***Intravenous ceftriaxone and metronidazole*** - This patient has **orbital cellulitis**, evidenced by **proptosis**, **ophthalmoplegia** (restricted eye movements with diplopia), and **fever**, requiring urgent **intravenous antibiotics** to prevent complications like **vision loss** or **intracranial spread**. - **Ceftriaxone** provides broad-spectrum coverage against common respiratory pathogens (e.g., *Streptococcus pneumoniae*, *Haemophilus influenzae*) and some Gram-negatives, while **metronidazole** effectively targets **anaerobic bacteria**, which are frequently involved in sinusitis-related orbital infections. *Oral co-amoxiclav alone* - **Oral antibiotics** are generally insufficient for treating established **orbital cellulitis** due to the severity of the infection and the potential for rapid progression and **sight-threatening complications**. - While **co-amoxiclav** is a broad-spectrum oral antibiotic, it lacks the necessary **bioavailability** and **tissue penetration** to adequately treat a severe, deep-seated infection like orbital cellulitis, which requires **intravenous therapy**. *Intravenous flucloxacillin and benzylpenicillin* - This regimen primarily targets **Gram-positive cocci** such as *Staphylococcus aureus* (flucloxacillin) and *Streptococcus pyogenes* (benzylpenicillin), and some other streptococci. - However, it provides **inadequate coverage** for crucial pathogens in sinusitis-related orbital cellulitis, specifically **Gram-negative bacteria** (e.g., *Haemophilus influenzae*, *Moraxella catarrhalis*) and **anaerobes**, which are frequently implicated. *Intravenous vancomycin, ceftazidime, and metronidazole* - This is a very broad-spectrum regimen, typically reserved for severe, **healthcare-associated infections**, or when there is a high suspicion of **MRSA**, **Pseudomonas aeruginosa**, or highly resistant organisms. - For community-acquired orbital cellulitis secondary to ethmoid sinusitis, this combination is considered **overkill** and can contribute to **antibiotic resistance** without significant additional benefit over a more targeted, yet broad, regimen. *Oral doxycycline and metronidazole* - Similar to other oral regimens, this combination is **inappropriate** for the management of **orbital cellulitis** given the patient's systemic symptoms, **proptosis**, and risk of **vision loss**. - While **doxycycline** has some activity against atypical pathogens and certain Gram-positives, and metronidazole covers anaerobes, the **oral route** does not provide the rapid, high concentrations needed for this emergent condition.

Question 235: A 44-year-old man is admitted with community-acquired pneumonia and started on intravenous co-amoxiclav. After 48 hours, he is clinically improved with reduced oxygen requirements and is apyrexial. His CRP has fallen from 245 mg/L to 89 mg/L. According to antimicrobial stewardship principles, what is the most appropriate next step in his antibiotic management?

A. Continue intravenous co-amoxiclav for a total of 7 days
B. Switch to oral co-amoxiclav and plan for early discharge (Correct Answer)
C. Change to intravenous piperacillin-tazobactam for broader coverage
D. Stop antibiotics as he is clinically improved and apyrexial
E. Continue intravenous antibiotics until CRP normalizes completely

Explanation: ***Switch to oral co-amoxiclav and plan for early discharge*** - The patient meets criteria for an **IV-to-oral switch (IVOS)**, demonstrating **clinical stability** (apyrexial, reduced oxygen requirements) and **biochemical improvement** (falling CRP). - This approach aligns with **antimicrobial stewardship principles**, reducing risks of **IV line complications**, decreasing healthcare costs, and facilitating **early discharge**. *Continue intravenous co-amoxiclav for a total of 7 days* - Continuing intravenous therapy when a patient is clinically improving violates **antimicrobial stewardship** and unnecessarily prolongs hospital stay and risk of **IV-related complications** like **phlebitis**. - Most patients with improving **community-acquired pneumonia (CAP)** can be safely switched to oral antibiotics within **48-72 hours** of clinical stability. *Change to intravenous piperacillin-tazobactam for broader coverage* - Escalating to a **broader-spectrum antibiotic** is inappropriate as the patient is showing clear clinical and biochemical improvement on the current regimen, indicating its effectiveness. - Unnecessary broadening of antibiotic coverage contributes to **antibiotic resistance** and increases the risk of healthcare-associated infections, including ***Clostridioides difficile***. *Stop antibiotics as he is clinically improved and apyrexial* - While the patient is improving, stopping antibiotics after only 48 hours for **pneumonia** is premature and significantly increases the risk of **clinical relapse** or **treatment failure**. - A full course of antibiotics, typically 5-7 days for **moderate-to-severe CAP**, is required to ensure complete **pathogen eradication**. *Continue intravenous antibiotics until CRP normalizes completely* - **CRP** is a **lagging indicator** of inflammation; clinical stability, rather than complete normalization of CRP, is the primary determinant for an **IV-to-oral switch**. - Waiting for CRP to fully normalize would lead to unnecessarily **prolonged intravenous therapy** and extended hospital stays, contrary to good **antimicrobial stewardship**.

Question 236: A 29-year-old woman presents to A&E with a 24-hour history of rapidly progressive pain, swelling, and discolouration of her right forearm following a minor cut while gardening. On examination, the affected area is dusky purple with bullae formation, and there is crepitus on palpation. She has severe pain disproportionate to the clinical findings. Her temperature is 38.9°C, heart rate 118 bpm, and blood pressure 95/60 mmHg. Blood tests show WCC 18.2 × 10⁹/L, CRP 285 mg/L, creatinine 156 μmol/L, and lactate 4.2 mmol/L. What is the most appropriate immediate management?

A. Start intravenous flucloxacillin and arrange outpatient follow-up in 48 hours
B. Arrange urgent surgical debridement and start broad-spectrum intravenous antibiotics including clindamycin (Correct Answer)
C. Perform incision and drainage under local anaesthetic in A&E
D. Start oral co-amoxiclav and arrange same-day review by the orthopaedic team
E. Obtain blood cultures and await sensitivities before starting antibiotics

Explanation: ***Arrange urgent surgical debridement and start broad-spectrum intravenous antibiotics including clindamycin*** - The patient presents with classic signs of **necrotising fasciitis**, including **pain disproportionate to findings**, **crepitus**, dusky discolouration, and systemic toxicity (sepsis). - Immediate **surgical debridement** is the definitive life-saving intervention, and **clindamycin** is added to suppress bacterial toxin production. *Start intravenous flucloxacillin and arrange outpatient follow-up in 48 hours* - Flucloxacillin alone is inadequate for a polymicrobial or **Group A Strep** necrotising infection and lacks toxin-inhibiting properties. - Outpatient follow-up is dangerously inappropriate for a patient in **septic shock** with a surgical emergency. *Perform incision and drainage under local anaesthetic in A&E* - This procedure is for localized abscesses and is completely insufficient for a **deep-seated fascial infection** that requires wide excision. - **Local anaesthetic** is ineffective in necrotic or infected tissue and would delay the necessary transfer to the **operating theatre**. *Start oral co-amoxiclav and arrange same-day review by the orthopaedic team* - Oral antibiotics have no place in the management of suspected **necrotising fasciitis** or severe sepsis due to poor bioavailability and severity. - While orthopaedic or general surgery review is needed, the management must be **urgent surgical exploration**, not just an elective-style review. *Obtain blood cultures and await sensitivities before starting antibiotics* - While blood cultures should be taken, **antibiotic therapy** and surgery must never be delayed for culture results in life-threatening infections. - The mortality rate for necrotising fasciitis increases significantly with every hour that **surgical intervention** is postponed.

Question 237: A hospital antimicrobial stewardship team is reviewing the prescribing practices on surgical wards. They identify that prophylactic antibiotics for elective colorectal surgery are frequently continued beyond 24 hours postoperatively in patients without complications. Which of the following best describes the primary risk of this practice?

A. Increased risk of surgical site infections due to altered normal flora
B. Development of antimicrobial resistance and increased risk of Clostridioides difficile infection (Correct Answer)
C. Higher incidence of postoperative venous thromboembolism
D. Increased risk of acute kidney injury from nephrotoxic antibiotics
E. Development of antibiotic-associated hepatotoxicity

Explanation: ***Development of antimicrobial resistance and increased risk of Clostridioides difficile infection*** - Prolonged antibiotic exposure creates **selective pressure** on bacterial populations, leading to the emergence and spread of **multidrug-resistant organisms (MDROs)**. - Extended antibiotic prophylaxis significantly disrupts the **normal gastrointestinal flora**, thereby increasing a patient's risk for **Clostridioides difficile infection (CDI)**, without providing additional surgical benefit. *Increased risk of surgical site infections due to altered normal flora* - While antibiotics do alter normal flora, extending prophylaxis beyond the recommended duration has not been shown to increase the rate of **surgical site infections (SSIs)**; instead, it simply fails to offer further protection. - The primary concern of stewardship for prolonged use is not a paradoxical increase in **SSIs**, but the wider ecological impact and secondary complications of **unnecessary drug exposure**. *Higher incidence of postoperative venous thromboembolism* - There is no direct clinical or physiological association between **extended antibiotic prophylaxis** and an increased risk of **venous thromboembolism (VTE)**. - **VTE risk** in surgical patients is primarily related to factors such as **immobility**, type of surgery, and patient-specific coagulation risks, not the duration of antimicrobial administration. *Increased risk of acute kidney injury from nephrotoxic antibiotics* - While some antibiotics (e.g., aminoglycosides, vancomycin) are known to be **nephrotoxic**, this is a risk specific to certain drug classes and individual patient vulnerabilities, not the primary overarching risk of **prolonged prophylaxis** in general. - Many common prophylactic regimens used in colorectal surgery (e.g., cephalosporins) carry a lower inherent risk of **acute kidney injury (AKI)** compared to the broader threat of resistance. *Development of antibiotic-associated hepatotoxicity* - **Hepatotoxicity** is an adverse drug reaction that can occur with various medications, including some antibiotics (e.g., amoxicillin-clavulanate, erythromycin), but it is often idiosyncratic or dose-dependent and not the most prevalent or critical risk of prolonged prophylactic use. - Antimicrobial stewardship prioritizes the population-level threats of **antimicrobial resistance** and **Clostridioides difficile infection** due to their widespread impact and morbidity/mortality implications in hospital settings.

Question 238: A 52-year-old man with type 2 diabetes presents with a carbuncle on the back of his neck. The lesion consists of multiple interconnected furuncles with several draining points. The surrounding area shows erythema extending 3cm beyond the lesion margins. He is apyrexial and haemodynamically stable. What is the most likely causative organism?

A. Streptococcus pyogenes
B. Pseudomonas aeruginosa
C. Staphylococcus aureus (Correct Answer)
D. Escherichia coli
E. Proteus mirabilis

Explanation: ***Staphylococcus aureus*** - A **carbuncle** is a severe skin infection characterized by a cluster of interconnected **furuncles** with multiple draining points, overwhelmingly caused by **Staphylococcus aureus**. - **Type 2 diabetes mellitus** is a significant risk factor, predisposing individuals to *S. aureus* skin infections due to compromised immune responses and increased skin colonization. *Streptococcus pyogenes* - While *S. pyogenes* is a common cause of superficial skin infections, it typically manifests as diffuse infections like **erysipelas** or **cellulitis**, not the deep, purulent, and multi-loculated presentation of a carbuncle. - It is not the primary pathogen associated with **folliculitis** and deep abscess formation originating from hair follicles. *Pseudomonas aeruginosa* - This organism is commonly associated with specific exposures like **hot tub folliculitis**, **burn wound infections**, or infections in severely **immunocompromised** individuals. - It is an uncommon cause of **community-acquired carbuncles** in a patient who is otherwise stable and apyrexial. *Escherichia coli* - **Escherichia coli** is predominantly a cause of **urinary tract infections** and intra-abdominal infections, and rarely causes primary skin and soft tissue infections like carbuncles. - It lacks the typical **virulence factors** to initiate and sustain deep, localized purulent follicular infections on the skin. *Proteus mirabilis* - Like *E. coli*, **Proteus mirabilis** is a gram-negative rod primarily associated with **urinary tract infections** and hospital-acquired wound infections. - It is not a recognized common cause of **furuncles or carbuncles** in the community setting or in diabetic patients without specific predisposing factors like surgical wounds.

Question 239: A 35-year-old woman presents to her GP with a 4-day history of a red, tender area on her right shin following a minor scratch from her cat. The affected area measures 8cm x 6cm, is warm to touch, and there is no evidence of purulence or lymphangitis. She is systemically well with normal observations. She has no known drug allergies. According to current antimicrobial stewardship principles, what is the most appropriate initial management?

A. Prescribe oral flucloxacillin 500mg four times daily for 7 days
B. Mark the area with a pen, provide safety-netting advice, and review if worsening (Correct Answer)
C. Prescribe oral co-amoxiclav 625mg three times daily for 7 days
D. Arrange same-day hospital admission for intravenous antibiotics
E. Prescribe oral clarithromycin 500mg twice daily for 5 days

Explanation: ***Mark the area with a pen, provide safety-netting advice, and review if worsening***- According to **antimicrobial stewardship** principles, mild cases where the patient is **systemically well** with **localized erythema** may be managed by **watchful waiting** or marking the boundary to monitor spread.- This approach avoids **unnecessary antibiotic exposure**, reduces the risk of **antibiotic resistance**, and is appropriate for small, stable areas of inflammation that do not show rapid progression.*Prescribe oral flucloxacillin 500mg four times daily for 7 days*- **Flucloxacillin** is typically the first-line treatment for cellulitis caused by Gram-positive bacteria, but immediate antibiotics may not be necessary for a **very minor, localized scratch**.- Prescribing antibiotics without evidence of **systemic involvement** or significant spreading goes against the principle of minimizing unnecessary antimicrobial use in a localized, mild presentation.*Prescribe oral co-amoxiclav 625mg three times daily for 7 days*- **Co-amoxiclav** is usually reserved for **infected animal bites** where polymicrobial coverage including **Pasteurella multocida** is needed, rather than minor scratches.- Using a **broad-spectrum antibiotic** when there is no clear evidence of significant infection or systemic illness contributes to the development of **antimicrobial resistance**.*Arrange same-day hospital admission for intravenous antibiotics*- Hospital admission for **intravenous antibiotics** is indicated for patients with **systemic sepsis**, facial involvement, or rapidly progressing infection despite oral therapy.- This patient is **systemically well** with **normal observations**, localized symptoms, and no signs of rapid progression, making hospital-based management clinically unnecessary.*Prescribe oral clarithromycin 500mg twice daily for 5 days*- **Clarithromycin** is an alternative for patients with a **penicillin allergy**, which this patient explicitly does not have.- Like flucloxacillin, immediate antibiotic therapy with macrolides is not the most appropriate first step for a **well patient** with a stable, minor localized reaction, adhering to **antimicrobial stewardship**.

Question 240: A 67-year-old man with peripheral vascular disease presents with a diabetic foot ulcer on his right heel with surrounding erythema extending 4cm, purulent discharge, and exposed bone visible in the ulcer base. X-ray shows cortical erosion. Temperature is 37.8°C. Deep tissue cultures are pending. According to current guidelines, which statement about antibiotic therapy is most accurate?

A. Empirical antibiotics should cover Staphylococcus aureus, streptococci, gram-negative organisms, and anaerobes (Correct Answer)
B. Antibiotics are not indicated as surgical debridement provides adequate source control
C. Oral antibiotics are adequate regardless of severity given the chronic nature of diabetic foot infections
D. Empirical therapy should target Pseudomonas aeruginosa as the most likely organism
E. Duration of antibiotic therapy should be 6 weeks minimum due to osteomyelitis

Explanation: ***Empirical antibiotics should cover Staphylococcus aureus, streptococci, gram-negative organisms, and anaerobes***- This patient has a **moderate-to-severe diabetic foot infection** with **osteomyelitis**, indicated by exposed bone, cortical erosion, purulent discharge, and erythema, which typically involves a **polymicrobial** flora.- Initial **empirical therapy** for severe diabetic foot infections must be broad-spectrum to cover the most common pathogens, including **Staphylococcus aureus**, **streptococci**, various **gram-negative bacilli**, and **anaerobes**, especially given the presence of osteomyelitis and pending cultures.*Antibiotics are not indicated as surgical debridement provides adequate source control*- While **surgical debridement** is crucial for source control in infected diabetic foot ulcers, especially with exposed bone, it does not negate the need for **antibiotic therapy**.- The presence of clear signs of infection (erythema, purulent discharge, elevated temperature) and **osteomyelitis** mandates systemic antimicrobial treatment alongside surgical intervention.*Oral antibiotics are adequate regardless of severity given the chronic nature of diabetic foot infections*- This patient's presentation, including **exposed bone**, **cortical erosion**, **purulent discharge**, significant **erythema (4cm)**, and a **low-grade fever**, indicates a severe infection, likely requiring **intravenous (IV) antibiotics** initially.- Oral antibiotics are generally reserved for **mild-to-moderate infections** without signs of systemic involvement or osteomyelitis, or as step-down therapy after initial IV treatment.*Empirical therapy should target Pseudomonas aeruginosa as the most likely organism*- **Staphylococcus aureus** (including MRSA) and **streptococci** are the most common pathogens in diabetic foot infections, with **gram-negative bacteria** and **anaerobes** also being significant, especially in severe cases.- **Pseudomonas aeruginosa** is typically considered if there are specific risk factors, such as prolonged water exposure, previous **Pseudomonas** isolation, or failed prior broad-spectrum antibiotics, none of which are explicitly mentioned here as primary targets for initial empirical therapy.*Duration of antibiotic therapy should be 6 weeks minimum due to osteomyelitis*- The duration of antibiotic therapy for **diabetic foot osteomyelitis** is variable; while 6 weeks is often cited for medically managed cases or those with incomplete debridement, it can be significantly shortened to **2-4 weeks** if infected bone is completely **resected** during surgery.- The optimal duration depends on the extent of surgical debridement, the patient's clinical response, and the specific pathogens identified.

Question 241: A 58-year-old woman with poorly controlled diabetes presents with malignant otitis externa. CT shows skull base osteomyelitis. Tissue cultures grow Pseudomonas aeruginosa with the following sensitivities: ciprofloxacin (sensitive), gentamicin (sensitive), piperacillin-tazobactam (sensitive), meropenem (sensitive). She has normal renal function. Considering both efficacy and antimicrobial stewardship principles, what is the most appropriate long-term oral antibiotic for outpatient therapy?

A. Oral ciprofloxacin (Correct Answer)
B. Oral co-trimoxazole
C. Oral amoxicillin-clavulanate
D. Continued intravenous piperacillin-tazobactam via outpatient parenteral therapy
E. Oral linezolid

Explanation: ***Oral ciprofloxacin*** - **Ciprofloxacin** is a highly effective oral fluoroquinolone with excellent activity against **Pseudomonas aeruginosa**, which is the confirmed pathogen in this case and shown to be sensitive. - It offers superior **oral bioavailability** and **bone penetration**, making it the most appropriate and effective long-term oral treatment for **malignant otitis externa** with **skull base osteomyelitis**, adhering to antimicrobial stewardship principles by avoiding unnecessary IV therapy. *Oral co-trimoxazole* - **Co-trimoxazole** lacks reliable or significant activity against **Pseudomonas aeruginosa**, rendering it ineffective for treating this infection. - It is typically used for pathogens like MRSA, *Pneumocystis jirovecii*, or specific urinary tract infections, which are not the cause here. *Oral amoxicillin-clavulanate* - **Amoxicillin-clavulanate** does not provide coverage for **Pseudomonas aeruginosa** and would be ineffective against this specific pathogen. - Its spectrum primarily covers common community-acquired respiratory and skin pathogens, not serious *Pseudomonas* infections like **skull base osteomyelitis**. *Continued intravenous piperacillin-tazobactam via outpatient parenteral therapy* - Although **piperacillin-tazobactam** is effective, continuing **intravenous therapy** for long-term outpatient management is less desirable due to increased risks of **catheter-related infections**, thrombosis, and higher costs. - **Antimicrobial stewardship** emphasizes transitioning to an effective oral agent when available and appropriate, reducing the burden and risks associated with IV lines. *Oral linezolid* - **Linezolid** is primarily active against **Gram-positive organisms** such as MRSA and VRE; it has no activity against **Gram-negative bacteria**. - Therefore, it would be completely ineffective against **Pseudomonas aeruginosa**, the causative agent of **malignant otitis externa** in this patient.

Question 242: A 25-year-old intravenous drug user presents with fever (39.1°C), rigors, and multiple painful pustular lesions on his hands and feet. Several lesions have necrotic centres. He has a new cardiac murmur. Blood cultures grow Staphylococcus aureus sensitive to flucloxacillin. Echocardiogram confirms tricuspid valve endocarditis. What is the minimum recommended duration of intravenous antibiotic therapy?

A. 2 weeks
B. 4 weeks (Correct Answer)
C. 6 weeks
D. 8 weeks
E. 12 weeks

Explanation: ***4 weeks*** - For **native valve endocarditis** caused by **meticillin-sensitive Staphylococcus aureus (MSSA)**, a minimum of **4 weeks** of intravenous bactericidal therapy (such as flucloxacillin) is the standard recommendation. - Although this is **right-sided (tricuspid) endocarditis**, the presence of **metastatic septic emboli** (painful pustular and necrotic skin lesions) indicates disseminated infection and necessitates a full 4-week course. *2 weeks* - A **2-week** course is only considered in highly selected cases of **uncomplicated right-sided endocarditis** without systemic complications, such as a lack of pulmonary or peripheral septic emboli. - This patient's **pustular and necrotic skin lesions** are clear signs of disseminated infection, making a 2-week course inadequate and potentially dangerous for treatment failure. *6 weeks* - **6 weeks** of therapy is generally reserved for patients with **prosthetic valve endocarditis (PVE)**, infections caused by more resistant organisms (e.g., *Enterococcus*), or native valve endocarditis with **local complications** like an abscess. - While longer courses can be used for complicated cases or poor response, 6 weeks is not the standard minimum for native MSSA endocarditis without these specific indications. *8 weeks* - **8 weeks** is not a standard recommended duration for the primary treatment of **native valve MSSA endocarditis**, even with dissemination. - Such prolonged therapy is typically reserved for very severe, deep-seated **chronic infections** or persistent bacteremia despite initial standard treatment, which is not described here. *12 weeks* - **12 weeks** is an excessively long duration for **acute infective endocarditis** and is not supported by current clinical guidelines for *Staphylococcus aureus* endocarditis. - Overly prolonged antibiotic courses increase the risk of **drug toxicity**, **central line-associated bloodstream infections**, and the development of **antibiotic resistance**.

Question 243: A hospital pharmacy department is implementing an antimicrobial stewardship intervention. Audit data shows that 35% of surgical prophylaxis doses are continued beyond 24 hours post-operatively without documented indication. Which strategy addresses this issue while maintaining patient safety?

A. Automatic stop orders for surgical prophylaxis at 24 hours unless reauthorized (Correct Answer)
B. Pre-printed orders with maximum 24-hour duration for surgical prophylaxis
C. Pharmacist-led ward rounds to review all post-operative patients
D. Mandatory infectious diseases consultation for prophylaxis beyond 24 hours
E. Education sessions for surgeons about appropriate prophylaxis duration

Explanation: ***Automatic stop orders for surgical prophylaxis at 24 hours unless reauthorized*** - **Automatic stop orders** are a highly effective **passive antimicrobial stewardship intervention** that directly prevents the continuation of unnecessary prophylaxis. - This system ensures **patient safety** by requiring a specific **reauthorization** for extended use, preventing prolonged exposure to antibiotics without clinical justification. *Pre-printed orders with maximum 24-hour duration for surgical prophylaxis* - While **pre-printed orders** can promote appropriate initial prescribing, they lack the **enforcement mechanism** to prevent clinicians from extending prophylaxis manually. - This method is more of a **persuasive strategy** and less effective at preventing continuation beyond 24 hours compared to an automatic stop. *Pharmacist-led ward rounds to review all post-operative patients* - This strategy is **resource-intensive** and requires significant **pharmacist time**, making it difficult to implement consistently for all post-operative patients. - It is a **reactive intervention**, identifying issues after they occur, rather than a proactive systemic solution like an automatic stop order. *Mandatory infectious diseases consultation for prophylaxis beyond 24 hours* - Requiring a **mandatory ID consultation** for every extended prophylaxis would place an **unmanageable burden** on infectious disease specialists. - This approach can also introduce **delays in patient care** and is an overly restrictive measure for what should be a straightforward protocol adherence. *Education sessions for surgeons about appropriate prophylaxis duration* - While **education is crucial** for raising awareness, it often has **limited long-term impact** on behavior change when used in isolation. - It relies heavily on individual **memory and compliance**, which may not be sufficient to address a high rate (35%) of non-adherence.

Question 244: A 38-year-old man who recently returned from working on an agricultural farm presents with a rapidly progressive, painful ulcer on his forearm with surrounding purple discoloration and black eschar. He is febrile (38.9°C) and appears unwell. Examination reveals marked oedema extending to the upper arm with regional lymphadenopathy. What is the most likely diagnosis?

A. Cutaneous anthrax (Correct Answer)
B. Necrotising fasciitis
C. Ecthyma gangrenosum
D. Cutaneous leishmaniasis
E. Pyoderma gangrenosum

Explanation: ***Cutaneous anthrax*** - The combination of **agricultural exposure**, a rapidly progressive, painful ulcer with **purple discoloration**, **black eschar**, marked surrounding **oedema**, regional lymphadenopathy, and systemic symptoms like fever points strongly to cutaneous anthrax. - While classic anthrax lesions can be painless, severe forms can be painful and accompanied by significant systemic toxicity and extensive oedema, as described. *Necrotising fasciitis* - Typically characterized by excruciating **pain out of proportion** to the initial skin findings, rapid spread along **fascial planes**, and often features like **crepitus** due to gas production, which are not explicitly mentioned in the context of a central black eschar. - Although it involves rapid progression and systemic illness, the specific dermatological lesion with a **black eschar** and the distinct, non-pitting oedema differentiate it from typical necrotising fasciitis. *Ecthyma gangrenosum* - This condition is almost exclusively seen in **immunocompromised** or **neutropenic** patients, often associated with **Pseudomonas aeruginosa septicaemia**, leading to necrotic lesions via **hematogenous spread**. - The patient's presentation does not suggest immunosuppression, and the lesion's etiology is linked to direct exposure rather than a systemic infection causing cutaneous manifestations. *Cutaneous leishmaniasis* - Presents as a **painless, chronic ulcer** that evolves slowly over weeks to months after a **sandfly bite**, often with a raised, indurated border. - The described presentation is of an acutely painful, rapidly progressive ulcer with extensive oedema and systemic illness, which is inconsistent with the indolent nature of cutaneous leishmaniasis. *Pyoderma gangrenosum* - This is a **sterile neutrophilic dermatosis**, not an infection, typically associated with systemic inflammatory diseases such as **inflammatory bowel disease** or rheumatoid arthritis. - It presents with painful ulcers that have characteristic **undermined, violaceous borders** and often exhibit **pathergy**, features not consistent with a rapidly progressive, farm-exposure-related lesion with a black eschar.

Question 245: Which of the following situations best exemplifies the antimicrobial stewardship principle of 'de-escalation' therapy?

A. Switching from IV to oral antibiotics when a patient can tolerate oral medication
B. Narrowing from piperacillin-tazobactam to amoxicillin after blood cultures grow sensitive Streptococcus pneumoniae (Correct Answer)
C. Reducing antibiotic duration from 14 to 7 days based on clinical improvement
D. Stopping prophylactic antibiotics 24 hours post-operatively
E. Changing from IV flucloxacillin to oral flucloxacillin for cellulitis

Explanation: ***Narrowing from piperacillin-tazobactam to amoxicillin after blood cultures grow sensitive Streptococcus pneumoniae*** - **De-escalation** is defined as narrowing the antimicrobial spectrum from broad empirical coverage to **targeted therapy** once a specific pathogen is identified and its sensitivities are known. - Replacing a broad-spectrum agent like **piperacillin-tazobactam** (effective against many gram-positive, gram-negative, and anaerobic bacteria) with a narrow-spectrum agent like **amoxicillin** (highly effective against susceptible *Streptococcus pneumoniae*) significantly reduces selective pressure and the risk of **antimicrobial resistance**. *Switching from IV to oral antibiotics when a patient can tolerate oral medication* - This process is known as **IV-to-oral switch** or sequential therapy, which focuses on **route optimization** rather than narrowing the spectrum of antimicrobial activity. - It aims to reduce **catheter-related infections** and hospital costs but is distinct from microbiological de-escalation. *Reducing antibiotic duration from 14 to 7 days based on clinical improvement* - This represents **duration optimization**, an important antimicrobial stewardship principle aimed at minimizing cumulative drug exposure and the development of resistance. - It does not involve changing the **antimicrobial spectrum** of the drug being used, only the length of treatment. *Stopping prophylactic antibiotics 24 hours post-operatively* - This is an example of adhering to **appropriate surgical prophylaxis** guidelines, which recommend short-course, usually single-dose, antibiotics to prevent surgical site infections. - It is a matter of **discontinuation** of a prophylactic regimen, not de-escalating a therapeutic regimen based on culture results. *Changing from IV flucloxacillin to oral flucloxacillin for cellulitis* - This is a classic **IV-to-oral conversion** where the spectrum of activity remains identical because the drug itself (flucloxacillin) has not changed. - It primarily improves **patient mobility** and facilitates discharge but does not constitute a narrow-spectrum de-escalation of therapy.

Question 246: A 72-year-old nursing home resident is treated for aspiration pneumonia with co-amoxiclav. After 10 days, he develops profuse watery diarrhoea (8 episodes/day), abdominal cramping, and fever (38.2°C). Stool sample is positive for Clostridioides difficile toxin. His WCC is 18 × 10⁹/L and creatinine 145 μmol/L (baseline 95 μmol/L). What is the most appropriate treatment?

A. Oral vancomycin 125mg four times daily (Correct Answer)
B. Oral metronidazole 400mg three times daily
C. Intravenous metronidazole 500mg three times daily
D. Oral fidaxomicin 200mg twice daily
E. Stop co-amoxiclav and observe

Explanation: ***Oral vancomycin 125mg four times daily***- This patient has **severe Clostridioides difficile infection (CDI)**, defined by a **White Cell Count (WCC) > 15 × 10⁹/L** and an **acute rise in creatinine** (> 50% above baseline).- Current clinical guidelines recommend **oral vancomycin** as the first-line treatment for the first episode of severe CDI due to superior cure rates and high **intraluminal concentrations**.*Oral metronidazole 400mg three times daily*- Historically used for mild disease, it is no longer recommended as a first-line agent because it is **less effective** than vancomycin in achieving clinical cure.- It should only be considered if vancomycin or fidaxomicin are unavailable or contraindicated in **non-severe** cases.*Intravenous metronidazole 500mg three times daily*- This route is reserved for patients with **life-threatening (fulminant) CDI**, such as those with **ileus**, toxic megacolon, or hypotension.- It is typically administered in combination with **high-dose oral/nasogastric vancomycin** to ensure the antibiotic reaches the colon via the bloodstream when oral transit is compromised.*Oral fidaxomicin 200mg twice daily*- While it is as effective as vancomycin and reduces the risk of **recurrence**, it is often reserved for patients at high risk of recurrence or those with a **first relapse**.- In many protocols, it is used as a second-line option for a first episode unless specific local guidelines or patient risk factors prioritize it over vancomycin.*Stop co-amoxiclav and observe*- While **discontinuing the offending antibiotic** (co-amoxiclav) is a necessary step in management, it is insufficient as mono-management for severe CDI.- Severe infection with systemic symptoms like **fever** and **leukocytosis** requires prompt initiation of targeted anti-clostridial pharmacotherapy to prevent complications.

Question 247: A 28-year-old woman presents with a 3-day history of a painful, red lump in her axilla. On examination, there is a 3cm tender, fluctuant, erythematous swelling with a visible central punctum. She is apyrexial with normal observations. What is the most appropriate initial management?

A. Incision and drainage with oral flucloxacillin
B. Oral flucloxacillin without drainage
C. Incision and drainage alone (Correct Answer)
D. Warm compresses and analgesia only
E. Aspiration with a wide-bore needle and oral antibiotics

Explanation: ***Incision and drainage alone*** - The patient has a localized **cutaneous abscess**, characterized by **fluctuance** and erythema; surgical **source control** via incision and drainage is the gold standard for management. - **Antibiotics** are not routinely indicated for simple abscesses in **immunocompetent** patients who are **apyrexial** and lack signs of systemic infection or significant surrounding cellulitis. *Incision and drainage with oral flucloxacillin* - Routine use of **antibiotics** following successful drainage of a simple abscess does not significantly improve cure rates or reduce recurrence in healthy patients. - Adding **flucloxacillin** should be reserved for those with **systemic upset**, extensive spreading cellulitis, or comorbidities like **diabetes**. *Oral flucloxacillin without drainage* - Antibiotics have poor penetration into the necrotic, **avascular center** of an abscess, making drainage necessary for resolution. - Relying solely on medication without addressing the **fluctuant collection** often leads to treatment failure and prolonged pain. *Warm compresses and analgesia only* - While warm compresses can help a very early, small furuncle to **localize** or spontaneously drain, they are insufficient once a 3cm **fluctuant mass** has formed. - Definitive **surgical intervention** is required at this stage to relieve pressure and evacuate the purulent material effectively. *Aspiration with a wide-bore needle and oral antibiotics* - **Needle aspiration** is associated with higher failure and **recurrence rates** compared to a formal incision and drainage for cutaneous abscesses. - Combining sub-optimal drainage with **unnecessary antibiotics** goes against **antimicrobial stewardship** principles when the patient is otherwise well.

Question 248: A hospital's antimicrobial stewardship committee is reviewing prescribing data and notes that carbapenem use has increased by 40% over 6 months without corresponding changes in case mix or severity of illness. Which intervention is most likely to effectively reduce inappropriate carbapenem use?

A. Mandatory infectious diseases consultation for all carbapenem prescriptions
B. Prospective audit with feedback and formulary restriction requiring approval (Correct Answer)
C. Educational lectures for junior doctors about carbapenem resistance
D. Email reminders to all prescribers about antimicrobial stewardship
E. Removal of carbapenems from the hospital formulary

Explanation: ***Prospective audit with feedback and formulary restriction requiring approval***- This approach is considered the **gold standard** for antimicrobial stewardship, involving real-time review of prescriptions by experts followed by direct **communicated recommendations** to the clinician.- **Formulary restriction** provides immediate control over high-priority drugs like carbapenems, while the **audit and feedback** component ensures long-term behavioral change through clinical education.*Mandatory infectious diseases consultation for all carbapenem prescriptions*- While effective, this strategy is highly **resource-intensive** and can lead to significant delays in initiating treatment for critically ill patients.- It may create friction between departments and is often less scalable compared to a **system-wide stewardship** audit process.*Educational lectures for junior doctors about carbapenem resistance*- Passive education alone has a **minimal and unsustainable** impact on prescribing patterns when used as a standalone intervention.- While important for knowledge, it lacks the **real-time clinical decision support** required to alter prescribing behaviors in a high-pressure hospital environment.*Email reminders to all prescribers about antimicrobial stewardship*- This is a low-intensity intervention that often suffers from **alert fatigue**, leading clinicians to ignore the messaging.- It lacks the **active oversight** and clinical nuance required to handle specific cases involving potential multidrug-resistant organisms.*Removal of carbapenems from the hospital formulary*- This is clinically impractical and dangerous, as carbapenems are essential for managing **ESBL-producing organisms** and severe sepsis.- Total removal would force clinicians to use other broad-spectrum agents, potentially causing **collateral damage** and shifting resistance patterns to other antibiotic classes.

Question 249: A 42-year-old homeless man presents with extensive cellulitis of the left leg with multiple areas of skin breakdown and purulent discharge. Swabs grow meticillin-resistant Staphylococcus aureus (MRSA). He has a documented severe penicillin allergy (anaphylaxis). Which antibiotic is most appropriate for treating his infection?

A. Intravenous vancomycin (Correct Answer)
B. Intravenous teicoplanin
C. Oral linezolid
D. Intravenous daptomycin
E. Oral doxycycline

Explanation: ***Intravenous vancomycin***- **Intravenous vancomycin** is the gold-standard, first-line treatment for severe **MRSA** skin and soft tissue infections requiring hospitalization and provides reliable bactericidal activity.- As a **glycopeptide**, it does not exhibit cross-reactivity with **beta-lactams**, making it the safest and most appropriate choice for a patient with a history of **penicillin-induced anaphylaxis**.*Intravenous teicoplanin*- While also a **glycopeptide**, it is generally considered an alternative to vancomycin and often requires complex **loading doses** to reach therapeutic levels rapidly.- In clinical practice, vancomycin is preferred for initial stabilization of serious **MRSA infections** due to a more robust evidence base in acute settings.*Oral linezolid*- **Linezolid** is typically reserved for cases where **glycopeptides** are contraindicated, such as significant **renal impairment** or documented resistance.- It carries a higher risk of adverse effects like **bone marrow suppression** and **serotonin syndrome** and is significantly more expensive than vancomycin.*Intravenous daptomycin*- Although effective against Gram-positive bacteria, **daptomycin** is usually reserved for **MRSA bacteraemia** or right-sided endocarditis rather than primary cellulitis.- It is not the standard first-line agent for skin infections in the UK unless other options have failed or are unsuitable.*Oral doxycycline*- **Oral doxycycline** is insufficient for severe, extensive cellulitis with skin breakdown, which requires the rapid bioavailability and potency of **intravenous therapy**.- While it can be used for minor **community-acquired MRSA**, it lacks the systemic efficacy needed for a patient with purulent discharge and potential systemic involvement.

Question 250: A 55-year-old woman with type 2 diabetes presents with necrotising fasciitis of the right thigh following minor trauma. She is hypotensive (BP 85/50 mmHg), tachycardic (HR 125/min), and has crepitus extending proximally. Blood results show lactate 4.2 mmol/L, creatinine 185 μmol/L, and WCC 22 × 10⁹/L with left shift. What is the most appropriate immediate antimicrobial regimen?

A. Intravenous flucloxacillin and clindamycin
B. Intravenous benzylpenicillin and clindamycin
C. Intravenous piperacillin-tazobactam, clindamycin, and vancomycin (Correct Answer)
D. Intravenous meropenem alone
E. Intravenous co-amoxiclav and metronidazole

Explanation: ***Intravenous piperacillin-tazobactam, clindamycin, and vancomycin*** - In a diabetic patient with **Type 1 (polymicrobial)** necrotising fasciitis, broad-spectrum coverage including **MRSA**, **Gram-negatives**, and **anaerobes** is essential for survival. - **Clindamycin** is added specifically for its **antitoxin effect** by inhibiting bacterial protein synthesis and suppressed toxin production from Group A Streptococcus. *Intravenous flucloxacillin and clindamycin* - This regimen provides good coverage for **Group A Streptococcus** and **Staphylococcus aureus**, but lacks essential **Gram-negative** and **anaerobic** coverage. - In a patient with **diabetes** and sepsis, the risk of polymicrobial infection is high, making this spectrum too narrow. *Intravenous benzylpenicillin and clindamycin* - This is the standard treatment for **Type 2 (monomicrobial)** necrotising fasciitis caused by Group A Streptococcus. - It fails to cover **Gram-negative bacilli** and **Staphylococcus aureus**, which are common in necrotising fasciitis following minor trauma in diabetics. *Intravenous meropenem alone* - While **meropenem** provides excellent broad-spectrum coverage, it does not possess the **antitoxin properties** that clindamycin offers. - Monotherapy lacks specific **MRSA coverage**, which is a significant concern in patients with co-morbidities like **diabetes mellitus**. *Intravenous co-amoxiclav and metronidazole* - This combination provides some Gram-negative and anaerobic coverage but is insufficient for the **high bacterial load** and severity of this surgical emergency. - It lacks the **anti-toxin effect** of clindamycin and does not provide adequate protection against resistant organisms like **MRSA**.

Question 251: According to the UK Department of Health's 'Start Smart - Then Focus' antimicrobial stewardship toolkit, what is the recommended timeframe for reviewing and documenting antimicrobial prescriptions after initiation?

A. Within 24 hours
B. Within 48-72 hours (Correct Answer)
C. Within 5 days
D. Within 7 days
E. At completion of therapy

Explanation: ***Within 48-72 hours*** - The **'Start Smart - Then Focus'** toolkit mandates a clinical review at the **48-72 hour** mark to determine one of five outcomes: stop, switch to oral, change, continue, or OPAT. - This specific timeframe is chosen because it allows **microbiological culture results** and initial clinical response to inform definitive therapy decisions. *Within 24 hours* - Reviewing at **24 hours** is often too early because most **culture and sensitivity** results are not yet available for a targeted therapy switch. - While clinical monitoring is ongoing, the formal **stewardship documentation** requirement specifically targets the 48-72 hour window for the 'Focus' phase. *Within 5 days* - Waiting until **5 days** increases the risk of **antimicrobial toxicity** and delayed de-escalation from broad-spectrum to narrow-spectrum agents. - This delay exceeds the UK Department of Health's evidence-based guidelines for preventing **unnecessary exposure** to parenteral or broad-spectrum antibiotics. *Within 7 days* - A **7-day** timeframe is far too late for a primary stewardship review and may lead to prolonged hospital stays and increased risk of **C. difficile** infections. - Most empirical courses for simple infections would have concluded by this time, missing the opportunity for **early optimization**. *At completion of therapy* - Reviewing only at **completion** defeats the purpose of stewardship, which aims to optimize the **dose, route, and duration** during the treatment course. - It fails to provide the mandatory intervention needed to stop **inappropriate prescriptions** before the full course is finished.

Question 252: A 32-year-old injection drug user presents with a painful, fluctuant swelling on his left forearm. Incision and drainage is performed, yielding 15mL of purulent material. Gram stain shows gram-positive cocci in clusters. The patient is otherwise well with normal observations. Which empirical antibiotic regimen is most appropriate pending culture results?

A. Oral flucloxacillin alone
B. Oral co-amoxiclav and doxycycline
C. Intravenous vancomycin
D. Oral flucloxacillin and rifampicin
E. No antibiotics required following adequate drainage (Correct Answer)

Explanation: ***No antibiotics required following adequate drainage***- For a **simple cutaneous abscess** in an immunocompetent patient with normal observations, **incision and drainage** is considered definitive treatment without the need for antibiotics.- Clinical guidelines suggest that once **source control** is achieved, antibiotics offer minimal benefit unless there is evidence of **systemic inflammatory response** or extensive surrounding **cellulitis**.*Oral flucloxacillin alone*- While **flucloxacillin** is excellent for **Gram-positive cocci** like MSSA, it is unnecessary for a localized, drained abscess in a stable patient.- Overuse of antibiotics in cases where **surgical drainage** is sufficient contributes to the development of **antimicrobial resistance**.*Oral co-amoxiclav and doxycycline*- This combination provides broad coverage, including against **MRSA** (via doxycycline), but is not indicated for a simple, well-drained **skin and soft tissue infection**.- Broad-spectrum agents like **co-amoxiclav** increase the risk of side effects and **Clostridioides difficile** infection without providing clinical benefit in this scenario.*Intravenous vancomycin*- **Intravenous vancomycin** is reserved for severe, life-threatening infections or cases where **MRSA** is suspected and the patient is **haemodynamically unstable**.- This patient has **normal observations** and is "otherwise well," making inpatient parenteral therapy inappropriate and unnecessary.*Oral flucloxacillin and rifampicin*- **Rifampicin** is rarely used as a primary agent for skin infections and is typically reserved for **prosthetic joint infections** or adjunctive treatment in specialized cases.- Adding a second agent increases the risk of **drug-drug interactions** and hepatotoxicity without improving outcomes for a **drained abscess**.

Question 253: A 68-year-old diabetic patient with hospital-acquired pneumonia has been receiving intravenous piperacillin-tazobactam for 5 days. Blood cultures grow Pseudomonas aeruginosa sensitive to all tested antibiotics. The patient has clinically improved, is apyrexial for 48 hours, and inflammatory markers are trending downward (CRP decreased from 185 to 65 mg/L). Which action best demonstrates appropriate antimicrobial stewardship?

A. Continue IV piperacillin-tazobactam for a total of 14 days
B. Switch to IV meropenem for broader coverage
C. Switch to oral ciprofloxacin to complete the course (Correct Answer)
D. Stop all antibiotics as the patient has improved
E. Add IV gentamicin for synergistic effect

Explanation: ***Switch to oral ciprofloxacin to complete the course*** - Antimicrobial stewardship emphasizes an **IV-to-oral switch** when a patient is clinically stable, afebrile, and can tolerate oral medications. - **Oral ciprofloxacin** has excellent bioavailability and is a highly effective agent against **Pseudomonas aeruginosa**, allowing for safe and efficient completion of treatment while reducing risks associated with prolonged IV access. *Continue IV piperacillin-tazobactam for a total of 14 days* - Continuing IV therapy beyond clinical stability increases the risk of **catheter-related bloodstream infections** and prolongs hospital stay/costs. - For most hospital-acquired pneumonias, a **7-day course** of antibiotics is typically sufficient, especially for gram-negative organisms like Pseudomonas, unless complicated by abscess or empyema. *Switch to IV meropenem for broader coverage* - Escalating to a **carbapenem** when the organism is known and sensitive to a narrower-spectrum agent like piperacillin-tazobactam promotes **antibiotic resistance**. - Broadening coverage is unnecessary as the patient is **clinically improving**, and the specific pathogen and its sensitivities are already known. *Stop all antibiotics as the patient has improved* - Stopping therapy after only 5 days for a **Pseudomonas aeruginosa** infection, even with improvement, carries a high risk of **treatment failure** and clinical relapse. - Standard guidelines recommend completing a defined course of treatment (typically **7 days**) to ensure pathogen eradication and prevent resistance development. *Add IV gentamicin for synergistic effect* - **Double coverage** or synergistic therapy is generally not necessary for a stable patient with known sensitivities, especially after clinical improvement. - Adding **gentamicin** significantly increases the risk of serious adverse effects such as **nephrotoxicity** and ototoxicity without providing additional clinical benefit in this context.

Question 254: A 45-year-old man presents to the Emergency Department with a 2-day history of increasing pain, swelling, and redness of his right lower leg. He has a temperature of 38.5°C. Examination reveals a well-demarcated area of erythema extending from the ankle to mid-calf with associated warmth and tenderness. There is no crepitus or bullae. His inflammatory markers show CRP 145 mg/L and WCC 14.2 × 10⁹/L. What is the most appropriate initial antibiotic choice?

A. Intravenous flucloxacillin (Correct Answer)
B. Oral amoxicillin
C. Intravenous co-amoxiclav
D. Oral doxycycline
E. Intravenous meropenem

Explanation: ***Intravenous flucloxacillin*** - The patient presents with systemic features of infection (**fever**, **high CRP**, and **leukocytosis**), necessitating **intravenous therapy** for moderate-to-severe cellulitis. - **Flucloxacillin** is the first-line choice as it provides targeted coverage against the most common causative organisms: **Staphylococcus aureus** and **Streptococcus pyogenes**. *Oral amoxicillin* - Amoxicillin is ineffective against **Staphylococcus aureus** because the bacterium produces **beta-lactamases** that destroy the antibiotic. - Oral administration is inappropriate here due to the patient's **systemic toxicity** and the severity of clinical markers. *Intravenous co-amoxiclav* - While effective, **co-amoxiclav** provides unnecessarily broad-spectrum coverage, including against **anaerobes**, which are not typically involved in uncomplicated cellulitis. - It is usually reserved for **facial cellulitis**, animal bites, or cases where **Gram-negative** organisms are suspected. *Oral doxycycline* - **Doxycycline** is generally used as a second-line oral therapy for patients with a **penicillin allergy** but is not the primary choice for acute systemic infection. - The clinical severity (CRP 145) requires the rapid onset and bio-availability of **injectable antibiotics** rather than oral agents. *Intravenous meropenem* - **Meropenem** is a broad-spectrum **carbapenem** reserved for life-threatening infections or multi-drug resistant organisms. - Using it for standard cellulitis violates **antimicrobial stewardship** principles and risks increasing bacterial resistance.

Practice by Chapter

Antimicrobial stewardship

Practice Questions

Skin and soft tissue infections

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free

Common Infections — MCQs

Common Infections — MCQs

On this page